---
{"dg-publish":true,"permalink":"//2-2////14-p/"}
---

<script>
MathJax = {
  tex: {
    inlineMath: [[',
    displayMath: [['$', '$'], ['\\[', '\\]'\|'$', '$'], ['\\[', '\\]']],
    processEscapes: true,
  },
  svg: {
    fontCache: 'global'
  }
};
</script>
<script type="text/javascript" id="MathJax-script" async
  src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-svg.js">
</script>

---

>[!quote] Í≥µÏßÄ
>Î≥∏ ÏûêÎ£åÏùò Ï†ÄÏûëÍ∂åÏùÄ **KAISTUDY**Ïóê ÏûàÏäµÎãàÎã§.

---

> [!abstract]- üìñ Í∞ïÏùò ÌïúÎààÏóê Î≥¥Í∏∞: Precision Medicine & Systems Biology
> **"One Treatment Fits All(Í≥ºÍ±∞)ÏóêÏÑú Data-Driven Algorithm(ÎØ∏Îûò)ÏúºÎ°úÏùò ÏßÑÌôî"**
>
> 1.  **Introduction (Ìå®Îü¨Îã§ÏûÑÏùò Ï†ÑÌôò)**
>     * ÏùòÌïôÏùÄ ÏßÅÍ¥Ä(Intuition)Í≥º Ï¶ùÍ±∞(EBM)Î•º ÎÑòÏñ¥, **ÎπÖÎç∞Ïù¥ÌÑ∞ÏôÄ ÏïåÍ≥†Î¶¨Ï¶ò Í∏∞Î∞òÏùò Ï†ïÎ∞ÄÏùòÌïô(Precision Medicine)**ÏúºÎ°ú Ïù¥Îèô Ï§ëÏûÖÎãàÎã§.
>     * ÌïµÏã¨ÏùÄ ÌôòÏûêÎ•º ÌèâÍ∑†(Average)Ïù¥ ÏïÑÎãå **Ïú†Ï†ÑÏ≤¥(Genes), ÌôòÍ≤Ω(Environment), ÏÉùÌôúÏäµÍ¥Ä(Lifestyle)**Ïù¥ Í≤∞Ìï©Îêú Í≥†Ïú†Ìïú Í∞úÏ≤¥Î°ú Î≥¥Îäî Í≤ÉÏûÖÎãàÎã§.
> 2.  **Omics & Regulation (ÏÉùÎ™ÖÏùò Ïñ∏Ïñ¥ÏôÄ Ï°∞Ï†à)**
>     * Îã®Ïàú DNA ÏÑúÏó¥(Genome)ÎøêÎßå ÏïÑÎãàÎùº, Ïù¥Î•º Ï°∞Ï†àÌïòÎäî **Epigenome(ÌõÑÏÑ±Ïú†Ï†ÑÏ≤¥)**Í≥º Ïã§Ï†ú Í∏∞Îä•ÏùÑ ÏàòÌñâÌïòÎäî Proteome/MetabolomeÏùÑ ÌÜµÌï©Ìï¥Ïïº Ìï©ÎãàÎã§.
>     * ÌäπÌûà **Histone Modification**Í≥º **DNA Methylation**Ïù¥ Ïú†Ï†ÑÏûê Ïä§ÏúÑÏπò(On/Off)Î•º Í≤∞Ï†ïÌïòÎäî ÌïµÏã¨ Í∏∞Ï†ÑÏûÖÎãàÎã§.
> 3.  **Systems & Network (ÌÜµÌï©Ï†Å Î∂ÑÏÑù)**
>     * ÏßàÎ≥ëÏùÄ Îã®Ïùº Ïú†Ï†ÑÏûêÏùò Í≥†Ïû•Ïù¥ ÏïÑÎãàÎùº, **ÎÑ§Ìä∏ÏõåÌÅ¨(Network)Ïùò ÏÑ≠Îèô**ÏûÖÎãàÎã§.
>     * ÏÑ∏Ìè¨Ïùò Ïö¥Î™ÖÏùÄ **ÏÉÅÌÉú Í≥µÍ∞Ñ(State Space)** ÎÇ¥ÏóêÏÑú **ÎÅåÍ∞ú(Attractor)**Î°ú Ïù¥ÎèôÌïòÎäî Í∂§Ï†Å(Trajectory)ÏúºÎ°ú ÏàòÌïôÏ†Å Ï†ïÏùòÍ∞Ä Í∞ÄÎä•Ìï©ÎãàÎã§.
> 4.  **Clinical Application (ÏûÑÏÉÅ Ï†ÅÏö©)**
>     * Í≤∞Íµ≠ Ïù¥ Î™®Îì† Îç∞Ïù¥ÌÑ∞Î•º Ìï©Ï≥ê(Multi-omics Integration), ÌôòÏûêÎ•º Î∂ÑÏûê ÏàòÏ§ÄÏóêÏÑú Ï∏µÌôî(Stratification)ÌïòÍ≥†, **ÎÑ§Ìä∏ÏõåÌÅ¨ Í∏∞Î∞ò Ïã†ÏïΩ(Network Medicine)**ÏùÑ Ï†ÅÏö©ÌïòÏó¨ ÏÉùÏ°¥Ïú®ÏùÑ ÎÜíÏù¥Îäî Í≤ÉÏù¥ Î™©ÌëúÏûÖÎãàÎã§.

> [!example]- üíä ÌïµÏã¨ ÌÇ§ÏõåÎìú & ÏïºÎßà Ï†ïÎ¶¨
>
> ### 1. Precision MedicineÏùò Í∏∞Ï¥à (Data & P4)
> * **Ïò§Î∞îÎßàÏùò 3ÎåÄ Î≥ÄÏàò (2015):** ‚ë† Genes(Ïú†Ï†ÑÏûê) + ‚ë° Environment(ÌôòÍ≤Ω) + ‚ë¢ Lifestyle(ÏÉùÌôúÏäµÍ¥Ä) **(üî•Í∏∞Ï∂ú)**
> * **Îç∞Ïù¥ÌÑ∞ Íµ¨ÏÑ± ÎπÑÏú®:** **Exogenous(ÌôòÍ≤Ω/ÌñâÎèô) 60%** > Genomics 30% > Clinical 10%. (Î≥ëÏõê Îç∞Ïù¥ÌÑ∞Îäî ÎπôÏÇ∞Ïùò ÏùºÍ∞ÅÏûÑ **üî•ÏïºÎßà**)
> * **P4 Medicine:** **P**redictive(ÏòàÏ∏°), **P**reventive(ÏòàÎ∞©), **P**ersonalized(ÎßûÏ∂§), **P**articipatory(Ï∞∏Ïó¨).
>
> ### 2. Clinical Sequencing Í∏∞Ïà† ÎπÑÍµê (vs) **(üî•Ï°±Î≥¥: Ï†ÅÏùëÏ¶ù Íµ¨Î≥Ñ)**
> * **WGS (Whole Genome):** DNA Ï†ÑÏ≤¥(30Ïñµ Ïåç) Î∂ÑÏÑù. Point mutation, Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥(SV), CNV **Î™®Îëê Í≤ÄÏ∂ú Í∞ÄÎä•**.
> * **WES (Whole Exome):** Îã®Î∞±Ïßà ÏΩîÎî© Î∂ÄÏúÑ(**Exon, Ï†ÑÏ≤¥Ïùò 1%**)Îßå ÎÜçÏ∂ï(Baits)ÌïòÏó¨ Î∂ÑÏÑù. Í∞ÄÏÑ±ÎπÑ Ï¢ãÏùå. Point mutation, CNV Í≤ÄÏ∂ú.
> * **Targeted Panel (PCR Amplicon):** ÌäπÏ†ï ÏßàÎ≥ë Í¥ÄÎ†® Ïú†Ï†ÑÏûêÎßå Ï¶ùÌè≠. ÍπäÏùÄ Ìï¥ÏÉÅÎèÑ(Depth) Í∞ÄÎä•.
> * **RNA-seq (Transcriptome):** **Î∞úÌòÑÎüâ(Expression)**, ÏúµÌï© Ïú†Ï†ÑÏûê(Fusion), Splicing variant Í≤ÄÏ∂ú.
>
> ### 3. DNA Íµ¨Ï°∞ & p53 (Concrete Details)
> * **DNA ÏàòÏπò:** ÏßÄÎ¶Ñ **2nm**, Ìïú Î∞îÌÄ¥ **3.4nm**, ÏóºÍ∏∞ ÏÇ¨Ïù¥ **0.34nm**. **(üî•Í∏∞Ï∂ú: Ïà´Ïûê ÏïîÍ∏∞)**
> * **p53 Íµ¨Ï°∞:** **Tetramer(4ÎüâÏ≤¥)**Î°ú ÏûëÎèô. DNA Í≤∞Ìï© Î∂ÄÏúÑÏóê **Zinc atom(ÏïÑÏó∞)**Ïù¥ ÏïàÏ†ïÌôîÏ†úÎ°ú Î∞ïÌòÄ ÏûàÏùå. ÏïîÌôòÏûêÎäî Ï£ºÎ°ú Ïù¥ Í≤∞Ìï© Î∂ÄÏúÑÍ∞Ä ÎßùÍ∞ÄÏßê.
>
> ### 4. Epigenetics: Histone Code & Methylation
> * **Histone Tail:** Ï°∞Ï†àÏùò ÌïµÏã¨. (H3, H4 TailÏù¥ Ï§ëÏöî)
> * **Acetylation (Ac):** Lysine(K)Ïóê Î∂ôÏùå. Ï£ºÎ°ú **Activation (Ï†ÑÏÇ¨ Ï¥âÏßÑ)**. **(üî•ÏïºÎßà)**
> * **Methylation (Me):** Lysine(K)Ïóê Î∂ôÏùå. ÏúÑÏπòÏóê Îî∞Îùº Îã§Î¶Ñ (Ïòà: H3K4=Active, H3K9/27=Repression).
> * **DNA Methylation:** CytosineÏùò 5Î≤à ÌÉÑÏÜåÏóê $CH_3$ Î∂ÄÏ∞© ($5$-mC). Ï£ºÎ°ú **Silencing (Ï†ÑÏÇ¨ ÏñµÏ†ú)**.
>
> ### 5. Systems Biology: State Space & Attractor
> * **ÏÉÅÌÉú Î≤°ÌÑ∞ (State Vector):** $S = [x_1, x_2, ... x_N]$ (Ïú†Ï†ÑÏûê Î∞úÌòÑÎüâÏùò ÏßëÌï©).
> * **ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space):** Ïú†Ï†ÑÏûêÎì§ÏùÑ Ï∂ïÏúºÎ°ú ÌïòÎäî Îã§Ï∞®Ïõê Í≥µÍ∞Ñ. ÏÑ∏Ìè¨ ÏÉÅÌÉúÎäî Ïù¥ Í≥µÍ∞ÑÏùò **'Ï†ê'**ÏúºÎ°ú ÌëúÌòÑÎê®.
> * **Attractor (ÎÅåÍ∞ú):** ÎèôÏ†Å ÏãúÏä§ÌÖúÏù¥ ÏãúÍ∞ÑÏù¥ ÏßÄÎÇò ÏàòÎ†¥ÌïòÎäî ÏïàÏ†ïÎêú ÏÉÅÌÉú. ÏÉùÎ¨ºÌïôÏ†ÅÏúºÎ°ú **"Cell Type(Î∂ÑÌôîÎêú ÏÑ∏Ìè¨)"**ÏùÑ ÏùòÎØ∏Ìï®. **(üî•Í∞úÎÖê ÌïÑÏäπ)**
> * **Landscape Model:** Í≥µ(ÏÑ∏Ìè¨)Ïù¥ Í≥®ÏßúÍ∏∞(Attractor)Î°ú Íµ¥Îü¨Îñ®Ïñ¥ÏßÄÎäî Í≥ºÏ†ï = Î∂ÑÌôî(Differentiation). Ïú†Ï†ÑÏûê Î≥ÄÏù¥Îäî ÏßÄÌòï ÏûêÏ≤¥Î•º Î∞îÍøà.
>
> ### 6. Network Medicine & Survival Analysis
> * **Kaplan-Meier Curve:** XÏ∂ï(ÏãúÍ∞Ñ) vs YÏ∂ï(ÏÉùÏ°¥Ïú®). Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥(Signature)Ïóê Îî∞Îùº **Good vs Poor ÏòàÌõÑ Í∑∏Î£π**ÏùÑ ÎÇòÎàå Ïàò ÏûàÏùå. **(üî•ÏûÑÏÉÅ Ìï¥ÏÑù)**
> * **Drug Discovery:** ÏßàÎ≥ë ÎÑ§Ìä∏ÏõåÌÅ¨(Disease module)Î•º ÌÉÄÍ≤©ÌïòÎêò, ÌïÑÏàò ÏÉùÏ°¥ Ïú†Ï†ÑÏûê(Toxicity)Îäî Í±¥ÎìúÎ¶¨ÏßÄ ÏïäÎäî ÏïΩÎ¨ºÏùÑ Ï∞æÎäî Í≥ºÏ†ï.

---

> [!NOTE] Pages 1-7: Precision MedicineÏùò ÌÉúÎèôÍ≥º Big Data
> Ïûê, Ïù¥ Í∞ïÏùòÏùò ÏÑúÎßâÏûÖÎãàÎã§. Ïôú ÏßÄÍ∏à Ïù¥ ÏãúÏ†êÏóê 'Ï†ïÎ∞ÄÏùòÌïô(Precision Medicine)'Ïù¥ ÌôîÎëêÍ∞Ä ÎêòÎäîÏßÄ, Í∑∏Î¶¨Í≥† Í∑∏ Í∏∞Î∞òÏù¥ ÎêòÎäî **Big Data**Í∞Ä ÎèÑÎåÄÏ≤¥ Ïñ¥Îäê Ï†ïÎèÑ Í∑úÎ™®Ïù∏ÏßÄ Ïà´ÏûêÎ°ú ÌôïÏã§ÌïòÍ≤å Í∞êÏùÑ Ïû°Í≥† Í∞ÄÏïº Ìï©ÎãàÎã§. Ïò§Î∞îÎßà ÎåÄÌÜµÎ†πÏù¥ Ïñ∏Í∏âÌïú Ï†ïÏùòÎ∂ÄÌÑ∞ Îç∞Ïù¥ÌÑ∞Ïùò Íµ¨Ï≤¥Ï†ÅÏù∏ ÎπÑÏú®(%)ÍπåÏßÄ ÍººÍººÌûà Î¥ÖÏãúÎã§.
>
> > [!INFO] PAGE 1-2: Í∞úÎÖêÏùò ÏãúÏûë (Gianrico Farrugia)
> > 1ÌéòÏù¥ÏßÄ ÌëúÏßÄÎ•º ÎÑòÍ≤® 2ÌéòÏù¥ÏßÄÎ•º Î¥ÖÏãúÎã§. **Gianrico Farrugia**Ïùò ÏΩîÎ©òÌä∏Í∞Ä ÎÇòÏòµÎãàÎã§.
> > * ÌïµÏã¨ÏùÄ **"Treat the person as an individual"**ÏûÖÎãàÎã§. ÌôòÏûêÎ•º 'Í∑∏Î£π'Ïùò ÏùºÎ∂ÄÎ°ú Î≥¥Îäî Í≤å ÏïÑÎãàÎùº, Í∑∏ ÏÇ¨Îûå Í≥†Ïú†Ïùò **Genetic material(Ïú†Ï†Ñ Î¨ºÏßà)**Ïóê Í∏∞Î∞òÌï¥ ÏπòÎ£åÌïòÍ≤†Îã§Îäî Í±∞Ï£†. 
> > * Ïù¥Í≤å Î∞îÎ°ú **Individualized, Personalized, Precise**Ìïú ÏùòÎ£åÏùò Ï†ïÏùòÏûÖÎãàÎã§. Í∑∏ÎÉ• Ï¢ãÏùÄ Îßê Í∞ôÏßÄÎßå, 'Ïú†Ï†Ñ Î¨ºÏßà Í∏∞Î∞ò'Ïù¥ÎùºÎäî Ï†ÑÏ†ú Ï°∞Í±¥ÏùÑ Íº≠ Í∏∞ÏñµÌïòÏÑ∏Ïöî. 
>
> > [!IMPORTANT] PAGE 3-5: Precision Medicine Initiative (Ïò§Î∞îÎßà, 2015)
> > 3ÌéòÏù¥ÏßÄ ÏßÄÎèÑ Í∑∏Î¶ºÍ≥º 4ÌéòÏù¥ÏßÄ Ïò§Î∞îÎßà ÏÇ¨ÏßÑ Î≥¥Ïù¥Ï£†? **2015ÎÖÑ Ïó∞ÎëêÍµêÏÑú(State of the Union Address)**ÏóêÏÑú Î∞úÌëúÌïú ÎÇ¥Ïö©ÏûÖÎãàÎã§. 
> >
> > **1. Ï†ïÏùò (3p):** 
> > * ÏßàÎ≥ë ÏòàÎ∞©Í≥º ÏπòÎ£åÏóê ÏûàÏñ¥ÏÑú **ÏÑ∏ Í∞ÄÏßÄ Î≥ÄÏàò**Î•º Í≥†Î†§Ìï©ÎãàÎã§. Ïù¥Í±∞ ÏãúÌóòÏóê ÎÇòÏò§Î©¥ Î¨¥Ï°∞Í±¥ Ïç®Ïïº Ìï©ÎãàÎã§.
> >     1.  **Genes (Ïú†Ï†ÑÏûê)**
> >     2.  **Environment (ÌôòÍ≤Ω)**
> >     3.  **Lifestyle (ÏÉùÌôúÏäµÍ¥Ä)**
> >
> > **2. Íµ¨Ï≤¥Ï†Å Î™©Ìëú (5p):** 
> > * Îã®ÏàúÌûà ÏïΩÎßå Í∞úÎ∞úÌïòÎäî Í≤å ÏïÑÎãôÎãàÎã§.
> > * **100Îßå Î™Ö(1 million)** Ïù¥ÏÉÅÏùò ÎØ∏Íµ≠Ïù∏ ÏûêÏõêÎ¥âÏÇ¨ÏûêÎ°ú Íµ¨ÏÑ±Îêú Ïó∞Íµ¨ ÎÑ§Ìä∏ÏõåÌÅ¨ Íµ¨Ï∂ï. (Ïä§ÏºÄÏùºÏù¥ Îã§Î¶ÖÎãàÎã§, Ïà´Ïûê Ï≤¥ÌÅ¨!)
> > * ÌôòÏûêÍ∞Ä ÏûêÏã†Ïùò Í±¥Í∞ï Ï†ïÎ≥¥Ïóê Ï†ëÍ∑ºÌïòÏó¨ ÏπòÎ£åÏóê **ÌòëÎ†•(Collaborate)**ÌïòÍ≤å Ìï®.
> > * ÏÉàÎ°úÏö¥ ÏùòÎ£å Í∏∞Ïà†ÏùÑ ÏãúÏû•Ïóê Îçî **Îπ†Î•¥Í≤å(Faster)** ÎèÑÏûÖ.
>
> > [!INFO] PAGE 6: Ïôú ÏßÄÍ∏àÏù∏Í∞Ä? (Why Now?)
> > 6ÌéòÏù¥ÏßÄ ÌÖçÏä§Ìä∏Î•º Î≥¥ÏÑ∏Ïöî. Ïôú ÌïòÌïÑ ÏßÄÍ∏à Ï†ïÎ∞ÄÏùòÌïôÏùºÍπåÏöî? ÏÑ∏ Í∞ÄÏßÄ Í∏∞Ïà†Ï†Å Î∞∞Í≤ΩÏù¥ ÏûàÏäµÎãàÎã§. 
> > 1.  **Sequencing:** Ïù∏Í∞Ñ Ïú†Ï†ÑÏ≤¥(Human Genome) Î∂ÑÏÑù ÎπÑÏö©Í≥º ÏãúÍ∞ÑÏù¥ ÌöçÍ∏∞Ï†ÅÏúºÎ°ú Ï§ÑÏóàÏ£†.
> > 2.  **Improved Technologies:** ÏÉùÏùòÌïô Î∂ÑÏÑù(Biomedical analysis) Í∏∞Ïà†Ïùò Ìñ•ÏÉÅ.
> > 3.  **New Tools:** ÎåÄÏö©Îüâ Îç∞Ïù¥ÌÑ∞ÏÖã(Large datasets)ÏùÑ Îã§Î£∞ Ïàò ÏûàÎäî ÎèÑÍµ¨(Ïª¥Ìì®ÌåÖ ÌååÏõå, AI Îì±)Ïùò Îì±Ïû•.
>
> > [!IMPORTANT] PAGE 7: Ìó¨Ïä§ÏºÄÏñ¥ Îç∞Ïù¥ÌÑ∞Ïùò Ïã§Ï≤¥ (ÏàòÏπò ÏïîÍ∏∞!)
> > Ïûê, Ïó¨Í∏∞ **Î≥ÑÌëú** ÏπòÏÑ∏Ïöî. Ìó¨Ïä§ÏºÄÏñ¥ ÎπÖÎç∞Ïù¥ÌÑ∞Ïùò Íµ¨ÏÑ± ÎπÑÏú®Í≥º Ïö©ÎüâÏù¥ Íµ¨Ï≤¥Ï†ÅÏúºÎ°ú ÎÇòÏòµÎãàÎã§. ÌâÅÏ≥êÏÑú 'ÎßéÎã§'Í≥† ÌïòÎ©¥ ÏùòÎåÄÏÉù ÏïÑÎãàÏ£†. ÏàòÏπòÎ•º Î≥¥ÏÑ∏Ïöî.
> >
> > **1. Í±¥Í∞ï Í≤∞Ï†ï ÏöîÏù∏ (Determinants of Health) ÎπÑÏú®:** 
> > * **Exogenous data (Ïô∏Ïù∏ÏÑ± Îç∞Ïù¥ÌÑ∞):** ÌñâÎèô, ÏÇ¨ÌöåÍ≤ΩÏ†úÏ†Å, ÌôòÍ≤ΩÏ†Å ÏöîÏù∏. Î¨¥Î†§ **60%**Î•º Ï∞®ÏßÄÌï©ÎãàÎã§.
> > * **Genomics data (Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞):** **30%**. ÏÉùÍ∞ÅÎ≥¥Îã§ ÎπÑÏ§ëÏù¥ ÌÅ¨Ï£†?
> > * **Clinical data (ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞):** Í≤®Ïö∞ **10%**. Î≥ëÏõêÏóêÏÑú ÎÇòÏò§Îäî Îç∞Ïù¥ÌÑ∞Îäî ÎπôÏÇ∞Ïùò ÏùºÍ∞ÅÏù¥ÎùºÎäî Í≤ÅÎãàÎã§.
> >
> > **2. ÌèâÏÉù ÏÉùÏÑ±ÎêòÎäî Îç∞Ïù¥ÌÑ∞ Ïñë (Data per lifetime):** 
> > * Ï¥ùÎüâ: **1100 Terabytes (TB)**
> > * Exogenous: **1100 TB** (Í±∞Ïùò ÎåÄÎ∂ÄÎ∂Ñ)
> > * Genomics: **6 TB**
> > * Clinical: **0.4 TB** (ÏïÑÏ£º ÎØ∏ÎØ∏Ìï®)
> >
> > **3. ÎπÖÎç∞Ïù¥ÌÑ∞Ïùò 4V:** 
> > * **Volume (Ïñë)**, **Variety (Îã§ÏñëÏÑ±)**, **Velocity (ÏÜçÎèÑ)**, **Veracity (Ï†ïÌôïÏÑ±)**.
> > * ÌäπÌûà ÌïòÎã®Ïóê Î≥¥Î©¥ 2020ÎÖÑ Í∏∞Ï§ÄÏúºÎ°ú ÏùòÎ£å Îç∞Ïù¥ÌÑ∞Îäî **73ÏùºÎßàÎã§ 2Î∞∞**Î°ú Ï¶ùÍ∞ÄÌïúÎã§Í≥† ÎêòÏñ¥ ÏûàÏäµÎãàÎã§. Í∏àÏúµ(Finance) Î∂ÑÏïºÎ≥¥Îã§ Îç∞Ïù¥ÌÑ∞Í∞Ä Îçî ÎßéÏïÑÏöî. 

> [!NOTE] Pages 8-13: ÏùòÎ£å Ìå®Îü¨Îã§ÏûÑÏùò ÎåÄÏ†ÑÌôò (Paradigm Shift)
> Ïûê, Ïù¥Ï†ú ÏùòÌïôÏùò Ïó≠ÏÇ¨Î•º 3Îã®Í≥ÑÎ°ú ÎÇòÎà†ÏÑú Î®∏Î¶øÏÜçÏóê ÏßëÏñ¥ÎÑ£ÏùçÏãúÎã§. Í≥ºÍ±∞Ïùò ÏùòÏÇ¨Îì§ÏùÄ 'ÏßÅÍ¥Ä'Ïóê ÏùòÏ°¥ÌñàÏßÄÎßå, ÎØ∏ÎûòÏùò ÏùòÏÇ¨Îì§ÏùÄ **'ÏïåÍ≥†Î¶¨Ï¶ò'**ÏùÑ Îã§Î§ÑÏïº Ìï©ÎãàÎã§. Ïù¥ ÌååÌä∏Ïùò ÌïµÏã¨ÏùÄ **"One Treatment Fits All(Îã®Ïùº ÏπòÎ£å)"Ïùò Î™∞ÎùΩ**Í≥º **"Personalized(ÎßûÏ∂§Ìòï)"Ïùò Î∂ÄÏÉÅ**ÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 8: Ìå®Îü¨Îã§ÏûÑ 3Îã®Í≥Ñ (ÏãúÌóò ÏïºÎßà!)
> > 8ÌéòÏù¥ÏßÄ ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. ÏùòÌïôÏùÄ Ïù¥Î†áÍ≤å ÏßÑÌôîÌñàÏäµÎãàÎã§. Í∞Å Îã®Í≥ÑÏùò ÌÇ§ÏõåÎìúÎ•º Î∞òÎìúÏãú Îß§Ïπ≠ÏãúÌÇ§ÏÑ∏Ïöî.
> >
> > 1.  **Yesterday (Í≥ºÍ±∞):**
> >     * Í∏∞Î∞ò: **Symptom-based (Ï¶ùÏÉÅ Í∏∞Î∞ò)**
> >     * Î∞©Ïãù: **Intuition Medicine (ÏßÅÍ¥Ä ÏùòÌïô)** - ÏùòÏÇ¨Ïùò 'Í∞ê'Ïóê ÏùòÏ°¥ÌñàÏ£†.
> > 2.  **Today (ÌòÑÏû¨):**
> >     * Í∏∞Î∞ò: **Pattern-based (Ìå®ÌÑ¥ Í∏∞Î∞ò)**
> >     * Î∞©Ïãù: **Evidence-based Medicine (Ï¶ùÍ±∞ Í∏∞Î∞ò ÏùòÌïô, EBM)** - ÏûÑÏÉÅÏãúÌóò ÌÜµÍ≥ÑÍ∞Ä ÏôïÏù¥ÏóàÏäµÎãàÎã§.
> > 3.  **Tomorrow (ÎØ∏Îûò):**
> >     * Í∏∞Î∞ò: **Algorithm-based (ÏïåÍ≥†Î¶¨Ï¶ò Í∏∞Î∞ò)** - Ïó¨Í∏∞Í∞Ä ÌïµÏã¨ÏûÖÎãàÎã§.
> >     * Î∞©Ïãù: **Precision Medicine (Ï†ïÎ∞Ä ÏùòÌïô)** - Îç∞Ïù¥ÌÑ∞Í∞Ä ÏπòÎ£åÎ•º Í≤∞Ï†ïÌï©ÎãàÎã§.
>
> > [!INFO] PAGE 9: ÏÉàÎ°úÏö¥ ÌîåÎ†àÏù¥Ïñ¥Îì§ (IT Giants)
> > 9ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Î≥ëÏõê Î°úÍ≥†Í∞Ä ÏïÑÎãôÎãàÎã§. **Google Health, Google DeepMind, IBM Watson Health, Human Longevity Inc.** Í∞ôÏùÄ IT Í∏∞ÏóÖÎì§Ïù¥Ï£†.
> > * Ïù¥Îì§Ïù¥ ÎÖ∏Î¶¨Îäî Î∂ÑÏïºÍ∞Ä ÏïÑÎûò Ìä∏Î¶¨Ïóê ÎÇòÏòµÎãàÎã§:
> >     * **Oncology (Ï¢ÖÏñëÌïô)**
> >     * **Drug Discovery (Ïã†ÏïΩ Í∞úÎ∞ú)**
> >     * **Genomics (Ïú†Ï†ÑÏ≤¥Ìïô)**
> >     * **Patient Engagement (ÌôòÏûê Ï∞∏Ïó¨)**
> > * Ï¶â, Ìó¨Ïä§ÏºÄÏñ¥Ïùò Ï£ºÎèÑÍ∂åÏù¥ 'Îç∞Ïù¥ÌÑ∞Î•º Í∞ÄÏßÑ Í∏∞ÏóÖ'ÏúºÎ°ú ÎÑòÏñ¥Í∞ÄÍ≥† ÏûàÎã§Îäî Ï¶ùÍ±∞ÏûÖÎãàÎã§.
>
> > [!WARNING] PAGE 11-12: ÌòÑÏû¨ ÏùòÌïôÏùò ÌïúÍ≥Ñ (One Treatment Fits All)
> > 11ÌéòÏù¥ÏßÄ ÎèÑÏãùÏùÑ Î¥ÖÏãúÎã§. **"Current Medicine: One Treatment Fits All"**.
> > * ÎòëÍ∞ôÏùÄ ÏïΩ(Pill)ÏùÑ Î™®Îì† ÌôòÏûê(Ï¥àÎ°ù, Îπ®Í∞ï, ÌååÎûë ÏÑûÏó¨ ÏûàÎäî Í∑∏Î£π)ÏóêÍ≤å Ï§çÎãàÎã§.
> > * **Í≤∞Í≥º:**
> >     * ÏùºÎ∂ÄÎäî **Effect (Ìö®Í≥º ÏûàÏùå)**.
> >     * ÏùºÎ∂ÄÎäî **No effect (Ìö®Í≥º ÏóÜÏùå)** - Îèà ÎÇ≠ÎπÑÏ£†.
> >     * Ïã¨ÏßÄÏñ¥ ÏùºÎ∂ÄÎäî **Adverse effects (Î∂ÄÏûëÏö©)** - Ïù¥Í≤å Ï†úÏùº ÏúÑÌóòÌï©ÎãàÎã§.
> > * 12ÌéòÏù¥ÏßÄÎèÑ Í∞ôÏùÄ Îß•ÎùΩÏûÖÎãàÎã§. "Conventional approach"Îäî ÏßÑÎã®Ïù¥ Îä¶Ïñ¥ÏßÄÍ±∞ÎÇò(delayed), Ïò§ÏßÑ(mis-diagnosis)Ïù¥ ÏÉùÍ≤® ÏπòÎ£å Ìö®Ïú®Ïù¥ ÎÇÆÏäµÎãàÎã§.
>
> > [!IMPORTANT] PAGE 13: ÎØ∏Îûò ÏùòÌïô (Personalized Diagnostics)
> > 13ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ 11ÌéòÏù¥ÏßÄÏôÄ Î∞òÎåÄÏûÖÎãàÎã§. ÏàúÏÑúÍ∞Ä Î∞îÎÄùÎãàÎã§.
> > * **ÏÑ†(ÂÖà) ÏßÑÎã®:** ÏπòÎ£å Ï†ÑÏóê **Blood, DNA, Urine, Tissue Analysis**Î•º Î®ºÏ†Ä ÏàòÌñâÌï©ÎãàÎã§.
> > * **ÌõÑ(Âæå) Î∂ÑÎ•ò:** ÌôòÏûêÎì§ÏùÑ Îπ®Í∞ï, ÎÖ∏Îûë, ÌååÎûë Í∑∏Î£πÏúºÎ°ú **ÎØ∏Î¶¨ ÎÇòÎàïÎãàÎã§(Stratification)**.
> > * **Í≤∞Í≥º:** Í∞Å Í∑∏Î£πÏóê ÎßûÎäî ÏïΩÏùÑ Ìà¨Ïó¨ÌïòÎãàÍπå, Î™®Îì† ÌôòÏûêÏóêÍ≤åÏÑú **Effect (Ìö®Í≥º)**Í∞Ä ÎÇòÌÉÄÎÇ©ÎãàÎã§. Î∂ÄÏûëÏö©ÏùÄ ÏµúÏÜåÌôîÎêòÍ≥†Ïöî. Ïù¥Í≤å Ï†ïÎ∞ÄÏùòÌïôÏùò Í∂ÅÍ∑πÏ†Å Î™©ÌëúÏûÖÎãàÎã§.

> [!NOTE] Pages 14-21: P4 MedicineÍ≥º ÏãúÏä§ÌÖú ÏùòÌïô (Systems Medicine)
> Ïûê, Ï†ïÎ∞ÄÏùòÌïôÏùÑ Îã§Î•∏ ÎßêÎ°ú **'P4 Medicine'**Ïù¥ÎùºÍ≥†ÎèÑ Ìï©ÎãàÎã§. Ïù¥ 4Í∞ÄÏßÄ PÍ∞Ä Î≠îÏßÄ Î™®Î•¥Î©¥ Ïù¥ ÏàòÏóÖ ÌóõÎì§ÏùÄ Í≤ÅÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ Î∞©ÎåÄÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïñ¥ÎñªÍ≤å ÏöîÎ¶¨Ìï¥ÏÑú ÏûÑÏÉÅÏóê Ï†ÅÏö©ÌïòÎäîÏßÄ, Í∑∏ Î≥µÏû°Ìïú Í≥ºÏ†ïÏùÑ ÌïòÎÇòÏî© Î∂ÑÌï¥Ìï¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 14: P4 MedicineÏùò Ï†ïÏùò (ÏïîÍ∏∞ ÌïÑÏàò!)
> > 14ÌéòÏù¥ÏßÄ, ÏïÑÏ£º Ï§ëÏöîÌïú ÏïΩÏñ¥Í∞Ä ÎÇòÏòµÎãàÎã§. **P4 Medicine**.
> > 1.  **Predictive (ÏòàÏ∏°):** Î∞úÎ≥ë Ï†ÑÏóê ÎØ∏Î¶¨ ÏïàÎã§.
> > 2.  **Preventive (ÏòàÎ∞©):** ÏïÑÌîÑÍ∏∞ Ï†ÑÏóê ÎßâÎäîÎã§.
> > 3.  **Personalized (ÎßûÏ∂§):** ÎÑàÌïúÌÖå Îî± ÎßûÎäî ÏπòÎ£åÎ•º ÌïúÎã§.
> > 4.  **Participatory (Ï∞∏Ïó¨):** ÌôòÏûêÍ∞Ä ÏàòÎèôÏ†ÅÏù∏ Í∞ùÏ≤¥Í∞Ä ÏïÑÎãàÎùº, Îç∞Ïù¥ÌÑ∞ ÏÉùÏÇ∞ÏûêÎ°úÏÑú Ï∞∏Ïó¨ÌïúÎã§.
> >
> > * **ÌïµÏã¨ ÏßàÎ¨∏:** "Îç∞Ïù¥ÌÑ∞Îäî ÎÑòÏ≥êÎÇòÎäîÎç∞(More data), Ïù¥Í±∏ ÏñºÎßàÎÇò Ìö®Ïú®Ï†ÅÏúºÎ°ú ÏÇ¨Ïö©Ìï† Í≤ÉÏù∏Í∞Ä?" -> Í∑∏ Ìï¥ÎãµÏù¥ Î∞îÎ°ú **Systems Medicine**ÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 15: ÏûÑÏÉÅ Ï†ÅÏö© ÏÇ¨Ïù¥ÌÅ¥ (Clinical Deployment)
> > 15ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùò ÏàúÌôò Íµ¨Ï°∞Î•º Î≥¥ÏÑ∏Ïöî. Îç∞Ïù¥ÌÑ∞Í∞Ä Ïñ¥ÎñªÍ≤å ÌùêÎ•¥ÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§.
> > * **Screening (ÏÑ†Î≥Ñ) ‚Üí Diagnosis (ÏßÑÎã®) ‚Üí Staging & Phenotyping (Î≥ëÍ∏∞ ÏÑ§Ï†ï) ‚Üí Therapy & Monitoring (ÏπòÎ£å Î∞è Î™®ÎãàÌÑ∞ÎßÅ)**
> > * Ïù¥ Í≥ºÏ†ïÏóêÏÑú Ïñ¥Îñ§ Îç∞Ïù¥ÌÑ∞Í∞Ä Îì§Ïñ¥Í∞ÄÎÇòÏöî?
> >     * **-omic/biological:** Ïú†Ï†ÑÏ≤¥ Ï†ïÎ≥¥
> >     * **Electronic health records (EHR):** Î≥ëÏõê Í∏∞Î°ù
> >     * **Geospatial & Environmental:** Ïñ¥Îîî ÏÇ¨ÎäîÏßÄ, ÌôòÍ≤ΩÏùÄ Ïñ¥Îñ§ÏßÄ
> >     * **Personal monitoring:** Ïõ®Ïñ¥Îü¨Î∏î Í∏∞Í∏∞ Îç∞Ïù¥ÌÑ∞ Îì±
> > * Ïö∞Ï∏° ÌïòÎã®Ïùò ÏßàÎ¨∏Îì§Ïù¥ ÎÇ†Ïπ¥Î°≠ÏäµÎãàÎã§. "Í≥ºÍ±∞Î†•(History) Ï§ë Î¨¥ÏóáÏùÑ Î≥ºÍπå?", "ÌòÑÏû¨ ÏÉÅÌÉú(Current state)Îäî?", "Í∞úÏûÖ(Intervene) Í∏∞ÌöåÎäî?", "ÎØ∏Îûò ÏúÑÌóò(Risks)ÏùÄ?"
>
> > [!TIP] üí° PAGE 17-18: Îç∞Ïù¥ÌÑ∞Ïùò ÏõêÏ≤ú (Ï°±Î≥¥ ÏÜåÏä§)
> > Ïûê, Ïó¨Í∏∞ Ï†ÅÌòÄ ÏûàÎäî Îç∞Ïù¥ÌÑ∞Î≤†Ïù¥Ïä§ Ïù¥Î¶ÑÎì§, ÎààÏóê ÏùµÌòÄÎëêÏÑ∏Ïöî. ÎÇòÏ§ëÏóê Ïó∞Íµ¨Ìï† Îïå Î¨¥Ï°∞Í±¥ ÏîÅÎãàÎã§.
> >
> > **1. Technology Platforms (17p):**
> > * **Genomics & Transcriptomics:** ÏãúÌÄÄÏã± Îç∞Ïù¥ÌÑ∞ (ACGT...)
> > * **Proteomics & Metabolomics:** Îã®Î∞±Ïßà, ÎåÄÏÇ¨Î¨ºÏßà (MS-data ÏßàÎüâÎ∂ÑÏÑù)
> > * **Imaging:** ÏòÅÏÉÅ Îç∞Ïù¥ÌÑ∞
> >
> > **2. Public Databases (18p) - Î≥ÑÌëú!:**
> > * **TCGA (The Cancer Genome Atlas):** Ïïî Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Ïùò Î≥¥Î¨ºÏ∞ΩÍ≥†ÏûÖÎãàÎã§.
> > * **CCLE (Cancer Cell Line Encyclopedia):** Ïïî ÏÑ∏Ìè¨Ï£º Îç∞Ïù¥ÌÑ∞.
> > * **ClinicalTrials.gov:** ÏûÑÏÉÅÏãúÌóò Ï†ïÎ≥¥.
> > * **PubChem, DrugBank:** ÏïΩÎ¨º ÌôîÌïô Íµ¨Ï°∞ Î∞è ÌÉÄÍ≤ü Ï†ïÎ≥¥.
> > * **TOXNET:** ÎèÖÏÑ± Ï†ïÎ≥¥.
> > * Ïù¥ Îç∞Ïù¥ÌÑ∞Îì§Ïù¥ Îã§ Ïó∞Í≤∞ÎêòÏñ¥Ïïº ÎπÑÎ°úÏÜå 'Ï†ïÎ∞ÄÏùòÌïô'Ïù¥ Îê©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 19: AIÏôÄ Î®∏Ïã†Îü¨ÎãùÏùò Ïó≠Ìï† (ÏïåÍ≥†Î¶¨Ï¶ò Ïù¥Î¶Ñ Ï≤¥ÌÅ¨)
> > 19ÌéòÏù¥ÏßÄ Ïö∞Ï∏° ÌïòÎã®, Íπ®Ïïå Í∞ôÏùÄ Í∏ÄÏî®Î•º Î≥¥ÏÑ∏Ïöî. Îç∞Ïù¥ÌÑ∞Î•º Î∂ÑÏÑùÌïòÎäî ÎèÑÍµ¨Îì§ÏûÖÎãàÎã§.
> > * **Machine Learning (ML):** Í∏∞Í≥ÑÌïôÏäµ.
> > * **Deep Learning (DL):** Îî•Îü¨Îãù.
> > * **Íµ¨Ï≤¥Ï†Å ÏïåÍ≥†Î¶¨Ï¶ò:**
> >     * **SVM (Support Vector Machine)**
> >     * **RF (Random Forest)**
> >     * **LightGBM:** ÏµúÍ∑º ÎßéÏù¥ Ïì∞Ïù¥Îäî Î∂ÄÏä§ÌåÖ Î™®Îç∏Ïù¥Ï£†.
> > * **Í≥ºÏ†ï:** Feature selection(ÌäπÏßï ÏÑ†ÌÉù) ‚Üí Cross validation(ÍµêÏ∞® Í≤ÄÏ¶ù) ‚Üí Hyperparameter tuning(ÌäúÎãù) ‚Üí **Prediction(ÏòàÏ∏°)**. Ïù¥ ÌîÑÎ°úÏÑ∏Ïä§Í∞Ä Î®∏Î¶øÏÜçÏóê ÏûàÏñ¥Ïïº Ìï©ÎãàÎã§.
>
> > [!INFO] PAGE 20-21: Multi-OmicsÏùò ÌÜµÌï© (Integration)
> > 20ÌéòÏù¥ÏßÄ, ÏÇ¨Îûå Î™∏ÏùÑ **Systems Biology** Í¥ÄÏ†êÏóêÏÑú Î≥∏ Í∑∏Î¶ºÏûÖÎãàÎã§.
> > * ÏïΩÎ¨º(Drug A)Ïù¥ Îì§Ïñ¥Í∞ÄÎ©¥ Îã®ÏÑ†Ï†ÅÏù∏ Î∞òÏùëÎßå ÏûàÎäî Í≤å ÏïÑÎãàÎùº, Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨(Network)Î•º Í±¥ÎìúÎ¶ΩÎãàÎã§. Í∑∏ÎûòÏÑú Î∂ÄÏûëÏö©(AEs)ÎèÑ ÏÉùÍ∏∞Í≥†, ÏÉàÎ°úÏö¥ Ï†ÅÏùëÏ¶ù(New indications, Drug repositioning)ÎèÑ Î∞úÍ≤¨ÎêòÎäî Í±∞Ï£†.
> >
> > 21ÌéòÏù¥ÏßÄÍ∞Ä Í≤∞Î°†ÏûÖÎãàÎã§.
> > * **Multi-OMICS:** Genome, Epigenome, Transcriptome, Proteome, Metabolome, Microbiome... Ïù¥ Î™®Îì† Í±∏ Ìï©Ï≥êÏïº Ìï©ÎãàÎã§.
> > * **Integration (ÌÜµÌï©):** Îî∞Î°ú ÎÜÄÎ©¥ Ïì∞Î†àÍ∏∞ÏûÖÎãàÎã§. ÏÑûÏñ¥ÏÑú Î∂ÑÏÑùÌï¥Ïïº Ïú†ÏùòÎØ∏Ìïú **Signatures (ÌäπÏßï)**Í∞Ä ÎÇòÏò§Í≥†, Í∑∏Ï†úÏïº **Therapeutics (ÏπòÎ£åÎ≤ï)**Í∞Ä ÎÇòÏòµÎãàÎã§.

> [!NOTE] Pages 22-31: Ïú†Ï†ÑÏ≤¥Ìïô Í∏∞Ï¥à (Genomics Basics)
> Ïûê, Ïù¥Ï†ú **ÏÉùÎ™ÖÏùò Ïñ∏Ïñ¥(Language of Life)**Î•º Î∞∞Ïö∏ Ï∞®Î°ÄÏûÖÎãàÎã§. Í≥†Îì±ÌïôÍµê ÏÉùÎ¨º ÏãúÍ∞Ñ Í∞ôÎã§Í≥† Î∞©Ïã¨ÌïòÏßÄ ÎßàÏÑ∏Ïöî. Ïó¨Í∏∞ ÎÇòÏò§Îäî **ÏàòÏπò(nm, bp)**Îì§Í≥º **Îç∞Ïù¥ÌÑ∞Ïùò Í∑úÎ™®**Í∞Ä Ï†ïÎ∞ÄÏùòÌïôÏóêÏÑú Ïôú 'ÎπÖÎç∞Ïù¥ÌÑ∞'ÎùºÍ≥† Î∂àÎ¶¨ÎäîÏßÄ Í∑∏ Í∑ºÍ±∞Í∞Ä ÎêòÎãàÍπåÏöî.
>
> > [!INFO] PAGE 22: ÏÉùÎ¨ºÌïôÏ†Å Ï†ïÎ≥¥Ïùò ÌùêÎ¶Ñ (Central Dogma Í∑∏ Ïù¥ÏÉÅ)
> > 22ÌéòÏù¥ÏßÄ Îã§Ïù¥Ïñ¥Í∑∏Îû®ÏùÑ Î≥¥ÏÑ∏Ïöî. Ïö∞Î¶¨Í∞Ä ÏïÑÎäî ÏÑºÌä∏Îü¥ ÎèÑÍ∑∏Îßà(DNA ‚Üí RNA ‚Üí Protein)Í∞Ä Í∏∞Î≥∏Ïù¥ÏßÄÎßå, Í∑∏Î¶ºÏù¥ Ìõ®Ïî¨ Î≥µÏû°ÌïòÏ£†? 
> > * **Feedback Loops:** ÌôîÏÇ¥ÌëúÍ∞Ä Ìïú Î∞©Ìñ•ÏúºÎ°úÎßå Í∞ÄÏßÄ ÏïäÏäµÎãàÎã§. Îã®Î∞±Ïßà(Proteins)Ïù¥ Îã§Ïãú DNAÎÇò RNA Ï°∞Ï†àÏóê Í¥ÄÏó¨ÌïòÍ≥†, **ÌôòÍ≤Ω(Environment)**Ïù¥ ÏÑ∏Ìè¨ ÎåÄÏÇ¨(Cellular metabolism)Ïóê ÏòÅÌñ•ÏùÑ ÎØ∏ÏπòÎäî **ÏàúÌôò Íµ¨Ï°∞**ÏûÑÏùÑ Î™ÖÏã¨ÌïòÏÑ∏Ïöî. 
>
> > [!INFO] PAGE 23-24: Human Genome Project (HGP)
> > 23ÌéòÏù¥ÏßÄÏùò ÏàòÎßéÏùÄ ÏïåÌååÎ≤≥(ACGT...)Í≥º 24ÌéòÏù¥ÏßÄÏùò ÌååÌòï(Peaks) Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Ïù¥Í≤å Î∞îÎ°ú **Sanger Sequencing**Ïùò Í≤∞Í≥ºÎ¨ºÏûÖÎãàÎã§. 
> > * **Human Genome Project:** Ïù∏Í∞ÑÏùò Î™®Îì† DNA Í∏ÄÏûêÎ•º ÏùΩÏñ¥ÎÇ¥Î†§Îäî Í±∞ÎåÄÌïú ÏãúÎèÑÏòÄÏ£†. ÌÅ¥Î¶∞ÌÑ¥ ÎåÄÌÜµÎ†π ÏÇ¨ÏßÑÎèÑ Î≥¥Ïù¥ÎÑ§Ïöî. 
>
> > [!IMPORTANT] PAGE 25: DNA Íµ¨Ï°∞Ïùò ÏàòÏπò (ÏïîÍ∏∞!)
> > 25ÌéòÏù¥ÏßÄ, Ïó¨Í∏∞ **Î≥ÑÌëú** Îã§ÏÑØ Í∞ú ÏπòÏÑ∏Ïöî. DNA Íµ¨Ï°∞Ïùò ÏàòÏπò, ÏãúÌóòÏóê ÎÇ¥Í∏∞ Îî± Ï¢ãÏäµÎãàÎã§.
> > * **Î∞©Ìñ•ÏÑ±:** **5' end (Ïù∏ÏÇ∞Í∏∞)**ÏóêÏÑú **3' end (ÏàòÏÇ∞Í∏∞, OH)**Î°ú Ïù¥Ïñ¥ÏßëÎãàÎã§. Îëê Í∞ÄÎã•ÏùÄ ÏÑúÎ°ú **Ïó≠ÌèâÌñâ(Anti-parallel)**Ìï©ÎãàÎã§. 
> > * **Î∞±Î≥∏(Backbone):** Ïù∏ÏÇ∞(Phosphate) + Îãπ(Deoxyribose)ÏúºÎ°ú Íµ¨ÏÑ±Îê©ÎãàÎã§. 
> > * **Ï£ºÏöî ÏàòÏπò:**
> >     * **ÏßÄÎ¶Ñ (Width):** **2 nm** 
> >     * **ÎÇòÏÑ† Ìïú Î∞îÌÄ¥ (One turn):** **3.4 nm** 
> >     * **ÏóºÍ∏∞ ÏÇ¨Ïù¥ Í±∞Î¶¨ (Distance between bases):** **0.34 nm** 
> > * **Groove:** ÎÑìÏùÄ **Major groove**ÏôÄ Ï¢ÅÏùÄ **Minor groove**Í∞Ä ÏûàÏäµÎãàÎã§. ÎÇòÏ§ëÏóê Îã®Î∞±ÏßàÏù¥ Ïó¨Í∏∞ ÎÅºÏñ¥Îì§Ïñ¥Í∞ÄÏÑú Í≤∞Ìï©Ìï©ÎãàÎã§. 
>
> > [!INFO] PAGE 28: Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Ïùò ÌÅ¨Í∏∞ (ÎπÑÏú†)
> > 28ÌéòÏù¥ÏßÄ, Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Í∞Ä ÏñºÎßàÎÇò Î∞©ÎåÄÌïúÏßÄ ÎπÑÏú†Î•º Îì§Ïñ¥ ÏÑ§Î™ÖÌï©ÎãàÎã§.
> > * **Ï†ÑÏ≤¥ Ïö©Îüâ:** Ïù∏Í∞Ñ DNAÎäî ÏïΩ **64Ïñµ Í∞ú(6.4 billion)**Ïùò Î¨∏ÏûêÎ°ú ÎêòÏñ¥ ÏûàÏäµÎãàÎã§. 
> > * **Ï±ÖÏúºÎ°ú ÏπòÎ©¥:** 500ÌéòÏù¥ÏßÄÏßúÎ¶¨ Ï±Ö **4,200Í∂å** Î∂ÑÎüâÏûÖÎãàÎã§. Ïñ¥ÎßàÏñ¥ÎßàÌïòÏ£†. 
> > * **ÏÑúÎπÑÏä§ ÎπÑÍµê:**
> >     * **Veritas (Whole Genome):** 4,200Í∂å Ï†ÑÏ≤¥Î•º ÏùΩÏñ¥Ï§çÎãàÎã§. 
> >     * **23andMe (SNP genotyping):** Ï†ÑÏ≤¥Ïùò **1% ÎØ∏Îßå**Îßå Î¥ÖÎãàÎã§. Ï±ÖÏúºÎ°ú ÏπòÎ©¥ Í≤®Ïö∞ **180ÌéòÏù¥ÏßÄ** ÏùΩÎäî ÏÖàÏù¥Ï£†. Ïù¥ Ï∞®Ïù¥Î•º ÏïÑÎäî Í≤å Ï§ëÏöîÌï©ÎãàÎã§. 
>
> > [!INFO] PAGE 30-31: ÏÉùÎ™ÖÏùò Í≥ÑÏ∏µ Íµ¨Ï°∞ÏôÄ ÏóºÏÉâÏ≤¥
> > * **Í≥ÑÏ∏µ (30p):** Macromolecule(DNA) ‚Üí Organelle ‚Üí Cell ‚Üí Tissue ‚Üí Organ ‚Üí Organism ÏàúÏÑúÎ°ú Î≥µÏû°Ìï¥ÏßëÎãàÎã§. 
> > * **ÏóºÏÉâÏ≤¥ (31p):** Ïù∏Í∞ÑÏùÄ **23Ïåç(23 pairs)**Ïùò ÏóºÏÉâÏ≤¥Î•º Í∞ÄÏßëÎãàÎã§. (Ï¥ù 46Í∞ú) 
> > * **ÏÉÅÎèô ÏóºÏÉâÏ≤¥ (Homologous pairs):** Î∂ÄÎ™®Î°úÎ∂ÄÌÑ∞ Í∞ÅÍ∞Å ÌïòÎÇòÏî© Î¨ºÎ†§Î∞õÏùÄ Ìïú ÏåçÏûÖÎãàÎã§.
> >     * **Allele (ÎåÄÎ¶ΩÏú†Ï†ÑÏûê):** Í∞ôÏùÄ ÏúÑÏπòÏóê ÏûàÎäî Ïú†Ï†ÑÏûê Î≤ÑÏ†ÑÏùÑ ÎßêÌï©ÎãàÎã§. Í∑∏Î¶ºÏùò **Allele A**ÏôÄ **Allele a**Î•º Î≥¥ÏÑ∏Ïöî. Ïù¥Í≤å ÌòïÏßà(Ïòà: Î®∏Î¶¨ÏÉâ)ÏùÑ Í≤∞Ï†ïÌï©ÎãàÎã§. 

> [!NOTE] Pages 32-40: Ïú†Ï†ÑÏûê Î∞úÌòÑÍ≥º ÏûÑÏÉÅ ÏãúÌÄÄÏã± Í∏∞Ïà†
> Ïûê, DNAÏóê Ï†ÅÌûå Ï†ïÎ≥¥Í∞Ä Ïñ¥ÎñªÍ≤å Ïö∞Î¶¨ ÎààÏóê Î≥¥Ïù¥Îäî ÌäπÏßï(Phenotype)ÏúºÎ°ú ÎÇòÌÉÄÎÇòÎäîÏßÄ, Í∑∏Î¶¨Í≥† Í∑∏ Ï†ïÎ≥¥Î•º ÏùΩÏñ¥ÎÇ¥Îäî Í∏∞Ïà†ÏóêÎäî Ïñ¥Îñ§ Í≤ÉÎì§Ïù¥ ÏûàÎäîÏßÄ 'Ìï¥ÏÉÅÎèÑ'Î≥ÑÎ°ú ÎúØÏñ¥Î¥ÖÏãúÎã§. ÌäπÌûà **39ÌéòÏù¥ÏßÄ**Îäî ÏûÑÏÉÅ ÏãúÌóòÏù¥ÎÇò Íµ≠Í∞ÄÍ≥†ÏãúÏóêÎèÑ Îã®Í≥®Î°ú ÎÇòÏò§Îäî Í∞úÎÖêÏù¥Îãà Îàà ÌÅ¨Í≤å Îú®ÏÑ∏Ïöî.
>
> > [!INFO] PAGE 32-33: GenotypeÏóêÏÑú PhenotypeÍπåÏßÄ (Layer Íµ¨Ï°∞)
> > 32ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùò Îã§ÏñëÌïú ÏÇ¨ÎûåÎì§ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å Îã§ **Phenotype(ÌëúÌòÑÌòï)**ÏûÖÎãàÎã§.
> > * **ÌïµÏã¨ ÏßàÎ¨∏ (33p):** ÎèÑÎåÄÏ≤¥ Ïñ¥Îñ§ Î¨ºÎ¶¨Ï†Å Î©îÏª§ÎãàÏ¶òÏù¥ Ïö∞Î¶¨Ïùò Ïô∏Î™®ÏôÄ Í∏∞Îä•ÏùÑ Í≤∞Ï†ïÌï†ÍπåÏöî?
> > * **Ï†ïÎ≥¥Ïùò Í≥ÑÏ∏µ (Level):**
> >     * **Genome (Ïú†Ï†ÑÏ≤¥)**: Í∞ÄÏû• Î∞ëÎ∞îÎã• ÏÑ§Í≥ÑÎèÑ.
> >     * **Epigenome (ÌõÑÏÑ±Ïú†Ï†ÑÏ≤¥)**: ÏÑ§Í≥ÑÎèÑÏùò Ïä§ÏúÑÏπò.
> >     * **Transcriptome (Ï†ÑÏÇ¨Ï≤¥)**: Î≥µÏÇ¨Îêú Î™ÖÎ†πÏÑú.
> >     * **Proteome (Îã®Î∞±ÏßàÏ≤¥)**: Ïã§Ï†ú ÏùºÍæº.
> >     * **Metabolome (ÎåÄÏÇ¨Ï≤¥)**: ÏùºÍæºÏù¥ ÎßåÎì† Í≤∞Í≥ºÎ¨º.
> >     * **Phenome (ÌëúÌòÑÌòïÏ≤¥)**: ÏµúÏ¢ÖÏ†ÅÏù∏ ÏÉùÎ¨ºÌïôÏ†Å ÌäπÏßï.
> > * Ïù¥ Î™®Îì† **Biologic Process(ÏÉùÎ¨ºÌïôÏ†Å Í≥ºÏ†ï)**Í∞Ä Ïó∞Í≤∞ÎêòÏñ¥Ïïº ÎπÑÎ°úÏÜå 'ÎÇò'ÎùºÎäî ÏÇ¨ÎûåÏù¥ ÏÑ§Î™ÖÎê©ÎãàÎã§. 
>
> > [!INFO] PAGE 34-37: Ïú†Ï†ÑÏûê(Gene)ÏôÄ Î∞úÌòÑ(Expression)
> > 34ÌéòÏù¥ÏßÄ, 'Ïú†Ï†ÑÏûê'Ïùò Ï†ïÏùòÎ•º Î∂ÑÏûêÏ†Å Í¥ÄÏ†êÏóêÏÑú ÌôïÏã§Ìûà Ìï©ÏãúÎã§.
> > * **Ï†ïÏùò:** Îã®Î∞±ÏßàÏù¥ÎÇò RNAÎ•º ÏΩîÎî©ÌïòÎäî DNA Ï°∞Í∞Å + **"Ïñ∏Ï†ú, Ïñ¥ÎîîÏÑú, ÏñºÎßàÎÇò(when, where, what amounts)"** ÎßåÎì§ÏßÄ Í≤∞Ï†ïÌïòÎäî Î™ÖÎ†πÏñ¥ÍπåÏßÄ Ìè¨Ìï®ÏûÖÎãàÎã§. 
> > * **Expression (36p):**
> >     * **Transcription (Ï†ÑÏÇ¨):** Ìïµ(Nucleus) ÏïàÏóêÏÑú DNA ‚Üí mRNA. (ÏÑ±ÏàôÌïú mRNAÍ∞Ä Îê®) 
> >     * **Translation (Î≤àÏó≠):** ÏÑ∏Ìè¨Ïßà(Cytoplasm)Î°ú ÎÇòÏôÄÏÑú mRNA ‚Üí Protein. 
>
> > [!IMPORTANT] PAGE 39: Clinical Sequencing Ï¢ÖÎ•ò (Ï°±Î≥¥ ÏïºÎßà! ‚òÖ)
> > Ïûê, Ïó¨Í∏∞ **Î≥ÑÌëú 5Í∞ú** Î∞ïÏúºÏÑ∏Ïöî. Î≥ëÏõêÏóêÏÑú "Ïú†Ï†ÑÏûê Í≤ÄÏÇ¨Ìï©ÏãúÎã§" Ìï† Îïå Îã§ Í∞ôÏùÄ Í≤å ÏïÑÎãôÎãàÎã§. Í∞Å Î∞©Î≤ïÏù¥ **Î¨¥ÏóáÏùÑ(Target)** Î≥¥Í≥† **Ïñ¥Îñ§ ÎèåÏó∞Î≥ÄÏù¥(Application)**Î•º Ïû°ÎäîÏßÄ Îß§Ïπ≠Ìï¥Ïïº Ìï©ÎãàÎã§.
> >
> > 1.  **Whole Genome Sequencing (WGS, Ï†ÑÏû• Ïú†Ï†ÑÏ≤¥):**
> >     * **Î≤îÏúÑ:** DNA Ï†ÑÏ≤¥.
> >     * **Ïû°Îäî Í≤É:** **Structural variants (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥)**, Point mutations, Copy number variation (CNV). Îã§ Ïû°ÏäµÎãàÎã§. 
> > 2.  **Whole-Exome Sequencing (WES):**
> >     * **Î≤îÏúÑ:** **Exon baits**Î•º Ïç®ÏÑú Îã®Î∞±Ïßà ÎßåÎìúÎäî **1% (Exon)**Îßå Î¥ÖÎãàÎã§. Í∞ÄÏÑ±ÎπÑÍ∞Ä Ï¢ãÏ£†.
> >     * **Ïû°Îäî Í≤É:** Point mutations, CNV. (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥Îäî Ïûò Î™ª Î¥ÖÎãàÎã§) 
> > 3.  **PCR Amplicon (Targeted Panel):**
> >     * **Î≤îÏúÑ:** ÌäπÏ†ï Ïú†Ï†ÑÏûêÎßå Ï¶ùÌè≠.
> >     * **Ïû°Îäî Í≤É:** Point mutations, Deletions. ÌäπÏ†ï ÏßàÎ≥ë ÌÉÄÍ≤üÌåÖÌï† Îïå ÏîÅÎãàÎã§. 
> > 4.  **Transcriptome (RNA-seq):**
> >     * **Î≤îÏúÑ:** RNA Ï†ÑÏ≤¥.
> >     * **Ïû°Îäî Í≤É:** **Gene expression (Î∞úÌòÑÎüâ)**, **Gene fusions (ÏúµÌï© Ïú†Ï†ÑÏûê)**, Splice variants. 
>
> > [!INFO] PAGE 40: Genotype LayerÎ≥Ñ Î≥ÄÏù¥ Ï¢ÖÎ•ò (Ïö©Ïñ¥ Ï†ïÎ¶¨)
> > 40ÌéòÏù¥ÏßÄ ÌëúÎäî ÏïûÏùò ÎÇ¥Ïö©ÏùÑ Ï†ïÎ¶¨Ìïú Í≤ÅÎãàÎã§. Í∞Å Î†àÎ≤®ÏóêÏÑú ÏùºÏñ¥ÎÇòÎäî **Event** Ïö©Ïñ¥Î•º Ïô∏Ïö∞ÏÑ∏Ïöî.
> > * **Genome:** SNP (Îã®Ïùº ÏóºÍ∏∞ Îã§ÌòïÏÑ±), InDel (ÏÇΩÏûÖ/Í≤∞Ïã§), CNV (Î≥µÏ†úÏàò Î≥ÄÏù¥), SV (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥). 
> > * **Transcriptome:** Gene expression Î≥ÄÌôî, Alternative splicing(ÏÑ†ÌÉùÏ†Å Ïä§ÌîåÎùºÏù¥Ïã±). 
> > * **Proteome:** PTM (Post-translational modification, Î≤àÏó≠ ÌõÑ Î≥ÄÌòï). 

> [!NOTE] Pages 41-51: Ï†ÑÏÇ¨ Ï°∞Ï†àÍ≥º Îã®Î∞±ÏßàÏ≤¥ (Regulation & Proteome)
> Ïûê, DNAÏóê Ï†ïÎ≥¥Í∞Ä ÏûàÎã§Í≥† ÎÅùÏù¥ ÏïÑÎãôÎãàÎã§. Í∑∏Í±∏ ÏùΩÏñ¥ÎÇ¥Í≥†(Transcription), Í∞ÄÍ≥µÌïòÍ≥†(Splicing), Îã®Î∞±ÏßàÎ°ú ÎßåÎì§Í≥†(Translation), Îòê ÏàòÏ†ï(PTM)Ìï¥Ïïº ÎπÑÎ°úÏÜå Í∏∞Îä•Ïù¥ ÏÉùÍπÅÎãàÎã§. Ïù¥ Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨Í∞Ä Í≥†Ïû• ÎÇòÎ©¥ Í∑∏Í≤å Î∞îÎ°ú 'Ïïî'Ïù¥Í≥† 'ÏßàÎ≥ë'ÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 41-43: Ï†ÑÏÇ¨ ÎÑ§Ìä∏ÏõåÌÅ¨ÏôÄ Chromatin (Ï°∞Ï†àÏùò ÏãúÏûë)
> > 41ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. ÏÑ∏Ìè¨Ìïµ(Nucleus)ÏóêÏÑú ÏùºÏñ¥ÎÇòÎäî ÏùºÎì§ÏûÖÎãàÎã§.
> > * **Transcriptional networks (Ï†ÑÏÇ¨ ÎÑ§Ìä∏ÏõåÌÅ¨):**
> >     * **Transcription Factors (TF):** Ï†ÑÏÇ¨Î•º ÏãúÏûëÌïòÎäî Ïó¥Ïá†ÏûÖÎãàÎã§. 
> >     * **Cofactors & Chromatin regulation:** TFÎ•º ÎèÑÏôÄÏ£ºÍ±∞ÎÇò Î∞©Ìï¥ÌïòÎäî ÏπúÍµ¨Îì§Ïù¥Ï£†. 
> >     * **DNA Methylation & Histone Modification:** DNAÎ•º Í∞êÍ≥† ÏûàÎäî Ïã§Ìå®(Histone)Î•º Ï°∞Ïù¥Í±∞ÎÇò ÌíÄÏñ¥ÏÑú Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌï©ÎãàÎã§. (EpigeneticsÏùò ÌïµÏã¨) 
> > * **42ÌéòÏù¥ÏßÄ Íµ¨Ï°∞:** DNAÎäî Í∑∏ÎÉ• ÏûàÎäî Í≤å ÏïÑÎãàÎùº **Histone**Ïóê Í∞êÍ≤® **Nucleosome**ÏùÑ ÌòïÏÑ±Ìï©ÎãàÎã§. Ï†ÑÏÇ¨Í∞Ä ÏùºÏñ¥ÎÇòÎ†§Î©¥ Ïù¥ Íµ¨Ï°∞Í∞Ä ÌíÄÎ†§Ïïº ÌïòÎäîÎç∞, Í∑∏ Ïó¥Î¶∞ Î∂ÄÏúÑÎ•º **DNase I hypersensitive sites**ÎùºÍ≥† Ìï©ÎãàÎã§. "Ïó¨Í∏∞Í∞Ä ÌôúÏÑ± Î∂ÄÏúÑÎã§"ÎùºÎäî ÎúªÏù¥Ï£†. 
> > * **43ÌéòÏù¥ÏßÄ ÏõêÍ±∞Î¶¨ Ï°∞Ï†à:** **Long-range regulatory elements**Î•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏûê Î∞îÎ°ú ÏòÜÏù¥ ÏïÑÎãàÎùº ÏïÑÏ£º Î©ÄÎ¶¨ Îñ®Ïñ¥ÏßÑ Í≥≥ÏóêÏÑúÎèÑ Ï°∞Ï†à Ïã†Ìò∏Î•º Î≥¥ÎÉÖÎãàÎã§. DNAÍ∞Ä Í≥†Î¶¨Ï≤òÎüº ÌúòÏñ¥Ï†∏ÏÑú(Looping) ÎßåÎÇòÎäî Í≤ÅÎãàÎã§. 
>
> > [!INFO] PAGE 44-45: Ï†ÑÏÇ¨ Îã®ÏúÑÏùò Ìï¥Î∂Ä (Anatomy of Transcription)
> > 44ÌéòÏù¥ÏßÄ, Ïú†Ï†ÑÏûêÏùò Íµ¨Ï°∞Î•º ÎúØÏñ¥Î¥ÖÏãúÎã§. Ïö©Ïñ¥ Ï†ïÌôïÌûà ÏïÑÏÖîÏïº Ìï©ÎãàÎã§.
> > * **Promoter (Cis-regulatory region):** Ï†ÑÏÇ¨ ÏãúÏûë ÏúÑÏπòÎ•º Ïû°ÏïÑÏ£ºÎäî Í≥≥. **Basal (core) promoter**ÏôÄ **Module (Enhancer)**Î°ú ÎÇòÎâ©ÎãàÎã§. 
> > * **Transcription Unit:** Ïã§Ï†ú Î≥µÏÇ¨ÎêòÎäî Íµ¨Í∞Ñ. **Exon(ÎÇ®Îäî Î∂ÄÎ∂Ñ)**Í≥º **Intron(Î≤ÑÎ†§ÏßÄÎäî Î∂ÄÎ∂Ñ)**, Í∑∏Î¶¨Í≥† ÏñëÎÅùÏùò **UTR (Untranslated Region)**Ïù¥ ÏûàÏäµÎãàÎã§. 
> > * **45ÌéòÏù¥ÏßÄ Looping:** ÏïÑÍπå ÎßêÌïú ÏõêÍ±∞Î¶¨ Ï°∞Ï†àÏù¥ Ïñ¥ÎñªÍ≤å ÏùºÏñ¥ÎÇòÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§. **Looping factors**Í∞Ä DNAÎ•º ÌúòÍ≤å ÎßåÎì§Ïñ¥ Î©ÄÎ¶¨ ÏûàÎäî EnhancerÎ•º Promoter Í∑ºÏ≤òÎ°ú ÎÅåÍ≥† ÏòµÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 46: p53 Íµ¨Ï°∞ ÏÉÅÏÑ∏ (ÏïºÎßà/Í∏∞Ï∂ú Ìè¨Ïù∏Ìä∏ ‚òÖ)
> > Ïûê, ÏùòÎåÄÏÉùÏù¥ÎùºÎ©¥ **p53** Î™®Î•¥Î©¥ Í∞ÑÏ≤©ÏûÖÎãàÎã§. 'Ïú†Ï†ÑÏ≤¥Ïùò ÏàòÌò∏Ïûê'Ï£†. 46ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ ÌòÑÎØ∏Í≤Ω Î≥¥ÎìØ Î≥¥ÏÑ∏Ïöî.
> > * **Íµ¨Ï°∞Ï†Å ÌäπÏßï:**
> >     * **DNA-binding domain:** DNAÏôÄ ÏßÅÏ†ë Í≤∞Ìï©ÌïòÎäî Î∂ÄÏúÑ. Ïó¨Í∏∞Ïóê **Zinc atom (ÏïÑÏó∞ ÏõêÏûê)**Ïù¥ **Stabilizer(ÏïàÏ†ïÌôîÏ†ú)**Î°ú Î∞ïÌòÄ ÏûàÏäµÎãàÎã§. 
> >     * **Tetramerization domain:** p53ÏùÄ ÌòºÏûê Ïùº Ïïà Ìï©ÎãàÎã§. 4Í∞úÍ∞Ä Î≠âÏ≥êÏÑú(Tetramer) ÏùºÌï©ÎãàÎã§. 
> >     * **Transcription domain:** Ï†ÑÏÇ¨Î•º ÌôúÏÑ±ÌôîÌïòÎäî Î∂ÄÏúÑ. 
> > * **ÏûÑÏÉÅ Ïó∞Í≥Ñ:** ÏïîÌôòÏûêÏóêÏÑú p53 Î≥ÄÏù¥Í∞Ä Î∞úÍ≤¨ÎêòÎ©¥, Ï£ºÎ°ú Ï†Ä **DNA-binding domain**Ïù¥ ÎßùÍ∞ÄÏ†∏ÏÑú DNAÎ•º Î™ª Ïû°Í≤å ÎêòÎäî Í≤ΩÏö∞Í∞Ä ÎßéÏäµÎãàÎã§.
> >   ![Pasted image 20251209101527.png](/img/user/%ED%95%99%EC%97%85/%EC%98%88%202-2/%EB%B6%84%EC%9E%90%EC%9C%A0%EC%A0%84%ED%95%99/%EC%82%AC%EC%A0%84%EC%A0%95%EB%A6%AC%EB%B3%B8/%EA%B8%B0%EB%A7%90/%EB%8F%99%EB%B4%89%EC%9D%B4%EB%AF%B8%EC%A7%80/Pasted%20image%2020251209101527.png)
>
> > [!INFO] PAGE 47-48: SplicingÍ≥º Ï†ÑÏÇ¨Ïùò Î≥µÏû°ÏÑ±
> > 47ÌéòÏù¥ÏßÄÎ•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏûê ÌïòÎÇò(Gene 1)ÏóêÏÑú ÌôîÏÇ¥ÌëúÍ∞Ä Ïó¨Îü¨ Í∞ú ÎÇòÏò§Ï£†?
> > * **Alternative Splicing:** ÏóëÏÜêÏùÑ Ïñ¥ÎñªÍ≤å Ï°∞Î¶ΩÌïòÎäêÎÉêÏóê Îî∞Îùº ÌïòÎÇòÏùò Ïú†Ï†ÑÏûêÏóêÏÑú Ïó¨Îü¨ Ï¢ÖÎ•òÏùò mRNA(Transcripts)Í∞Ä ÎÇòÏòµÎãàÎã§.
> > * **Reverse Strand Transcripts:** Ïã¨ÏßÄÏñ¥ Î∞òÎåÄ Í∞ÄÎã•ÏóêÏÑúÎèÑ Ï†ÑÏÇ¨Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. 
> > * 48ÌéòÏù¥ÏßÄÎäî Îçî Î≥µÏû°Ìï©ÎãàÎã§. **tiRNA, PASR, ncRNA** Í∞ôÏùÄ ÎπÑÏïîÌò∏Ìôî RNAÎì§ÎèÑ ÏóÑÏ≤≠ÎÇòÍ≤å ÏèüÏïÑÏ†∏ ÎÇòÏòµÎãàÎã§. Ïö∞Î¶¨ Î™∏ÏùÄ ÏÉùÍ∞ÅÎ≥¥Îã§ Ìõ®Ïî¨ ÏàòÎã§Ïä§ÎüΩÏäµÎãàÎã§. 
>
> > [!INFO] PAGE 49-51: ProteomeÍ≥º PTM (Î≤àÏó≠ ÌõÑ Î≥ÄÌòï)
> > 49ÌéòÏù¥ÏßÄ Ïö∞Ï∏°ÏùÑ Î≥¥ÏÑ∏Ïöî. Îã®Î∞±ÏßàÏù¥ ÎßåÎì§Ïñ¥ÏßÑ ÌõÑ(Translation)ÏóêÎèÑ ÎÅùÏù¥ ÏïÑÎãôÎãàÎã§. **Post-translational modifications (PTM)**Ïù¥ ÏùºÏñ¥ÎÇ©ÎãàÎã§.
> > * **Ï¢ÖÎ•ò (Ïô∏Ïö∞ÏÑ∏Ïöî):**
> >     * **Phosphorylation (Ïù∏ÏÇ∞Ìôî):** Ïä§ÏúÑÏπò Ïó≠Ìï† (Í∞ÄÏû• Ï§ëÏöî). 
> >     * **Glycosylation (ÎãπÌôî):** ÎãπÏùÑ Î∂ôÏûÑ. 
> >     * **Acetylation (ÏïÑÏÑ∏Ìã∏Ìôî)** 
> >     * **Ubiquitination (Ïú†ÎπÑÌÄ¥Ìã¥Ìôî):** Î∂ÑÌï¥ Ïã†Ìò∏. 
> >     * **SUMOylation:** Îã®Î∞±Ïßà Í∏∞Îä• Ï°∞Ï†à. 
> > * **Í≤∞Î°† (50-51p):** Ïú†Ï†ÑÏûêÎäî ÌïòÎÇòÏßÄÎßå, SplicingÍ≥º PTMÏùÑ Í±∞ÏπòÎ©¥ ÏàòÏã≠, ÏàòÎ∞± Í∞ÄÏßÄÏùò **Mature proteins**Í∞Ä ÏÉùÍπÅÎãàÎã§. Í∑∏ÎûòÏÑú ProteomeÏù¥ GenomeÎ≥¥Îã§ Ìõ®Ïî¨ Î≥µÏû°Ìïú Í≤ÅÎãàÎã§. 

> [!NOTE] Pages 52-59: ÎåÄÏÇ¨Ï≤¥ÏôÄ ÌëúÌòÑÌòï (Metabolome & Phenotype)
> Ïûê, DNAÏóêÏÑú ÏãúÏûëÎêú Ïó¨Ï†ïÏù¥ ÎìúÎîîÏñ¥ Ïö∞Î¶¨ Î™∏Ïùò Ïã§Ï†ú Í∏∞Îä•Ïù∏ 'ÎåÄÏÇ¨'ÏôÄ 'ÌëúÌòÑÌòï'Ïóê ÎèÑÎã¨ÌñàÏäµÎãàÎã§. Ïú†Ï†ÑÏûêÍ∞Ä ÏïÑÎ¨¥Î¶¨ Ï¢ãÏïÑÎèÑ ÌôòÍ≤ΩÏù¥ ÎÇòÏÅòÎ©¥ Î≥ëÏù¥ ÏÉùÍ∏∞Îäî ÏõêÎ¶¨, Í∑∏Î¶¨Í≥† Ïïî ÌôòÏûêÏùò ÏÑ∏Ìè¨Î•º ÎñºÏñ¥ÎÇ¥ÏÑú Ïã§Ï†úÎ°ú ÏïΩÏùÑ Ï≥êÎ≥¥Îäî(Functional Assay) ÏµúÏã† Í∏∞Î≤ïÍπåÏßÄ ÏîπÏñ¥Î®πÏñ¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 53: Ïã†Ìò∏ Ï†ÑÎã¨Í≥º ÎåÄÏÇ¨ Í≤ΩÎ°ú (ÌöåÎ°úÎèÑ Î∂ÑÏÑù)
> > 53ÌéòÏù¥ÏßÄ Ï¢åÏ∏° Í∑∏Î¶º, ÏïÑÏ£º Ï†ÑÌòïÏ†ÅÏù∏ **ÏÑ∏Ìè¨ Ïã†Ìò∏ Ï†ÑÎã¨(Signaling Pathway)** ÌöåÎ°úÎèÑÏûÖÎãàÎã§. ÏàúÏÑúÎ•º Ïô∏Ïö∞ÏÑ∏Ïöî.
> > 1.  **Sensor (Í∞êÏßÄÍ∏∞):** ÏÑ∏Ìè¨ÎßâÏùò **Ligand + Receptor**Í∞Ä Ïã†Ìò∏Î•º Î∞õÏäµÎãàÎã§.
> > 2.  **Transducer (Î≥ÄÌôòÍ∏∞):** Ïù∏ÏÇ∞Ìôî(P) Îì±ÏùÑ ÌÜµÌï¥ Ïã†Ìò∏Î•º ÏïàÏúºÎ°ú Ï†ÑÎã¨Ìï©ÎãàÎã§.
> > 3.  **Circuit (ÌöåÎ°ú):** ÏÑ∏Ìè¨Ïßà(Cytoplasm) ÎÇ¥Ïùò Î≥µÏû°Ìïú Ïã†Ìò∏ ÎÑ§Ìä∏ÏõåÌÅ¨.
> > 4.  **Actuator (Íµ¨ÎèôÍ∏∞):** Ìïµ(Nucleus)ÏúºÎ°ú Îì§Ïñ¥Í∞Ä **DNA**Ïùò Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌï©ÎãàÎã§.
> >
> > * **Ïö∞Ï∏° Í∑∏Î¶º (Multi-omics flow):**
> >     * **Genome:** Gene 1, 2...
> >     * **Proteome:** Protein A, B, C... Ìö®ÏÜå(Enzyme)Îì§Ïù¥Ï£†.
> >     * **Metabolome:** Ìö®ÏÜåÎì§Ïù¥ Í∏∞Ïßà(a)ÏùÑ ÏÉùÏÇ∞Î¨º(b)Î°ú Î∞îÍøâÎãàÎã§. **Feedback loop** (Ï†êÏÑ† ÌôîÏÇ¥Ìëú)Í∞Ä Ï°¥Ïû¨ÌïòÏó¨ ÎåÄÏÇ¨ ÏÇ∞Î¨ºÏù¥ Îã§Ïãú Ïú†Ï†ÑÏûê Î∞úÌòÑÏùÑ Ï°∞Ï†àÌïòÍ∏∞ÎèÑ Ìï©ÎãàÎã§.
>
> > [!INFO] PAGE 54: Metabolome (ÎåÄÏÇ¨Ï≤¥)Ïùò ÏúÑÏπò
> > 54ÌéòÏù¥ÏßÄ ÌëúÏóêÏÑú Îπ®Í∞Ñ Î∞ïÏä§Î•º Î≥¥ÏÑ∏Ïöî.
> > * **Metabolome:** GenotypeÎ≥¥Îã§Îäî **Phenotype**Ïóê Ìõ®Ïî¨ Í∞ÄÍπùÏäµÎãàÎã§. Ï¶â, **"ÌòÑÏû¨ Î™∏ ÏÉÅÌÉúÎ•º Í∞ÄÏû• Ïã§ÏãúÍ∞ÑÏúºÎ°ú Î∞òÏòÅÌïòÎäî ÏßÄÌëú"**ÏûÖÎãàÎã§. Ïú†Ï†ÑÏûêÎäî ÌÉúÏñ¥ÎÇ† Îïå Í≤∞Ï†ïÎêòÏßÄÎßå, ÎåÄÏÇ¨Ï≤¥Îäî ÏïÑÏπ® Î®πÏóàÎÉê Íµ∂ÏóàÎÉêÏóê Îî∞Îùº Îã¨ÎùºÏßÄÎãàÍπåÏöî. 
>
> > [!IMPORTANT] PAGE 56: Ïú†Ï†ÑÏûêÏôÄ ÌôòÍ≤ΩÏùò ÏÉÅÌò∏ÏûëÏö© (Landscape Model)
> > Ïûê, Ïù¥ Í∑∏Î¶º Ïù¥Ìï¥ Î™ªÌïòÎ©¥ ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïô ÍΩùÏûÖÎãàÎã§. Í≥µÏù¥ Íµ¥Îü¨Í∞ÄÎäî Í≤ΩÎ°ú(Trajectory)Í∞Ä ÏÑ∏Ìè¨Ïùò Ïö¥Î™ÖÏûÖÎãàÎã§.
> > * **a (Phenotypic state):** Í≥µÏù¥ Íµ¥Îü¨ÎÇ¥Î†§ÏôÄ Í≥®ÏßúÍ∏∞(Attractor)Ïù∏ **P1~P5** Ï§ë ÌïòÎÇòÏóê ÏïàÏ∞©Ìï©ÎãàÎã§. Ïù¥Í≤å Ï†ïÏÉÅÏ†ÅÏù∏ Î∂ÑÌôîÏûÖÎãàÎã§. 
> > * **b (Environmental factor):** Ïô∏Î∂Ä ÌôòÍ≤ΩÏù¥ Í≥µÏùÑ Î∞ÄÏñ¥Î≤ÑÎ¶ΩÎãàÎã§. Í∑∏Îü¨Î©¥ ÏõêÎûò Í∞ÄÏïº Ìï† Í∏∏(Trajectory)ÏùÑ Î≤óÏñ¥ÎÇò Îã§Î•∏ ÌëúÌòÑÌòïÏúºÎ°ú Í∞ÄÍ≤å ÎêòÏ£†. 
> > * **c (Genetic factor):** Ïú†Ï†ÑÏûê Î≥ÄÏù¥Í∞Ä ÏÉùÍ∏∞Î©¥? **ÏßÄÌòï(Landscape) ÏûêÏ≤¥**Í∞Ä Î∞îÎÄùÎãàÎã§. Í≥®ÏßúÍ∏∞ Î™®ÏñëÏù¥ Î∞îÎÄåÏñ¥ÏÑú Í≥µÏù¥ ÏóâÎö±Ìïú Í≥≥ÏúºÎ°ú Íµ¥Îü¨Í∞ÄÍ≤å ÎßåÎì≠ÎãàÎã§. 
> > * **d (Noise):** ÌäπÎ≥ÑÌïú ÏöîÏù∏ ÏóÜÏñ¥ÎèÑ ÌôïÎ•†Ï†ÅÏù∏ Ïû°Ïùå(Stochasticity)ÎßåÏúºÎ°úÎèÑ Í≤∞Í≥ºÍ∞Ä Îã¨ÎùºÏßà Ïàò ÏûàÏäµÎãàÎã§. 
>
> > [!TIP] üí° PAGE 57-58: Ï∞®ÏÑ∏ÎåÄ Í∏∞Îä•ÏÑ± Î∂ÑÏÑù (Next-Gen Functional Assays)
> > 57-58ÌéòÏù¥ÏßÄÎäî Ïã§Ï†ú Î≥ëÏõêÏóêÏÑú Ïïî ÌôòÏûê Ï°∞ÏßÅÏùÑ ÎñºÏñ¥ÎÇ¥ÏÑú ÌïòÎäî Í≤ÄÏÇ¨Îì§ÏûÖÎãàÎã§. **"ÌôòÏûê ÎßûÏ∂§Ìòï ÏπòÎ£å(Precision Medicine)"**Ïùò ÏµúÏ†ÑÏÑ†Ïù¥Ï£†.
> >
> > **1. Í≤ÄÏ≤¥ ÌôïÎ≥¥ (57p):**
> > * **Solid tumours (Í≥†ÌòïÏïî):** Biopsy(ÏÉùÍ≤Ä) ÎòêÎäî CTCs(ÏàúÌôò Ï¢ÖÏñë ÏÑ∏Ìè¨).
> > * **Haematological (ÌòàÏï°Ïïî):** Bone marrow biopsy(Í≥®Ïàò ÏÉùÍ≤Ä).
> > * Ïù¥Í±∏Î°ú **Organoids (Ïò§Í∞ÄÎÖ∏Ïù¥Îìú, ÎØ∏Îãà Ïû•Í∏∞)**Î•º ÎßåÎì≠ÎãàÎã§. 
> >
> > **2. ÌïµÏã¨ Î∂ÑÏÑùÎ≤ï (58p - Ïö©Ïñ¥ ÏïîÍ∏∞):**
> > * **Kinase profiling:** Ïù∏ÏÇ∞Ìôî Ìö®ÏÜå ÌôúÏÑ± Ï∏°Ï†ï. 
> > * **Immuno-flow / FACS:** Ìï≠Ï≤¥Î•º Ïù¥Ïö©Ìï¥ Îã®Î∞±Ïßà Î∞úÌòÑ Î∂ÑÏÑù. 
> > * **DBP (Dynamic BH3 Profiling):** ÏÑ∏Ìè¨Í∞Ä ÏñºÎßàÎÇò Ï£ΩÍ∏∞ Ïâ¨Ïö¥ÏßÄ(**Apoptotic priming**) Ï∏°Ï†ï. 
> > * **Cytotoxicity (ÏÑ∏Ìè¨ ÎèÖÏÑ±):** ÏïΩ Ï≥§ÏùÑ Îïå ÏñºÎßàÎÇò Ï£ΩÎÇò? (**ATP levels, MTT** Îì±ÏúºÎ°ú Ï∏°Ï†ï). 
> > * **PDX (Patient-Derived Xenograft):** Ï•ê(Mouse)Ïóê ÌôòÏûê ÏïîÏùÑ Ïù¥ÏãùÌï¥ÏÑú ÌÖåÏä§Ìä∏. Í∞ÄÏû• Ï†ïÌôïÌïòÏßÄÎßå ÎπÑÏã∏Í≥† Ïò§Îûò Í±∏Î¶º. 
>
> > [!INFO] PAGE 59: Phenome (ÌòÑÏÉÅÏ≤¥)Ïùò Íµ¨ÏÑ±
> > 59ÌéòÏù¥ÏßÄ ÎßàÏßÄÎßâ Îã®Í≥ÑÏûÖÎãàÎã§.
> > * Í≤∞Íµ≠ Ïù¥ Î™®Îì† Í≥ºÏ†ïÏùò ÎÅùÏùÄ Î¨¥ÏóáÏù∏Í∞Ä?
> > * **Tumorigenesis (Ï¢ÖÏñë ÌòïÏÑ±)**
> > * **Angiogenesis (ÌòàÍ¥Ä ÏÉùÏÑ±)**
> > * **Metastasis (Ï†ÑÏù¥)**
> > * Ïù¥Îü∞ Í±∞ÏãúÏ†ÅÏù∏ ÌäπÏßïÎì§ÏùÑ **Phenome**Ïù¥ÎùºÍ≥† Î∂ÄÎ¶ÖÎãàÎã§. 

> [!NOTE] Pages 60-66: ÌõÑÏÑ±Ïú†Ï†ÑÌïô ÌòÅÎ™Ö (Epigenomic Revolution)
> Ïûê, DNA ÏóºÍ∏∞ÏÑúÏó¥Ïù¥ Ïö¥Î™ÖÏùò Ï†ÑÎ∂ÄÍ∞Ä ÏïÑÎãôÎãàÎã§. ÎòëÍ∞ôÏùÄ ÏïÖÎ≥¥(DNA)Î•º Í∞ÄÏßÄÍ≥†ÎèÑ Ïó∞Ï£ºÏûê(ÏÑ∏Ìè¨)Ïóê Îî∞Îùº Ïä¨Ìîà Í≥°Ïù¥ ÎêòÍ∏∞ÎèÑ ÌïòÍ≥† Í∏∞ÏÅú Í≥°Ïù¥ ÎêòÍ∏∞ÎèÑ ÌïòÏ£†. Í∑∏Í≤å Î∞îÎ°ú **Epigenetics**ÏûÖÎãàÎã§. Ïó¨Í∏∞ÏÑúÎäî **ChromatinÏùò Íµ¨Ï°∞ Î≥ÄÌôî**ÏôÄ **Histone Code**Î•º Ìï¥ÎèÖÌïòÎäî Í≤å ÌïµÏã¨ÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 60-61: ChromatinÏùò Í∞úÌèêÏôÄ Histone Tail
> > 60ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî.
> > * **Compact DNA (a):** ÍΩÅÍΩÅ Í∞êÍ≤® ÏûàÏäµÎãàÎã§. Ïù¥Îü¨Î©¥ Ï†ÑÏÇ¨ Ïù∏Ïûê(TF)Í∞Ä Ï†ëÍ∑ºÏùÑ Î™ª ÌïòÏ£†. **"Gene Inactive"** ÏÉÅÌÉúÏûÖÎãàÎã§. 
> > * **Relaxed DNA (b):** Íµ¨Ï°∞Í∞Ä ÌíÄÎ†∏ÏäµÎãàÎã§(Alteration of structure). DNAÍ∞Ä ÎÖ∏Ï∂úÎêòÎãà Ï†ÑÏÇ¨(Transcription)Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. **"Gene Active"** ÏÉÅÌÉúÏûÖÎãàÎã§. 
> >
> > 61ÌéòÏù¥ÏßÄÎ•º Î≥¥ÏÑ∏Ïöî. Ïù¥ ChromatinÏùÑ ÎßåÎìúÎäî Ïã§Ìå®Í∞Ä **Histone**Ïù¥Ï£†.
> > * **Íµ¨ÏÑ±:** **H2A, H2B, H3, H4**Í∞Ä Í∞ÅÍ∞Å 2Í∞úÏî© Î™®Ïó¨ 8ÎüâÏ≤¥(Octamer)Î•º Ïù¥Î£πÎãàÎã§. 
> > * **Tail (Íº¨Î¶¨):** Í∑∏Î¶ºÏóê ÏÇêÏ£ΩÏÇêÏ£Ω ÌäÄÏñ¥ÎÇòÏò® ÏÑ†Îì§ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å **Histone Tail**ÏûÖÎãàÎã§. Ïó¨Í∏∞Í∞Ä Î∞îÎ°ú ÌôîÌïôÏ†Å Î≥ÄÌòïÏù¥ ÏùºÏñ¥ÎÇòÎäî **'Ï°∞Ï†à Ïä§ÏúÑÏπò'**ÏûÖÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 62: ÌûàÏä§ÌÜ§ ÏΩîÎìú (Histone Code) ÏÉÅÏÑ∏ Î∂ÑÏÑù (‚òÖÏïîÍ∏∞)
> > 62ÌéòÏù¥ÏßÄ, Íπ®Ïïå Í∞ôÏùÄ ÏïåÌååÎ≤≥Îì§Ïù¥ ÎÇòÏòµÎãàÎã§. Ïù¥Í≤å ÌûàÏä§ÌÜ§ Íº¨Î¶¨Ïùò ÏïÑÎØ∏ÎÖ∏ÏÇ∞ ÏÑúÏó¥ÏûÖÎãàÎã§. ÏãúÌóòÏóê ÎÇòÏòµÎãàÎã§.
> >
> > **1. H3 Tail (ÏúÑÏ™Ω Í∑∏Î¶º):** 
> > * ÏÑúÏó¥ ÏãúÏûë: **N-ARTKQTARKSTGGK...** (Ïù¥Í±∞ ÎààÏóê ÏùµÌûàÏÑ∏Ïöî) 
> > * Ï£ºÏöî Î≥ÄÌòï ÏúÑÏπò (Ïà´ÏûêÎäî ÏïÑÎØ∏ÎÖ∏ÏÇ∞ Î≤àÌò∏):
> >     * **K (Lysine, Î¶¨Ïã†):** Ï£ºÎ°ú **Me (Methylation)**ÏôÄ **Ac (Acetylation)**Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. (Ïòà: K4, K9, K27) 
> >     * **S (Serine, ÏÑ∏Î¶∞):** Ï£ºÎ°ú **P (Phosphorylation, Ïù∏ÏÇ∞Ìôî)**Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. (Ïòà: S10, S28) 
> >
> > **2. H4 Tail (ÏïÑÎûòÏ™Ω Í∑∏Î¶º):** 
> > * ÏÑúÏó¥ ÏãúÏûë: **N-SGRGKGGK...** 
> > * Ïó¨Í∏∞ÎèÑ **Acetylation (Ac)**Ïù¥ ÏûîÎú© Î∂ôÏñ¥ ÏûàÏ£†? (K5, K8, K12, K16 Îì±) 
> >
> > **3. H2A & H2B:**
> > * **Ub (Ubiquitination):** Ïú†ÎπÑÌÄ¥Ìã¥Ïù¥ Î∂ôÍ∏∞ÎèÑ Ìï©ÎãàÎã§. 
> >
> > **[ÍµêÏàòÎãòÏùò ÌåÅ]** "KÏóê AcetylÍ∏∞Í∞Ä Î∂ôÏúºÎ©¥(Acetylation) Ï†ÑÏÇ¨Í∞Ä **Ï¥âÏßÑ**ÎêòÍ≥†, MethylÍ∏∞Í∞Ä Î∂ôÏúºÎ©¥(Methylation) ÏúÑÏπòÏóê Îî∞Îùº Ï¥âÏßÑÎêòÍ∏∞ÎèÑ ÌïòÍ≥† ÏñµÏ†úÎêòÍ∏∞ÎèÑ ÌïúÎã§." Ïù¥ ÏõêÏπôÏùÑ Íº≠ Í∏∞ÏñµÌïòÏÑ∏Ïöî.
>
> > [!IMPORTANT] PAGE 63: DNA Methylation (ÌôîÌïô Íµ¨Ï°∞)
> > 63ÌéòÏù¥ÏßÄ, Ïù¥Î≤àÏóî ÌûàÏä§ÌÜ§Ïù¥ ÏïÑÎãàÎùº DNA ÏßÅÏ†ë Î≥ÄÌòïÏûÖÎãàÎã§.
> > * **ÎåÄÏÉÅ:** **Cytosine (C, ÏãúÌÜ†Ïã†)** ÏóºÍ∏∞. 
> > * **Î≥ÄÌôî:** ÏãúÌÜ†Ïã†Ïùò 5Î≤à ÌÉÑÏÜå ÏúÑÏπòÏóê **Methyl group ($CH_3$)**Ïù¥ Î∂ôÏäµÎãàÎã§.
> > * **Í≤∞Í≥º:** **5-methylcytosine**Ïù¥ Îê©ÎãàÎã§. 
> > * **Í∏∞Îä•:** Ï£ºÎ°ú Ïú†Ï†ÑÏûê Î∞úÌòÑÏùÑ **ÏñµÏ†ú(Silencing)**ÌïòÎäî ÏûêÎ¨ºÏá† Ïó≠Ìï†ÏùÑ Ìï©ÎãàÎã§. Í∑∏Î¶ºÏùò ÌôîÌïô Íµ¨Ï°∞Ïãù($NH_2$ Î∞ëÏóê $H$Í∞Ä $CH_3$Î°ú Î∞îÎÄåÎäî Î∂ÄÎ∂Ñ)ÏùÑ ÌôïÏù∏ÌïòÏÑ∏Ïöî. 
>
> > [!INFO] PAGE 64-66: EpigenomeÏùò ÏúÑÏÉÅÍ≥º ÌÜµÌï©
> > 64ÌéòÏù¥ÏßÄ ÌëúÏùò Îπ®Í∞Ñ Î∞ïÏä§Î•º Î≥¥ÏÑ∏Ïöî.
> > * **EpigenomeÏùò Íµ¨ÏÑ± ÏöîÏÜå:**
> >     1.  **Methylation (DNA Î©îÌã∏Ìôî)** 
> >     2.  **Histone modification (ÌûàÏä§ÌÜ§ Î≥ÄÌòï)** 
> >     3.  **miRNA & LncRNA:** ÎπÑÏïîÌò∏Ìôî RNAÎì§ÎèÑ ÌõÑÏÑ±Ïú†Ï†ÑÌïôÏ†Å Ï°∞Ï†àÏóê Í¥ÄÏó¨Ìï©ÎãàÎã§. 
> >
> > 66ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ Ïù¥ Î™®Îì† Í≤å ÌÜµÌï©Îêú Î™®ÏäµÏûÖÎãàÎã§.
> > * **DNA Methylation**Ïù¥ ÎêòÏñ¥ ÏûàÍ≥†, **Histone**Îì§Ïù¥ Î≠âÏ≥ê ÏûàÏúºÎ©¥(Nucleosome) Ï†ëÍ∑º Î∂àÍ∞Ä.
> > * Î∞òÎ©¥ **DNase I hypersensitive sites**Îäî ÌûàÏä§ÌÜ§Ïù¥ ÏóÜÎäî Ïó¥Î¶∞ Íµ¨Í∞ÑÏúºÎ°ú, Ïó¨Í∏∞Í∞Ä **Functional genomic elements(Í∏∞Îä•Ï†Å Ïú†Ï†ÑÏ≤¥ ÏöîÏÜå)**Í∞Ä ÏûëÎèôÌïòÎäî Í≥≥ÏûÖÎãàÎã§. 

> [!NOTE] Pages 67-73: ÌõÑÏÑ±Ïú†Ï†ÑÌïôÍ≥º ÏßàÎ≥ë, Í∑∏Î¶¨Í≥† ENCODE
> Ïûê, "Ïú†Ï†ÑÏûêÎäî Ïö¥Î™ÖÏù¥ ÏïÑÎãàÎã§"ÎùºÎäî Îßê Îì§Ïñ¥Î¥§Ï£†? Í∑∏ Í≥ºÌïôÏ†Å Í∑ºÍ±∞Í∞Ä Ïó¨Í∏∞ Îã§ ÏûàÏäµÎãàÎã§. ÌôòÍ≤Ω(Îã§Ïù¥Ïñ¥Ìä∏, Ïä§Ìä∏Î†àÏä§)Ïù¥ Ïñ¥ÎñªÍ≤å ÎÇ¥ Ïú†Ï†ÑÏûêÏùò Ïä§ÏúÑÏπòÎ•º Ï°∞ÏûëÌï¥ÏÑú ÏïîÏù¥ÎÇò ÎãπÎá®Î≥ëÏùÑ ÏùºÏúºÌÇ§ÎäîÏßÄ, Í∑∏Î¶¨Í≥† Ïú†Ï†Ñ Ï†ïÎ≥¥Î•º ÎÑòÏñ¥ÏÑ† '4Ï∞®Ïõê Ïú†Ï†Ñ'Ïù¥ Î¨¥ÏóáÏù∏ÏßÄ ÏÇ¥Ìé¥Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 67-68: ENCODE ÌîÑÎ°úÏ†ùÌä∏ (ÌïÑÏàò ÏÉÅÏãù)
> > 67ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ ÏïûÏÑú Î∞∞Ïö¥ Ï†ÑÏÇ¨ Ï°∞Ï†àÏùò Ï¥ùÏ†ïÎ¶¨ÏûÖÎãàÎã§.  Ïù¥ Î≥µÏû°Ìïú Ï°∞Ï†à Î∂ÄÏúÑÎì§ÏùÑ Ï†ÑÎ∂Ä Îã§ ÏßÄÎèÑÏóê ÌëúÏãúÌïòÎ†§Îäî ÏãúÎèÑÍ∞Ä ÏûàÏóàÏúºÎãà, Î∞îÎ°ú **ENCODE**ÏûÖÎãàÎã§.
> > * **Ï†ïÏùò (68p):** **The Encyclopedia of DNA Elements**. 'DNA ÏöîÏÜå Î∞±Í≥ºÏÇ¨Ï†Ñ' ÌîÑÎ°úÏ†ùÌä∏ÏûÖÎãàÎã§. 
> > * **Î™©Ìëú:** Ïù∏Í∞Ñ Í≤åÎÜàÏùò **'Î™®Îì† Í∏∞Îä•Ï†Å ÏöîÏÜå(All functional elements)'**Î•º ÏãùÎ≥ÑÌïòÎäî Í≤É. 
> > * **ÎÇ¥Ïö©:** Îã®ÏàúÌûà Ïú†Ï†ÑÏûêÎßå Ï∞æÎäî Í≤å ÏïÑÎãàÎùº, **Regulatory elements(Ï°∞Ï†à Ïù∏Ïûê)**, **Exon variants**, **Alternative promoters** Îì± 'Í∏∞Îä•'ÏùÑ ÌïòÎäî Î™®Îì† Í≤ÉÏùÑ Ï∞æÏäµÎãàÎã§. 
>
> > [!INFO] PAGE 69: ÌõÑÏÑ±Ïú†Ï†ÑÌïôÏ†Å Ïä§ÏúÑÏπò (Active vs Inactive)
> > 69ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Í∞ôÏùÄ DNAÎùºÎèÑ ÏÉÅÌÉúÍ∞Ä Îã§Î¶ÖÎãàÎã§.
> > * **Inactive (ÎπÑÌôúÏÑ±):** DNAÍ∞Ä **Methylation** ÎêòÏñ¥ ÏûàÍ≥†, HistoneÏù¥ ÍΩâ Î≠âÏ≥êÏÑú(Inaccessible) Ïú†Ï†ÑÏûêÍ∞Ä Í∫ºÏ†∏ ÏûàÏäµÎãàÎã§. 
> > * **Active (ÌôúÏÑ±):** **Histone Modification**Ïóê ÏùòÌï¥ Íµ¨Ï°∞Í∞Ä ÌíÄÎ†§ ÏûàÍ≥†(Accessible), Ïú†Ï†ÑÏûêÍ∞Ä ÏºúÏ†∏ ÏûàÏäµÎãàÎã§. 
> > * **ÌïµÏã¨:** ÏãùÏù¥ÏöîÎ≤ï(Dietary sources) Í∞ôÏùÄ ÌôòÍ≤Ω ÏöîÏù∏Ïù¥ Î©îÌã∏Í∏∞(Methyl group)Î•º Ï†úÍ≥µÌï¥ÏÑú Ïù¥ Ïä§ÏúÑÏπòÎ•º Ï°∞ÏûëÌï† Ïàò ÏûàÎã§Îäî Í≤ÅÎãàÎã§. 
>
> > [!WARNING] PAGE 70: ÌôòÍ≤ΩÍ≥º ÏßàÎ≥ëÏùò Ïó∞Í≤∞Í≥†Î¶¨ (Environment-Disease Link)
> > 70ÌéòÏù¥ÏßÄ, Ïó¨Í∏∞Í∞Ä ÏûÑÏÉÅÏ†ÅÏúºÎ°ú Ï†úÏùº Ï§ëÏöîÌï©ÎãàÎã§. Ïôú ÎÇòÏÅú Í±∞ Î®πÏúºÎ©¥ ÏïîÏóê Í±∏Î¶¥ÍπåÏöî?
> > * **ÏòÅÌñ• ÏöîÏù∏ (Factors):** **Diet(ÏãùÎã®)**, **Aging(ÎÖ∏Ìôî)**, **Drugs**, **Environmental chemicals**, Ïã¨ÏßÄÏñ¥ **Development(Î∞úÎã¨ Í≥ºÏ†ï)**ÍπåÏßÄ. 
> > * **Í∏∞Ï†Ñ:** Ïù¥ ÏöîÏù∏Îì§Ïù¥ **DNA Methylation**Ïù¥ÎÇò **Histone Modification**ÏùÑ Î≥ÄÌôîÏãúÌÇµÎãàÎã§. 
> > * **Í≤∞Í≥º (Health Endpoints):** Ïú†Ï†ÑÏûêÍ∞Ä ÏûòÎ™ª ÏºúÏßÄÍ±∞ÎÇò Í∫ºÏ†∏ÏÑú **Cancer(Ïïî)**, **Autoimmune disease(ÏûêÍ∞ÄÎ©¥Ïó≠ÏßàÌôò)**, **Diabetes(ÎãπÎá®)** Îì±Ïù¥ Î∞úÏÉùÌï©ÎãàÎã§. 
>
> > [!INFO] PAGE 71: Ïú†Ï†ÑÏùò 4Í∞ÄÏßÄ Ï∞®Ïõê (4 Dimensions)
> > 71ÌéòÏù¥ÏßÄ ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏùÄ DNA(Genetic)Î°úÎßå ÎêòÎäî Í≤å ÏïÑÎãôÎãàÎã§. 
> > 1.  **Genetic:** DNA ÏóºÍ∏∞ÏÑúÏó¥.
> > 2.  **Epigenetic:** Chromatin marks, RNA silencing Îì±. (ÏÑ∏Ìè¨ Í∏∞Ïñµ)
> > 3.  **Behavioral:** ÌñâÎèôÏ†Å Ï†ÑÏàò (Îî∞Îùº ÌïòÍ∏∞ Îì±).
> > 4.  **Symbolic:** Ïñ∏Ïñ¥, Î¨∏Ìôî Îì± Ïù∏Í∞Ñ Í≥†Ïú†Ïùò Ï†ÑÏàò.
>
> > [!IMPORTANT] PAGE 72: ÌûàÏä§ÌÜ§ ÎßàÌÅ¨Ïùò Íµ¨Ï≤¥Ï†Å Í∏∞Îä• (Ïã¨Ìôî ‚òÖ)
> > 72ÌéòÏù¥ÏßÄ Ïõê ÏïàÏùò Í∏∞Ìò∏Îì§ÏùÑ Ìï¥ÏÑùÌï¥Ïïº Ìï©ÎãàÎã§. **K(ÎùºÏù¥Ïã†)**Ïóê Î≠êÍ∞Ä Î∂ôÎäêÎÉêÏóê Îî∞Îùº Ïö¥Î™ÖÏù¥ Í∞àÎ¶ΩÎãàÎã§. 
> > * **MeK4 (H3K4me):** Ï£ºÎ°ú **Activation (ÌôúÏÑ±Ìôî)**ÏôÄ Í¥ÄÎ†®Îê©ÎãàÎã§.
> > * **MeK9, MeK27 (H3K9me, H3K27me):** Ï£ºÎ°ú **Repression (ÏñµÏ†ú)**ÏôÄ Í¥ÄÎ†®Îê©ÎãàÎã§. (ÌôîÏÇ¥ÌëúÍ∞Ä ÏñµÏ†ú Î™®ÏñëÏù∏ Í≤É ÌôïÏù∏!) 
> > * **AcK (Acetylation):** Í±∞Ïùò Ìï≠ÏÉÅ **Activation**ÏûÖÎãàÎã§.
> > * **CpG Methylation:** DNA Î©îÌã∏ÌôîÎäî Ï£ºÎ°ú **ÏñµÏ†ú**ÏûÖÎãàÎã§.
> > * Ïù¥Îì§Ïù¥ ÏÑúÎ°ú ÏÉÅÌò∏ÏûëÏö©(Cross-talk)ÌïòÎ©∞ Ï†ïÍµêÌïòÍ≤å Ï°∞Ï†àÌï©ÎãàÎã§.
>
> > [!INFO] PAGE 73: EpigenomeÏùò ÌÜµÌï©Ï†Å ÏúÑÏπò
> > 73ÌéòÏù¥ÏßÄ, Îã§Ïãú ÌïúÎ≤à Ï†ÑÏ≤¥ ÏßÄÎèÑÎ•º Î¥ÖÎãàÎã§.
> > * **Epigenome**ÏùÄ GenomeÍ≥º Transcriptome ÏÇ¨Ïù¥ÏóêÏÑú Ï†ïÎ≥¥Ïùò ÌùêÎ¶ÑÏùÑ ÌÜµÏ†úÌïòÎäî **'Í≤ÄÎ¨∏ÏÜå'** Ïó≠Ìï†ÏùÑ Ìï©ÎãàÎã§. Ïó¨Í∏∞ÏÑú **Tumorigenesis(Ïïî Î∞úÏÉù)** Îì±Ïùò Ïö¥Î™ÖÏù¥ 1Ï∞®Ï†ÅÏúºÎ°ú Í≤∞Ï†ïÎêòÎäî Í≤ÉÏûÖÎãàÎã§. 

> [!NOTE] Pages 74-80: ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïôÏùò ÎèÑÍµ¨ÏôÄ Multi-Omics
> Ïûê, Ïù¥Ï†ú Ïù¥Î°†ÏùÄ Ï∂©Î∂ÑÌï©ÎãàÎã§. Ïã§Ï†úÎ°ú Ïù¥ Î∞©ÎåÄÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïñ¥ÎñªÍ≤å ÎΩëÏïÑÎÇ¥Í≥†(Microarray), Ïñ¥ÎñªÍ≤å Î∂ÑÏÑùÌï¥ÏÑú(AI), ÌôòÏûêÎ•º Î∂ÑÎ•ò(Stratification)ÌïòÎäîÏßÄ, Í∑∏ 'Î¨¥Í∏∞'Îì§ÏùÑ Ï†êÍ≤ÄÌï¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 74: Multi-OmicsÏôÄ AIÏùò Í≤∞Ìï© (ÏïåÍ≥†Î¶¨Ï¶ò Ï≤¥ÌÅ¨)
> > 74ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ Ï†ïÎ∞ÄÏùòÌïôÏùò 'Ï†ÑÌà¨ ÏßÄÎèÑ'ÏûÖÎãàÎã§. 
> > * **Multi-Omics:** Genome, Epigenome, Transcriptome, Proteome, MetabolomeÏùÑ Ï†ÑÎ∂Ä Ìï©Ïπ©ÎãàÎã§.
> > * **AI & Machine Learning:** Ïù¥ Îç∞Ïù¥ÌÑ∞Î•º ÏÇ¨ÎûåÏù¥ ÎààÏúºÎ°ú Î™ª Î¥ÖÎãàÎã§. AIÍ∞Ä ÌïÑÏöîÌïòÏ£†. Ïó¨Í∏∞Ïóê Ïì∞Ïù¥Îäî ÏïåÍ≥†Î¶¨Ï¶ò Ïù¥Î¶ÑÎì§ÏùÑ Íº≠ ÎààÏó¨Í≤®Î≥¥ÏÑ∏Ïöî.
> >     * **SVM (Support Vector Machine)** 
> >     * **DT (Decision Tree)** 
> >     * **RF (Random Forest)** 
> >     * **LightGBM:** ÏµúÍ∑º Îç∞Ïù¥ÌÑ∞ Î∂ÑÏÑù ÎåÄÌöåÏóêÏÑú ÎßéÏù¥ Ïì∞Ïù¥Îäî Í∞ïÎ†•Ìïú Î∂ÄÏä§ÌåÖ Î™®Îç∏ÏûÖÎãàÎã§. 
> >     * **Deep Learning (Îî•Îü¨Îãù):** Ïù¥ÎØ∏ÏßÄÎÇò ÎπÑÏ†ïÌòï Îç∞Ïù¥ÌÑ∞ Î∂ÑÏÑùÏóê Í∞ïÌïòÏ£†. 
> > * **Í≥ºÏ†ï:** Îç∞Ïù¥ÌÑ∞ ÌÜµÌï©(Data Integration) ‚Üí ÌäπÏßï ÏÑ†ÌÉù(Feature Selection) ‚Üí ÏòàÏ∏°(Prediction).
>
> > [!INFO] PAGE 75-76: ÌôòÏûê Ï∏µÌôî (Stratification)ÏôÄ Omics Ï†ïÏùò
> > 75ÌéòÏù¥ÏßÄ, ÏïåÎ°ùÎã¨Î°ùÌïú ÏÇ¨Îûå Í∑∏Î¶º Î≥¥Ïù¥Ï£†? 
> > * Í≥ºÍ±∞Ïóî Îã§ ÎòëÍ∞ôÏùÄ ÏÇ¨Îûå(Average patient) Ï∑®Í∏âÌñàÏßÄÎßå, Ïù¥Ï†úÎäî Îç∞Ïù¥ÌÑ∞Î•º ÌÜµÌï¥ **"Stratification(Ï∏µÌôî)"**Ìï©ÎãàÎã§. Í∑∏Î£πÏùÑ ÎÇòÎààÎã§Îäî ÎúªÏûÖÎãàÎã§. Í∑∏ÎûòÏïº **High effective treatment**Í∞Ä Í∞ÄÎä•ÌïòÎãàÍπåÏöî.
> >
> > 76ÌéòÏù¥ÏßÄ, Ïö©Ïñ¥ Ï†ïÎ¶¨ÌïòÍ≥† Í∞ëÏãúÎã§. 
> > * **Omics:** "-ome"ÏùÄ Ï†ÑÏ≤¥(Complete knowledge)Î•º ÎúªÌï©ÎãàÎã§.
> > * **Transcriptomics:** RNA Ï†ÑÏ≤¥.
> > * **Proteomics:** Îã®Î∞±Ïßà Ï†ÑÏ≤¥.
> > * **Metabolomics:** ÎåÄÏÇ¨Î¨ºÏßà Ï†ÑÏ≤¥.
>
> > [!IMPORTANT] PAGE 77-79: DNA Microarray ÏõêÎ¶¨ (ÏÉÅÏÑ∏ Ïä§Ìéô ÏïîÍ∏∞)
> > 77ÌéòÏù¥ÏßÄ, Ïù¥Í≤å Î∞îÎ°ú ÏàòÎßå Í∞úÏùò Ïú†Ï†ÑÏûêÎ•º Ìïú Î∞©Ïóê Í≤ÄÏÇ¨ÌïòÎäî **DNA Microarray** Ïπ©ÏûÖÎãàÎã§. ÏàòÏπòÎ•º Î≥¥ÏÑ∏Ïöî.
> > * **ÌÅ¨Í∏∞:** Ï†ÑÏ≤¥ Ïπ©ÏùÄ **3cm x 7cm** Ï†ïÎèÑÏûÖÎãàÎã§. Ïä¨ÎùºÏù¥Îìú Í∏ÄÎùºÏä§ ÌÅ¨Í∏∞Ï£†. 
> > * **Spot:** Í∑∏ ÏïàÏóê ÏûëÏùÄ Ï†êÎì§Ïù¥ Ï∞çÌòÄ ÏûàÎäîÎç∞, Í∞Å Ï†êÏùò ÏßÄÎ¶ÑÏùÄ **150¬µm**, Ï†ê ÏÇ¨Ïù¥ Í∞ÑÍ≤©ÏùÄ **300¬µm**ÏûÖÎãàÎã§. 
> > * **ÏõêÎ¶¨:**
> >     1.  Ïπ© ÏúÑÏóê **Probe DNA(ÌÉêÏπ®)**Î•º ÎØ∏Î¶¨ Ïã¨Ïñ¥ÎÜìÏäµÎãàÎã§. (ÏàòÎßå Í∞ú) 
> >     2.  ÌôòÏûêÏùò ÏÉòÌîå(RNA)ÏùÑ Ïó≠Ï†ÑÏÇ¨Ìï¥ÏÑú **Fluorescent tagging(ÌòïÍ¥ë ÌëúÏßÄ)**ÏùÑ Î∂ôÏù∏ DNA(cDNA)Î°ú ÎßåÎì≠ÎãàÎã§. 
> >     3.  Ïπ© ÏúÑÏóê ÎøåÎ¶¨Î©¥, Ïßù(ÏÉÅÎ≥¥Ï†Å ÏÑúÏó¥)Ïù¥ ÎßûÎäî Í≤ÉÎÅºÎ¶¨ Îì§Îü¨Î∂ôÏäµÎãàÎã§. Ïù¥Í±∏ **Hybridization(ÌòºÏÑ±Ìôî)**Ïù¥ÎùºÍ≥† Ìï©ÎãàÎã§. 
> > * **Ìï¥ÏÑù (78p):** 
> >     * ÌäπÏ†ï ÏÉâÍπî(Î≥¥ÌÜµ Îπ®Í∞ï/Ï¥àÎ°ù)Ïù¥ ÎπõÎÇòÎ©¥ Í∑∏ Ïú†Ï†ÑÏûêÍ∞Ä Î∞úÌòÑÎêú Í≤ÉÏûÖÎãàÎã§.
> >     * Îëê ÏÉâÏù¥ ÏÑûÏó¨(ÎÖ∏Îûë) ÎÇòÏò§Î©¥ Îëò Îã§ ÏûàÎäî Í±∞Í≥†Ïöî.
> 
>
> > [!INFO] PAGE 80: HeatmapÍ≥º Ï¢ÖÏñë Î∂ÑÎ•ò (Taxonomy)
> > 80ÌéòÏù¥ÏßÄ, ÎßàÏπò Î™®ÏûêÏù¥ÌÅ¨ Í∞ôÏùÄ Í∑∏Î¶ºÏù¥ **Heatmap**ÏûÖÎãàÎã§. 
> > * **Í∞ÄÎ°úÏ§Ñ:** Ïú†Ï†ÑÏûê ÌïòÎÇòÌïòÎÇò.
> > * **ÏÑ∏Î°úÏ§Ñ:** ÌôòÏûê Ìïú Î™Ö Ìïú Î™Ö.
> > * **ÏÉâÍπî:** Îπ®Í∞ÑÏÉâÏùÄ Î∞úÌòÑ ÎÜíÏùå(High), Ï¥àÎ°ùÏÉâÏùÄ ÎÇÆÏùå(Low)ÏùÑ Ï£ºÎ°ú ÎÇòÌÉÄÎÉÖÎãàÎã§.
> > * **Dendrogram (ÎÇòÎ≠áÍ∞ÄÏßÄ Í∑∏Î¶º):** ÏúÑÏ™ΩÏóê ÏûàÎäî Í∞ÄÏßÄ Í∑∏Î¶ºÏûÖÎãàÎã§. Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥Ïù¥ ÎπÑÏä∑Ìïú ÌôòÏûêÎÅºÎ¶¨ Î¨∂Ïñ¥Ï§çÎãàÎã§(Clustering).
> > * **Í≤∞Í≥º:** ÌôòÏûêÎì§Ïù¥ **A, B, C, D** ÎÑ§ Í∞ÄÏßÄ Í∑∏Î£π(Tumor classes)ÏúºÎ°ú ÍπîÎÅîÌïòÍ≤å ÎÇòÎâòÎäî Í±∞ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å Î∞îÎ°ú Ï†ïÎ∞ÄÏùòÌïôÏùò ÏãúÏûëÏûÖÎãàÎã§.

> [!NOTE] Pages 81-89: ÎÑ§Ìä∏ÏõåÌÅ¨ ÎèôÏó≠Ìïô (Network Dynamics)
> Ïûê, ÏßÄÍ∏àÍπåÏßÄ Î∞∞Ïö¥ Ïú†Ï†ÑÏûê, Îã®Î∞±Ïßà, ÎåÄÏÇ¨Ï≤¥Îì§ÏùÑ Îã§ Ïó∞Í≤∞ÌïòÎ©¥ Ïñ¥ÎñªÍ≤å Îê†ÍπåÏöî? Îã®ÏàúÌïú ÏÑ†(Line)Ïù¥ ÏïÑÎãàÎùº Î≥µÏû°Ìïú **ÎÑ§Ìä∏ÏõåÌÅ¨(Network)**Í∞Ä Îê©ÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ ÎÑ§Ìä∏ÏõåÌÅ¨Ïùò ÏõÄÏßÅÏûÑÏùÑ ÏàòÌïôÏ†ÅÏúºÎ°ú ÌëúÌòÑÌïú Í≤ÉÏù¥ Î∞îÎ°ú **State Space(ÏÉÅÌÉú Í≥µÍ∞Ñ)**ÏûÖÎãàÎã§. Ïù¥ Í∞úÎÖêÏùÑ Ïù¥Ìï¥Ìï¥Ïïº "ÏÑ∏Ìè¨Í∞Ä Î∂ÑÌôîÌïúÎã§"Îäî ÎßêÏùò ÏßÑÏßú ÏùòÎØ∏Î•º ÏïåÍ≤å Îê©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 81: Ï¢ÖÏñëÏùò Ïù¥ÏßàÏÑ± (Tumor Heterogeneity)
> > 81ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Ïïî Îç©Ïñ¥Î¶¨Í∞Ä Îã§ ÎòëÍ∞ôÏùÄ ÏÑ∏Ìè¨Í∞Ä ÏïÑÎãàÎùºÎäî Ï¶ùÍ±∞ÏûÖÎãàÎã§. 
> > * **Clonal Evolution:**
> >     * **Monoclonal:** ÌïòÎÇòÏùò Ï°∞ÏÉÅÏóêÏÑú ÏãúÏûëÌï¥ ÎπÑÏä∑ÌïòÍ≤å ÏûêÎûå.
> >     * **Polyclonal:** Ïó¨Îü¨ Ï°∞ÏÉÅÏù¥ ÏÑûÏó¨ÏÑú ÏïÑÏ£º Îã§ÏñëÌïú(Polygenomic) Ïïî Ï°∞ÏßÅÏùÑ ÌòïÏÑ±. ÏπòÎ£åÍ∞Ä Ïñ¥Î†µÍ≤†Ï£†?
> > * **Cancer Stem Cells (Ïïî Ï§ÑÍ∏∞ÏÑ∏Ìè¨):**
> >     * **Single vs Multiple progenitors:** Ï§ÑÍ∏∞ÏÑ∏Ìè¨ ÌïòÎÇòÏóêÏÑú ÏôîÎÉê, Ïó¨Îü¨ Í∞úÏóêÏÑú ÏôîÎÉêÏóê Îî∞Îùº ÏïîÏùò Î≥µÏû°ÎèÑÍ∞Ä Îã¨ÎùºÏßëÎãàÎã§.
> > * **Í≤∞Î°†:** ÏïîÏùÄ **Polygenomic Tumor**Ïù∏ Í≤ΩÏö∞Í∞Ä ÎßéÏïÑÏÑú, ÏïΩ ÌïòÎÇòÎ°ú(One target) ÏôÑÏπòÍ∞Ä ÌûòÎì† Í≤ÅÎãàÎã§.
>
> > [!INFO] PAGE 82-84: Pathway vs Network View
> > 84ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏù¥ ÌïµÏã¨ÏûÖÎãàÎã§. Í¥ÄÏ†êÏùÑ Î∞îÍæ∏ÏÑ∏Ïöî. 
> > * **Pathway View (A):** $X1 \rightarrow X2$. ÏÑ†ÌòïÏ†ÅÏù¥Í≥† Îã®ÏàúÌï©ÎãàÎã§. "AÏù¥Î©¥ BÎã§"ÎùºÎäî ÏãùÏù¥Ï£†.
> > * **Network View (B):** $X1$Í≥º $X2$Í∞Ä Í±∞ÎåÄÌïú Í±∞ÎØ∏Ï§ÑÏùò ÏùºÎ∂ÄÏùº ÎøêÏûÖÎãàÎã§. $X1$ÏùÑ Í±¥ÎìúÎ¶¨Î©¥ $X2$Îßå Î≥ÄÌïòÎäî Í≤å ÏïÑÎãàÎùº ÎÑ§Ìä∏ÏõåÌÅ¨ Ï†ÑÏ≤¥Í∞Ä Ï∂úÎ†ÅÍ±∞Î¶ΩÎãàÎã§. Ïù¥Í≤å ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïôÏùò Í¥ÄÏ†êÏûÖÎãàÎã§.
> > * 83ÌéòÏù¥ÏßÄÏùò Î≥µÏû°Ìïú ÌôîÏÇ¥Ìëú(Activation/Inhibition)Îì§Ïù¥ Î™®Ïó¨ÏÑú Ïù¥ ÎÑ§Ìä∏ÏõåÌÅ¨Î•º ÎßåÎì≠ÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 85: 3Í≥ÑÏ∏µ ÌÜµÌï© Í≥µÍ∞Ñ (Space Integration)
> > 85ÌéòÏù¥ÏßÄ, 3Í∞úÏùò Ìåê(Layer)Ïù¥ Í≤πÏ≥êÏ†∏ ÏûàÏ£†? 
> > 1.  **Gene Space (Ïú†Ï†ÑÏûê Í≥µÍ∞Ñ):** Gene 1, 2, 3...
> > 2.  **Protein Space (Îã®Î∞±Ïßà Í≥µÍ∞Ñ):** Protein 1, 2, 3...
> > 3.  **Metabolic Space (ÎåÄÏÇ¨ Í≥µÍ∞Ñ):** Metabolite 1, 2...
> > * **Feedback:** Îß® Ïò§Î•∏Ï™Ω ÌôîÏÇ¥ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. **Metabolite 2**Í∞Ä Îã§Ïãú **Gene 4**Ïùò Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌïòÎü¨ ÎÇ¥Î†§Í∞ëÎãàÎã§. Ïù¥Î†áÍ≤å Ï∏µÍ∞Ñ ÏÜåÌÜµÏù¥ ÌôúÎ∞úÌï©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 86-87: ÏÉÅÌÉú Î≤°ÌÑ∞ÏôÄ ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space) - ‚òÖÍ∞úÎÖê ÌïÑÏäπ
> > Ïûê, Ïó¨Í∏∞ ÏßëÏ§ëÌïòÏÑ∏Ïöî. ÏÑ∏Ìè¨Ïùò ÏÉÅÌÉúÎ•º ÏàòÌïôÏúºÎ°ú Ï†ïÏùòÌï©ÎãàÎã§.
> >
> > **1. ÏÉÅÌÉú Î≤°ÌÑ∞ (State Vector, 86p):**
> > * Ïú†Ï†ÑÏûê $N$Í∞úÏùò Î∞úÌòÑÎüâÏùÑ Ïà´ÏûêÎ°ú Ï≠â ÎÇòÏó¥Ìïú Í≤ÅÎãàÎã§. 
> > * Ïãù: $$S = [x_1, x_2, ..., x_N]$$ (Ïòà: $x_1$ÏùÄ Ïú†Ï†ÑÏûê 1Ïùò Î∞úÌòÑÎüâ)
> >
> > **2. ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space, 87p):**
> > * 87ÌéòÏù¥ÏßÄÏùò ÌÅêÎ∏å(Cube) Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. 
> > * **Ï∂ï (Axis):** Í∞Å Ïú†Ï†ÑÏûê($X_1, X_2, X_3$)Í∞Ä $x, y, z$ Ï∂ïÏù¥ Îê©ÎãàÎã§.
> > * **Ï†ê (Point):** ÌäπÏ†ï ÏãúÏ†ê($t_1$)Ïùò ÏÑ∏Ìè¨ ÏÉÅÌÉú($S_1$)Îäî Ïù¥ Í≥µÍ∞Ñ ÏïàÏùò **'Ï†ê ÌïòÎÇò'**Î°ú Ï∞çÌûôÎãàÎã§. (Ïòà: $[3.0, 3.0, 3.0]$)
> > * **Í∂§Ï†Å (Trajectory):** ÏãúÍ∞ÑÏù¥ ÏßÄÎÇ®Ïóê Îî∞Îùº ÏÑ∏Ìè¨Ïùò Ïú†Ï†ÑÏûê Î∞úÌòÑÏù¥ Î≥ÄÌïòÏ£†? Ï†êÏù¥ Ïù¥ÎèôÌïòÎ©¥ÏÑú Í∑∏Î¶¨Îäî ÏÑ†ÏûÖÎãàÎã§.
> > * **Attractor (ÎÅåÍ∞ú):** Îπ®Í∞Ñ Ï†ê($S^*$)ÏùÑ Î≥¥ÏÑ∏Ïöî. Ï†êÎì§Ïù¥ Í≤∞Íµ≠ Ïñ¥ÎîîÎ°ú Î™®Ïù¥ÎÇòÏöî? ÏïàÏ†ïÏ†ÅÏù∏ ÏÉÅÌÉúÎ°ú ÏàòÎ†¥ÌïòÏ£†? Ïù¥ ÎèÑÏ∞©Ï†êÏù¥ Î∞îÎ°ú **"ÏÑ∏Ìè¨ ÌÉÄÏûÖ(Cell Type)"**ÏûÖÎãàÎã§.
> >     * "Ï§ÑÍ∏∞ÏÑ∏Ìè¨Í∞Ä Î∂ÑÌôîÌï¥ÏÑú ÌîºÎ∂ÄÏÑ∏Ìè¨Í∞Ä ÎêêÎã§" = "ÏÉÅÌÉú Í≥µÍ∞ÑÏóêÏÑú Ï†êÏù¥ Ïù¥ÎèôÌï¥ ÌîºÎ∂ÄÏÑ∏Ìè¨ÎùºÎäî AttractorÏóê Îπ†Ï°åÎã§."
>
> > [!INFO] PAGE 88-89: WaddingtonÏùò ÌíçÍ≤Ω (Epigenetic Landscape) ÏàòÌïôÏ†Å Ìï¥ÏÑù
> > 89ÌéòÏù¥ÏßÄ, ÏïÑÍπå Î≥∏ Í≥µ Íµ¥Îü¨Í∞ÄÎäî Í∑∏Î¶ºÏùÑ Îã§Ïãú ÏàòÌïôÏ†ÅÏúºÎ°ú Î¥ÖÎãàÎã§. 
> > * **Basin of attraction (ÎÅåÍ∞ú Ïú†Ïó≠):** Í≥µÏù¥ Íµ¥Îü¨ Îñ®Ïñ¥ÏßÄÎäî Í≥®ÏßúÍ∏∞ÏûÖÎãàÎã§.
> > * **Quasi-potential U:** ÏóêÎÑàÏßÄ Ï§ÄÏúÑ Í∞ôÏùÄ Í≤ÅÎãàÎã§. ÎÇÆÏùÑÏàòÎ°ù ÏïàÏ†ïÏ†ÅÏù¥Ï£†.
> > * **Attractors:** Í≥®ÏßúÍ∏∞ Î∞îÎã•. Ïó¨Í∏∞Ïóê ÏïàÏ∞©ÌïòÎ©¥ **Mature cell types (ÏÑ±Ïàô ÏÑ∏Ìè¨)**Í∞Ä ÎêòÎäî Í≤ÅÎãàÎã§.
> > * **Unused attractors:** ÏßÑÌôîÏ†ÅÏúºÎ°ú ÏµúÏ†ÅÌôîÎêòÏßÄ ÏïäÏùÄ, Î≤ÑÎ†§ÏßÑ ÏõÖÎç©Ïù¥Îì§ÎèÑ Ï°¥Ïû¨Ìï† Ïàò ÏûàÏäµÎãàÎã§. (ÏïîÏÑ∏Ìè¨Í∞Ä Ïó¨Í∏∞Î°ú Í∞à ÏàòÎèÑ ÏûàÏ£†)

> [!NOTE] Pages 90-97: ÎÑ§Ìä∏ÏõåÌÅ¨ ÏùòÌïôÍ≥º Ïã†ÏïΩ Í∞úÎ∞ú (Network Medicine)
> Ïûê, Ïù¥Ï†ú Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨ Ïù¥Î°†Ïù¥ Ïã§Ï†ú ÌôòÏûêÎ•º ÏÇ¥Î¶¨Îäî Í∏∞Ïà†Î°ú Î∞îÎÄùÎãàÎã§. ÌôòÏûêÏùò Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥(Signature)Îßå Î≥¥Í≥†ÎèÑ "Ïù¥ ÌôòÏûêÎäî 5ÎÖÑ Îí§Ïóê ÏÉùÏ°¥Ìï† ÌôïÎ•†Ïù¥ ÎÜíÎã§/ÎÇÆÎã§"Î•º ÎßûÏ∂îÍ≥†, ÎÑ§Ìä∏ÏõåÌÅ¨Ïùò ÌäπÏ†ï Î∂ÄÏúÑÎßå Í≥µÍ≤©ÌïòÎäî Ï†ïÎ∞Ä ÌÉÄÍ≤© ÏïΩÎ¨ºÏùÑ Í∞úÎ∞úÌïòÎäî Í≥ºÏ†ïÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 90: ÏòàÌõÑ ÏòàÏ∏° Î™®Îç∏ (Survival Prediction) - ‚òÖÏûÑÏÉÅ ÌïÑÏàò
> > 90ÌéòÏù¥ÏßÄ Í∑∏Î¶º, Î≥ëÏõêÏóêÏÑú Îß§Ïùº Î≥¥Îäî Îç∞Ïù¥ÌÑ∞ÏûÖÎãàÎã§. Ìï¥ÏÑùÌï† Ï§Ñ ÏïåÏïÑÏïº Ìï©ÎãàÎã§. 
> > 1.  **Heatmap (Ï¢åÏ∏°):** 70Í∞úÏùò **Reporter genes** Î∞úÌòÑ Ìå®ÌÑ¥ÏùÑ Î∂ÑÏÑùÌñàÎçîÎãà, ÌôòÏûêÎì§Ïù¥ Îëê Í∑∏Î£πÏúºÎ°ú ÎÇòÎâ©ÎãàÎã§.
> >     * **Good signature:** ÏòàÌõÑÍ∞Ä Ï¢ãÏùÄ Ìå®ÌÑ¥.
> >     * **Poor signature:** ÏòàÌõÑÍ∞Ä ÎÇòÏÅú Ìå®ÌÑ¥.
> > 2.  **Survival Curve (Ïö∞Ï∏° Í∑∏ÎûòÌîÑ):** Ïù¥Í≤å Í∑∏ Ïú†Î™ÖÌïú **Ïπ¥ÌîåÎûÄ-ÎßàÏù¥Ïñ¥(Kaplan-Meier) ÏÉùÏ°¥ Í≥°ÏÑ†**ÏûÖÎãàÎã§.
> >     * **XÏ∂ï:** ÏãúÍ∞Ñ(Years).
> >     * **YÏ∂ï:** Ï†ÑÏ≤¥ ÏÉùÏ°¥Ïú®(Overall survival, 1.0 = 100%).
> >     * **Ìï¥ÏÑù:** **Poor signature(Îπ®Í∞Ñ ÏÑ†)** ÌôòÏûêÎì§ÏùÄ 2~4ÎÖÑ ÏÇ¨Ïù¥Ïóê Í∏âÍ≤©Ìûà ÏÇ¨ÎßùÌïòÏó¨ ÏÉùÏ°¥Ïú®Ïù¥ 0.2(20%) Î∞ëÏúºÎ°ú Îñ®Ïñ¥ÏßëÎãàÎã§. Î∞òÎ©¥ **Good signature(ÌååÎûÄ ÏÑ†)**Îäî 10ÎÖÑÏù¥ ÏßÄÎÇòÎèÑ ÏÉùÏ°¥Ïú®Ïù¥ ÎÜíÏäµÎãàÎã§.
> >     * **ÏùòÏùò:** "ÎãπÏã†ÏùÄ Poor signatureÎãà Îçî Í≥µÍ≤©Ï†ÅÏù∏ Ìï≠ÏïîÏ†úÎ•º ÏîÅÏãúÎã§"ÎùºÎäî **Clinically useful prediction(ÏûÑÏÉÅÏ†Å ÌåêÎã®)**Ïù¥ Í∞ÄÎä•Ìï¥ÏßëÎãàÎã§.
>
> > [!INFO] PAGE 92-93: ÎÑ§Ìä∏ÏõåÌÅ¨ ÏùòÌïôÏùò Ï†ïÏùò
> > 92ÌéòÏù¥ÏßÄ, **Network Medicine**Ïù¥ÎûÄ? 
> > * Ïù∏Íµ¨ ÏßëÎã®(Population)Ïùò ÍπäÏùÄ ÌëúÌòÑÌòï(Deep phenotyping) Îç∞Ïù¥ÌÑ∞Î•º Î™®ÏïÑÏÑú, Í∞úÏù∏Îì§ÏùÑ **ÎÑ§Ìä∏ÏõåÌÅ¨ ÏßÄÌëú(Network metrics)**Ïóê Îî∞Îùº ÌÅ¥Îü¨Ïä§ÌÑ∞ÎßÅ(Cluster)ÌïòÎäî Í≤ÅÎãàÎã§.
> > * **Ìå®Îü¨Îã§ÏûÑ Î≥ÄÌôî (93p):** 
> >     * Í≥ºÍ±∞: **Average patient (ÌèâÍ∑† ÌôòÏûê)**Î•º ÏúÑÌïú ÏïΩ. (Ïûò Ïïà Îì£Í±∞ÎÇò Î∂ÄÏûëÏö©)
> >     * ÌòÑÏû¨: ÌôòÏûêÏùò **Genetics, Microbes, Chemical composition**Ïóê Îî± ÎßûÏ∂ò(Tailored) ÏïΩ.
>
> > [!IMPORTANT] PAGE 94-97: ÎÑ§Ìä∏ÏõåÌÅ¨ Í∏∞Î∞ò Ïã†ÏïΩ Í∞úÎ∞ú (Network-based Drug Discovery)
> > 94ÌéòÏù¥ÏßÄÎ∂ÄÌÑ∞Îäî Ïã†ÏïΩ Í∞úÎ∞ú ÌîÑÎ°úÏÑ∏Ïä§ÏûÖÎãàÎã§.
> > * **Îç∞Ïù¥ÌÑ∞ ÌÜµÌï© (94p):** DNA/RNA Î≥ÄÏù¥, Îã®Î∞±Ïßà(Proteomics), ÎåÄÏÇ¨Ï≤¥(Metabolite), ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞(Clinical data), Î¨∏Ìóå(Literature)ÏùÑ Îã§ ÏÑûÏñ¥ÏÑú Í±∞ÎåÄÌïú ÌîåÎû´ÌèºÏùÑ ÎßåÎì≠ÎãàÎã§. 
> >
> > * **ÎÑ§Ìä∏ÏõåÌÅ¨ ÌÉÄÍ≤üÌåÖ (95-97p):** Ïù¥ Í∑∏Î¶ºÏùÑ Ïûò Î≥¥ÏÑ∏Ïöî. 
> >     * Ï†ÑÏ≤¥ ÎÑ§Ìä∏ÏõåÌÅ¨ ÏïàÏóê **Disease subtype 1** (ÌååÎûÄÏÉâ ÏòÅÏó≠)Í≥º **Disease subtype 2** (Ï¥àÎ°ùÏÉâ ÏòÅÏó≠)Í∞Ä ÏÑúÎ°ú Îã§Î•∏ ÏúÑÏπòÏóê Ï°¥Ïû¨Ìï©ÎãàÎã§. Ï¶â, Í∞ôÏùÄ Î≥ëÏù¥ÎùºÎèÑ Î∞úÎ≥ë Í∏∞Ï†Ñ(ÎÑ§Ìä∏ÏõåÌÅ¨ Î™®Îìà)Ïù¥ Îã§Î¶ÖÎãàÎã§.
> >     * **Toxicity (ÎèÖÏÑ±):** Îπ®Í∞ÑÏÉâ ÏòÅÏó≠ÏùÄ Í±¥ÎìúÎ¶¨Î©¥ Ïïà ÎêòÎäî Ï§ëÏöîÌïú ÏÉùÎ™Ö Ïú†ÏßÄ Í∏∞Îä•(Ïòà: Ïã¨Ïû• Î∞ïÎèô)Ïùº Ïàò ÏûàÏäµÎãàÎã§.
> >     * **Screening:** **High-throughput screening**ÏùÑ ÌÜµÌï¥ ÏàòÎßå Í∞ÄÏßÄ ÌôîÌï©Î¨ºÏùÑ ÎøåÎ†§Î¥ÖÎãàÎã§.
> >     * **Î™©Ìëú:** Îπ®Í∞ÑÏÉâ(ÎèÖÏÑ±)ÏùÄ ÌîºÌïòÍ≥†, ÎÇ¥ ÌôòÏûêÏùò ÌÉÄÏûÖ(Ïòà: Subtype 2)Ïóê Ìï¥ÎãπÌïòÎäî ÎÑ§Ìä∏ÏõåÌÅ¨Îßå Ï†ïÌôïÌûà ÌÉÄÍ≤©ÌïòÎäî ÏïΩÎ¨ºÏùÑ Ï∞æÎäî Í≤ÉÏûÖÎãàÎã§.

> [!NOTE] Pages 98-113: ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨ÏôÄ ÎîîÏßÄÌÑ∏ Ìó¨Ïä§Ïùò ÎØ∏Îûò
> Ïûê, Ïù¥Ï†ú ÎßàÏßÄÎßâ ÌçºÏ¶êÏùÑ ÎßûÏ∂•ÏãúÎã§. Íµ¨Í∏Ä ÎßµÏù¥ Ïó¨Îü¨ Î†àÏù¥Ïñ¥(ÍµêÌÜµ, ÏúÑÏÑ±, ÏßÄÎèÑ)Î•º Í≤πÏ≥êÏÑú Í∏∏ÏùÑ Î≥¥Ïó¨Ï£ºÎìØ, Ïö∞Î¶¨ Î™∏Ïùò Îç∞Ïù¥ÌÑ∞ÎèÑ Í≤πÏ≥êÏïº Î≥¥ÏûÖÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ Î™®Îì† Í≤ÉÏù¥ IT Í∏∞Ïà†(IoMT)Í≥º Í≤∞Ìï©ÌïòÏó¨ ÏßÑÏ†ïÌïú **'ÌôòÏûê Ï§ëÏã¨ ÏùòÎ£å'**Í∞Ä ÏôÑÏÑ±ÎêòÎäî Í≤ÉÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 98-99: Íµ¨Í∏Ä ÎßµÍ≥º ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨ (Analogy)
> > 98ÌéòÏù¥ÏßÄ, ÏïÑÏ£º ÌõåÎ•≠Ìïú ÎπÑÏú†Í∞Ä ÎÇòÏòµÎãàÎã§. 
> > * **Google Maps:** ÏßÄÎ¶¨Ï†Å ÏúÑÏπò(Geographical Positioning)Î•º Ï§ëÏã¨ÏúºÎ°ú ÍµêÌÜµ, Í±¥Î¨º, ÏúÑÏÑ± ÏÇ¨ÏßÑ Îì± Ïó¨Îü¨ Ï∏µ(Layers)Ïùò Ï†ïÎ≥¥Î•º Í≤πÏ≥êÏÑú Î≥¥Ïó¨Ï§çÎãàÎã§.
> > * **Information Commons (ÏùòÎ£å Ï†ïÎ≥¥ Í≥µÏú†ÏßÄ):** ÎßàÏ∞¨Í∞ÄÏßÄÏûÖÎãàÎã§. **"Í∞úÎ≥Ñ ÌôòÏûê(Individual Patients)"**Î•º Ï§ëÏã¨ÏúºÎ°ú Îã§Ïùå Ï†ïÎ≥¥Îì§ÏùÑ Í≤πÏ≥êÏïº Ìï©ÎãàÎã§.
> >     * **Signs and Symptoms (Ï¶ùÏÉÅ)**
> >     * **Exposome (ÌôòÍ≤Ω ÎÖ∏Ï∂ú)**
> >     * **Genome (Ïú†Ï†ÑÏûê)**
> >     * **Epigenome & Microbiome**
> > * **Í≤∞Î°†:** ÌôòÏûê Ìïú Î™Ö Ìïú Î™ÖÏù¥ ÎßàÏπò Íµ¨Í∏Ä ÎßµÏùò Ï¢åÌëúÏ≤òÎüº, Î™®Îì† Ï†ïÎ≥¥Í∞Ä ÌÜµÌï©Îêú **ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨**Ïùò Ï§ëÏã¨Ïù¥ Îê©ÎãàÎã§.
> 
>
> > [!IMPORTANT] PAGE 100: ÏóëÏä§Ìè¨Ï¢Ä (Exposome) - ÌôòÍ≤ΩÏùò Ï†ïÎüâÌôî (‚òÖ)
> > 100ÌéòÏù¥ÏßÄ, ÌôòÍ≤Ω(Environment)ÏùÑ Îú¨Íµ¨Î¶Ñ Ïû°Îäî ÏñòÍ∏∞Í∞Ä ÏïÑÎãàÎùº Í≥ºÌïôÏ†ÅÏúºÎ°ú Ï†ïÏùòÌï©ÎãàÎã§. Ïù¥Í≤å **Exposome**ÏûÖÎãàÎã§. 
> > * **Ï†ïÏùò:** ÎÇ¥Î∂Ä ÌôîÌïô ÌôòÍ≤Ω(Internal chemical environment)Ïóê ÎèÑÎã¨ÌïòÎäî **Î™®Îì† ÎÖ∏Ï∂úÏùò Ï¥ùÌï©**ÏûÖÎãàÎã§.
> > * **Íµ¨ÏÑ± ÏöîÏÜå:**
> >     * **External (Ïô∏Î∂Ä):** Stress, Lifestyle, Drugs, Diet, Pollution Îì±.
> >     * **Internal (ÎÇ¥Î∂Ä):** Xenobiotics(Ïù¥Î¨ºÏßà), Inflammation(ÏóºÏ¶ù), Oxidative stress(ÏÇ∞Ìôî Ïä§Ìä∏Î†àÏä§), **Gut flora(Ïû•ÎÇ¥ ÎØ∏ÏÉùÎ¨º)**.
> > * **Í≤ÄÏ∂ú:** Ïù¥Îü∞ ÏöîÏù∏Îì§ÏùÄ ÌòàÏï°Ïù¥ÎÇò ÌòàÏ≤≠(Blood or serum)ÏóêÏÑú **Biomarkers(ÏÉùÏ≤¥ÌëúÏßÄÏûê)**Î°ú Í≤ÄÏ∂ú Í∞ÄÎä•Ìï©ÎãàÎã§. Ï¶â, "Ïä§Ìä∏Î†àÏä§ Î∞õÏïòÎã§"Í∞Ä ÏïÑÎãàÎùº "Ïä§Ìä∏Î†àÏä§ ÎßàÏª§ ÏàòÏπòÍ∞Ä XÎã§"ÎùºÍ≥† ÎßêÌï† Ïàò ÏûàÍ≤å Îêú Í±∞Ï£†.
>
> > [!INFO] PAGE 101-104: ÏÉàÎ°úÏö¥ Î∂ÑÎ•ò Ï≤¥Í≥Ñ (Taxonomy)
> > Ïù¥ Ïä¨ÎùºÏù¥ÎìúÎì§ÏùÄ ÌùêÎ¶ÑÎßå Î≥¥Î©¥ Îê©ÎãàÎã§. 
> > * **Information Commons:** ÌôòÏûêÎì§Ïùò Îç∞Ïù¥ÌÑ∞Í∞Ä Î™®Ïó¨ Í≥µÏú†ÏßÄÎ•º ÌòïÏÑ±ÌïòÍ≥†,
> > * **Taxonomic classification:** Í≥ºÍ±∞Ïùò 'Ï¶ùÏÉÅ' Í∏∞Î∞ò Î∂ÑÎ•òÍ∞Ä ÏïÑÎãàÎùº, Î∂ÑÏûêÏ†Å ÏõêÏù∏Ïóê Í∏∞Î∞òÌïú **'ÏßàÎ≥ë Î∂ÑÎ•ò(Taxonomy)'**Í∞Ä ÏÉàÎ°ú Ïì∞Ïù¥Í≤å Îê©ÎãàÎã§. (Ïòà: ÌèêÏïî 1Í∏∞Í∞Ä ÏïÑÎãàÎùº, EGFR Î≥ÄÏù¥ ÏñëÏÑ± ÌèêÏïî)
> > * **Knowledge network-based medicine:** Í≤∞Íµ≠ Î™®Îì† ÏπòÎ£åÎäî Ïù¥ ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨Ïóê Í∏∞Î∞òÌïòÍ≤å Îê©ÎãàÎã§.
>
> > [!INFO] PAGE 105-113: ÎîîÏßÄÌÑ∏ Ìó¨Ïä§ ÌòÅÎ™Ö (Tech Revolution)
> > ÎßàÏßÄÎßâ ÏÑπÏÖòÏûÖÎãàÎã§. Ï†ïÎ∞ÄÏùòÌïôÏùÑ Í∞ÄÎä•ÌïòÍ≤å ÌïòÎäî Í∏∞Ïà†Ï†Å Î∞∞Í≤ΩÏûÖÎãàÎã§. 
> > * **IoMT (Internet of Medical Things):** ÏùòÎ£å ÏÇ¨Î¨º Ïù∏ÌÑ∞ÎÑ∑. Ïõ®Ïñ¥Îü¨Î∏î Í∏∞Í∏∞ Îì±Ïù¥ Ïã§ÏãúÍ∞ÑÏúºÎ°ú ÌôòÏûê Îç∞Ïù¥ÌÑ∞Î•º ÏèüÏïÑÎÉÖÎãàÎã§.
> > * **Big Data & AI:** ÏèüÏïÑÏßÄÎäî Îç∞Ïù¥ÌÑ∞Î•º Î∂ÑÏÑùÌï©ÎãàÎã§.
> > * **Rising of Precision Medicine:** Ïù¥ Î™®Îì† Í≤ÉÏù¥ Ìï©Ï≥êÏ†∏ Ï†ïÎ∞ÄÏùòÌïôÏù¥ Î∂ÄÏÉÅÌïòÍ≥† ÏûàÏäµÎãàÎã§.
> > * **Q & A (113p):** ÏßàÎ¨∏ ÏûàÎÇòÏöî?

, ',
    displayMath: [['$$', '$$'], ['\\[', '\\]']],
    processEscapes: true,
  },
  svg: {
    fontCache: 'global'
  }
};
</script>
<script type="text/javascript" id="MathJax-script" async
  src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-svg.js">
</script>

---

>[!quote] Í≥µÏßÄ
>Î≥∏ ÏûêÎ£åÏùò Ï†ÄÏûëÍ∂åÏùÄ **KAISTUDY**Ïóê ÏûàÏäµÎãàÎã§.

---

> [!abstract]- üìñ Í∞ïÏùò ÌïúÎààÏóê Î≥¥Í∏∞: Precision Medicine & Systems Biology
> **"One Treatment Fits All(Í≥ºÍ±∞)ÏóêÏÑú Data-Driven Algorithm(ÎØ∏Îûò)ÏúºÎ°úÏùò ÏßÑÌôî"**
>
> 1.  **Introduction (Ìå®Îü¨Îã§ÏûÑÏùò Ï†ÑÌôò)**
>     * ÏùòÌïôÏùÄ ÏßÅÍ¥Ä(Intuition)Í≥º Ï¶ùÍ±∞(EBM)Î•º ÎÑòÏñ¥, **ÎπÖÎç∞Ïù¥ÌÑ∞ÏôÄ ÏïåÍ≥†Î¶¨Ï¶ò Í∏∞Î∞òÏùò Ï†ïÎ∞ÄÏùòÌïô(Precision Medicine)**ÏúºÎ°ú Ïù¥Îèô Ï§ëÏûÖÎãàÎã§.
>     * ÌïµÏã¨ÏùÄ ÌôòÏûêÎ•º ÌèâÍ∑†(Average)Ïù¥ ÏïÑÎãå **Ïú†Ï†ÑÏ≤¥(Genes), ÌôòÍ≤Ω(Environment), ÏÉùÌôúÏäµÍ¥Ä(Lifestyle)**Ïù¥ Í≤∞Ìï©Îêú Í≥†Ïú†Ìïú Í∞úÏ≤¥Î°ú Î≥¥Îäî Í≤ÉÏûÖÎãàÎã§.
> 2.  **Omics & Regulation (ÏÉùÎ™ÖÏùò Ïñ∏Ïñ¥ÏôÄ Ï°∞Ï†à)**
>     * Îã®Ïàú DNA ÏÑúÏó¥(Genome)ÎøêÎßå ÏïÑÎãàÎùº, Ïù¥Î•º Ï°∞Ï†àÌïòÎäî **Epigenome(ÌõÑÏÑ±Ïú†Ï†ÑÏ≤¥)**Í≥º Ïã§Ï†ú Í∏∞Îä•ÏùÑ ÏàòÌñâÌïòÎäî Proteome/MetabolomeÏùÑ ÌÜµÌï©Ìï¥Ïïº Ìï©ÎãàÎã§.
>     * ÌäπÌûà **Histone Modification**Í≥º **DNA Methylation**Ïù¥ Ïú†Ï†ÑÏûê Ïä§ÏúÑÏπò(On/Off)Î•º Í≤∞Ï†ïÌïòÎäî ÌïµÏã¨ Í∏∞Ï†ÑÏûÖÎãàÎã§.
> 3.  **Systems & Network (ÌÜµÌï©Ï†Å Î∂ÑÏÑù)**
>     * ÏßàÎ≥ëÏùÄ Îã®Ïùº Ïú†Ï†ÑÏûêÏùò Í≥†Ïû•Ïù¥ ÏïÑÎãàÎùº, **ÎÑ§Ìä∏ÏõåÌÅ¨(Network)Ïùò ÏÑ≠Îèô**ÏûÖÎãàÎã§.
>     * ÏÑ∏Ìè¨Ïùò Ïö¥Î™ÖÏùÄ **ÏÉÅÌÉú Í≥µÍ∞Ñ(State Space)** ÎÇ¥ÏóêÏÑú **ÎÅåÍ∞ú(Attractor)**Î°ú Ïù¥ÎèôÌïòÎäî Í∂§Ï†Å(Trajectory)ÏúºÎ°ú ÏàòÌïôÏ†Å Ï†ïÏùòÍ∞Ä Í∞ÄÎä•Ìï©ÎãàÎã§.
> 4.  **Clinical Application (ÏûÑÏÉÅ Ï†ÅÏö©)**
>     * Í≤∞Íµ≠ Ïù¥ Î™®Îì† Îç∞Ïù¥ÌÑ∞Î•º Ìï©Ï≥ê(Multi-omics Integration), ÌôòÏûêÎ•º Î∂ÑÏûê ÏàòÏ§ÄÏóêÏÑú Ï∏µÌôî(Stratification)ÌïòÍ≥†, **ÎÑ§Ìä∏ÏõåÌÅ¨ Í∏∞Î∞ò Ïã†ÏïΩ(Network Medicine)**ÏùÑ Ï†ÅÏö©ÌïòÏó¨ ÏÉùÏ°¥Ïú®ÏùÑ ÎÜíÏù¥Îäî Í≤ÉÏù¥ Î™©ÌëúÏûÖÎãàÎã§.

> [!example]- üíä ÌïµÏã¨ ÌÇ§ÏõåÎìú & ÏïºÎßà Ï†ïÎ¶¨
>
> ### 1. Precision MedicineÏùò Í∏∞Ï¥à (Data & P4)
> * **Ïò§Î∞îÎßàÏùò 3ÎåÄ Î≥ÄÏàò (2015):** ‚ë† Genes(Ïú†Ï†ÑÏûê) + ‚ë° Environment(ÌôòÍ≤Ω) + ‚ë¢ Lifestyle(ÏÉùÌôúÏäµÍ¥Ä) **(üî•Í∏∞Ï∂ú)**
> * **Îç∞Ïù¥ÌÑ∞ Íµ¨ÏÑ± ÎπÑÏú®:** **Exogenous(ÌôòÍ≤Ω/ÌñâÎèô) 60%** > Genomics 30% > Clinical 10%. (Î≥ëÏõê Îç∞Ïù¥ÌÑ∞Îäî ÎπôÏÇ∞Ïùò ÏùºÍ∞ÅÏûÑ **üî•ÏïºÎßà**)
> * **P4 Medicine:** **P**redictive(ÏòàÏ∏°), **P**reventive(ÏòàÎ∞©), **P**ersonalized(ÎßûÏ∂§), **P**articipatory(Ï∞∏Ïó¨).
>
> ### 2. Clinical Sequencing Í∏∞Ïà† ÎπÑÍµê (vs) **(üî•Ï°±Î≥¥: Ï†ÅÏùëÏ¶ù Íµ¨Î≥Ñ)**
> * **WGS (Whole Genome):** DNA Ï†ÑÏ≤¥(30Ïñµ Ïåç) Î∂ÑÏÑù. Point mutation, Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥(SV), CNV **Î™®Îëê Í≤ÄÏ∂ú Í∞ÄÎä•**.
> * **WES (Whole Exome):** Îã®Î∞±Ïßà ÏΩîÎî© Î∂ÄÏúÑ(**Exon, Ï†ÑÏ≤¥Ïùò 1%**)Îßå ÎÜçÏ∂ï(Baits)ÌïòÏó¨ Î∂ÑÏÑù. Í∞ÄÏÑ±ÎπÑ Ï¢ãÏùå. Point mutation, CNV Í≤ÄÏ∂ú.
> * **Targeted Panel (PCR Amplicon):** ÌäπÏ†ï ÏßàÎ≥ë Í¥ÄÎ†® Ïú†Ï†ÑÏûêÎßå Ï¶ùÌè≠. ÍπäÏùÄ Ìï¥ÏÉÅÎèÑ(Depth) Í∞ÄÎä•.
> * **RNA-seq (Transcriptome):** **Î∞úÌòÑÎüâ(Expression)**, ÏúµÌï© Ïú†Ï†ÑÏûê(Fusion), Splicing variant Í≤ÄÏ∂ú.
>
> ### 3. DNA Íµ¨Ï°∞ & p53 (Concrete Details)
> * **DNA ÏàòÏπò:** ÏßÄÎ¶Ñ **2nm**, Ìïú Î∞îÌÄ¥ **3.4nm**, ÏóºÍ∏∞ ÏÇ¨Ïù¥ **0.34nm**. **(üî•Í∏∞Ï∂ú: Ïà´Ïûê ÏïîÍ∏∞)**
> * **p53 Íµ¨Ï°∞:** **Tetramer(4ÎüâÏ≤¥)**Î°ú ÏûëÎèô. DNA Í≤∞Ìï© Î∂ÄÏúÑÏóê **Zinc atom(ÏïÑÏó∞)**Ïù¥ ÏïàÏ†ïÌôîÏ†úÎ°ú Î∞ïÌòÄ ÏûàÏùå. ÏïîÌôòÏûêÎäî Ï£ºÎ°ú Ïù¥ Í≤∞Ìï© Î∂ÄÏúÑÍ∞Ä ÎßùÍ∞ÄÏßê.
>
> ### 4. Epigenetics: Histone Code & Methylation
> * **Histone Tail:** Ï°∞Ï†àÏùò ÌïµÏã¨. (H3, H4 TailÏù¥ Ï§ëÏöî)
> * **Acetylation (Ac):** Lysine(K)Ïóê Î∂ôÏùå. Ï£ºÎ°ú **Activation (Ï†ÑÏÇ¨ Ï¥âÏßÑ)**. **(üî•ÏïºÎßà)**
> * **Methylation (Me):** Lysine(K)Ïóê Î∂ôÏùå. ÏúÑÏπòÏóê Îî∞Îùº Îã§Î¶Ñ (Ïòà: H3K4=Active, H3K9/27=Repression).
> * **DNA Methylation:** CytosineÏùò 5Î≤à ÌÉÑÏÜåÏóê $CH_3$ Î∂ÄÏ∞© ($5$-mC). Ï£ºÎ°ú **Silencing (Ï†ÑÏÇ¨ ÏñµÏ†ú)**.
>
> ### 5. Systems Biology: State Space & Attractor
> * **ÏÉÅÌÉú Î≤°ÌÑ∞ (State Vector):** $S = [x_1, x_2, ... x_N]$ (Ïú†Ï†ÑÏûê Î∞úÌòÑÎüâÏùò ÏßëÌï©).
> * **ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space):** Ïú†Ï†ÑÏûêÎì§ÏùÑ Ï∂ïÏúºÎ°ú ÌïòÎäî Îã§Ï∞®Ïõê Í≥µÍ∞Ñ. ÏÑ∏Ìè¨ ÏÉÅÌÉúÎäî Ïù¥ Í≥µÍ∞ÑÏùò **'Ï†ê'**ÏúºÎ°ú ÌëúÌòÑÎê®.
> * **Attractor (ÎÅåÍ∞ú):** ÎèôÏ†Å ÏãúÏä§ÌÖúÏù¥ ÏãúÍ∞ÑÏù¥ ÏßÄÎÇò ÏàòÎ†¥ÌïòÎäî ÏïàÏ†ïÎêú ÏÉÅÌÉú. ÏÉùÎ¨ºÌïôÏ†ÅÏúºÎ°ú **"Cell Type(Î∂ÑÌôîÎêú ÏÑ∏Ìè¨)"**ÏùÑ ÏùòÎØ∏Ìï®. **(üî•Í∞úÎÖê ÌïÑÏäπ)**
> * **Landscape Model:** Í≥µ(ÏÑ∏Ìè¨)Ïù¥ Í≥®ÏßúÍ∏∞(Attractor)Î°ú Íµ¥Îü¨Îñ®Ïñ¥ÏßÄÎäî Í≥ºÏ†ï = Î∂ÑÌôî(Differentiation). Ïú†Ï†ÑÏûê Î≥ÄÏù¥Îäî ÏßÄÌòï ÏûêÏ≤¥Î•º Î∞îÍøà.
>
> ### 6. Network Medicine & Survival Analysis
> * **Kaplan-Meier Curve:** XÏ∂ï(ÏãúÍ∞Ñ) vs YÏ∂ï(ÏÉùÏ°¥Ïú®). Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥(Signature)Ïóê Îî∞Îùº **Good vs Poor ÏòàÌõÑ Í∑∏Î£π**ÏùÑ ÎÇòÎàå Ïàò ÏûàÏùå. **(üî•ÏûÑÏÉÅ Ìï¥ÏÑù)**
> * **Drug Discovery:** ÏßàÎ≥ë ÎÑ§Ìä∏ÏõåÌÅ¨(Disease module)Î•º ÌÉÄÍ≤©ÌïòÎêò, ÌïÑÏàò ÏÉùÏ°¥ Ïú†Ï†ÑÏûê(Toxicity)Îäî Í±¥ÎìúÎ¶¨ÏßÄ ÏïäÎäî ÏïΩÎ¨ºÏùÑ Ï∞æÎäî Í≥ºÏ†ï.

---

> [!NOTE] Pages 1-7: Precision MedicineÏùò ÌÉúÎèôÍ≥º Big Data
> Ïûê, Ïù¥ Í∞ïÏùòÏùò ÏÑúÎßâÏûÖÎãàÎã§. Ïôú ÏßÄÍ∏à Ïù¥ ÏãúÏ†êÏóê 'Ï†ïÎ∞ÄÏùòÌïô(Precision Medicine)'Ïù¥ ÌôîÎëêÍ∞Ä ÎêòÎäîÏßÄ, Í∑∏Î¶¨Í≥† Í∑∏ Í∏∞Î∞òÏù¥ ÎêòÎäî **Big Data**Í∞Ä ÎèÑÎåÄÏ≤¥ Ïñ¥Îäê Ï†ïÎèÑ Í∑úÎ™®Ïù∏ÏßÄ Ïà´ÏûêÎ°ú ÌôïÏã§ÌïòÍ≤å Í∞êÏùÑ Ïû°Í≥† Í∞ÄÏïº Ìï©ÎãàÎã§. Ïò§Î∞îÎßà ÎåÄÌÜµÎ†πÏù¥ Ïñ∏Í∏âÌïú Ï†ïÏùòÎ∂ÄÌÑ∞ Îç∞Ïù¥ÌÑ∞Ïùò Íµ¨Ï≤¥Ï†ÅÏù∏ ÎπÑÏú®(%)ÍπåÏßÄ ÍººÍººÌûà Î¥ÖÏãúÎã§.
>
> > [!INFO] PAGE 1-2: Í∞úÎÖêÏùò ÏãúÏûë (Gianrico Farrugia)
> > 1ÌéòÏù¥ÏßÄ ÌëúÏßÄÎ•º ÎÑòÍ≤® 2ÌéòÏù¥ÏßÄÎ•º Î¥ÖÏãúÎã§. **Gianrico Farrugia**Ïùò ÏΩîÎ©òÌä∏Í∞Ä ÎÇòÏòµÎãàÎã§.
> > * ÌïµÏã¨ÏùÄ **"Treat the person as an individual"**ÏûÖÎãàÎã§. ÌôòÏûêÎ•º 'Í∑∏Î£π'Ïùò ÏùºÎ∂ÄÎ°ú Î≥¥Îäî Í≤å ÏïÑÎãàÎùº, Í∑∏ ÏÇ¨Îûå Í≥†Ïú†Ïùò **Genetic material(Ïú†Ï†Ñ Î¨ºÏßà)**Ïóê Í∏∞Î∞òÌï¥ ÏπòÎ£åÌïòÍ≤†Îã§Îäî Í±∞Ï£†. 
> > * Ïù¥Í≤å Î∞îÎ°ú **Individualized, Personalized, Precise**Ìïú ÏùòÎ£åÏùò Ï†ïÏùòÏûÖÎãàÎã§. Í∑∏ÎÉ• Ï¢ãÏùÄ Îßê Í∞ôÏßÄÎßå, 'Ïú†Ï†Ñ Î¨ºÏßà Í∏∞Î∞ò'Ïù¥ÎùºÎäî Ï†ÑÏ†ú Ï°∞Í±¥ÏùÑ Íº≠ Í∏∞ÏñµÌïòÏÑ∏Ïöî. 
>
> > [!IMPORTANT] PAGE 3-5: Precision Medicine Initiative (Ïò§Î∞îÎßà, 2015)
> > 3ÌéòÏù¥ÏßÄ ÏßÄÎèÑ Í∑∏Î¶ºÍ≥º 4ÌéòÏù¥ÏßÄ Ïò§Î∞îÎßà ÏÇ¨ÏßÑ Î≥¥Ïù¥Ï£†? **2015ÎÖÑ Ïó∞ÎëêÍµêÏÑú(State of the Union Address)**ÏóêÏÑú Î∞úÌëúÌïú ÎÇ¥Ïö©ÏûÖÎãàÎã§. 
> >
> > **1. Ï†ïÏùò (3p):** 
> > * ÏßàÎ≥ë ÏòàÎ∞©Í≥º ÏπòÎ£åÏóê ÏûàÏñ¥ÏÑú **ÏÑ∏ Í∞ÄÏßÄ Î≥ÄÏàò**Î•º Í≥†Î†§Ìï©ÎãàÎã§. Ïù¥Í±∞ ÏãúÌóòÏóê ÎÇòÏò§Î©¥ Î¨¥Ï°∞Í±¥ Ïç®Ïïº Ìï©ÎãàÎã§.
> >     1.  **Genes (Ïú†Ï†ÑÏûê)**
> >     2.  **Environment (ÌôòÍ≤Ω)**
> >     3.  **Lifestyle (ÏÉùÌôúÏäµÍ¥Ä)**
> >
> > **2. Íµ¨Ï≤¥Ï†Å Î™©Ìëú (5p):** 
> > * Îã®ÏàúÌûà ÏïΩÎßå Í∞úÎ∞úÌïòÎäî Í≤å ÏïÑÎãôÎãàÎã§.
> > * **100Îßå Î™Ö(1 million)** Ïù¥ÏÉÅÏùò ÎØ∏Íµ≠Ïù∏ ÏûêÏõêÎ¥âÏÇ¨ÏûêÎ°ú Íµ¨ÏÑ±Îêú Ïó∞Íµ¨ ÎÑ§Ìä∏ÏõåÌÅ¨ Íµ¨Ï∂ï. (Ïä§ÏºÄÏùºÏù¥ Îã§Î¶ÖÎãàÎã§, Ïà´Ïûê Ï≤¥ÌÅ¨!)
> > * ÌôòÏûêÍ∞Ä ÏûêÏã†Ïùò Í±¥Í∞ï Ï†ïÎ≥¥Ïóê Ï†ëÍ∑ºÌïòÏó¨ ÏπòÎ£åÏóê **ÌòëÎ†•(Collaborate)**ÌïòÍ≤å Ìï®.
> > * ÏÉàÎ°úÏö¥ ÏùòÎ£å Í∏∞Ïà†ÏùÑ ÏãúÏû•Ïóê Îçî **Îπ†Î•¥Í≤å(Faster)** ÎèÑÏûÖ.
>
> > [!INFO] PAGE 6: Ïôú ÏßÄÍ∏àÏù∏Í∞Ä? (Why Now?)
> > 6ÌéòÏù¥ÏßÄ ÌÖçÏä§Ìä∏Î•º Î≥¥ÏÑ∏Ïöî. Ïôú ÌïòÌïÑ ÏßÄÍ∏à Ï†ïÎ∞ÄÏùòÌïôÏùºÍπåÏöî? ÏÑ∏ Í∞ÄÏßÄ Í∏∞Ïà†Ï†Å Î∞∞Í≤ΩÏù¥ ÏûàÏäµÎãàÎã§. 
> > 1.  **Sequencing:** Ïù∏Í∞Ñ Ïú†Ï†ÑÏ≤¥(Human Genome) Î∂ÑÏÑù ÎπÑÏö©Í≥º ÏãúÍ∞ÑÏù¥ ÌöçÍ∏∞Ï†ÅÏúºÎ°ú Ï§ÑÏóàÏ£†.
> > 2.  **Improved Technologies:** ÏÉùÏùòÌïô Î∂ÑÏÑù(Biomedical analysis) Í∏∞Ïà†Ïùò Ìñ•ÏÉÅ.
> > 3.  **New Tools:** ÎåÄÏö©Îüâ Îç∞Ïù¥ÌÑ∞ÏÖã(Large datasets)ÏùÑ Îã§Î£∞ Ïàò ÏûàÎäî ÎèÑÍµ¨(Ïª¥Ìì®ÌåÖ ÌååÏõå, AI Îì±)Ïùò Îì±Ïû•.
>
> > [!IMPORTANT] PAGE 7: Ìó¨Ïä§ÏºÄÏñ¥ Îç∞Ïù¥ÌÑ∞Ïùò Ïã§Ï≤¥ (ÏàòÏπò ÏïîÍ∏∞!)
> > Ïûê, Ïó¨Í∏∞ **Î≥ÑÌëú** ÏπòÏÑ∏Ïöî. Ìó¨Ïä§ÏºÄÏñ¥ ÎπÖÎç∞Ïù¥ÌÑ∞Ïùò Íµ¨ÏÑ± ÎπÑÏú®Í≥º Ïö©ÎüâÏù¥ Íµ¨Ï≤¥Ï†ÅÏúºÎ°ú ÎÇòÏòµÎãàÎã§. ÌâÅÏ≥êÏÑú 'ÎßéÎã§'Í≥† ÌïòÎ©¥ ÏùòÎåÄÏÉù ÏïÑÎãàÏ£†. ÏàòÏπòÎ•º Î≥¥ÏÑ∏Ïöî.
> >
> > **1. Í±¥Í∞ï Í≤∞Ï†ï ÏöîÏù∏ (Determinants of Health) ÎπÑÏú®:** 
> > * **Exogenous data (Ïô∏Ïù∏ÏÑ± Îç∞Ïù¥ÌÑ∞):** ÌñâÎèô, ÏÇ¨ÌöåÍ≤ΩÏ†úÏ†Å, ÌôòÍ≤ΩÏ†Å ÏöîÏù∏. Î¨¥Î†§ **60%**Î•º Ï∞®ÏßÄÌï©ÎãàÎã§.
> > * **Genomics data (Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞):** **30%**. ÏÉùÍ∞ÅÎ≥¥Îã§ ÎπÑÏ§ëÏù¥ ÌÅ¨Ï£†?
> > * **Clinical data (ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞):** Í≤®Ïö∞ **10%**. Î≥ëÏõêÏóêÏÑú ÎÇòÏò§Îäî Îç∞Ïù¥ÌÑ∞Îäî ÎπôÏÇ∞Ïùò ÏùºÍ∞ÅÏù¥ÎùºÎäî Í≤ÅÎãàÎã§.
> >
> > **2. ÌèâÏÉù ÏÉùÏÑ±ÎêòÎäî Îç∞Ïù¥ÌÑ∞ Ïñë (Data per lifetime):** 
> > * Ï¥ùÎüâ: **1100 Terabytes (TB)**
> > * Exogenous: **1100 TB** (Í±∞Ïùò ÎåÄÎ∂ÄÎ∂Ñ)
> > * Genomics: **6 TB**
> > * Clinical: **0.4 TB** (ÏïÑÏ£º ÎØ∏ÎØ∏Ìï®)
> >
> > **3. ÎπÖÎç∞Ïù¥ÌÑ∞Ïùò 4V:** 
> > * **Volume (Ïñë)**, **Variety (Îã§ÏñëÏÑ±)**, **Velocity (ÏÜçÎèÑ)**, **Veracity (Ï†ïÌôïÏÑ±)**.
> > * ÌäπÌûà ÌïòÎã®Ïóê Î≥¥Î©¥ 2020ÎÖÑ Í∏∞Ï§ÄÏúºÎ°ú ÏùòÎ£å Îç∞Ïù¥ÌÑ∞Îäî **73ÏùºÎßàÎã§ 2Î∞∞**Î°ú Ï¶ùÍ∞ÄÌïúÎã§Í≥† ÎêòÏñ¥ ÏûàÏäµÎãàÎã§. Í∏àÏúµ(Finance) Î∂ÑÏïºÎ≥¥Îã§ Îç∞Ïù¥ÌÑ∞Í∞Ä Îçî ÎßéÏïÑÏöî. 

> [!NOTE] Pages 8-13: ÏùòÎ£å Ìå®Îü¨Îã§ÏûÑÏùò ÎåÄÏ†ÑÌôò (Paradigm Shift)
> Ïûê, Ïù¥Ï†ú ÏùòÌïôÏùò Ïó≠ÏÇ¨Î•º 3Îã®Í≥ÑÎ°ú ÎÇòÎà†ÏÑú Î®∏Î¶øÏÜçÏóê ÏßëÏñ¥ÎÑ£ÏùçÏãúÎã§. Í≥ºÍ±∞Ïùò ÏùòÏÇ¨Îì§ÏùÄ 'ÏßÅÍ¥Ä'Ïóê ÏùòÏ°¥ÌñàÏßÄÎßå, ÎØ∏ÎûòÏùò ÏùòÏÇ¨Îì§ÏùÄ **'ÏïåÍ≥†Î¶¨Ï¶ò'**ÏùÑ Îã§Î§ÑÏïº Ìï©ÎãàÎã§. Ïù¥ ÌååÌä∏Ïùò ÌïµÏã¨ÏùÄ **"One Treatment Fits All(Îã®Ïùº ÏπòÎ£å)"Ïùò Î™∞ÎùΩ**Í≥º **"Personalized(ÎßûÏ∂§Ìòï)"Ïùò Î∂ÄÏÉÅ**ÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 8: Ìå®Îü¨Îã§ÏûÑ 3Îã®Í≥Ñ (ÏãúÌóò ÏïºÎßà!)
> > 8ÌéòÏù¥ÏßÄ ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. ÏùòÌïôÏùÄ Ïù¥Î†áÍ≤å ÏßÑÌôîÌñàÏäµÎãàÎã§. Í∞Å Îã®Í≥ÑÏùò ÌÇ§ÏõåÎìúÎ•º Î∞òÎìúÏãú Îß§Ïπ≠ÏãúÌÇ§ÏÑ∏Ïöî.
> >
> > 1.  **Yesterday (Í≥ºÍ±∞):**
> >     * Í∏∞Î∞ò: **Symptom-based (Ï¶ùÏÉÅ Í∏∞Î∞ò)**
> >     * Î∞©Ïãù: **Intuition Medicine (ÏßÅÍ¥Ä ÏùòÌïô)** - ÏùòÏÇ¨Ïùò 'Í∞ê'Ïóê ÏùòÏ°¥ÌñàÏ£†.
> > 2.  **Today (ÌòÑÏû¨):**
> >     * Í∏∞Î∞ò: **Pattern-based (Ìå®ÌÑ¥ Í∏∞Î∞ò)**
> >     * Î∞©Ïãù: **Evidence-based Medicine (Ï¶ùÍ±∞ Í∏∞Î∞ò ÏùòÌïô, EBM)** - ÏûÑÏÉÅÏãúÌóò ÌÜµÍ≥ÑÍ∞Ä ÏôïÏù¥ÏóàÏäµÎãàÎã§.
> > 3.  **Tomorrow (ÎØ∏Îûò):**
> >     * Í∏∞Î∞ò: **Algorithm-based (ÏïåÍ≥†Î¶¨Ï¶ò Í∏∞Î∞ò)** - Ïó¨Í∏∞Í∞Ä ÌïµÏã¨ÏûÖÎãàÎã§.
> >     * Î∞©Ïãù: **Precision Medicine (Ï†ïÎ∞Ä ÏùòÌïô)** - Îç∞Ïù¥ÌÑ∞Í∞Ä ÏπòÎ£åÎ•º Í≤∞Ï†ïÌï©ÎãàÎã§.
>
> > [!INFO] PAGE 9: ÏÉàÎ°úÏö¥ ÌîåÎ†àÏù¥Ïñ¥Îì§ (IT Giants)
> > 9ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Î≥ëÏõê Î°úÍ≥†Í∞Ä ÏïÑÎãôÎãàÎã§. **Google Health, Google DeepMind, IBM Watson Health, Human Longevity Inc.** Í∞ôÏùÄ IT Í∏∞ÏóÖÎì§Ïù¥Ï£†.
> > * Ïù¥Îì§Ïù¥ ÎÖ∏Î¶¨Îäî Î∂ÑÏïºÍ∞Ä ÏïÑÎûò Ìä∏Î¶¨Ïóê ÎÇòÏòµÎãàÎã§:
> >     * **Oncology (Ï¢ÖÏñëÌïô)**
> >     * **Drug Discovery (Ïã†ÏïΩ Í∞úÎ∞ú)**
> >     * **Genomics (Ïú†Ï†ÑÏ≤¥Ìïô)**
> >     * **Patient Engagement (ÌôòÏûê Ï∞∏Ïó¨)**
> > * Ï¶â, Ìó¨Ïä§ÏºÄÏñ¥Ïùò Ï£ºÎèÑÍ∂åÏù¥ 'Îç∞Ïù¥ÌÑ∞Î•º Í∞ÄÏßÑ Í∏∞ÏóÖ'ÏúºÎ°ú ÎÑòÏñ¥Í∞ÄÍ≥† ÏûàÎã§Îäî Ï¶ùÍ±∞ÏûÖÎãàÎã§.
>
> > [!WARNING] PAGE 11-12: ÌòÑÏû¨ ÏùòÌïôÏùò ÌïúÍ≥Ñ (One Treatment Fits All)
> > 11ÌéòÏù¥ÏßÄ ÎèÑÏãùÏùÑ Î¥ÖÏãúÎã§. **"Current Medicine: One Treatment Fits All"**.
> > * ÎòëÍ∞ôÏùÄ ÏïΩ(Pill)ÏùÑ Î™®Îì† ÌôòÏûê(Ï¥àÎ°ù, Îπ®Í∞ï, ÌååÎûë ÏÑûÏó¨ ÏûàÎäî Í∑∏Î£π)ÏóêÍ≤å Ï§çÎãàÎã§.
> > * **Í≤∞Í≥º:**
> >     * ÏùºÎ∂ÄÎäî **Effect (Ìö®Í≥º ÏûàÏùå)**.
> >     * ÏùºÎ∂ÄÎäî **No effect (Ìö®Í≥º ÏóÜÏùå)** - Îèà ÎÇ≠ÎπÑÏ£†.
> >     * Ïã¨ÏßÄÏñ¥ ÏùºÎ∂ÄÎäî **Adverse effects (Î∂ÄÏûëÏö©)** - Ïù¥Í≤å Ï†úÏùº ÏúÑÌóòÌï©ÎãàÎã§.
> > * 12ÌéòÏù¥ÏßÄÎèÑ Í∞ôÏùÄ Îß•ÎùΩÏûÖÎãàÎã§. "Conventional approach"Îäî ÏßÑÎã®Ïù¥ Îä¶Ïñ¥ÏßÄÍ±∞ÎÇò(delayed), Ïò§ÏßÑ(mis-diagnosis)Ïù¥ ÏÉùÍ≤® ÏπòÎ£å Ìö®Ïú®Ïù¥ ÎÇÆÏäµÎãàÎã§.
>
> > [!IMPORTANT] PAGE 13: ÎØ∏Îûò ÏùòÌïô (Personalized Diagnostics)
> > 13ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ 11ÌéòÏù¥ÏßÄÏôÄ Î∞òÎåÄÏûÖÎãàÎã§. ÏàúÏÑúÍ∞Ä Î∞îÎÄùÎãàÎã§.
> > * **ÏÑ†(ÂÖà) ÏßÑÎã®:** ÏπòÎ£å Ï†ÑÏóê **Blood, DNA, Urine, Tissue Analysis**Î•º Î®ºÏ†Ä ÏàòÌñâÌï©ÎãàÎã§.
> > * **ÌõÑ(Âæå) Î∂ÑÎ•ò:** ÌôòÏûêÎì§ÏùÑ Îπ®Í∞ï, ÎÖ∏Îûë, ÌååÎûë Í∑∏Î£πÏúºÎ°ú **ÎØ∏Î¶¨ ÎÇòÎàïÎãàÎã§(Stratification)**.
> > * **Í≤∞Í≥º:** Í∞Å Í∑∏Î£πÏóê ÎßûÎäî ÏïΩÏùÑ Ìà¨Ïó¨ÌïòÎãàÍπå, Î™®Îì† ÌôòÏûêÏóêÍ≤åÏÑú **Effect (Ìö®Í≥º)**Í∞Ä ÎÇòÌÉÄÎÇ©ÎãàÎã§. Î∂ÄÏûëÏö©ÏùÄ ÏµúÏÜåÌôîÎêòÍ≥†Ïöî. Ïù¥Í≤å Ï†ïÎ∞ÄÏùòÌïôÏùò Í∂ÅÍ∑πÏ†Å Î™©ÌëúÏûÖÎãàÎã§.

> [!NOTE] Pages 14-21: P4 MedicineÍ≥º ÏãúÏä§ÌÖú ÏùòÌïô (Systems Medicine)
> Ïûê, Ï†ïÎ∞ÄÏùòÌïôÏùÑ Îã§Î•∏ ÎßêÎ°ú **'P4 Medicine'**Ïù¥ÎùºÍ≥†ÎèÑ Ìï©ÎãàÎã§. Ïù¥ 4Í∞ÄÏßÄ PÍ∞Ä Î≠îÏßÄ Î™®Î•¥Î©¥ Ïù¥ ÏàòÏóÖ ÌóõÎì§ÏùÄ Í≤ÅÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ Î∞©ÎåÄÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïñ¥ÎñªÍ≤å ÏöîÎ¶¨Ìï¥ÏÑú ÏûÑÏÉÅÏóê Ï†ÅÏö©ÌïòÎäîÏßÄ, Í∑∏ Î≥µÏû°Ìïú Í≥ºÏ†ïÏùÑ ÌïòÎÇòÏî© Î∂ÑÌï¥Ìï¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 14: P4 MedicineÏùò Ï†ïÏùò (ÏïîÍ∏∞ ÌïÑÏàò!)
> > 14ÌéòÏù¥ÏßÄ, ÏïÑÏ£º Ï§ëÏöîÌïú ÏïΩÏñ¥Í∞Ä ÎÇòÏòµÎãàÎã§. **P4 Medicine**.
> > 1.  **Predictive (ÏòàÏ∏°):** Î∞úÎ≥ë Ï†ÑÏóê ÎØ∏Î¶¨ ÏïàÎã§.
> > 2.  **Preventive (ÏòàÎ∞©):** ÏïÑÌîÑÍ∏∞ Ï†ÑÏóê ÎßâÎäîÎã§.
> > 3.  **Personalized (ÎßûÏ∂§):** ÎÑàÌïúÌÖå Îî± ÎßûÎäî ÏπòÎ£åÎ•º ÌïúÎã§.
> > 4.  **Participatory (Ï∞∏Ïó¨):** ÌôòÏûêÍ∞Ä ÏàòÎèôÏ†ÅÏù∏ Í∞ùÏ≤¥Í∞Ä ÏïÑÎãàÎùº, Îç∞Ïù¥ÌÑ∞ ÏÉùÏÇ∞ÏûêÎ°úÏÑú Ï∞∏Ïó¨ÌïúÎã§.
> >
> > * **ÌïµÏã¨ ÏßàÎ¨∏:** "Îç∞Ïù¥ÌÑ∞Îäî ÎÑòÏ≥êÎÇòÎäîÎç∞(More data), Ïù¥Í±∏ ÏñºÎßàÎÇò Ìö®Ïú®Ï†ÅÏúºÎ°ú ÏÇ¨Ïö©Ìï† Í≤ÉÏù∏Í∞Ä?" -> Í∑∏ Ìï¥ÎãµÏù¥ Î∞îÎ°ú **Systems Medicine**ÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 15: ÏûÑÏÉÅ Ï†ÅÏö© ÏÇ¨Ïù¥ÌÅ¥ (Clinical Deployment)
> > 15ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùò ÏàúÌôò Íµ¨Ï°∞Î•º Î≥¥ÏÑ∏Ïöî. Îç∞Ïù¥ÌÑ∞Í∞Ä Ïñ¥ÎñªÍ≤å ÌùêÎ•¥ÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§.
> > * **Screening (ÏÑ†Î≥Ñ) ‚Üí Diagnosis (ÏßÑÎã®) ‚Üí Staging & Phenotyping (Î≥ëÍ∏∞ ÏÑ§Ï†ï) ‚Üí Therapy & Monitoring (ÏπòÎ£å Î∞è Î™®ÎãàÌÑ∞ÎßÅ)**
> > * Ïù¥ Í≥ºÏ†ïÏóêÏÑú Ïñ¥Îñ§ Îç∞Ïù¥ÌÑ∞Í∞Ä Îì§Ïñ¥Í∞ÄÎÇòÏöî?
> >     * **-omic/biological:** Ïú†Ï†ÑÏ≤¥ Ï†ïÎ≥¥
> >     * **Electronic health records (EHR):** Î≥ëÏõê Í∏∞Î°ù
> >     * **Geospatial & Environmental:** Ïñ¥Îîî ÏÇ¨ÎäîÏßÄ, ÌôòÍ≤ΩÏùÄ Ïñ¥Îñ§ÏßÄ
> >     * **Personal monitoring:** Ïõ®Ïñ¥Îü¨Î∏î Í∏∞Í∏∞ Îç∞Ïù¥ÌÑ∞ Îì±
> > * Ïö∞Ï∏° ÌïòÎã®Ïùò ÏßàÎ¨∏Îì§Ïù¥ ÎÇ†Ïπ¥Î°≠ÏäµÎãàÎã§. "Í≥ºÍ±∞Î†•(History) Ï§ë Î¨¥ÏóáÏùÑ Î≥ºÍπå?", "ÌòÑÏû¨ ÏÉÅÌÉú(Current state)Îäî?", "Í∞úÏûÖ(Intervene) Í∏∞ÌöåÎäî?", "ÎØ∏Îûò ÏúÑÌóò(Risks)ÏùÄ?"
>
> > [!TIP] üí° PAGE 17-18: Îç∞Ïù¥ÌÑ∞Ïùò ÏõêÏ≤ú (Ï°±Î≥¥ ÏÜåÏä§)
> > Ïûê, Ïó¨Í∏∞ Ï†ÅÌòÄ ÏûàÎäî Îç∞Ïù¥ÌÑ∞Î≤†Ïù¥Ïä§ Ïù¥Î¶ÑÎì§, ÎààÏóê ÏùµÌòÄÎëêÏÑ∏Ïöî. ÎÇòÏ§ëÏóê Ïó∞Íµ¨Ìï† Îïå Î¨¥Ï°∞Í±¥ ÏîÅÎãàÎã§.
> >
> > **1. Technology Platforms (17p):**
> > * **Genomics & Transcriptomics:** ÏãúÌÄÄÏã± Îç∞Ïù¥ÌÑ∞ (ACGT...)
> > * **Proteomics & Metabolomics:** Îã®Î∞±Ïßà, ÎåÄÏÇ¨Î¨ºÏßà (MS-data ÏßàÎüâÎ∂ÑÏÑù)
> > * **Imaging:** ÏòÅÏÉÅ Îç∞Ïù¥ÌÑ∞
> >
> > **2. Public Databases (18p) - Î≥ÑÌëú!:**
> > * **TCGA (The Cancer Genome Atlas):** Ïïî Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Ïùò Î≥¥Î¨ºÏ∞ΩÍ≥†ÏûÖÎãàÎã§.
> > * **CCLE (Cancer Cell Line Encyclopedia):** Ïïî ÏÑ∏Ìè¨Ï£º Îç∞Ïù¥ÌÑ∞.
> > * **ClinicalTrials.gov:** ÏûÑÏÉÅÏãúÌóò Ï†ïÎ≥¥.
> > * **PubChem, DrugBank:** ÏïΩÎ¨º ÌôîÌïô Íµ¨Ï°∞ Î∞è ÌÉÄÍ≤ü Ï†ïÎ≥¥.
> > * **TOXNET:** ÎèÖÏÑ± Ï†ïÎ≥¥.
> > * Ïù¥ Îç∞Ïù¥ÌÑ∞Îì§Ïù¥ Îã§ Ïó∞Í≤∞ÎêòÏñ¥Ïïº ÎπÑÎ°úÏÜå 'Ï†ïÎ∞ÄÏùòÌïô'Ïù¥ Îê©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 19: AIÏôÄ Î®∏Ïã†Îü¨ÎãùÏùò Ïó≠Ìï† (ÏïåÍ≥†Î¶¨Ï¶ò Ïù¥Î¶Ñ Ï≤¥ÌÅ¨)
> > 19ÌéòÏù¥ÏßÄ Ïö∞Ï∏° ÌïòÎã®, Íπ®Ïïå Í∞ôÏùÄ Í∏ÄÏî®Î•º Î≥¥ÏÑ∏Ïöî. Îç∞Ïù¥ÌÑ∞Î•º Î∂ÑÏÑùÌïòÎäî ÎèÑÍµ¨Îì§ÏûÖÎãàÎã§.
> > * **Machine Learning (ML):** Í∏∞Í≥ÑÌïôÏäµ.
> > * **Deep Learning (DL):** Îî•Îü¨Îãù.
> > * **Íµ¨Ï≤¥Ï†Å ÏïåÍ≥†Î¶¨Ï¶ò:**
> >     * **SVM (Support Vector Machine)**
> >     * **RF (Random Forest)**
> >     * **LightGBM:** ÏµúÍ∑º ÎßéÏù¥ Ïì∞Ïù¥Îäî Î∂ÄÏä§ÌåÖ Î™®Îç∏Ïù¥Ï£†.
> > * **Í≥ºÏ†ï:** Feature selection(ÌäπÏßï ÏÑ†ÌÉù) ‚Üí Cross validation(ÍµêÏ∞® Í≤ÄÏ¶ù) ‚Üí Hyperparameter tuning(ÌäúÎãù) ‚Üí **Prediction(ÏòàÏ∏°)**. Ïù¥ ÌîÑÎ°úÏÑ∏Ïä§Í∞Ä Î®∏Î¶øÏÜçÏóê ÏûàÏñ¥Ïïº Ìï©ÎãàÎã§.
>
> > [!INFO] PAGE 20-21: Multi-OmicsÏùò ÌÜµÌï© (Integration)
> > 20ÌéòÏù¥ÏßÄ, ÏÇ¨Îûå Î™∏ÏùÑ **Systems Biology** Í¥ÄÏ†êÏóêÏÑú Î≥∏ Í∑∏Î¶ºÏûÖÎãàÎã§.
> > * ÏïΩÎ¨º(Drug A)Ïù¥ Îì§Ïñ¥Í∞ÄÎ©¥ Îã®ÏÑ†Ï†ÅÏù∏ Î∞òÏùëÎßå ÏûàÎäî Í≤å ÏïÑÎãàÎùº, Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨(Network)Î•º Í±¥ÎìúÎ¶ΩÎãàÎã§. Í∑∏ÎûòÏÑú Î∂ÄÏûëÏö©(AEs)ÎèÑ ÏÉùÍ∏∞Í≥†, ÏÉàÎ°úÏö¥ Ï†ÅÏùëÏ¶ù(New indications, Drug repositioning)ÎèÑ Î∞úÍ≤¨ÎêòÎäî Í±∞Ï£†.
> >
> > 21ÌéòÏù¥ÏßÄÍ∞Ä Í≤∞Î°†ÏûÖÎãàÎã§.
> > * **Multi-OMICS:** Genome, Epigenome, Transcriptome, Proteome, Metabolome, Microbiome... Ïù¥ Î™®Îì† Í±∏ Ìï©Ï≥êÏïº Ìï©ÎãàÎã§.
> > * **Integration (ÌÜµÌï©):** Îî∞Î°ú ÎÜÄÎ©¥ Ïì∞Î†àÍ∏∞ÏûÖÎãàÎã§. ÏÑûÏñ¥ÏÑú Î∂ÑÏÑùÌï¥Ïïº Ïú†ÏùòÎØ∏Ìïú **Signatures (ÌäπÏßï)**Í∞Ä ÎÇòÏò§Í≥†, Í∑∏Ï†úÏïº **Therapeutics (ÏπòÎ£åÎ≤ï)**Í∞Ä ÎÇòÏòµÎãàÎã§.

> [!NOTE] Pages 22-31: Ïú†Ï†ÑÏ≤¥Ìïô Í∏∞Ï¥à (Genomics Basics)
> Ïûê, Ïù¥Ï†ú **ÏÉùÎ™ÖÏùò Ïñ∏Ïñ¥(Language of Life)**Î•º Î∞∞Ïö∏ Ï∞®Î°ÄÏûÖÎãàÎã§. Í≥†Îì±ÌïôÍµê ÏÉùÎ¨º ÏãúÍ∞Ñ Í∞ôÎã§Í≥† Î∞©Ïã¨ÌïòÏßÄ ÎßàÏÑ∏Ïöî. Ïó¨Í∏∞ ÎÇòÏò§Îäî **ÏàòÏπò(nm, bp)**Îì§Í≥º **Îç∞Ïù¥ÌÑ∞Ïùò Í∑úÎ™®**Í∞Ä Ï†ïÎ∞ÄÏùòÌïôÏóêÏÑú Ïôú 'ÎπÖÎç∞Ïù¥ÌÑ∞'ÎùºÍ≥† Î∂àÎ¶¨ÎäîÏßÄ Í∑∏ Í∑ºÍ±∞Í∞Ä ÎêòÎãàÍπåÏöî.
>
> > [!INFO] PAGE 22: ÏÉùÎ¨ºÌïôÏ†Å Ï†ïÎ≥¥Ïùò ÌùêÎ¶Ñ (Central Dogma Í∑∏ Ïù¥ÏÉÅ)
> > 22ÌéòÏù¥ÏßÄ Îã§Ïù¥Ïñ¥Í∑∏Îû®ÏùÑ Î≥¥ÏÑ∏Ïöî. Ïö∞Î¶¨Í∞Ä ÏïÑÎäî ÏÑºÌä∏Îü¥ ÎèÑÍ∑∏Îßà(DNA ‚Üí RNA ‚Üí Protein)Í∞Ä Í∏∞Î≥∏Ïù¥ÏßÄÎßå, Í∑∏Î¶ºÏù¥ Ìõ®Ïî¨ Î≥µÏû°ÌïòÏ£†? 
> > * **Feedback Loops:** ÌôîÏÇ¥ÌëúÍ∞Ä Ìïú Î∞©Ìñ•ÏúºÎ°úÎßå Í∞ÄÏßÄ ÏïäÏäµÎãàÎã§. Îã®Î∞±Ïßà(Proteins)Ïù¥ Îã§Ïãú DNAÎÇò RNA Ï°∞Ï†àÏóê Í¥ÄÏó¨ÌïòÍ≥†, **ÌôòÍ≤Ω(Environment)**Ïù¥ ÏÑ∏Ìè¨ ÎåÄÏÇ¨(Cellular metabolism)Ïóê ÏòÅÌñ•ÏùÑ ÎØ∏ÏπòÎäî **ÏàúÌôò Íµ¨Ï°∞**ÏûÑÏùÑ Î™ÖÏã¨ÌïòÏÑ∏Ïöî. 
>
> > [!INFO] PAGE 23-24: Human Genome Project (HGP)
> > 23ÌéòÏù¥ÏßÄÏùò ÏàòÎßéÏùÄ ÏïåÌååÎ≤≥(ACGT...)Í≥º 24ÌéòÏù¥ÏßÄÏùò ÌååÌòï(Peaks) Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Ïù¥Í≤å Î∞îÎ°ú **Sanger Sequencing**Ïùò Í≤∞Í≥ºÎ¨ºÏûÖÎãàÎã§. 
> > * **Human Genome Project:** Ïù∏Í∞ÑÏùò Î™®Îì† DNA Í∏ÄÏûêÎ•º ÏùΩÏñ¥ÎÇ¥Î†§Îäî Í±∞ÎåÄÌïú ÏãúÎèÑÏòÄÏ£†. ÌÅ¥Î¶∞ÌÑ¥ ÎåÄÌÜµÎ†π ÏÇ¨ÏßÑÎèÑ Î≥¥Ïù¥ÎÑ§Ïöî. 
>
> > [!IMPORTANT] PAGE 25: DNA Íµ¨Ï°∞Ïùò ÏàòÏπò (ÏïîÍ∏∞!)
> > 25ÌéòÏù¥ÏßÄ, Ïó¨Í∏∞ **Î≥ÑÌëú** Îã§ÏÑØ Í∞ú ÏπòÏÑ∏Ïöî. DNA Íµ¨Ï°∞Ïùò ÏàòÏπò, ÏãúÌóòÏóê ÎÇ¥Í∏∞ Îî± Ï¢ãÏäµÎãàÎã§.
> > * **Î∞©Ìñ•ÏÑ±:** **5' end (Ïù∏ÏÇ∞Í∏∞)**ÏóêÏÑú **3' end (ÏàòÏÇ∞Í∏∞, OH)**Î°ú Ïù¥Ïñ¥ÏßëÎãàÎã§. Îëê Í∞ÄÎã•ÏùÄ ÏÑúÎ°ú **Ïó≠ÌèâÌñâ(Anti-parallel)**Ìï©ÎãàÎã§. 
> > * **Î∞±Î≥∏(Backbone):** Ïù∏ÏÇ∞(Phosphate) + Îãπ(Deoxyribose)ÏúºÎ°ú Íµ¨ÏÑ±Îê©ÎãàÎã§. 
> > * **Ï£ºÏöî ÏàòÏπò:**
> >     * **ÏßÄÎ¶Ñ (Width):** **2 nm** 
> >     * **ÎÇòÏÑ† Ìïú Î∞îÌÄ¥ (One turn):** **3.4 nm** 
> >     * **ÏóºÍ∏∞ ÏÇ¨Ïù¥ Í±∞Î¶¨ (Distance between bases):** **0.34 nm** 
> > * **Groove:** ÎÑìÏùÄ **Major groove**ÏôÄ Ï¢ÅÏùÄ **Minor groove**Í∞Ä ÏûàÏäµÎãàÎã§. ÎÇòÏ§ëÏóê Îã®Î∞±ÏßàÏù¥ Ïó¨Í∏∞ ÎÅºÏñ¥Îì§Ïñ¥Í∞ÄÏÑú Í≤∞Ìï©Ìï©ÎãàÎã§. 
>
> > [!INFO] PAGE 28: Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Ïùò ÌÅ¨Í∏∞ (ÎπÑÏú†)
> > 28ÌéòÏù¥ÏßÄ, Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Í∞Ä ÏñºÎßàÎÇò Î∞©ÎåÄÌïúÏßÄ ÎπÑÏú†Î•º Îì§Ïñ¥ ÏÑ§Î™ÖÌï©ÎãàÎã§.
> > * **Ï†ÑÏ≤¥ Ïö©Îüâ:** Ïù∏Í∞Ñ DNAÎäî ÏïΩ **64Ïñµ Í∞ú(6.4 billion)**Ïùò Î¨∏ÏûêÎ°ú ÎêòÏñ¥ ÏûàÏäµÎãàÎã§. 
> > * **Ï±ÖÏúºÎ°ú ÏπòÎ©¥:** 500ÌéòÏù¥ÏßÄÏßúÎ¶¨ Ï±Ö **4,200Í∂å** Î∂ÑÎüâÏûÖÎãàÎã§. Ïñ¥ÎßàÏñ¥ÎßàÌïòÏ£†. 
> > * **ÏÑúÎπÑÏä§ ÎπÑÍµê:**
> >     * **Veritas (Whole Genome):** 4,200Í∂å Ï†ÑÏ≤¥Î•º ÏùΩÏñ¥Ï§çÎãàÎã§. 
> >     * **23andMe (SNP genotyping):** Ï†ÑÏ≤¥Ïùò **1% ÎØ∏Îßå**Îßå Î¥ÖÎãàÎã§. Ï±ÖÏúºÎ°ú ÏπòÎ©¥ Í≤®Ïö∞ **180ÌéòÏù¥ÏßÄ** ÏùΩÎäî ÏÖàÏù¥Ï£†. Ïù¥ Ï∞®Ïù¥Î•º ÏïÑÎäî Í≤å Ï§ëÏöîÌï©ÎãàÎã§. 
>
> > [!INFO] PAGE 30-31: ÏÉùÎ™ÖÏùò Í≥ÑÏ∏µ Íµ¨Ï°∞ÏôÄ ÏóºÏÉâÏ≤¥
> > * **Í≥ÑÏ∏µ (30p):** Macromolecule(DNA) ‚Üí Organelle ‚Üí Cell ‚Üí Tissue ‚Üí Organ ‚Üí Organism ÏàúÏÑúÎ°ú Î≥µÏû°Ìï¥ÏßëÎãàÎã§. 
> > * **ÏóºÏÉâÏ≤¥ (31p):** Ïù∏Í∞ÑÏùÄ **23Ïåç(23 pairs)**Ïùò ÏóºÏÉâÏ≤¥Î•º Í∞ÄÏßëÎãàÎã§. (Ï¥ù 46Í∞ú) 
> > * **ÏÉÅÎèô ÏóºÏÉâÏ≤¥ (Homologous pairs):** Î∂ÄÎ™®Î°úÎ∂ÄÌÑ∞ Í∞ÅÍ∞Å ÌïòÎÇòÏî© Î¨ºÎ†§Î∞õÏùÄ Ìïú ÏåçÏûÖÎãàÎã§.
> >     * **Allele (ÎåÄÎ¶ΩÏú†Ï†ÑÏûê):** Í∞ôÏùÄ ÏúÑÏπòÏóê ÏûàÎäî Ïú†Ï†ÑÏûê Î≤ÑÏ†ÑÏùÑ ÎßêÌï©ÎãàÎã§. Í∑∏Î¶ºÏùò **Allele A**ÏôÄ **Allele a**Î•º Î≥¥ÏÑ∏Ïöî. Ïù¥Í≤å ÌòïÏßà(Ïòà: Î®∏Î¶¨ÏÉâ)ÏùÑ Í≤∞Ï†ïÌï©ÎãàÎã§. 

> [!NOTE] Pages 32-40: Ïú†Ï†ÑÏûê Î∞úÌòÑÍ≥º ÏûÑÏÉÅ ÏãúÌÄÄÏã± Í∏∞Ïà†
> Ïûê, DNAÏóê Ï†ÅÌûå Ï†ïÎ≥¥Í∞Ä Ïñ¥ÎñªÍ≤å Ïö∞Î¶¨ ÎààÏóê Î≥¥Ïù¥Îäî ÌäπÏßï(Phenotype)ÏúºÎ°ú ÎÇòÌÉÄÎÇòÎäîÏßÄ, Í∑∏Î¶¨Í≥† Í∑∏ Ï†ïÎ≥¥Î•º ÏùΩÏñ¥ÎÇ¥Îäî Í∏∞Ïà†ÏóêÎäî Ïñ¥Îñ§ Í≤ÉÎì§Ïù¥ ÏûàÎäîÏßÄ 'Ìï¥ÏÉÅÎèÑ'Î≥ÑÎ°ú ÎúØÏñ¥Î¥ÖÏãúÎã§. ÌäπÌûà **39ÌéòÏù¥ÏßÄ**Îäî ÏûÑÏÉÅ ÏãúÌóòÏù¥ÎÇò Íµ≠Í∞ÄÍ≥†ÏãúÏóêÎèÑ Îã®Í≥®Î°ú ÎÇòÏò§Îäî Í∞úÎÖêÏù¥Îãà Îàà ÌÅ¨Í≤å Îú®ÏÑ∏Ïöî.
>
> > [!INFO] PAGE 32-33: GenotypeÏóêÏÑú PhenotypeÍπåÏßÄ (Layer Íµ¨Ï°∞)
> > 32ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùò Îã§ÏñëÌïú ÏÇ¨ÎûåÎì§ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å Îã§ **Phenotype(ÌëúÌòÑÌòï)**ÏûÖÎãàÎã§.
> > * **ÌïµÏã¨ ÏßàÎ¨∏ (33p):** ÎèÑÎåÄÏ≤¥ Ïñ¥Îñ§ Î¨ºÎ¶¨Ï†Å Î©îÏª§ÎãàÏ¶òÏù¥ Ïö∞Î¶¨Ïùò Ïô∏Î™®ÏôÄ Í∏∞Îä•ÏùÑ Í≤∞Ï†ïÌï†ÍπåÏöî?
> > * **Ï†ïÎ≥¥Ïùò Í≥ÑÏ∏µ (Level):**
> >     * **Genome (Ïú†Ï†ÑÏ≤¥)**: Í∞ÄÏû• Î∞ëÎ∞îÎã• ÏÑ§Í≥ÑÎèÑ.
> >     * **Epigenome (ÌõÑÏÑ±Ïú†Ï†ÑÏ≤¥)**: ÏÑ§Í≥ÑÎèÑÏùò Ïä§ÏúÑÏπò.
> >     * **Transcriptome (Ï†ÑÏÇ¨Ï≤¥)**: Î≥µÏÇ¨Îêú Î™ÖÎ†πÏÑú.
> >     * **Proteome (Îã®Î∞±ÏßàÏ≤¥)**: Ïã§Ï†ú ÏùºÍæº.
> >     * **Metabolome (ÎåÄÏÇ¨Ï≤¥)**: ÏùºÍæºÏù¥ ÎßåÎì† Í≤∞Í≥ºÎ¨º.
> >     * **Phenome (ÌëúÌòÑÌòïÏ≤¥)**: ÏµúÏ¢ÖÏ†ÅÏù∏ ÏÉùÎ¨ºÌïôÏ†Å ÌäπÏßï.
> > * Ïù¥ Î™®Îì† **Biologic Process(ÏÉùÎ¨ºÌïôÏ†Å Í≥ºÏ†ï)**Í∞Ä Ïó∞Í≤∞ÎêòÏñ¥Ïïº ÎπÑÎ°úÏÜå 'ÎÇò'ÎùºÎäî ÏÇ¨ÎûåÏù¥ ÏÑ§Î™ÖÎê©ÎãàÎã§. 
>
> > [!INFO] PAGE 34-37: Ïú†Ï†ÑÏûê(Gene)ÏôÄ Î∞úÌòÑ(Expression)
> > 34ÌéòÏù¥ÏßÄ, 'Ïú†Ï†ÑÏûê'Ïùò Ï†ïÏùòÎ•º Î∂ÑÏûêÏ†Å Í¥ÄÏ†êÏóêÏÑú ÌôïÏã§Ìûà Ìï©ÏãúÎã§.
> > * **Ï†ïÏùò:** Îã®Î∞±ÏßàÏù¥ÎÇò RNAÎ•º ÏΩîÎî©ÌïòÎäî DNA Ï°∞Í∞Å + **"Ïñ∏Ï†ú, Ïñ¥ÎîîÏÑú, ÏñºÎßàÎÇò(when, where, what amounts)"** ÎßåÎì§ÏßÄ Í≤∞Ï†ïÌïòÎäî Î™ÖÎ†πÏñ¥ÍπåÏßÄ Ìè¨Ìï®ÏûÖÎãàÎã§. 
> > * **Expression (36p):**
> >     * **Transcription (Ï†ÑÏÇ¨):** Ìïµ(Nucleus) ÏïàÏóêÏÑú DNA ‚Üí mRNA. (ÏÑ±ÏàôÌïú mRNAÍ∞Ä Îê®) 
> >     * **Translation (Î≤àÏó≠):** ÏÑ∏Ìè¨Ïßà(Cytoplasm)Î°ú ÎÇòÏôÄÏÑú mRNA ‚Üí Protein. 
>
> > [!IMPORTANT] PAGE 39: Clinical Sequencing Ï¢ÖÎ•ò (Ï°±Î≥¥ ÏïºÎßà! ‚òÖ)
> > Ïûê, Ïó¨Í∏∞ **Î≥ÑÌëú 5Í∞ú** Î∞ïÏúºÏÑ∏Ïöî. Î≥ëÏõêÏóêÏÑú "Ïú†Ï†ÑÏûê Í≤ÄÏÇ¨Ìï©ÏãúÎã§" Ìï† Îïå Îã§ Í∞ôÏùÄ Í≤å ÏïÑÎãôÎãàÎã§. Í∞Å Î∞©Î≤ïÏù¥ **Î¨¥ÏóáÏùÑ(Target)** Î≥¥Í≥† **Ïñ¥Îñ§ ÎèåÏó∞Î≥ÄÏù¥(Application)**Î•º Ïû°ÎäîÏßÄ Îß§Ïπ≠Ìï¥Ïïº Ìï©ÎãàÎã§.
> >
> > 1.  **Whole Genome Sequencing (WGS, Ï†ÑÏû• Ïú†Ï†ÑÏ≤¥):**
> >     * **Î≤îÏúÑ:** DNA Ï†ÑÏ≤¥.
> >     * **Ïû°Îäî Í≤É:** **Structural variants (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥)**, Point mutations, Copy number variation (CNV). Îã§ Ïû°ÏäµÎãàÎã§. 
> > 2.  **Whole-Exome Sequencing (WES):**
> >     * **Î≤îÏúÑ:** **Exon baits**Î•º Ïç®ÏÑú Îã®Î∞±Ïßà ÎßåÎìúÎäî **1% (Exon)**Îßå Î¥ÖÎãàÎã§. Í∞ÄÏÑ±ÎπÑÍ∞Ä Ï¢ãÏ£†.
> >     * **Ïû°Îäî Í≤É:** Point mutations, CNV. (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥Îäî Ïûò Î™ª Î¥ÖÎãàÎã§) 
> > 3.  **PCR Amplicon (Targeted Panel):**
> >     * **Î≤îÏúÑ:** ÌäπÏ†ï Ïú†Ï†ÑÏûêÎßå Ï¶ùÌè≠.
> >     * **Ïû°Îäî Í≤É:** Point mutations, Deletions. ÌäπÏ†ï ÏßàÎ≥ë ÌÉÄÍ≤üÌåÖÌï† Îïå ÏîÅÎãàÎã§. 
> > 4.  **Transcriptome (RNA-seq):**
> >     * **Î≤îÏúÑ:** RNA Ï†ÑÏ≤¥.
> >     * **Ïû°Îäî Í≤É:** **Gene expression (Î∞úÌòÑÎüâ)**, **Gene fusions (ÏúµÌï© Ïú†Ï†ÑÏûê)**, Splice variants. 
>
> > [!INFO] PAGE 40: Genotype LayerÎ≥Ñ Î≥ÄÏù¥ Ï¢ÖÎ•ò (Ïö©Ïñ¥ Ï†ïÎ¶¨)
> > 40ÌéòÏù¥ÏßÄ ÌëúÎäî ÏïûÏùò ÎÇ¥Ïö©ÏùÑ Ï†ïÎ¶¨Ìïú Í≤ÅÎãàÎã§. Í∞Å Î†àÎ≤®ÏóêÏÑú ÏùºÏñ¥ÎÇòÎäî **Event** Ïö©Ïñ¥Î•º Ïô∏Ïö∞ÏÑ∏Ïöî.
> > * **Genome:** SNP (Îã®Ïùº ÏóºÍ∏∞ Îã§ÌòïÏÑ±), InDel (ÏÇΩÏûÖ/Í≤∞Ïã§), CNV (Î≥µÏ†úÏàò Î≥ÄÏù¥), SV (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥). 
> > * **Transcriptome:** Gene expression Î≥ÄÌôî, Alternative splicing(ÏÑ†ÌÉùÏ†Å Ïä§ÌîåÎùºÏù¥Ïã±). 
> > * **Proteome:** PTM (Post-translational modification, Î≤àÏó≠ ÌõÑ Î≥ÄÌòï). 

> [!NOTE] Pages 41-51: Ï†ÑÏÇ¨ Ï°∞Ï†àÍ≥º Îã®Î∞±ÏßàÏ≤¥ (Regulation & Proteome)
> Ïûê, DNAÏóê Ï†ïÎ≥¥Í∞Ä ÏûàÎã§Í≥† ÎÅùÏù¥ ÏïÑÎãôÎãàÎã§. Í∑∏Í±∏ ÏùΩÏñ¥ÎÇ¥Í≥†(Transcription), Í∞ÄÍ≥µÌïòÍ≥†(Splicing), Îã®Î∞±ÏßàÎ°ú ÎßåÎì§Í≥†(Translation), Îòê ÏàòÏ†ï(PTM)Ìï¥Ïïº ÎπÑÎ°úÏÜå Í∏∞Îä•Ïù¥ ÏÉùÍπÅÎãàÎã§. Ïù¥ Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨Í∞Ä Í≥†Ïû• ÎÇòÎ©¥ Í∑∏Í≤å Î∞îÎ°ú 'Ïïî'Ïù¥Í≥† 'ÏßàÎ≥ë'ÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 41-43: Ï†ÑÏÇ¨ ÎÑ§Ìä∏ÏõåÌÅ¨ÏôÄ Chromatin (Ï°∞Ï†àÏùò ÏãúÏûë)
> > 41ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. ÏÑ∏Ìè¨Ìïµ(Nucleus)ÏóêÏÑú ÏùºÏñ¥ÎÇòÎäî ÏùºÎì§ÏûÖÎãàÎã§.
> > * **Transcriptional networks (Ï†ÑÏÇ¨ ÎÑ§Ìä∏ÏõåÌÅ¨):**
> >     * **Transcription Factors (TF):** Ï†ÑÏÇ¨Î•º ÏãúÏûëÌïòÎäî Ïó¥Ïá†ÏûÖÎãàÎã§. 
> >     * **Cofactors & Chromatin regulation:** TFÎ•º ÎèÑÏôÄÏ£ºÍ±∞ÎÇò Î∞©Ìï¥ÌïòÎäî ÏπúÍµ¨Îì§Ïù¥Ï£†. 
> >     * **DNA Methylation & Histone Modification:** DNAÎ•º Í∞êÍ≥† ÏûàÎäî Ïã§Ìå®(Histone)Î•º Ï°∞Ïù¥Í±∞ÎÇò ÌíÄÏñ¥ÏÑú Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌï©ÎãàÎã§. (EpigeneticsÏùò ÌïµÏã¨) 
> > * **42ÌéòÏù¥ÏßÄ Íµ¨Ï°∞:** DNAÎäî Í∑∏ÎÉ• ÏûàÎäî Í≤å ÏïÑÎãàÎùº **Histone**Ïóê Í∞êÍ≤® **Nucleosome**ÏùÑ ÌòïÏÑ±Ìï©ÎãàÎã§. Ï†ÑÏÇ¨Í∞Ä ÏùºÏñ¥ÎÇòÎ†§Î©¥ Ïù¥ Íµ¨Ï°∞Í∞Ä ÌíÄÎ†§Ïïº ÌïòÎäîÎç∞, Í∑∏ Ïó¥Î¶∞ Î∂ÄÏúÑÎ•º **DNase I hypersensitive sites**ÎùºÍ≥† Ìï©ÎãàÎã§. "Ïó¨Í∏∞Í∞Ä ÌôúÏÑ± Î∂ÄÏúÑÎã§"ÎùºÎäî ÎúªÏù¥Ï£†. 
> > * **43ÌéòÏù¥ÏßÄ ÏõêÍ±∞Î¶¨ Ï°∞Ï†à:** **Long-range regulatory elements**Î•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏûê Î∞îÎ°ú ÏòÜÏù¥ ÏïÑÎãàÎùº ÏïÑÏ£º Î©ÄÎ¶¨ Îñ®Ïñ¥ÏßÑ Í≥≥ÏóêÏÑúÎèÑ Ï°∞Ï†à Ïã†Ìò∏Î•º Î≥¥ÎÉÖÎãàÎã§. DNAÍ∞Ä Í≥†Î¶¨Ï≤òÎüº ÌúòÏñ¥Ï†∏ÏÑú(Looping) ÎßåÎÇòÎäî Í≤ÅÎãàÎã§. 
>
> > [!INFO] PAGE 44-45: Ï†ÑÏÇ¨ Îã®ÏúÑÏùò Ìï¥Î∂Ä (Anatomy of Transcription)
> > 44ÌéòÏù¥ÏßÄ, Ïú†Ï†ÑÏûêÏùò Íµ¨Ï°∞Î•º ÎúØÏñ¥Î¥ÖÏãúÎã§. Ïö©Ïñ¥ Ï†ïÌôïÌûà ÏïÑÏÖîÏïº Ìï©ÎãàÎã§.
> > * **Promoter (Cis-regulatory region):** Ï†ÑÏÇ¨ ÏãúÏûë ÏúÑÏπòÎ•º Ïû°ÏïÑÏ£ºÎäî Í≥≥. **Basal (core) promoter**ÏôÄ **Module (Enhancer)**Î°ú ÎÇòÎâ©ÎãàÎã§. 
> > * **Transcription Unit:** Ïã§Ï†ú Î≥µÏÇ¨ÎêòÎäî Íµ¨Í∞Ñ. **Exon(ÎÇ®Îäî Î∂ÄÎ∂Ñ)**Í≥º **Intron(Î≤ÑÎ†§ÏßÄÎäî Î∂ÄÎ∂Ñ)**, Í∑∏Î¶¨Í≥† ÏñëÎÅùÏùò **UTR (Untranslated Region)**Ïù¥ ÏûàÏäµÎãàÎã§. 
> > * **45ÌéòÏù¥ÏßÄ Looping:** ÏïÑÍπå ÎßêÌïú ÏõêÍ±∞Î¶¨ Ï°∞Ï†àÏù¥ Ïñ¥ÎñªÍ≤å ÏùºÏñ¥ÎÇòÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§. **Looping factors**Í∞Ä DNAÎ•º ÌúòÍ≤å ÎßåÎì§Ïñ¥ Î©ÄÎ¶¨ ÏûàÎäî EnhancerÎ•º Promoter Í∑ºÏ≤òÎ°ú ÎÅåÍ≥† ÏòµÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 46: p53 Íµ¨Ï°∞ ÏÉÅÏÑ∏ (ÏïºÎßà/Í∏∞Ï∂ú Ìè¨Ïù∏Ìä∏ ‚òÖ)
> > Ïûê, ÏùòÎåÄÏÉùÏù¥ÎùºÎ©¥ **p53** Î™®Î•¥Î©¥ Í∞ÑÏ≤©ÏûÖÎãàÎã§. 'Ïú†Ï†ÑÏ≤¥Ïùò ÏàòÌò∏Ïûê'Ï£†. 46ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ ÌòÑÎØ∏Í≤Ω Î≥¥ÎìØ Î≥¥ÏÑ∏Ïöî.
> > * **Íµ¨Ï°∞Ï†Å ÌäπÏßï:**
> >     * **DNA-binding domain:** DNAÏôÄ ÏßÅÏ†ë Í≤∞Ìï©ÌïòÎäî Î∂ÄÏúÑ. Ïó¨Í∏∞Ïóê **Zinc atom (ÏïÑÏó∞ ÏõêÏûê)**Ïù¥ **Stabilizer(ÏïàÏ†ïÌôîÏ†ú)**Î°ú Î∞ïÌòÄ ÏûàÏäµÎãàÎã§. 
> >     * **Tetramerization domain:** p53ÏùÄ ÌòºÏûê Ïùº Ïïà Ìï©ÎãàÎã§. 4Í∞úÍ∞Ä Î≠âÏ≥êÏÑú(Tetramer) ÏùºÌï©ÎãàÎã§. 
> >     * **Transcription domain:** Ï†ÑÏÇ¨Î•º ÌôúÏÑ±ÌôîÌïòÎäî Î∂ÄÏúÑ. 
> > * **ÏûÑÏÉÅ Ïó∞Í≥Ñ:** ÏïîÌôòÏûêÏóêÏÑú p53 Î≥ÄÏù¥Í∞Ä Î∞úÍ≤¨ÎêòÎ©¥, Ï£ºÎ°ú Ï†Ä **DNA-binding domain**Ïù¥ ÎßùÍ∞ÄÏ†∏ÏÑú DNAÎ•º Î™ª Ïû°Í≤å ÎêòÎäî Í≤ΩÏö∞Í∞Ä ÎßéÏäµÎãàÎã§.
> >   ![Pasted image 20251209101527.png](/img/user/%ED%95%99%EC%97%85/%EC%98%88%202-2/%EB%B6%84%EC%9E%90%EC%9C%A0%EC%A0%84%ED%95%99/%EC%82%AC%EC%A0%84%EC%A0%95%EB%A6%AC%EB%B3%B8/%EA%B8%B0%EB%A7%90/%EB%8F%99%EB%B4%89%EC%9D%B4%EB%AF%B8%EC%A7%80/Pasted%20image%2020251209101527.png)
>
> > [!INFO] PAGE 47-48: SplicingÍ≥º Ï†ÑÏÇ¨Ïùò Î≥µÏû°ÏÑ±
> > 47ÌéòÏù¥ÏßÄÎ•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏûê ÌïòÎÇò(Gene 1)ÏóêÏÑú ÌôîÏÇ¥ÌëúÍ∞Ä Ïó¨Îü¨ Í∞ú ÎÇòÏò§Ï£†?
> > * **Alternative Splicing:** ÏóëÏÜêÏùÑ Ïñ¥ÎñªÍ≤å Ï°∞Î¶ΩÌïòÎäêÎÉêÏóê Îî∞Îùº ÌïòÎÇòÏùò Ïú†Ï†ÑÏûêÏóêÏÑú Ïó¨Îü¨ Ï¢ÖÎ•òÏùò mRNA(Transcripts)Í∞Ä ÎÇòÏòµÎãàÎã§.
> > * **Reverse Strand Transcripts:** Ïã¨ÏßÄÏñ¥ Î∞òÎåÄ Í∞ÄÎã•ÏóêÏÑúÎèÑ Ï†ÑÏÇ¨Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. 
> > * 48ÌéòÏù¥ÏßÄÎäî Îçî Î≥µÏû°Ìï©ÎãàÎã§. **tiRNA, PASR, ncRNA** Í∞ôÏùÄ ÎπÑÏïîÌò∏Ìôî RNAÎì§ÎèÑ ÏóÑÏ≤≠ÎÇòÍ≤å ÏèüÏïÑÏ†∏ ÎÇòÏòµÎãàÎã§. Ïö∞Î¶¨ Î™∏ÏùÄ ÏÉùÍ∞ÅÎ≥¥Îã§ Ìõ®Ïî¨ ÏàòÎã§Ïä§ÎüΩÏäµÎãàÎã§. 
>
> > [!INFO] PAGE 49-51: ProteomeÍ≥º PTM (Î≤àÏó≠ ÌõÑ Î≥ÄÌòï)
> > 49ÌéòÏù¥ÏßÄ Ïö∞Ï∏°ÏùÑ Î≥¥ÏÑ∏Ïöî. Îã®Î∞±ÏßàÏù¥ ÎßåÎì§Ïñ¥ÏßÑ ÌõÑ(Translation)ÏóêÎèÑ ÎÅùÏù¥ ÏïÑÎãôÎãàÎã§. **Post-translational modifications (PTM)**Ïù¥ ÏùºÏñ¥ÎÇ©ÎãàÎã§.
> > * **Ï¢ÖÎ•ò (Ïô∏Ïö∞ÏÑ∏Ïöî):**
> >     * **Phosphorylation (Ïù∏ÏÇ∞Ìôî):** Ïä§ÏúÑÏπò Ïó≠Ìï† (Í∞ÄÏû• Ï§ëÏöî). 
> >     * **Glycosylation (ÎãπÌôî):** ÎãπÏùÑ Î∂ôÏûÑ. 
> >     * **Acetylation (ÏïÑÏÑ∏Ìã∏Ìôî)** 
> >     * **Ubiquitination (Ïú†ÎπÑÌÄ¥Ìã¥Ìôî):** Î∂ÑÌï¥ Ïã†Ìò∏. 
> >     * **SUMOylation:** Îã®Î∞±Ïßà Í∏∞Îä• Ï°∞Ï†à. 
> > * **Í≤∞Î°† (50-51p):** Ïú†Ï†ÑÏûêÎäî ÌïòÎÇòÏßÄÎßå, SplicingÍ≥º PTMÏùÑ Í±∞ÏπòÎ©¥ ÏàòÏã≠, ÏàòÎ∞± Í∞ÄÏßÄÏùò **Mature proteins**Í∞Ä ÏÉùÍπÅÎãàÎã§. Í∑∏ÎûòÏÑú ProteomeÏù¥ GenomeÎ≥¥Îã§ Ìõ®Ïî¨ Î≥µÏû°Ìïú Í≤ÅÎãàÎã§. 

> [!NOTE] Pages 52-59: ÎåÄÏÇ¨Ï≤¥ÏôÄ ÌëúÌòÑÌòï (Metabolome & Phenotype)
> Ïûê, DNAÏóêÏÑú ÏãúÏûëÎêú Ïó¨Ï†ïÏù¥ ÎìúÎîîÏñ¥ Ïö∞Î¶¨ Î™∏Ïùò Ïã§Ï†ú Í∏∞Îä•Ïù∏ 'ÎåÄÏÇ¨'ÏôÄ 'ÌëúÌòÑÌòï'Ïóê ÎèÑÎã¨ÌñàÏäµÎãàÎã§. Ïú†Ï†ÑÏûêÍ∞Ä ÏïÑÎ¨¥Î¶¨ Ï¢ãÏïÑÎèÑ ÌôòÍ≤ΩÏù¥ ÎÇòÏÅòÎ©¥ Î≥ëÏù¥ ÏÉùÍ∏∞Îäî ÏõêÎ¶¨, Í∑∏Î¶¨Í≥† Ïïî ÌôòÏûêÏùò ÏÑ∏Ìè¨Î•º ÎñºÏñ¥ÎÇ¥ÏÑú Ïã§Ï†úÎ°ú ÏïΩÏùÑ Ï≥êÎ≥¥Îäî(Functional Assay) ÏµúÏã† Í∏∞Î≤ïÍπåÏßÄ ÏîπÏñ¥Î®πÏñ¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 53: Ïã†Ìò∏ Ï†ÑÎã¨Í≥º ÎåÄÏÇ¨ Í≤ΩÎ°ú (ÌöåÎ°úÎèÑ Î∂ÑÏÑù)
> > 53ÌéòÏù¥ÏßÄ Ï¢åÏ∏° Í∑∏Î¶º, ÏïÑÏ£º Ï†ÑÌòïÏ†ÅÏù∏ **ÏÑ∏Ìè¨ Ïã†Ìò∏ Ï†ÑÎã¨(Signaling Pathway)** ÌöåÎ°úÎèÑÏûÖÎãàÎã§. ÏàúÏÑúÎ•º Ïô∏Ïö∞ÏÑ∏Ïöî.
> > 1.  **Sensor (Í∞êÏßÄÍ∏∞):** ÏÑ∏Ìè¨ÎßâÏùò **Ligand + Receptor**Í∞Ä Ïã†Ìò∏Î•º Î∞õÏäµÎãàÎã§.
> > 2.  **Transducer (Î≥ÄÌôòÍ∏∞):** Ïù∏ÏÇ∞Ìôî(P) Îì±ÏùÑ ÌÜµÌï¥ Ïã†Ìò∏Î•º ÏïàÏúºÎ°ú Ï†ÑÎã¨Ìï©ÎãàÎã§.
> > 3.  **Circuit (ÌöåÎ°ú):** ÏÑ∏Ìè¨Ïßà(Cytoplasm) ÎÇ¥Ïùò Î≥µÏû°Ìïú Ïã†Ìò∏ ÎÑ§Ìä∏ÏõåÌÅ¨.
> > 4.  **Actuator (Íµ¨ÎèôÍ∏∞):** Ìïµ(Nucleus)ÏúºÎ°ú Îì§Ïñ¥Í∞Ä **DNA**Ïùò Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌï©ÎãàÎã§.
> >
> > * **Ïö∞Ï∏° Í∑∏Î¶º (Multi-omics flow):**
> >     * **Genome:** Gene 1, 2...
> >     * **Proteome:** Protein A, B, C... Ìö®ÏÜå(Enzyme)Îì§Ïù¥Ï£†.
> >     * **Metabolome:** Ìö®ÏÜåÎì§Ïù¥ Í∏∞Ïßà(a)ÏùÑ ÏÉùÏÇ∞Î¨º(b)Î°ú Î∞îÍøâÎãàÎã§. **Feedback loop** (Ï†êÏÑ† ÌôîÏÇ¥Ìëú)Í∞Ä Ï°¥Ïû¨ÌïòÏó¨ ÎåÄÏÇ¨ ÏÇ∞Î¨ºÏù¥ Îã§Ïãú Ïú†Ï†ÑÏûê Î∞úÌòÑÏùÑ Ï°∞Ï†àÌïòÍ∏∞ÎèÑ Ìï©ÎãàÎã§.
>
> > [!INFO] PAGE 54: Metabolome (ÎåÄÏÇ¨Ï≤¥)Ïùò ÏúÑÏπò
> > 54ÌéòÏù¥ÏßÄ ÌëúÏóêÏÑú Îπ®Í∞Ñ Î∞ïÏä§Î•º Î≥¥ÏÑ∏Ïöî.
> > * **Metabolome:** GenotypeÎ≥¥Îã§Îäî **Phenotype**Ïóê Ìõ®Ïî¨ Í∞ÄÍπùÏäµÎãàÎã§. Ï¶â, **"ÌòÑÏû¨ Î™∏ ÏÉÅÌÉúÎ•º Í∞ÄÏû• Ïã§ÏãúÍ∞ÑÏúºÎ°ú Î∞òÏòÅÌïòÎäî ÏßÄÌëú"**ÏûÖÎãàÎã§. Ïú†Ï†ÑÏûêÎäî ÌÉúÏñ¥ÎÇ† Îïå Í≤∞Ï†ïÎêòÏßÄÎßå, ÎåÄÏÇ¨Ï≤¥Îäî ÏïÑÏπ® Î®πÏóàÎÉê Íµ∂ÏóàÎÉêÏóê Îî∞Îùº Îã¨ÎùºÏßÄÎãàÍπåÏöî. 
>
> > [!IMPORTANT] PAGE 56: Ïú†Ï†ÑÏûêÏôÄ ÌôòÍ≤ΩÏùò ÏÉÅÌò∏ÏûëÏö© (Landscape Model)
> > Ïûê, Ïù¥ Í∑∏Î¶º Ïù¥Ìï¥ Î™ªÌïòÎ©¥ ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïô ÍΩùÏûÖÎãàÎã§. Í≥µÏù¥ Íµ¥Îü¨Í∞ÄÎäî Í≤ΩÎ°ú(Trajectory)Í∞Ä ÏÑ∏Ìè¨Ïùò Ïö¥Î™ÖÏûÖÎãàÎã§.
> > * **a (Phenotypic state):** Í≥µÏù¥ Íµ¥Îü¨ÎÇ¥Î†§ÏôÄ Í≥®ÏßúÍ∏∞(Attractor)Ïù∏ **P1~P5** Ï§ë ÌïòÎÇòÏóê ÏïàÏ∞©Ìï©ÎãàÎã§. Ïù¥Í≤å Ï†ïÏÉÅÏ†ÅÏù∏ Î∂ÑÌôîÏûÖÎãàÎã§. 
> > * **b (Environmental factor):** Ïô∏Î∂Ä ÌôòÍ≤ΩÏù¥ Í≥µÏùÑ Î∞ÄÏñ¥Î≤ÑÎ¶ΩÎãàÎã§. Í∑∏Îü¨Î©¥ ÏõêÎûò Í∞ÄÏïº Ìï† Í∏∏(Trajectory)ÏùÑ Î≤óÏñ¥ÎÇò Îã§Î•∏ ÌëúÌòÑÌòïÏúºÎ°ú Í∞ÄÍ≤å ÎêòÏ£†. 
> > * **c (Genetic factor):** Ïú†Ï†ÑÏûê Î≥ÄÏù¥Í∞Ä ÏÉùÍ∏∞Î©¥? **ÏßÄÌòï(Landscape) ÏûêÏ≤¥**Í∞Ä Î∞îÎÄùÎãàÎã§. Í≥®ÏßúÍ∏∞ Î™®ÏñëÏù¥ Î∞îÎÄåÏñ¥ÏÑú Í≥µÏù¥ ÏóâÎö±Ìïú Í≥≥ÏúºÎ°ú Íµ¥Îü¨Í∞ÄÍ≤å ÎßåÎì≠ÎãàÎã§. 
> > * **d (Noise):** ÌäπÎ≥ÑÌïú ÏöîÏù∏ ÏóÜÏñ¥ÎèÑ ÌôïÎ•†Ï†ÅÏù∏ Ïû°Ïùå(Stochasticity)ÎßåÏúºÎ°úÎèÑ Í≤∞Í≥ºÍ∞Ä Îã¨ÎùºÏßà Ïàò ÏûàÏäµÎãàÎã§. 
>
> > [!TIP] üí° PAGE 57-58: Ï∞®ÏÑ∏ÎåÄ Í∏∞Îä•ÏÑ± Î∂ÑÏÑù (Next-Gen Functional Assays)
> > 57-58ÌéòÏù¥ÏßÄÎäî Ïã§Ï†ú Î≥ëÏõêÏóêÏÑú Ïïî ÌôòÏûê Ï°∞ÏßÅÏùÑ ÎñºÏñ¥ÎÇ¥ÏÑú ÌïòÎäî Í≤ÄÏÇ¨Îì§ÏûÖÎãàÎã§. **"ÌôòÏûê ÎßûÏ∂§Ìòï ÏπòÎ£å(Precision Medicine)"**Ïùò ÏµúÏ†ÑÏÑ†Ïù¥Ï£†.
> >
> > **1. Í≤ÄÏ≤¥ ÌôïÎ≥¥ (57p):**
> > * **Solid tumours (Í≥†ÌòïÏïî):** Biopsy(ÏÉùÍ≤Ä) ÎòêÎäî CTCs(ÏàúÌôò Ï¢ÖÏñë ÏÑ∏Ìè¨).
> > * **Haematological (ÌòàÏï°Ïïî):** Bone marrow biopsy(Í≥®Ïàò ÏÉùÍ≤Ä).
> > * Ïù¥Í±∏Î°ú **Organoids (Ïò§Í∞ÄÎÖ∏Ïù¥Îìú, ÎØ∏Îãà Ïû•Í∏∞)**Î•º ÎßåÎì≠ÎãàÎã§. 
> >
> > **2. ÌïµÏã¨ Î∂ÑÏÑùÎ≤ï (58p - Ïö©Ïñ¥ ÏïîÍ∏∞):**
> > * **Kinase profiling:** Ïù∏ÏÇ∞Ìôî Ìö®ÏÜå ÌôúÏÑ± Ï∏°Ï†ï. 
> > * **Immuno-flow / FACS:** Ìï≠Ï≤¥Î•º Ïù¥Ïö©Ìï¥ Îã®Î∞±Ïßà Î∞úÌòÑ Î∂ÑÏÑù. 
> > * **DBP (Dynamic BH3 Profiling):** ÏÑ∏Ìè¨Í∞Ä ÏñºÎßàÎÇò Ï£ΩÍ∏∞ Ïâ¨Ïö¥ÏßÄ(**Apoptotic priming**) Ï∏°Ï†ï. 
> > * **Cytotoxicity (ÏÑ∏Ìè¨ ÎèÖÏÑ±):** ÏïΩ Ï≥§ÏùÑ Îïå ÏñºÎßàÎÇò Ï£ΩÎÇò? (**ATP levels, MTT** Îì±ÏúºÎ°ú Ï∏°Ï†ï). 
> > * **PDX (Patient-Derived Xenograft):** Ï•ê(Mouse)Ïóê ÌôòÏûê ÏïîÏùÑ Ïù¥ÏãùÌï¥ÏÑú ÌÖåÏä§Ìä∏. Í∞ÄÏû• Ï†ïÌôïÌïòÏßÄÎßå ÎπÑÏã∏Í≥† Ïò§Îûò Í±∏Î¶º. 
>
> > [!INFO] PAGE 59: Phenome (ÌòÑÏÉÅÏ≤¥)Ïùò Íµ¨ÏÑ±
> > 59ÌéòÏù¥ÏßÄ ÎßàÏßÄÎßâ Îã®Í≥ÑÏûÖÎãàÎã§.
> > * Í≤∞Íµ≠ Ïù¥ Î™®Îì† Í≥ºÏ†ïÏùò ÎÅùÏùÄ Î¨¥ÏóáÏù∏Í∞Ä?
> > * **Tumorigenesis (Ï¢ÖÏñë ÌòïÏÑ±)**
> > * **Angiogenesis (ÌòàÍ¥Ä ÏÉùÏÑ±)**
> > * **Metastasis (Ï†ÑÏù¥)**
> > * Ïù¥Îü∞ Í±∞ÏãúÏ†ÅÏù∏ ÌäπÏßïÎì§ÏùÑ **Phenome**Ïù¥ÎùºÍ≥† Î∂ÄÎ¶ÖÎãàÎã§. 

> [!NOTE] Pages 60-66: ÌõÑÏÑ±Ïú†Ï†ÑÌïô ÌòÅÎ™Ö (Epigenomic Revolution)
> Ïûê, DNA ÏóºÍ∏∞ÏÑúÏó¥Ïù¥ Ïö¥Î™ÖÏùò Ï†ÑÎ∂ÄÍ∞Ä ÏïÑÎãôÎãàÎã§. ÎòëÍ∞ôÏùÄ ÏïÖÎ≥¥(DNA)Î•º Í∞ÄÏßÄÍ≥†ÎèÑ Ïó∞Ï£ºÏûê(ÏÑ∏Ìè¨)Ïóê Îî∞Îùº Ïä¨Ìîà Í≥°Ïù¥ ÎêòÍ∏∞ÎèÑ ÌïòÍ≥† Í∏∞ÏÅú Í≥°Ïù¥ ÎêòÍ∏∞ÎèÑ ÌïòÏ£†. Í∑∏Í≤å Î∞îÎ°ú **Epigenetics**ÏûÖÎãàÎã§. Ïó¨Í∏∞ÏÑúÎäî **ChromatinÏùò Íµ¨Ï°∞ Î≥ÄÌôî**ÏôÄ **Histone Code**Î•º Ìï¥ÎèÖÌïòÎäî Í≤å ÌïµÏã¨ÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 60-61: ChromatinÏùò Í∞úÌèêÏôÄ Histone Tail
> > 60ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî.
> > * **Compact DNA (a):** ÍΩÅÍΩÅ Í∞êÍ≤® ÏûàÏäµÎãàÎã§. Ïù¥Îü¨Î©¥ Ï†ÑÏÇ¨ Ïù∏Ïûê(TF)Í∞Ä Ï†ëÍ∑ºÏùÑ Î™ª ÌïòÏ£†. **"Gene Inactive"** ÏÉÅÌÉúÏûÖÎãàÎã§. 
> > * **Relaxed DNA (b):** Íµ¨Ï°∞Í∞Ä ÌíÄÎ†∏ÏäµÎãàÎã§(Alteration of structure). DNAÍ∞Ä ÎÖ∏Ï∂úÎêòÎãà Ï†ÑÏÇ¨(Transcription)Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. **"Gene Active"** ÏÉÅÌÉúÏûÖÎãàÎã§. 
> >
> > 61ÌéòÏù¥ÏßÄÎ•º Î≥¥ÏÑ∏Ïöî. Ïù¥ ChromatinÏùÑ ÎßåÎìúÎäî Ïã§Ìå®Í∞Ä **Histone**Ïù¥Ï£†.
> > * **Íµ¨ÏÑ±:** **H2A, H2B, H3, H4**Í∞Ä Í∞ÅÍ∞Å 2Í∞úÏî© Î™®Ïó¨ 8ÎüâÏ≤¥(Octamer)Î•º Ïù¥Î£πÎãàÎã§. 
> > * **Tail (Íº¨Î¶¨):** Í∑∏Î¶ºÏóê ÏÇêÏ£ΩÏÇêÏ£Ω ÌäÄÏñ¥ÎÇòÏò® ÏÑ†Îì§ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å **Histone Tail**ÏûÖÎãàÎã§. Ïó¨Í∏∞Í∞Ä Î∞îÎ°ú ÌôîÌïôÏ†Å Î≥ÄÌòïÏù¥ ÏùºÏñ¥ÎÇòÎäî **'Ï°∞Ï†à Ïä§ÏúÑÏπò'**ÏûÖÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 62: ÌûàÏä§ÌÜ§ ÏΩîÎìú (Histone Code) ÏÉÅÏÑ∏ Î∂ÑÏÑù (‚òÖÏïîÍ∏∞)
> > 62ÌéòÏù¥ÏßÄ, Íπ®Ïïå Í∞ôÏùÄ ÏïåÌååÎ≤≥Îì§Ïù¥ ÎÇòÏòµÎãàÎã§. Ïù¥Í≤å ÌûàÏä§ÌÜ§ Íº¨Î¶¨Ïùò ÏïÑÎØ∏ÎÖ∏ÏÇ∞ ÏÑúÏó¥ÏûÖÎãàÎã§. ÏãúÌóòÏóê ÎÇòÏòµÎãàÎã§.
> >
> > **1. H3 Tail (ÏúÑÏ™Ω Í∑∏Î¶º):** 
> > * ÏÑúÏó¥ ÏãúÏûë: **N-ARTKQTARKSTGGK...** (Ïù¥Í±∞ ÎààÏóê ÏùµÌûàÏÑ∏Ïöî) 
> > * Ï£ºÏöî Î≥ÄÌòï ÏúÑÏπò (Ïà´ÏûêÎäî ÏïÑÎØ∏ÎÖ∏ÏÇ∞ Î≤àÌò∏):
> >     * **K (Lysine, Î¶¨Ïã†):** Ï£ºÎ°ú **Me (Methylation)**ÏôÄ **Ac (Acetylation)**Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. (Ïòà: K4, K9, K27) 
> >     * **S (Serine, ÏÑ∏Î¶∞):** Ï£ºÎ°ú **P (Phosphorylation, Ïù∏ÏÇ∞Ìôî)**Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. (Ïòà: S10, S28) 
> >
> > **2. H4 Tail (ÏïÑÎûòÏ™Ω Í∑∏Î¶º):** 
> > * ÏÑúÏó¥ ÏãúÏûë: **N-SGRGKGGK...** 
> > * Ïó¨Í∏∞ÎèÑ **Acetylation (Ac)**Ïù¥ ÏûîÎú© Î∂ôÏñ¥ ÏûàÏ£†? (K5, K8, K12, K16 Îì±) 
> >
> > **3. H2A & H2B:**
> > * **Ub (Ubiquitination):** Ïú†ÎπÑÌÄ¥Ìã¥Ïù¥ Î∂ôÍ∏∞ÎèÑ Ìï©ÎãàÎã§. 
> >
> > **[ÍµêÏàòÎãòÏùò ÌåÅ]** "KÏóê AcetylÍ∏∞Í∞Ä Î∂ôÏúºÎ©¥(Acetylation) Ï†ÑÏÇ¨Í∞Ä **Ï¥âÏßÑ**ÎêòÍ≥†, MethylÍ∏∞Í∞Ä Î∂ôÏúºÎ©¥(Methylation) ÏúÑÏπòÏóê Îî∞Îùº Ï¥âÏßÑÎêòÍ∏∞ÎèÑ ÌïòÍ≥† ÏñµÏ†úÎêòÍ∏∞ÎèÑ ÌïúÎã§." Ïù¥ ÏõêÏπôÏùÑ Íº≠ Í∏∞ÏñµÌïòÏÑ∏Ïöî.
>
> > [!IMPORTANT] PAGE 63: DNA Methylation (ÌôîÌïô Íµ¨Ï°∞)
> > 63ÌéòÏù¥ÏßÄ, Ïù¥Î≤àÏóî ÌûàÏä§ÌÜ§Ïù¥ ÏïÑÎãàÎùº DNA ÏßÅÏ†ë Î≥ÄÌòïÏûÖÎãàÎã§.
> > * **ÎåÄÏÉÅ:** **Cytosine (C, ÏãúÌÜ†Ïã†)** ÏóºÍ∏∞. 
> > * **Î≥ÄÌôî:** ÏãúÌÜ†Ïã†Ïùò 5Î≤à ÌÉÑÏÜå ÏúÑÏπòÏóê **Methyl group ($CH_3$)**Ïù¥ Î∂ôÏäµÎãàÎã§.
> > * **Í≤∞Í≥º:** **5-methylcytosine**Ïù¥ Îê©ÎãàÎã§. 
> > * **Í∏∞Îä•:** Ï£ºÎ°ú Ïú†Ï†ÑÏûê Î∞úÌòÑÏùÑ **ÏñµÏ†ú(Silencing)**ÌïòÎäî ÏûêÎ¨ºÏá† Ïó≠Ìï†ÏùÑ Ìï©ÎãàÎã§. Í∑∏Î¶ºÏùò ÌôîÌïô Íµ¨Ï°∞Ïãù($NH_2$ Î∞ëÏóê $H$Í∞Ä $CH_3$Î°ú Î∞îÎÄåÎäî Î∂ÄÎ∂Ñ)ÏùÑ ÌôïÏù∏ÌïòÏÑ∏Ïöî. 
>
> > [!INFO] PAGE 64-66: EpigenomeÏùò ÏúÑÏÉÅÍ≥º ÌÜµÌï©
> > 64ÌéòÏù¥ÏßÄ ÌëúÏùò Îπ®Í∞Ñ Î∞ïÏä§Î•º Î≥¥ÏÑ∏Ïöî.
> > * **EpigenomeÏùò Íµ¨ÏÑ± ÏöîÏÜå:**
> >     1.  **Methylation (DNA Î©îÌã∏Ìôî)** 
> >     2.  **Histone modification (ÌûàÏä§ÌÜ§ Î≥ÄÌòï)** 
> >     3.  **miRNA & LncRNA:** ÎπÑÏïîÌò∏Ìôî RNAÎì§ÎèÑ ÌõÑÏÑ±Ïú†Ï†ÑÌïôÏ†Å Ï°∞Ï†àÏóê Í¥ÄÏó¨Ìï©ÎãàÎã§. 
> >
> > 66ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ Ïù¥ Î™®Îì† Í≤å ÌÜµÌï©Îêú Î™®ÏäµÏûÖÎãàÎã§.
> > * **DNA Methylation**Ïù¥ ÎêòÏñ¥ ÏûàÍ≥†, **Histone**Îì§Ïù¥ Î≠âÏ≥ê ÏûàÏúºÎ©¥(Nucleosome) Ï†ëÍ∑º Î∂àÍ∞Ä.
> > * Î∞òÎ©¥ **DNase I hypersensitive sites**Îäî ÌûàÏä§ÌÜ§Ïù¥ ÏóÜÎäî Ïó¥Î¶∞ Íµ¨Í∞ÑÏúºÎ°ú, Ïó¨Í∏∞Í∞Ä **Functional genomic elements(Í∏∞Îä•Ï†Å Ïú†Ï†ÑÏ≤¥ ÏöîÏÜå)**Í∞Ä ÏûëÎèôÌïòÎäî Í≥≥ÏûÖÎãàÎã§. 

> [!NOTE] Pages 67-73: ÌõÑÏÑ±Ïú†Ï†ÑÌïôÍ≥º ÏßàÎ≥ë, Í∑∏Î¶¨Í≥† ENCODE
> Ïûê, "Ïú†Ï†ÑÏûêÎäî Ïö¥Î™ÖÏù¥ ÏïÑÎãàÎã§"ÎùºÎäî Îßê Îì§Ïñ¥Î¥§Ï£†? Í∑∏ Í≥ºÌïôÏ†Å Í∑ºÍ±∞Í∞Ä Ïó¨Í∏∞ Îã§ ÏûàÏäµÎãàÎã§. ÌôòÍ≤Ω(Îã§Ïù¥Ïñ¥Ìä∏, Ïä§Ìä∏Î†àÏä§)Ïù¥ Ïñ¥ÎñªÍ≤å ÎÇ¥ Ïú†Ï†ÑÏûêÏùò Ïä§ÏúÑÏπòÎ•º Ï°∞ÏûëÌï¥ÏÑú ÏïîÏù¥ÎÇò ÎãπÎá®Î≥ëÏùÑ ÏùºÏúºÌÇ§ÎäîÏßÄ, Í∑∏Î¶¨Í≥† Ïú†Ï†Ñ Ï†ïÎ≥¥Î•º ÎÑòÏñ¥ÏÑ† '4Ï∞®Ïõê Ïú†Ï†Ñ'Ïù¥ Î¨¥ÏóáÏù∏ÏßÄ ÏÇ¥Ìé¥Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 67-68: ENCODE ÌîÑÎ°úÏ†ùÌä∏ (ÌïÑÏàò ÏÉÅÏãù)
> > 67ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ ÏïûÏÑú Î∞∞Ïö¥ Ï†ÑÏÇ¨ Ï°∞Ï†àÏùò Ï¥ùÏ†ïÎ¶¨ÏûÖÎãàÎã§.  Ïù¥ Î≥µÏû°Ìïú Ï°∞Ï†à Î∂ÄÏúÑÎì§ÏùÑ Ï†ÑÎ∂Ä Îã§ ÏßÄÎèÑÏóê ÌëúÏãúÌïòÎ†§Îäî ÏãúÎèÑÍ∞Ä ÏûàÏóàÏúºÎãà, Î∞îÎ°ú **ENCODE**ÏûÖÎãàÎã§.
> > * **Ï†ïÏùò (68p):** **The Encyclopedia of DNA Elements**. 'DNA ÏöîÏÜå Î∞±Í≥ºÏÇ¨Ï†Ñ' ÌîÑÎ°úÏ†ùÌä∏ÏûÖÎãàÎã§. 
> > * **Î™©Ìëú:** Ïù∏Í∞Ñ Í≤åÎÜàÏùò **'Î™®Îì† Í∏∞Îä•Ï†Å ÏöîÏÜå(All functional elements)'**Î•º ÏãùÎ≥ÑÌïòÎäî Í≤É. 
> > * **ÎÇ¥Ïö©:** Îã®ÏàúÌûà Ïú†Ï†ÑÏûêÎßå Ï∞æÎäî Í≤å ÏïÑÎãàÎùº, **Regulatory elements(Ï°∞Ï†à Ïù∏Ïûê)**, **Exon variants**, **Alternative promoters** Îì± 'Í∏∞Îä•'ÏùÑ ÌïòÎäî Î™®Îì† Í≤ÉÏùÑ Ï∞æÏäµÎãàÎã§. 
>
> > [!INFO] PAGE 69: ÌõÑÏÑ±Ïú†Ï†ÑÌïôÏ†Å Ïä§ÏúÑÏπò (Active vs Inactive)
> > 69ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Í∞ôÏùÄ DNAÎùºÎèÑ ÏÉÅÌÉúÍ∞Ä Îã§Î¶ÖÎãàÎã§.
> > * **Inactive (ÎπÑÌôúÏÑ±):** DNAÍ∞Ä **Methylation** ÎêòÏñ¥ ÏûàÍ≥†, HistoneÏù¥ ÍΩâ Î≠âÏ≥êÏÑú(Inaccessible) Ïú†Ï†ÑÏûêÍ∞Ä Í∫ºÏ†∏ ÏûàÏäµÎãàÎã§. 
> > * **Active (ÌôúÏÑ±):** **Histone Modification**Ïóê ÏùòÌï¥ Íµ¨Ï°∞Í∞Ä ÌíÄÎ†§ ÏûàÍ≥†(Accessible), Ïú†Ï†ÑÏûêÍ∞Ä ÏºúÏ†∏ ÏûàÏäµÎãàÎã§. 
> > * **ÌïµÏã¨:** ÏãùÏù¥ÏöîÎ≤ï(Dietary sources) Í∞ôÏùÄ ÌôòÍ≤Ω ÏöîÏù∏Ïù¥ Î©îÌã∏Í∏∞(Methyl group)Î•º Ï†úÍ≥µÌï¥ÏÑú Ïù¥ Ïä§ÏúÑÏπòÎ•º Ï°∞ÏûëÌï† Ïàò ÏûàÎã§Îäî Í≤ÅÎãàÎã§. 
>
> > [!WARNING] PAGE 70: ÌôòÍ≤ΩÍ≥º ÏßàÎ≥ëÏùò Ïó∞Í≤∞Í≥†Î¶¨ (Environment-Disease Link)
> > 70ÌéòÏù¥ÏßÄ, Ïó¨Í∏∞Í∞Ä ÏûÑÏÉÅÏ†ÅÏúºÎ°ú Ï†úÏùº Ï§ëÏöîÌï©ÎãàÎã§. Ïôú ÎÇòÏÅú Í±∞ Î®πÏúºÎ©¥ ÏïîÏóê Í±∏Î¶¥ÍπåÏöî?
> > * **ÏòÅÌñ• ÏöîÏù∏ (Factors):** **Diet(ÏãùÎã®)**, **Aging(ÎÖ∏Ìôî)**, **Drugs**, **Environmental chemicals**, Ïã¨ÏßÄÏñ¥ **Development(Î∞úÎã¨ Í≥ºÏ†ï)**ÍπåÏßÄ. 
> > * **Í∏∞Ï†Ñ:** Ïù¥ ÏöîÏù∏Îì§Ïù¥ **DNA Methylation**Ïù¥ÎÇò **Histone Modification**ÏùÑ Î≥ÄÌôîÏãúÌÇµÎãàÎã§. 
> > * **Í≤∞Í≥º (Health Endpoints):** Ïú†Ï†ÑÏûêÍ∞Ä ÏûòÎ™ª ÏºúÏßÄÍ±∞ÎÇò Í∫ºÏ†∏ÏÑú **Cancer(Ïïî)**, **Autoimmune disease(ÏûêÍ∞ÄÎ©¥Ïó≠ÏßàÌôò)**, **Diabetes(ÎãπÎá®)** Îì±Ïù¥ Î∞úÏÉùÌï©ÎãàÎã§. 
>
> > [!INFO] PAGE 71: Ïú†Ï†ÑÏùò 4Í∞ÄÏßÄ Ï∞®Ïõê (4 Dimensions)
> > 71ÌéòÏù¥ÏßÄ ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏùÄ DNA(Genetic)Î°úÎßå ÎêòÎäî Í≤å ÏïÑÎãôÎãàÎã§. 
> > 1.  **Genetic:** DNA ÏóºÍ∏∞ÏÑúÏó¥.
> > 2.  **Epigenetic:** Chromatin marks, RNA silencing Îì±. (ÏÑ∏Ìè¨ Í∏∞Ïñµ)
> > 3.  **Behavioral:** ÌñâÎèôÏ†Å Ï†ÑÏàò (Îî∞Îùº ÌïòÍ∏∞ Îì±).
> > 4.  **Symbolic:** Ïñ∏Ïñ¥, Î¨∏Ìôî Îì± Ïù∏Í∞Ñ Í≥†Ïú†Ïùò Ï†ÑÏàò.
>
> > [!IMPORTANT] PAGE 72: ÌûàÏä§ÌÜ§ ÎßàÌÅ¨Ïùò Íµ¨Ï≤¥Ï†Å Í∏∞Îä• (Ïã¨Ìôî ‚òÖ)
> > 72ÌéòÏù¥ÏßÄ Ïõê ÏïàÏùò Í∏∞Ìò∏Îì§ÏùÑ Ìï¥ÏÑùÌï¥Ïïº Ìï©ÎãàÎã§. **K(ÎùºÏù¥Ïã†)**Ïóê Î≠êÍ∞Ä Î∂ôÎäêÎÉêÏóê Îî∞Îùº Ïö¥Î™ÖÏù¥ Í∞àÎ¶ΩÎãàÎã§. 
> > * **MeK4 (H3K4me):** Ï£ºÎ°ú **Activation (ÌôúÏÑ±Ìôî)**ÏôÄ Í¥ÄÎ†®Îê©ÎãàÎã§.
> > * **MeK9, MeK27 (H3K9me, H3K27me):** Ï£ºÎ°ú **Repression (ÏñµÏ†ú)**ÏôÄ Í¥ÄÎ†®Îê©ÎãàÎã§. (ÌôîÏÇ¥ÌëúÍ∞Ä ÏñµÏ†ú Î™®ÏñëÏù∏ Í≤É ÌôïÏù∏!) 
> > * **AcK (Acetylation):** Í±∞Ïùò Ìï≠ÏÉÅ **Activation**ÏûÖÎãàÎã§.
> > * **CpG Methylation:** DNA Î©îÌã∏ÌôîÎäî Ï£ºÎ°ú **ÏñµÏ†ú**ÏûÖÎãàÎã§.
> > * Ïù¥Îì§Ïù¥ ÏÑúÎ°ú ÏÉÅÌò∏ÏûëÏö©(Cross-talk)ÌïòÎ©∞ Ï†ïÍµêÌïòÍ≤å Ï°∞Ï†àÌï©ÎãàÎã§.
>
> > [!INFO] PAGE 73: EpigenomeÏùò ÌÜµÌï©Ï†Å ÏúÑÏπò
> > 73ÌéòÏù¥ÏßÄ, Îã§Ïãú ÌïúÎ≤à Ï†ÑÏ≤¥ ÏßÄÎèÑÎ•º Î¥ÖÎãàÎã§.
> > * **Epigenome**ÏùÄ GenomeÍ≥º Transcriptome ÏÇ¨Ïù¥ÏóêÏÑú Ï†ïÎ≥¥Ïùò ÌùêÎ¶ÑÏùÑ ÌÜµÏ†úÌïòÎäî **'Í≤ÄÎ¨∏ÏÜå'** Ïó≠Ìï†ÏùÑ Ìï©ÎãàÎã§. Ïó¨Í∏∞ÏÑú **Tumorigenesis(Ïïî Î∞úÏÉù)** Îì±Ïùò Ïö¥Î™ÖÏù¥ 1Ï∞®Ï†ÅÏúºÎ°ú Í≤∞Ï†ïÎêòÎäî Í≤ÉÏûÖÎãàÎã§. 

> [!NOTE] Pages 74-80: ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïôÏùò ÎèÑÍµ¨ÏôÄ Multi-Omics
> Ïûê, Ïù¥Ï†ú Ïù¥Î°†ÏùÄ Ï∂©Î∂ÑÌï©ÎãàÎã§. Ïã§Ï†úÎ°ú Ïù¥ Î∞©ÎåÄÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïñ¥ÎñªÍ≤å ÎΩëÏïÑÎÇ¥Í≥†(Microarray), Ïñ¥ÎñªÍ≤å Î∂ÑÏÑùÌï¥ÏÑú(AI), ÌôòÏûêÎ•º Î∂ÑÎ•ò(Stratification)ÌïòÎäîÏßÄ, Í∑∏ 'Î¨¥Í∏∞'Îì§ÏùÑ Ï†êÍ≤ÄÌï¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 74: Multi-OmicsÏôÄ AIÏùò Í≤∞Ìï© (ÏïåÍ≥†Î¶¨Ï¶ò Ï≤¥ÌÅ¨)
> > 74ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ Ï†ïÎ∞ÄÏùòÌïôÏùò 'Ï†ÑÌà¨ ÏßÄÎèÑ'ÏûÖÎãàÎã§. 
> > * **Multi-Omics:** Genome, Epigenome, Transcriptome, Proteome, MetabolomeÏùÑ Ï†ÑÎ∂Ä Ìï©Ïπ©ÎãàÎã§.
> > * **AI & Machine Learning:** Ïù¥ Îç∞Ïù¥ÌÑ∞Î•º ÏÇ¨ÎûåÏù¥ ÎààÏúºÎ°ú Î™ª Î¥ÖÎãàÎã§. AIÍ∞Ä ÌïÑÏöîÌïòÏ£†. Ïó¨Í∏∞Ïóê Ïì∞Ïù¥Îäî ÏïåÍ≥†Î¶¨Ï¶ò Ïù¥Î¶ÑÎì§ÏùÑ Íº≠ ÎààÏó¨Í≤®Î≥¥ÏÑ∏Ïöî.
> >     * **SVM (Support Vector Machine)** 
> >     * **DT (Decision Tree)** 
> >     * **RF (Random Forest)** 
> >     * **LightGBM:** ÏµúÍ∑º Îç∞Ïù¥ÌÑ∞ Î∂ÑÏÑù ÎåÄÌöåÏóêÏÑú ÎßéÏù¥ Ïì∞Ïù¥Îäî Í∞ïÎ†•Ìïú Î∂ÄÏä§ÌåÖ Î™®Îç∏ÏûÖÎãàÎã§. 
> >     * **Deep Learning (Îî•Îü¨Îãù):** Ïù¥ÎØ∏ÏßÄÎÇò ÎπÑÏ†ïÌòï Îç∞Ïù¥ÌÑ∞ Î∂ÑÏÑùÏóê Í∞ïÌïòÏ£†. 
> > * **Í≥ºÏ†ï:** Îç∞Ïù¥ÌÑ∞ ÌÜµÌï©(Data Integration) ‚Üí ÌäπÏßï ÏÑ†ÌÉù(Feature Selection) ‚Üí ÏòàÏ∏°(Prediction).
>
> > [!INFO] PAGE 75-76: ÌôòÏûê Ï∏µÌôî (Stratification)ÏôÄ Omics Ï†ïÏùò
> > 75ÌéòÏù¥ÏßÄ, ÏïåÎ°ùÎã¨Î°ùÌïú ÏÇ¨Îûå Í∑∏Î¶º Î≥¥Ïù¥Ï£†? 
> > * Í≥ºÍ±∞Ïóî Îã§ ÎòëÍ∞ôÏùÄ ÏÇ¨Îûå(Average patient) Ï∑®Í∏âÌñàÏßÄÎßå, Ïù¥Ï†úÎäî Îç∞Ïù¥ÌÑ∞Î•º ÌÜµÌï¥ **"Stratification(Ï∏µÌôî)"**Ìï©ÎãàÎã§. Í∑∏Î£πÏùÑ ÎÇòÎààÎã§Îäî ÎúªÏûÖÎãàÎã§. Í∑∏ÎûòÏïº **High effective treatment**Í∞Ä Í∞ÄÎä•ÌïòÎãàÍπåÏöî.
> >
> > 76ÌéòÏù¥ÏßÄ, Ïö©Ïñ¥ Ï†ïÎ¶¨ÌïòÍ≥† Í∞ëÏãúÎã§. 
> > * **Omics:** "-ome"ÏùÄ Ï†ÑÏ≤¥(Complete knowledge)Î•º ÎúªÌï©ÎãàÎã§.
> > * **Transcriptomics:** RNA Ï†ÑÏ≤¥.
> > * **Proteomics:** Îã®Î∞±Ïßà Ï†ÑÏ≤¥.
> > * **Metabolomics:** ÎåÄÏÇ¨Î¨ºÏßà Ï†ÑÏ≤¥.
>
> > [!IMPORTANT] PAGE 77-79: DNA Microarray ÏõêÎ¶¨ (ÏÉÅÏÑ∏ Ïä§Ìéô ÏïîÍ∏∞)
> > 77ÌéòÏù¥ÏßÄ, Ïù¥Í≤å Î∞îÎ°ú ÏàòÎßå Í∞úÏùò Ïú†Ï†ÑÏûêÎ•º Ìïú Î∞©Ïóê Í≤ÄÏÇ¨ÌïòÎäî **DNA Microarray** Ïπ©ÏûÖÎãàÎã§. ÏàòÏπòÎ•º Î≥¥ÏÑ∏Ïöî.
> > * **ÌÅ¨Í∏∞:** Ï†ÑÏ≤¥ Ïπ©ÏùÄ **3cm x 7cm** Ï†ïÎèÑÏûÖÎãàÎã§. Ïä¨ÎùºÏù¥Îìú Í∏ÄÎùºÏä§ ÌÅ¨Í∏∞Ï£†. 
> > * **Spot:** Í∑∏ ÏïàÏóê ÏûëÏùÄ Ï†êÎì§Ïù¥ Ï∞çÌòÄ ÏûàÎäîÎç∞, Í∞Å Ï†êÏùò ÏßÄÎ¶ÑÏùÄ **150¬µm**, Ï†ê ÏÇ¨Ïù¥ Í∞ÑÍ≤©ÏùÄ **300¬µm**ÏûÖÎãàÎã§. 
> > * **ÏõêÎ¶¨:**
> >     1.  Ïπ© ÏúÑÏóê **Probe DNA(ÌÉêÏπ®)**Î•º ÎØ∏Î¶¨ Ïã¨Ïñ¥ÎÜìÏäµÎãàÎã§. (ÏàòÎßå Í∞ú) 
> >     2.  ÌôòÏûêÏùò ÏÉòÌîå(RNA)ÏùÑ Ïó≠Ï†ÑÏÇ¨Ìï¥ÏÑú **Fluorescent tagging(ÌòïÍ¥ë ÌëúÏßÄ)**ÏùÑ Î∂ôÏù∏ DNA(cDNA)Î°ú ÎßåÎì≠ÎãàÎã§. 
> >     3.  Ïπ© ÏúÑÏóê ÎøåÎ¶¨Î©¥, Ïßù(ÏÉÅÎ≥¥Ï†Å ÏÑúÏó¥)Ïù¥ ÎßûÎäî Í≤ÉÎÅºÎ¶¨ Îì§Îü¨Î∂ôÏäµÎãàÎã§. Ïù¥Í±∏ **Hybridization(ÌòºÏÑ±Ìôî)**Ïù¥ÎùºÍ≥† Ìï©ÎãàÎã§. 
> > * **Ìï¥ÏÑù (78p):** 
> >     * ÌäπÏ†ï ÏÉâÍπî(Î≥¥ÌÜµ Îπ®Í∞ï/Ï¥àÎ°ù)Ïù¥ ÎπõÎÇòÎ©¥ Í∑∏ Ïú†Ï†ÑÏûêÍ∞Ä Î∞úÌòÑÎêú Í≤ÉÏûÖÎãàÎã§.
> >     * Îëê ÏÉâÏù¥ ÏÑûÏó¨(ÎÖ∏Îûë) ÎÇòÏò§Î©¥ Îëò Îã§ ÏûàÎäî Í±∞Í≥†Ïöî.
> 
>
> > [!INFO] PAGE 80: HeatmapÍ≥º Ï¢ÖÏñë Î∂ÑÎ•ò (Taxonomy)
> > 80ÌéòÏù¥ÏßÄ, ÎßàÏπò Î™®ÏûêÏù¥ÌÅ¨ Í∞ôÏùÄ Í∑∏Î¶ºÏù¥ **Heatmap**ÏûÖÎãàÎã§. 
> > * **Í∞ÄÎ°úÏ§Ñ:** Ïú†Ï†ÑÏûê ÌïòÎÇòÌïòÎÇò.
> > * **ÏÑ∏Î°úÏ§Ñ:** ÌôòÏûê Ìïú Î™Ö Ìïú Î™Ö.
> > * **ÏÉâÍπî:** Îπ®Í∞ÑÏÉâÏùÄ Î∞úÌòÑ ÎÜíÏùå(High), Ï¥àÎ°ùÏÉâÏùÄ ÎÇÆÏùå(Low)ÏùÑ Ï£ºÎ°ú ÎÇòÌÉÄÎÉÖÎãàÎã§.
> > * **Dendrogram (ÎÇòÎ≠áÍ∞ÄÏßÄ Í∑∏Î¶º):** ÏúÑÏ™ΩÏóê ÏûàÎäî Í∞ÄÏßÄ Í∑∏Î¶ºÏûÖÎãàÎã§. Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥Ïù¥ ÎπÑÏä∑Ìïú ÌôòÏûêÎÅºÎ¶¨ Î¨∂Ïñ¥Ï§çÎãàÎã§(Clustering).
> > * **Í≤∞Í≥º:** ÌôòÏûêÎì§Ïù¥ **A, B, C, D** ÎÑ§ Í∞ÄÏßÄ Í∑∏Î£π(Tumor classes)ÏúºÎ°ú ÍπîÎÅîÌïòÍ≤å ÎÇòÎâòÎäî Í±∞ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å Î∞îÎ°ú Ï†ïÎ∞ÄÏùòÌïôÏùò ÏãúÏûëÏûÖÎãàÎã§.

> [!NOTE] Pages 81-89: ÎÑ§Ìä∏ÏõåÌÅ¨ ÎèôÏó≠Ìïô (Network Dynamics)
> Ïûê, ÏßÄÍ∏àÍπåÏßÄ Î∞∞Ïö¥ Ïú†Ï†ÑÏûê, Îã®Î∞±Ïßà, ÎåÄÏÇ¨Ï≤¥Îì§ÏùÑ Îã§ Ïó∞Í≤∞ÌïòÎ©¥ Ïñ¥ÎñªÍ≤å Îê†ÍπåÏöî? Îã®ÏàúÌïú ÏÑ†(Line)Ïù¥ ÏïÑÎãàÎùº Î≥µÏû°Ìïú **ÎÑ§Ìä∏ÏõåÌÅ¨(Network)**Í∞Ä Îê©ÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ ÎÑ§Ìä∏ÏõåÌÅ¨Ïùò ÏõÄÏßÅÏûÑÏùÑ ÏàòÌïôÏ†ÅÏúºÎ°ú ÌëúÌòÑÌïú Í≤ÉÏù¥ Î∞îÎ°ú **State Space(ÏÉÅÌÉú Í≥µÍ∞Ñ)**ÏûÖÎãàÎã§. Ïù¥ Í∞úÎÖêÏùÑ Ïù¥Ìï¥Ìï¥Ïïº "ÏÑ∏Ìè¨Í∞Ä Î∂ÑÌôîÌïúÎã§"Îäî ÎßêÏùò ÏßÑÏßú ÏùòÎØ∏Î•º ÏïåÍ≤å Îê©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 81: Ï¢ÖÏñëÏùò Ïù¥ÏßàÏÑ± (Tumor Heterogeneity)
> > 81ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Ïïî Îç©Ïñ¥Î¶¨Í∞Ä Îã§ ÎòëÍ∞ôÏùÄ ÏÑ∏Ìè¨Í∞Ä ÏïÑÎãàÎùºÎäî Ï¶ùÍ±∞ÏûÖÎãàÎã§. 
> > * **Clonal Evolution:**
> >     * **Monoclonal:** ÌïòÎÇòÏùò Ï°∞ÏÉÅÏóêÏÑú ÏãúÏûëÌï¥ ÎπÑÏä∑ÌïòÍ≤å ÏûêÎûå.
> >     * **Polyclonal:** Ïó¨Îü¨ Ï°∞ÏÉÅÏù¥ ÏÑûÏó¨ÏÑú ÏïÑÏ£º Îã§ÏñëÌïú(Polygenomic) Ïïî Ï°∞ÏßÅÏùÑ ÌòïÏÑ±. ÏπòÎ£åÍ∞Ä Ïñ¥Î†µÍ≤†Ï£†?
> > * **Cancer Stem Cells (Ïïî Ï§ÑÍ∏∞ÏÑ∏Ìè¨):**
> >     * **Single vs Multiple progenitors:** Ï§ÑÍ∏∞ÏÑ∏Ìè¨ ÌïòÎÇòÏóêÏÑú ÏôîÎÉê, Ïó¨Îü¨ Í∞úÏóêÏÑú ÏôîÎÉêÏóê Îî∞Îùº ÏïîÏùò Î≥µÏû°ÎèÑÍ∞Ä Îã¨ÎùºÏßëÎãàÎã§.
> > * **Í≤∞Î°†:** ÏïîÏùÄ **Polygenomic Tumor**Ïù∏ Í≤ΩÏö∞Í∞Ä ÎßéÏïÑÏÑú, ÏïΩ ÌïòÎÇòÎ°ú(One target) ÏôÑÏπòÍ∞Ä ÌûòÎì† Í≤ÅÎãàÎã§.
>
> > [!INFO] PAGE 82-84: Pathway vs Network View
> > 84ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏù¥ ÌïµÏã¨ÏûÖÎãàÎã§. Í¥ÄÏ†êÏùÑ Î∞îÍæ∏ÏÑ∏Ïöî. 
> > * **Pathway View (A):** $X1 \rightarrow X2$. ÏÑ†ÌòïÏ†ÅÏù¥Í≥† Îã®ÏàúÌï©ÎãàÎã§. "AÏù¥Î©¥ BÎã§"ÎùºÎäî ÏãùÏù¥Ï£†.
> > * **Network View (B):** $X1$Í≥º $X2$Í∞Ä Í±∞ÎåÄÌïú Í±∞ÎØ∏Ï§ÑÏùò ÏùºÎ∂ÄÏùº ÎøêÏûÖÎãàÎã§. $X1$ÏùÑ Í±¥ÎìúÎ¶¨Î©¥ $X2$Îßå Î≥ÄÌïòÎäî Í≤å ÏïÑÎãàÎùº ÎÑ§Ìä∏ÏõåÌÅ¨ Ï†ÑÏ≤¥Í∞Ä Ï∂úÎ†ÅÍ±∞Î¶ΩÎãàÎã§. Ïù¥Í≤å ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïôÏùò Í¥ÄÏ†êÏûÖÎãàÎã§.
> > * 83ÌéòÏù¥ÏßÄÏùò Î≥µÏû°Ìïú ÌôîÏÇ¥Ìëú(Activation/Inhibition)Îì§Ïù¥ Î™®Ïó¨ÏÑú Ïù¥ ÎÑ§Ìä∏ÏõåÌÅ¨Î•º ÎßåÎì≠ÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 85: 3Í≥ÑÏ∏µ ÌÜµÌï© Í≥µÍ∞Ñ (Space Integration)
> > 85ÌéòÏù¥ÏßÄ, 3Í∞úÏùò Ìåê(Layer)Ïù¥ Í≤πÏ≥êÏ†∏ ÏûàÏ£†? 
> > 1.  **Gene Space (Ïú†Ï†ÑÏûê Í≥µÍ∞Ñ):** Gene 1, 2, 3...
> > 2.  **Protein Space (Îã®Î∞±Ïßà Í≥µÍ∞Ñ):** Protein 1, 2, 3...
> > 3.  **Metabolic Space (ÎåÄÏÇ¨ Í≥µÍ∞Ñ):** Metabolite 1, 2...
> > * **Feedback:** Îß® Ïò§Î•∏Ï™Ω ÌôîÏÇ¥ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. **Metabolite 2**Í∞Ä Îã§Ïãú **Gene 4**Ïùò Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌïòÎü¨ ÎÇ¥Î†§Í∞ëÎãàÎã§. Ïù¥Î†áÍ≤å Ï∏µÍ∞Ñ ÏÜåÌÜµÏù¥ ÌôúÎ∞úÌï©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 86-87: ÏÉÅÌÉú Î≤°ÌÑ∞ÏôÄ ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space) - ‚òÖÍ∞úÎÖê ÌïÑÏäπ
> > Ïûê, Ïó¨Í∏∞ ÏßëÏ§ëÌïòÏÑ∏Ïöî. ÏÑ∏Ìè¨Ïùò ÏÉÅÌÉúÎ•º ÏàòÌïôÏúºÎ°ú Ï†ïÏùòÌï©ÎãàÎã§.
> >
> > **1. ÏÉÅÌÉú Î≤°ÌÑ∞ (State Vector, 86p):**
> > * Ïú†Ï†ÑÏûê $N$Í∞úÏùò Î∞úÌòÑÎüâÏùÑ Ïà´ÏûêÎ°ú Ï≠â ÎÇòÏó¥Ìïú Í≤ÅÎãàÎã§. 
> > * Ïãù: $$S = [x_1, x_2, ..., x_N]$$ (Ïòà: $x_1$ÏùÄ Ïú†Ï†ÑÏûê 1Ïùò Î∞úÌòÑÎüâ)
> >
> > **2. ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space, 87p):**
> > * 87ÌéòÏù¥ÏßÄÏùò ÌÅêÎ∏å(Cube) Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. 
> > * **Ï∂ï (Axis):** Í∞Å Ïú†Ï†ÑÏûê($X_1, X_2, X_3$)Í∞Ä $x, y, z$ Ï∂ïÏù¥ Îê©ÎãàÎã§.
> > * **Ï†ê (Point):** ÌäπÏ†ï ÏãúÏ†ê($t_1$)Ïùò ÏÑ∏Ìè¨ ÏÉÅÌÉú($S_1$)Îäî Ïù¥ Í≥µÍ∞Ñ ÏïàÏùò **'Ï†ê ÌïòÎÇò'**Î°ú Ï∞çÌûôÎãàÎã§. (Ïòà: $[3.0, 3.0, 3.0]$)
> > * **Í∂§Ï†Å (Trajectory):** ÏãúÍ∞ÑÏù¥ ÏßÄÎÇ®Ïóê Îî∞Îùº ÏÑ∏Ìè¨Ïùò Ïú†Ï†ÑÏûê Î∞úÌòÑÏù¥ Î≥ÄÌïòÏ£†? Ï†êÏù¥ Ïù¥ÎèôÌïòÎ©¥ÏÑú Í∑∏Î¶¨Îäî ÏÑ†ÏûÖÎãàÎã§.
> > * **Attractor (ÎÅåÍ∞ú):** Îπ®Í∞Ñ Ï†ê($S^*$)ÏùÑ Î≥¥ÏÑ∏Ïöî. Ï†êÎì§Ïù¥ Í≤∞Íµ≠ Ïñ¥ÎîîÎ°ú Î™®Ïù¥ÎÇòÏöî? ÏïàÏ†ïÏ†ÅÏù∏ ÏÉÅÌÉúÎ°ú ÏàòÎ†¥ÌïòÏ£†? Ïù¥ ÎèÑÏ∞©Ï†êÏù¥ Î∞îÎ°ú **"ÏÑ∏Ìè¨ ÌÉÄÏûÖ(Cell Type)"**ÏûÖÎãàÎã§.
> >     * "Ï§ÑÍ∏∞ÏÑ∏Ìè¨Í∞Ä Î∂ÑÌôîÌï¥ÏÑú ÌîºÎ∂ÄÏÑ∏Ìè¨Í∞Ä ÎêêÎã§" = "ÏÉÅÌÉú Í≥µÍ∞ÑÏóêÏÑú Ï†êÏù¥ Ïù¥ÎèôÌï¥ ÌîºÎ∂ÄÏÑ∏Ìè¨ÎùºÎäî AttractorÏóê Îπ†Ï°åÎã§."
>
> > [!INFO] PAGE 88-89: WaddingtonÏùò ÌíçÍ≤Ω (Epigenetic Landscape) ÏàòÌïôÏ†Å Ìï¥ÏÑù
> > 89ÌéòÏù¥ÏßÄ, ÏïÑÍπå Î≥∏ Í≥µ Íµ¥Îü¨Í∞ÄÎäî Í∑∏Î¶ºÏùÑ Îã§Ïãú ÏàòÌïôÏ†ÅÏúºÎ°ú Î¥ÖÎãàÎã§. 
> > * **Basin of attraction (ÎÅåÍ∞ú Ïú†Ïó≠):** Í≥µÏù¥ Íµ¥Îü¨ Îñ®Ïñ¥ÏßÄÎäî Í≥®ÏßúÍ∏∞ÏûÖÎãàÎã§.
> > * **Quasi-potential U:** ÏóêÎÑàÏßÄ Ï§ÄÏúÑ Í∞ôÏùÄ Í≤ÅÎãàÎã§. ÎÇÆÏùÑÏàòÎ°ù ÏïàÏ†ïÏ†ÅÏù¥Ï£†.
> > * **Attractors:** Í≥®ÏßúÍ∏∞ Î∞îÎã•. Ïó¨Í∏∞Ïóê ÏïàÏ∞©ÌïòÎ©¥ **Mature cell types (ÏÑ±Ïàô ÏÑ∏Ìè¨)**Í∞Ä ÎêòÎäî Í≤ÅÎãàÎã§.
> > * **Unused attractors:** ÏßÑÌôîÏ†ÅÏúºÎ°ú ÏµúÏ†ÅÌôîÎêòÏßÄ ÏïäÏùÄ, Î≤ÑÎ†§ÏßÑ ÏõÖÎç©Ïù¥Îì§ÎèÑ Ï°¥Ïû¨Ìï† Ïàò ÏûàÏäµÎãàÎã§. (ÏïîÏÑ∏Ìè¨Í∞Ä Ïó¨Í∏∞Î°ú Í∞à ÏàòÎèÑ ÏûàÏ£†)

> [!NOTE] Pages 90-97: ÎÑ§Ìä∏ÏõåÌÅ¨ ÏùòÌïôÍ≥º Ïã†ÏïΩ Í∞úÎ∞ú (Network Medicine)
> Ïûê, Ïù¥Ï†ú Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨ Ïù¥Î°†Ïù¥ Ïã§Ï†ú ÌôòÏûêÎ•º ÏÇ¥Î¶¨Îäî Í∏∞Ïà†Î°ú Î∞îÎÄùÎãàÎã§. ÌôòÏûêÏùò Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥(Signature)Îßå Î≥¥Í≥†ÎèÑ "Ïù¥ ÌôòÏûêÎäî 5ÎÖÑ Îí§Ïóê ÏÉùÏ°¥Ìï† ÌôïÎ•†Ïù¥ ÎÜíÎã§/ÎÇÆÎã§"Î•º ÎßûÏ∂îÍ≥†, ÎÑ§Ìä∏ÏõåÌÅ¨Ïùò ÌäπÏ†ï Î∂ÄÏúÑÎßå Í≥µÍ≤©ÌïòÎäî Ï†ïÎ∞Ä ÌÉÄÍ≤© ÏïΩÎ¨ºÏùÑ Í∞úÎ∞úÌïòÎäî Í≥ºÏ†ïÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 90: ÏòàÌõÑ ÏòàÏ∏° Î™®Îç∏ (Survival Prediction) - ‚òÖÏûÑÏÉÅ ÌïÑÏàò
> > 90ÌéòÏù¥ÏßÄ Í∑∏Î¶º, Î≥ëÏõêÏóêÏÑú Îß§Ïùº Î≥¥Îäî Îç∞Ïù¥ÌÑ∞ÏûÖÎãàÎã§. Ìï¥ÏÑùÌï† Ï§Ñ ÏïåÏïÑÏïº Ìï©ÎãàÎã§. 
> > 1.  **Heatmap (Ï¢åÏ∏°):** 70Í∞úÏùò **Reporter genes** Î∞úÌòÑ Ìå®ÌÑ¥ÏùÑ Î∂ÑÏÑùÌñàÎçîÎãà, ÌôòÏûêÎì§Ïù¥ Îëê Í∑∏Î£πÏúºÎ°ú ÎÇòÎâ©ÎãàÎã§.
> >     * **Good signature:** ÏòàÌõÑÍ∞Ä Ï¢ãÏùÄ Ìå®ÌÑ¥.
> >     * **Poor signature:** ÏòàÌõÑÍ∞Ä ÎÇòÏÅú Ìå®ÌÑ¥.
> > 2.  **Survival Curve (Ïö∞Ï∏° Í∑∏ÎûòÌîÑ):** Ïù¥Í≤å Í∑∏ Ïú†Î™ÖÌïú **Ïπ¥ÌîåÎûÄ-ÎßàÏù¥Ïñ¥(Kaplan-Meier) ÏÉùÏ°¥ Í≥°ÏÑ†**ÏûÖÎãàÎã§.
> >     * **XÏ∂ï:** ÏãúÍ∞Ñ(Years).
> >     * **YÏ∂ï:** Ï†ÑÏ≤¥ ÏÉùÏ°¥Ïú®(Overall survival, 1.0 = 100%).
> >     * **Ìï¥ÏÑù:** **Poor signature(Îπ®Í∞Ñ ÏÑ†)** ÌôòÏûêÎì§ÏùÄ 2~4ÎÖÑ ÏÇ¨Ïù¥Ïóê Í∏âÍ≤©Ìûà ÏÇ¨ÎßùÌïòÏó¨ ÏÉùÏ°¥Ïú®Ïù¥ 0.2(20%) Î∞ëÏúºÎ°ú Îñ®Ïñ¥ÏßëÎãàÎã§. Î∞òÎ©¥ **Good signature(ÌååÎûÄ ÏÑ†)**Îäî 10ÎÖÑÏù¥ ÏßÄÎÇòÎèÑ ÏÉùÏ°¥Ïú®Ïù¥ ÎÜíÏäµÎãàÎã§.
> >     * **ÏùòÏùò:** "ÎãπÏã†ÏùÄ Poor signatureÎãà Îçî Í≥µÍ≤©Ï†ÅÏù∏ Ìï≠ÏïîÏ†úÎ•º ÏîÅÏãúÎã§"ÎùºÎäî **Clinically useful prediction(ÏûÑÏÉÅÏ†Å ÌåêÎã®)**Ïù¥ Í∞ÄÎä•Ìï¥ÏßëÎãàÎã§.
>
> > [!INFO] PAGE 92-93: ÎÑ§Ìä∏ÏõåÌÅ¨ ÏùòÌïôÏùò Ï†ïÏùò
> > 92ÌéòÏù¥ÏßÄ, **Network Medicine**Ïù¥ÎûÄ? 
> > * Ïù∏Íµ¨ ÏßëÎã®(Population)Ïùò ÍπäÏùÄ ÌëúÌòÑÌòï(Deep phenotyping) Îç∞Ïù¥ÌÑ∞Î•º Î™®ÏïÑÏÑú, Í∞úÏù∏Îì§ÏùÑ **ÎÑ§Ìä∏ÏõåÌÅ¨ ÏßÄÌëú(Network metrics)**Ïóê Îî∞Îùº ÌÅ¥Îü¨Ïä§ÌÑ∞ÎßÅ(Cluster)ÌïòÎäî Í≤ÅÎãàÎã§.
> > * **Ìå®Îü¨Îã§ÏûÑ Î≥ÄÌôî (93p):** 
> >     * Í≥ºÍ±∞: **Average patient (ÌèâÍ∑† ÌôòÏûê)**Î•º ÏúÑÌïú ÏïΩ. (Ïûò Ïïà Îì£Í±∞ÎÇò Î∂ÄÏûëÏö©)
> >     * ÌòÑÏû¨: ÌôòÏûêÏùò **Genetics, Microbes, Chemical composition**Ïóê Îî± ÎßûÏ∂ò(Tailored) ÏïΩ.
>
> > [!IMPORTANT] PAGE 94-97: ÎÑ§Ìä∏ÏõåÌÅ¨ Í∏∞Î∞ò Ïã†ÏïΩ Í∞úÎ∞ú (Network-based Drug Discovery)
> > 94ÌéòÏù¥ÏßÄÎ∂ÄÌÑ∞Îäî Ïã†ÏïΩ Í∞úÎ∞ú ÌîÑÎ°úÏÑ∏Ïä§ÏûÖÎãàÎã§.
> > * **Îç∞Ïù¥ÌÑ∞ ÌÜµÌï© (94p):** DNA/RNA Î≥ÄÏù¥, Îã®Î∞±Ïßà(Proteomics), ÎåÄÏÇ¨Ï≤¥(Metabolite), ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞(Clinical data), Î¨∏Ìóå(Literature)ÏùÑ Îã§ ÏÑûÏñ¥ÏÑú Í±∞ÎåÄÌïú ÌîåÎû´ÌèºÏùÑ ÎßåÎì≠ÎãàÎã§. 
> >
> > * **ÎÑ§Ìä∏ÏõåÌÅ¨ ÌÉÄÍ≤üÌåÖ (95-97p):** Ïù¥ Í∑∏Î¶ºÏùÑ Ïûò Î≥¥ÏÑ∏Ïöî. 
> >     * Ï†ÑÏ≤¥ ÎÑ§Ìä∏ÏõåÌÅ¨ ÏïàÏóê **Disease subtype 1** (ÌååÎûÄÏÉâ ÏòÅÏó≠)Í≥º **Disease subtype 2** (Ï¥àÎ°ùÏÉâ ÏòÅÏó≠)Í∞Ä ÏÑúÎ°ú Îã§Î•∏ ÏúÑÏπòÏóê Ï°¥Ïû¨Ìï©ÎãàÎã§. Ï¶â, Í∞ôÏùÄ Î≥ëÏù¥ÎùºÎèÑ Î∞úÎ≥ë Í∏∞Ï†Ñ(ÎÑ§Ìä∏ÏõåÌÅ¨ Î™®Îìà)Ïù¥ Îã§Î¶ÖÎãàÎã§.
> >     * **Toxicity (ÎèÖÏÑ±):** Îπ®Í∞ÑÏÉâ ÏòÅÏó≠ÏùÄ Í±¥ÎìúÎ¶¨Î©¥ Ïïà ÎêòÎäî Ï§ëÏöîÌïú ÏÉùÎ™Ö Ïú†ÏßÄ Í∏∞Îä•(Ïòà: Ïã¨Ïû• Î∞ïÎèô)Ïùº Ïàò ÏûàÏäµÎãàÎã§.
> >     * **Screening:** **High-throughput screening**ÏùÑ ÌÜµÌï¥ ÏàòÎßå Í∞ÄÏßÄ ÌôîÌï©Î¨ºÏùÑ ÎøåÎ†§Î¥ÖÎãàÎã§.
> >     * **Î™©Ìëú:** Îπ®Í∞ÑÏÉâ(ÎèÖÏÑ±)ÏùÄ ÌîºÌïòÍ≥†, ÎÇ¥ ÌôòÏûêÏùò ÌÉÄÏûÖ(Ïòà: Subtype 2)Ïóê Ìï¥ÎãπÌïòÎäî ÎÑ§Ìä∏ÏõåÌÅ¨Îßå Ï†ïÌôïÌûà ÌÉÄÍ≤©ÌïòÎäî ÏïΩÎ¨ºÏùÑ Ï∞æÎäî Í≤ÉÏûÖÎãàÎã§.

> [!NOTE] Pages 98-113: ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨ÏôÄ ÎîîÏßÄÌÑ∏ Ìó¨Ïä§Ïùò ÎØ∏Îûò
> Ïûê, Ïù¥Ï†ú ÎßàÏßÄÎßâ ÌçºÏ¶êÏùÑ ÎßûÏ∂•ÏãúÎã§. Íµ¨Í∏Ä ÎßµÏù¥ Ïó¨Îü¨ Î†àÏù¥Ïñ¥(ÍµêÌÜµ, ÏúÑÏÑ±, ÏßÄÎèÑ)Î•º Í≤πÏ≥êÏÑú Í∏∏ÏùÑ Î≥¥Ïó¨Ï£ºÎìØ, Ïö∞Î¶¨ Î™∏Ïùò Îç∞Ïù¥ÌÑ∞ÎèÑ Í≤πÏ≥êÏïº Î≥¥ÏûÖÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ Î™®Îì† Í≤ÉÏù¥ IT Í∏∞Ïà†(IoMT)Í≥º Í≤∞Ìï©ÌïòÏó¨ ÏßÑÏ†ïÌïú **'ÌôòÏûê Ï§ëÏã¨ ÏùòÎ£å'**Í∞Ä ÏôÑÏÑ±ÎêòÎäî Í≤ÉÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 98-99: Íµ¨Í∏Ä ÎßµÍ≥º ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨ (Analogy)
> > 98ÌéòÏù¥ÏßÄ, ÏïÑÏ£º ÌõåÎ•≠Ìïú ÎπÑÏú†Í∞Ä ÎÇòÏòµÎãàÎã§. 
> > * **Google Maps:** ÏßÄÎ¶¨Ï†Å ÏúÑÏπò(Geographical Positioning)Î•º Ï§ëÏã¨ÏúºÎ°ú ÍµêÌÜµ, Í±¥Î¨º, ÏúÑÏÑ± ÏÇ¨ÏßÑ Îì± Ïó¨Îü¨ Ï∏µ(Layers)Ïùò Ï†ïÎ≥¥Î•º Í≤πÏ≥êÏÑú Î≥¥Ïó¨Ï§çÎãàÎã§.
> > * **Information Commons (ÏùòÎ£å Ï†ïÎ≥¥ Í≥µÏú†ÏßÄ):** ÎßàÏ∞¨Í∞ÄÏßÄÏûÖÎãàÎã§. **"Í∞úÎ≥Ñ ÌôòÏûê(Individual Patients)"**Î•º Ï§ëÏã¨ÏúºÎ°ú Îã§Ïùå Ï†ïÎ≥¥Îì§ÏùÑ Í≤πÏ≥êÏïº Ìï©ÎãàÎã§.
> >     * **Signs and Symptoms (Ï¶ùÏÉÅ)**
> >     * **Exposome (ÌôòÍ≤Ω ÎÖ∏Ï∂ú)**
> >     * **Genome (Ïú†Ï†ÑÏûê)**
> >     * **Epigenome & Microbiome**
> > * **Í≤∞Î°†:** ÌôòÏûê Ìïú Î™Ö Ìïú Î™ÖÏù¥ ÎßàÏπò Íµ¨Í∏Ä ÎßµÏùò Ï¢åÌëúÏ≤òÎüº, Î™®Îì† Ï†ïÎ≥¥Í∞Ä ÌÜµÌï©Îêú **ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨**Ïùò Ï§ëÏã¨Ïù¥ Îê©ÎãàÎã§.
> 
>
> > [!IMPORTANT] PAGE 100: ÏóëÏä§Ìè¨Ï¢Ä (Exposome) - ÌôòÍ≤ΩÏùò Ï†ïÎüâÌôî (‚òÖ)
> > 100ÌéòÏù¥ÏßÄ, ÌôòÍ≤Ω(Environment)ÏùÑ Îú¨Íµ¨Î¶Ñ Ïû°Îäî ÏñòÍ∏∞Í∞Ä ÏïÑÎãàÎùº Í≥ºÌïôÏ†ÅÏúºÎ°ú Ï†ïÏùòÌï©ÎãàÎã§. Ïù¥Í≤å **Exposome**ÏûÖÎãàÎã§. 
> > * **Ï†ïÏùò:** ÎÇ¥Î∂Ä ÌôîÌïô ÌôòÍ≤Ω(Internal chemical environment)Ïóê ÎèÑÎã¨ÌïòÎäî **Î™®Îì† ÎÖ∏Ï∂úÏùò Ï¥ùÌï©**ÏûÖÎãàÎã§.
> > * **Íµ¨ÏÑ± ÏöîÏÜå:**
> >     * **External (Ïô∏Î∂Ä):** Stress, Lifestyle, Drugs, Diet, Pollution Îì±.
> >     * **Internal (ÎÇ¥Î∂Ä):** Xenobiotics(Ïù¥Î¨ºÏßà), Inflammation(ÏóºÏ¶ù), Oxidative stress(ÏÇ∞Ìôî Ïä§Ìä∏Î†àÏä§), **Gut flora(Ïû•ÎÇ¥ ÎØ∏ÏÉùÎ¨º)**.
> > * **Í≤ÄÏ∂ú:** Ïù¥Îü∞ ÏöîÏù∏Îì§ÏùÄ ÌòàÏï°Ïù¥ÎÇò ÌòàÏ≤≠(Blood or serum)ÏóêÏÑú **Biomarkers(ÏÉùÏ≤¥ÌëúÏßÄÏûê)**Î°ú Í≤ÄÏ∂ú Í∞ÄÎä•Ìï©ÎãàÎã§. Ï¶â, "Ïä§Ìä∏Î†àÏä§ Î∞õÏïòÎã§"Í∞Ä ÏïÑÎãàÎùº "Ïä§Ìä∏Î†àÏä§ ÎßàÏª§ ÏàòÏπòÍ∞Ä XÎã§"ÎùºÍ≥† ÎßêÌï† Ïàò ÏûàÍ≤å Îêú Í±∞Ï£†.
>
> > [!INFO] PAGE 101-104: ÏÉàÎ°úÏö¥ Î∂ÑÎ•ò Ï≤¥Í≥Ñ (Taxonomy)
> > Ïù¥ Ïä¨ÎùºÏù¥ÎìúÎì§ÏùÄ ÌùêÎ¶ÑÎßå Î≥¥Î©¥ Îê©ÎãàÎã§. 
> > * **Information Commons:** ÌôòÏûêÎì§Ïùò Îç∞Ïù¥ÌÑ∞Í∞Ä Î™®Ïó¨ Í≥µÏú†ÏßÄÎ•º ÌòïÏÑ±ÌïòÍ≥†,
> > * **Taxonomic classification:** Í≥ºÍ±∞Ïùò 'Ï¶ùÏÉÅ' Í∏∞Î∞ò Î∂ÑÎ•òÍ∞Ä ÏïÑÎãàÎùº, Î∂ÑÏûêÏ†Å ÏõêÏù∏Ïóê Í∏∞Î∞òÌïú **'ÏßàÎ≥ë Î∂ÑÎ•ò(Taxonomy)'**Í∞Ä ÏÉàÎ°ú Ïì∞Ïù¥Í≤å Îê©ÎãàÎã§. (Ïòà: ÌèêÏïî 1Í∏∞Í∞Ä ÏïÑÎãàÎùº, EGFR Î≥ÄÏù¥ ÏñëÏÑ± ÌèêÏïî)
> > * **Knowledge network-based medicine:** Í≤∞Íµ≠ Î™®Îì† ÏπòÎ£åÎäî Ïù¥ ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨Ïóê Í∏∞Î∞òÌïòÍ≤å Îê©ÎãàÎã§.
>
> > [!INFO] PAGE 105-113: ÎîîÏßÄÌÑ∏ Ìó¨Ïä§ ÌòÅÎ™Ö (Tech Revolution)
> > ÎßàÏßÄÎßâ ÏÑπÏÖòÏûÖÎãàÎã§. Ï†ïÎ∞ÄÏùòÌïôÏùÑ Í∞ÄÎä•ÌïòÍ≤å ÌïòÎäî Í∏∞Ïà†Ï†Å Î∞∞Í≤ΩÏûÖÎãàÎã§. 
> > * **IoMT (Internet of Medical Things):** ÏùòÎ£å ÏÇ¨Î¨º Ïù∏ÌÑ∞ÎÑ∑. Ïõ®Ïñ¥Îü¨Î∏î Í∏∞Í∏∞ Îì±Ïù¥ Ïã§ÏãúÍ∞ÑÏúºÎ°ú ÌôòÏûê Îç∞Ïù¥ÌÑ∞Î•º ÏèüÏïÑÎÉÖÎãàÎã§.
> > * **Big Data & AI:** ÏèüÏïÑÏßÄÎäî Îç∞Ïù¥ÌÑ∞Î•º Î∂ÑÏÑùÌï©ÎãàÎã§.
> > * **Rising of Precision Medicine:** Ïù¥ Î™®Îì† Í≤ÉÏù¥ Ìï©Ï≥êÏ†∏ Ï†ïÎ∞ÄÏùòÌïôÏù¥ Î∂ÄÏÉÅÌïòÍ≥† ÏûàÏäµÎãàÎã§.
> > * **Q & A (113p):** ÏßàÎ¨∏ ÏûàÎÇòÏöî?

], ['\\(', '\\)'\|',
    displayMath: [['$$', '$$'], ['\\[', '\\]']],
    processEscapes: true,
  },
  svg: {
    fontCache: 'global'
  }
};
</script>
<script type="text/javascript" id="MathJax-script" async
  src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-svg.js">
</script>

---

>[!quote] Í≥µÏßÄ
>Î≥∏ ÏûêÎ£åÏùò Ï†ÄÏûëÍ∂åÏùÄ **KAISTUDY**Ïóê ÏûàÏäµÎãàÎã§.

---

> [!abstract]- üìñ Í∞ïÏùò ÌïúÎààÏóê Î≥¥Í∏∞: Precision Medicine & Systems Biology
> **"One Treatment Fits All(Í≥ºÍ±∞)ÏóêÏÑú Data-Driven Algorithm(ÎØ∏Îûò)ÏúºÎ°úÏùò ÏßÑÌôî"**
>
> 1.  **Introduction (Ìå®Îü¨Îã§ÏûÑÏùò Ï†ÑÌôò)**
>     * ÏùòÌïôÏùÄ ÏßÅÍ¥Ä(Intuition)Í≥º Ï¶ùÍ±∞(EBM)Î•º ÎÑòÏñ¥, **ÎπÖÎç∞Ïù¥ÌÑ∞ÏôÄ ÏïåÍ≥†Î¶¨Ï¶ò Í∏∞Î∞òÏùò Ï†ïÎ∞ÄÏùòÌïô(Precision Medicine)**ÏúºÎ°ú Ïù¥Îèô Ï§ëÏûÖÎãàÎã§.
>     * ÌïµÏã¨ÏùÄ ÌôòÏûêÎ•º ÌèâÍ∑†(Average)Ïù¥ ÏïÑÎãå **Ïú†Ï†ÑÏ≤¥(Genes), ÌôòÍ≤Ω(Environment), ÏÉùÌôúÏäµÍ¥Ä(Lifestyle)**Ïù¥ Í≤∞Ìï©Îêú Í≥†Ïú†Ìïú Í∞úÏ≤¥Î°ú Î≥¥Îäî Í≤ÉÏûÖÎãàÎã§.
> 2.  **Omics & Regulation (ÏÉùÎ™ÖÏùò Ïñ∏Ïñ¥ÏôÄ Ï°∞Ï†à)**
>     * Îã®Ïàú DNA ÏÑúÏó¥(Genome)ÎøêÎßå ÏïÑÎãàÎùº, Ïù¥Î•º Ï°∞Ï†àÌïòÎäî **Epigenome(ÌõÑÏÑ±Ïú†Ï†ÑÏ≤¥)**Í≥º Ïã§Ï†ú Í∏∞Îä•ÏùÑ ÏàòÌñâÌïòÎäî Proteome/MetabolomeÏùÑ ÌÜµÌï©Ìï¥Ïïº Ìï©ÎãàÎã§.
>     * ÌäπÌûà **Histone Modification**Í≥º **DNA Methylation**Ïù¥ Ïú†Ï†ÑÏûê Ïä§ÏúÑÏπò(On/Off)Î•º Í≤∞Ï†ïÌïòÎäî ÌïµÏã¨ Í∏∞Ï†ÑÏûÖÎãàÎã§.
> 3.  **Systems & Network (ÌÜµÌï©Ï†Å Î∂ÑÏÑù)**
>     * ÏßàÎ≥ëÏùÄ Îã®Ïùº Ïú†Ï†ÑÏûêÏùò Í≥†Ïû•Ïù¥ ÏïÑÎãàÎùº, **ÎÑ§Ìä∏ÏõåÌÅ¨(Network)Ïùò ÏÑ≠Îèô**ÏûÖÎãàÎã§.
>     * ÏÑ∏Ìè¨Ïùò Ïö¥Î™ÖÏùÄ **ÏÉÅÌÉú Í≥µÍ∞Ñ(State Space)** ÎÇ¥ÏóêÏÑú **ÎÅåÍ∞ú(Attractor)**Î°ú Ïù¥ÎèôÌïòÎäî Í∂§Ï†Å(Trajectory)ÏúºÎ°ú ÏàòÌïôÏ†Å Ï†ïÏùòÍ∞Ä Í∞ÄÎä•Ìï©ÎãàÎã§.
> 4.  **Clinical Application (ÏûÑÏÉÅ Ï†ÅÏö©)**
>     * Í≤∞Íµ≠ Ïù¥ Î™®Îì† Îç∞Ïù¥ÌÑ∞Î•º Ìï©Ï≥ê(Multi-omics Integration), ÌôòÏûêÎ•º Î∂ÑÏûê ÏàòÏ§ÄÏóêÏÑú Ï∏µÌôî(Stratification)ÌïòÍ≥†, **ÎÑ§Ìä∏ÏõåÌÅ¨ Í∏∞Î∞ò Ïã†ÏïΩ(Network Medicine)**ÏùÑ Ï†ÅÏö©ÌïòÏó¨ ÏÉùÏ°¥Ïú®ÏùÑ ÎÜíÏù¥Îäî Í≤ÉÏù¥ Î™©ÌëúÏûÖÎãàÎã§.

> [!example]- üíä ÌïµÏã¨ ÌÇ§ÏõåÎìú & ÏïºÎßà Ï†ïÎ¶¨
>
> ### 1. Precision MedicineÏùò Í∏∞Ï¥à (Data & P4)
> * **Ïò§Î∞îÎßàÏùò 3ÎåÄ Î≥ÄÏàò (2015):** ‚ë† Genes(Ïú†Ï†ÑÏûê) + ‚ë° Environment(ÌôòÍ≤Ω) + ‚ë¢ Lifestyle(ÏÉùÌôúÏäµÍ¥Ä) **(üî•Í∏∞Ï∂ú)**
> * **Îç∞Ïù¥ÌÑ∞ Íµ¨ÏÑ± ÎπÑÏú®:** **Exogenous(ÌôòÍ≤Ω/ÌñâÎèô) 60%** > Genomics 30% > Clinical 10%. (Î≥ëÏõê Îç∞Ïù¥ÌÑ∞Îäî ÎπôÏÇ∞Ïùò ÏùºÍ∞ÅÏûÑ **üî•ÏïºÎßà**)
> * **P4 Medicine:** **P**redictive(ÏòàÏ∏°), **P**reventive(ÏòàÎ∞©), **P**ersonalized(ÎßûÏ∂§), **P**articipatory(Ï∞∏Ïó¨).
>
> ### 2. Clinical Sequencing Í∏∞Ïà† ÎπÑÍµê (vs) **(üî•Ï°±Î≥¥: Ï†ÅÏùëÏ¶ù Íµ¨Î≥Ñ)**
> * **WGS (Whole Genome):** DNA Ï†ÑÏ≤¥(30Ïñµ Ïåç) Î∂ÑÏÑù. Point mutation, Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥(SV), CNV **Î™®Îëê Í≤ÄÏ∂ú Í∞ÄÎä•**.
> * **WES (Whole Exome):** Îã®Î∞±Ïßà ÏΩîÎî© Î∂ÄÏúÑ(**Exon, Ï†ÑÏ≤¥Ïùò 1%**)Îßå ÎÜçÏ∂ï(Baits)ÌïòÏó¨ Î∂ÑÏÑù. Í∞ÄÏÑ±ÎπÑ Ï¢ãÏùå. Point mutation, CNV Í≤ÄÏ∂ú.
> * **Targeted Panel (PCR Amplicon):** ÌäπÏ†ï ÏßàÎ≥ë Í¥ÄÎ†® Ïú†Ï†ÑÏûêÎßå Ï¶ùÌè≠. ÍπäÏùÄ Ìï¥ÏÉÅÎèÑ(Depth) Í∞ÄÎä•.
> * **RNA-seq (Transcriptome):** **Î∞úÌòÑÎüâ(Expression)**, ÏúµÌï© Ïú†Ï†ÑÏûê(Fusion), Splicing variant Í≤ÄÏ∂ú.
>
> ### 3. DNA Íµ¨Ï°∞ & p53 (Concrete Details)
> * **DNA ÏàòÏπò:** ÏßÄÎ¶Ñ **2nm**, Ìïú Î∞îÌÄ¥ **3.4nm**, ÏóºÍ∏∞ ÏÇ¨Ïù¥ **0.34nm**. **(üî•Í∏∞Ï∂ú: Ïà´Ïûê ÏïîÍ∏∞)**
> * **p53 Íµ¨Ï°∞:** **Tetramer(4ÎüâÏ≤¥)**Î°ú ÏûëÎèô. DNA Í≤∞Ìï© Î∂ÄÏúÑÏóê **Zinc atom(ÏïÑÏó∞)**Ïù¥ ÏïàÏ†ïÌôîÏ†úÎ°ú Î∞ïÌòÄ ÏûàÏùå. ÏïîÌôòÏûêÎäî Ï£ºÎ°ú Ïù¥ Í≤∞Ìï© Î∂ÄÏúÑÍ∞Ä ÎßùÍ∞ÄÏßê.
>
> ### 4. Epigenetics: Histone Code & Methylation
> * **Histone Tail:** Ï°∞Ï†àÏùò ÌïµÏã¨. (H3, H4 TailÏù¥ Ï§ëÏöî)
> * **Acetylation (Ac):** Lysine(K)Ïóê Î∂ôÏùå. Ï£ºÎ°ú **Activation (Ï†ÑÏÇ¨ Ï¥âÏßÑ)**. **(üî•ÏïºÎßà)**
> * **Methylation (Me):** Lysine(K)Ïóê Î∂ôÏùå. ÏúÑÏπòÏóê Îî∞Îùº Îã§Î¶Ñ (Ïòà: H3K4=Active, H3K9/27=Repression).
> * **DNA Methylation:** CytosineÏùò 5Î≤à ÌÉÑÏÜåÏóê $CH_3$ Î∂ÄÏ∞© ($5$-mC). Ï£ºÎ°ú **Silencing (Ï†ÑÏÇ¨ ÏñµÏ†ú)**.
>
> ### 5. Systems Biology: State Space & Attractor
> * **ÏÉÅÌÉú Î≤°ÌÑ∞ (State Vector):** $S = [x_1, x_2, ... x_N]$ (Ïú†Ï†ÑÏûê Î∞úÌòÑÎüâÏùò ÏßëÌï©).
> * **ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space):** Ïú†Ï†ÑÏûêÎì§ÏùÑ Ï∂ïÏúºÎ°ú ÌïòÎäî Îã§Ï∞®Ïõê Í≥µÍ∞Ñ. ÏÑ∏Ìè¨ ÏÉÅÌÉúÎäî Ïù¥ Í≥µÍ∞ÑÏùò **'Ï†ê'**ÏúºÎ°ú ÌëúÌòÑÎê®.
> * **Attractor (ÎÅåÍ∞ú):** ÎèôÏ†Å ÏãúÏä§ÌÖúÏù¥ ÏãúÍ∞ÑÏù¥ ÏßÄÎÇò ÏàòÎ†¥ÌïòÎäî ÏïàÏ†ïÎêú ÏÉÅÌÉú. ÏÉùÎ¨ºÌïôÏ†ÅÏúºÎ°ú **"Cell Type(Î∂ÑÌôîÎêú ÏÑ∏Ìè¨)"**ÏùÑ ÏùòÎØ∏Ìï®. **(üî•Í∞úÎÖê ÌïÑÏäπ)**
> * **Landscape Model:** Í≥µ(ÏÑ∏Ìè¨)Ïù¥ Í≥®ÏßúÍ∏∞(Attractor)Î°ú Íµ¥Îü¨Îñ®Ïñ¥ÏßÄÎäî Í≥ºÏ†ï = Î∂ÑÌôî(Differentiation). Ïú†Ï†ÑÏûê Î≥ÄÏù¥Îäî ÏßÄÌòï ÏûêÏ≤¥Î•º Î∞îÍøà.
>
> ### 6. Network Medicine & Survival Analysis
> * **Kaplan-Meier Curve:** XÏ∂ï(ÏãúÍ∞Ñ) vs YÏ∂ï(ÏÉùÏ°¥Ïú®). Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥(Signature)Ïóê Îî∞Îùº **Good vs Poor ÏòàÌõÑ Í∑∏Î£π**ÏùÑ ÎÇòÎàå Ïàò ÏûàÏùå. **(üî•ÏûÑÏÉÅ Ìï¥ÏÑù)**
> * **Drug Discovery:** ÏßàÎ≥ë ÎÑ§Ìä∏ÏõåÌÅ¨(Disease module)Î•º ÌÉÄÍ≤©ÌïòÎêò, ÌïÑÏàò ÏÉùÏ°¥ Ïú†Ï†ÑÏûê(Toxicity)Îäî Í±¥ÎìúÎ¶¨ÏßÄ ÏïäÎäî ÏïΩÎ¨ºÏùÑ Ï∞æÎäî Í≥ºÏ†ï.

---

> [!NOTE] Pages 1-7: Precision MedicineÏùò ÌÉúÎèôÍ≥º Big Data
> Ïûê, Ïù¥ Í∞ïÏùòÏùò ÏÑúÎßâÏûÖÎãàÎã§. Ïôú ÏßÄÍ∏à Ïù¥ ÏãúÏ†êÏóê 'Ï†ïÎ∞ÄÏùòÌïô(Precision Medicine)'Ïù¥ ÌôîÎëêÍ∞Ä ÎêòÎäîÏßÄ, Í∑∏Î¶¨Í≥† Í∑∏ Í∏∞Î∞òÏù¥ ÎêòÎäî **Big Data**Í∞Ä ÎèÑÎåÄÏ≤¥ Ïñ¥Îäê Ï†ïÎèÑ Í∑úÎ™®Ïù∏ÏßÄ Ïà´ÏûêÎ°ú ÌôïÏã§ÌïòÍ≤å Í∞êÏùÑ Ïû°Í≥† Í∞ÄÏïº Ìï©ÎãàÎã§. Ïò§Î∞îÎßà ÎåÄÌÜµÎ†πÏù¥ Ïñ∏Í∏âÌïú Ï†ïÏùòÎ∂ÄÌÑ∞ Îç∞Ïù¥ÌÑ∞Ïùò Íµ¨Ï≤¥Ï†ÅÏù∏ ÎπÑÏú®(%)ÍπåÏßÄ ÍººÍººÌûà Î¥ÖÏãúÎã§.
>
> > [!INFO] PAGE 1-2: Í∞úÎÖêÏùò ÏãúÏûë (Gianrico Farrugia)
> > 1ÌéòÏù¥ÏßÄ ÌëúÏßÄÎ•º ÎÑòÍ≤® 2ÌéòÏù¥ÏßÄÎ•º Î¥ÖÏãúÎã§. **Gianrico Farrugia**Ïùò ÏΩîÎ©òÌä∏Í∞Ä ÎÇòÏòµÎãàÎã§.
> > * ÌïµÏã¨ÏùÄ **"Treat the person as an individual"**ÏûÖÎãàÎã§. ÌôòÏûêÎ•º 'Í∑∏Î£π'Ïùò ÏùºÎ∂ÄÎ°ú Î≥¥Îäî Í≤å ÏïÑÎãàÎùº, Í∑∏ ÏÇ¨Îûå Í≥†Ïú†Ïùò **Genetic material(Ïú†Ï†Ñ Î¨ºÏßà)**Ïóê Í∏∞Î∞òÌï¥ ÏπòÎ£åÌïòÍ≤†Îã§Îäî Í±∞Ï£†. 
> > * Ïù¥Í≤å Î∞îÎ°ú **Individualized, Personalized, Precise**Ìïú ÏùòÎ£åÏùò Ï†ïÏùòÏûÖÎãàÎã§. Í∑∏ÎÉ• Ï¢ãÏùÄ Îßê Í∞ôÏßÄÎßå, 'Ïú†Ï†Ñ Î¨ºÏßà Í∏∞Î∞ò'Ïù¥ÎùºÎäî Ï†ÑÏ†ú Ï°∞Í±¥ÏùÑ Íº≠ Í∏∞ÏñµÌïòÏÑ∏Ïöî. 
>
> > [!IMPORTANT] PAGE 3-5: Precision Medicine Initiative (Ïò§Î∞îÎßà, 2015)
> > 3ÌéòÏù¥ÏßÄ ÏßÄÎèÑ Í∑∏Î¶ºÍ≥º 4ÌéòÏù¥ÏßÄ Ïò§Î∞îÎßà ÏÇ¨ÏßÑ Î≥¥Ïù¥Ï£†? **2015ÎÖÑ Ïó∞ÎëêÍµêÏÑú(State of the Union Address)**ÏóêÏÑú Î∞úÌëúÌïú ÎÇ¥Ïö©ÏûÖÎãàÎã§. 
> >
> > **1. Ï†ïÏùò (3p):** 
> > * ÏßàÎ≥ë ÏòàÎ∞©Í≥º ÏπòÎ£åÏóê ÏûàÏñ¥ÏÑú **ÏÑ∏ Í∞ÄÏßÄ Î≥ÄÏàò**Î•º Í≥†Î†§Ìï©ÎãàÎã§. Ïù¥Í±∞ ÏãúÌóòÏóê ÎÇòÏò§Î©¥ Î¨¥Ï°∞Í±¥ Ïç®Ïïº Ìï©ÎãàÎã§.
> >     1.  **Genes (Ïú†Ï†ÑÏûê)**
> >     2.  **Environment (ÌôòÍ≤Ω)**
> >     3.  **Lifestyle (ÏÉùÌôúÏäµÍ¥Ä)**
> >
> > **2. Íµ¨Ï≤¥Ï†Å Î™©Ìëú (5p):** 
> > * Îã®ÏàúÌûà ÏïΩÎßå Í∞úÎ∞úÌïòÎäî Í≤å ÏïÑÎãôÎãàÎã§.
> > * **100Îßå Î™Ö(1 million)** Ïù¥ÏÉÅÏùò ÎØ∏Íµ≠Ïù∏ ÏûêÏõêÎ¥âÏÇ¨ÏûêÎ°ú Íµ¨ÏÑ±Îêú Ïó∞Íµ¨ ÎÑ§Ìä∏ÏõåÌÅ¨ Íµ¨Ï∂ï. (Ïä§ÏºÄÏùºÏù¥ Îã§Î¶ÖÎãàÎã§, Ïà´Ïûê Ï≤¥ÌÅ¨!)
> > * ÌôòÏûêÍ∞Ä ÏûêÏã†Ïùò Í±¥Í∞ï Ï†ïÎ≥¥Ïóê Ï†ëÍ∑ºÌïòÏó¨ ÏπòÎ£åÏóê **ÌòëÎ†•(Collaborate)**ÌïòÍ≤å Ìï®.
> > * ÏÉàÎ°úÏö¥ ÏùòÎ£å Í∏∞Ïà†ÏùÑ ÏãúÏû•Ïóê Îçî **Îπ†Î•¥Í≤å(Faster)** ÎèÑÏûÖ.
>
> > [!INFO] PAGE 6: Ïôú ÏßÄÍ∏àÏù∏Í∞Ä? (Why Now?)
> > 6ÌéòÏù¥ÏßÄ ÌÖçÏä§Ìä∏Î•º Î≥¥ÏÑ∏Ïöî. Ïôú ÌïòÌïÑ ÏßÄÍ∏à Ï†ïÎ∞ÄÏùòÌïôÏùºÍπåÏöî? ÏÑ∏ Í∞ÄÏßÄ Í∏∞Ïà†Ï†Å Î∞∞Í≤ΩÏù¥ ÏûàÏäµÎãàÎã§. 
> > 1.  **Sequencing:** Ïù∏Í∞Ñ Ïú†Ï†ÑÏ≤¥(Human Genome) Î∂ÑÏÑù ÎπÑÏö©Í≥º ÏãúÍ∞ÑÏù¥ ÌöçÍ∏∞Ï†ÅÏúºÎ°ú Ï§ÑÏóàÏ£†.
> > 2.  **Improved Technologies:** ÏÉùÏùòÌïô Î∂ÑÏÑù(Biomedical analysis) Í∏∞Ïà†Ïùò Ìñ•ÏÉÅ.
> > 3.  **New Tools:** ÎåÄÏö©Îüâ Îç∞Ïù¥ÌÑ∞ÏÖã(Large datasets)ÏùÑ Îã§Î£∞ Ïàò ÏûàÎäî ÎèÑÍµ¨(Ïª¥Ìì®ÌåÖ ÌååÏõå, AI Îì±)Ïùò Îì±Ïû•.
>
> > [!IMPORTANT] PAGE 7: Ìó¨Ïä§ÏºÄÏñ¥ Îç∞Ïù¥ÌÑ∞Ïùò Ïã§Ï≤¥ (ÏàòÏπò ÏïîÍ∏∞!)
> > Ïûê, Ïó¨Í∏∞ **Î≥ÑÌëú** ÏπòÏÑ∏Ïöî. Ìó¨Ïä§ÏºÄÏñ¥ ÎπÖÎç∞Ïù¥ÌÑ∞Ïùò Íµ¨ÏÑ± ÎπÑÏú®Í≥º Ïö©ÎüâÏù¥ Íµ¨Ï≤¥Ï†ÅÏúºÎ°ú ÎÇòÏòµÎãàÎã§. ÌâÅÏ≥êÏÑú 'ÎßéÎã§'Í≥† ÌïòÎ©¥ ÏùòÎåÄÏÉù ÏïÑÎãàÏ£†. ÏàòÏπòÎ•º Î≥¥ÏÑ∏Ïöî.
> >
> > **1. Í±¥Í∞ï Í≤∞Ï†ï ÏöîÏù∏ (Determinants of Health) ÎπÑÏú®:** 
> > * **Exogenous data (Ïô∏Ïù∏ÏÑ± Îç∞Ïù¥ÌÑ∞):** ÌñâÎèô, ÏÇ¨ÌöåÍ≤ΩÏ†úÏ†Å, ÌôòÍ≤ΩÏ†Å ÏöîÏù∏. Î¨¥Î†§ **60%**Î•º Ï∞®ÏßÄÌï©ÎãàÎã§.
> > * **Genomics data (Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞):** **30%**. ÏÉùÍ∞ÅÎ≥¥Îã§ ÎπÑÏ§ëÏù¥ ÌÅ¨Ï£†?
> > * **Clinical data (ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞):** Í≤®Ïö∞ **10%**. Î≥ëÏõêÏóêÏÑú ÎÇòÏò§Îäî Îç∞Ïù¥ÌÑ∞Îäî ÎπôÏÇ∞Ïùò ÏùºÍ∞ÅÏù¥ÎùºÎäî Í≤ÅÎãàÎã§.
> >
> > **2. ÌèâÏÉù ÏÉùÏÑ±ÎêòÎäî Îç∞Ïù¥ÌÑ∞ Ïñë (Data per lifetime):** 
> > * Ï¥ùÎüâ: **1100 Terabytes (TB)**
> > * Exogenous: **1100 TB** (Í±∞Ïùò ÎåÄÎ∂ÄÎ∂Ñ)
> > * Genomics: **6 TB**
> > * Clinical: **0.4 TB** (ÏïÑÏ£º ÎØ∏ÎØ∏Ìï®)
> >
> > **3. ÎπÖÎç∞Ïù¥ÌÑ∞Ïùò 4V:** 
> > * **Volume (Ïñë)**, **Variety (Îã§ÏñëÏÑ±)**, **Velocity (ÏÜçÎèÑ)**, **Veracity (Ï†ïÌôïÏÑ±)**.
> > * ÌäπÌûà ÌïòÎã®Ïóê Î≥¥Î©¥ 2020ÎÖÑ Í∏∞Ï§ÄÏúºÎ°ú ÏùòÎ£å Îç∞Ïù¥ÌÑ∞Îäî **73ÏùºÎßàÎã§ 2Î∞∞**Î°ú Ï¶ùÍ∞ÄÌïúÎã§Í≥† ÎêòÏñ¥ ÏûàÏäµÎãàÎã§. Í∏àÏúµ(Finance) Î∂ÑÏïºÎ≥¥Îã§ Îç∞Ïù¥ÌÑ∞Í∞Ä Îçî ÎßéÏïÑÏöî. 

> [!NOTE] Pages 8-13: ÏùòÎ£å Ìå®Îü¨Îã§ÏûÑÏùò ÎåÄÏ†ÑÌôò (Paradigm Shift)
> Ïûê, Ïù¥Ï†ú ÏùòÌïôÏùò Ïó≠ÏÇ¨Î•º 3Îã®Í≥ÑÎ°ú ÎÇòÎà†ÏÑú Î®∏Î¶øÏÜçÏóê ÏßëÏñ¥ÎÑ£ÏùçÏãúÎã§. Í≥ºÍ±∞Ïùò ÏùòÏÇ¨Îì§ÏùÄ 'ÏßÅÍ¥Ä'Ïóê ÏùòÏ°¥ÌñàÏßÄÎßå, ÎØ∏ÎûòÏùò ÏùòÏÇ¨Îì§ÏùÄ **'ÏïåÍ≥†Î¶¨Ï¶ò'**ÏùÑ Îã§Î§ÑÏïº Ìï©ÎãàÎã§. Ïù¥ ÌååÌä∏Ïùò ÌïµÏã¨ÏùÄ **"One Treatment Fits All(Îã®Ïùº ÏπòÎ£å)"Ïùò Î™∞ÎùΩ**Í≥º **"Personalized(ÎßûÏ∂§Ìòï)"Ïùò Î∂ÄÏÉÅ**ÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 8: Ìå®Îü¨Îã§ÏûÑ 3Îã®Í≥Ñ (ÏãúÌóò ÏïºÎßà!)
> > 8ÌéòÏù¥ÏßÄ ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. ÏùòÌïôÏùÄ Ïù¥Î†áÍ≤å ÏßÑÌôîÌñàÏäµÎãàÎã§. Í∞Å Îã®Í≥ÑÏùò ÌÇ§ÏõåÎìúÎ•º Î∞òÎìúÏãú Îß§Ïπ≠ÏãúÌÇ§ÏÑ∏Ïöî.
> >
> > 1.  **Yesterday (Í≥ºÍ±∞):**
> >     * Í∏∞Î∞ò: **Symptom-based (Ï¶ùÏÉÅ Í∏∞Î∞ò)**
> >     * Î∞©Ïãù: **Intuition Medicine (ÏßÅÍ¥Ä ÏùòÌïô)** - ÏùòÏÇ¨Ïùò 'Í∞ê'Ïóê ÏùòÏ°¥ÌñàÏ£†.
> > 2.  **Today (ÌòÑÏû¨):**
> >     * Í∏∞Î∞ò: **Pattern-based (Ìå®ÌÑ¥ Í∏∞Î∞ò)**
> >     * Î∞©Ïãù: **Evidence-based Medicine (Ï¶ùÍ±∞ Í∏∞Î∞ò ÏùòÌïô, EBM)** - ÏûÑÏÉÅÏãúÌóò ÌÜµÍ≥ÑÍ∞Ä ÏôïÏù¥ÏóàÏäµÎãàÎã§.
> > 3.  **Tomorrow (ÎØ∏Îûò):**
> >     * Í∏∞Î∞ò: **Algorithm-based (ÏïåÍ≥†Î¶¨Ï¶ò Í∏∞Î∞ò)** - Ïó¨Í∏∞Í∞Ä ÌïµÏã¨ÏûÖÎãàÎã§.
> >     * Î∞©Ïãù: **Precision Medicine (Ï†ïÎ∞Ä ÏùòÌïô)** - Îç∞Ïù¥ÌÑ∞Í∞Ä ÏπòÎ£åÎ•º Í≤∞Ï†ïÌï©ÎãàÎã§.
>
> > [!INFO] PAGE 9: ÏÉàÎ°úÏö¥ ÌîåÎ†àÏù¥Ïñ¥Îì§ (IT Giants)
> > 9ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Î≥ëÏõê Î°úÍ≥†Í∞Ä ÏïÑÎãôÎãàÎã§. **Google Health, Google DeepMind, IBM Watson Health, Human Longevity Inc.** Í∞ôÏùÄ IT Í∏∞ÏóÖÎì§Ïù¥Ï£†.
> > * Ïù¥Îì§Ïù¥ ÎÖ∏Î¶¨Îäî Î∂ÑÏïºÍ∞Ä ÏïÑÎûò Ìä∏Î¶¨Ïóê ÎÇòÏòµÎãàÎã§:
> >     * **Oncology (Ï¢ÖÏñëÌïô)**
> >     * **Drug Discovery (Ïã†ÏïΩ Í∞úÎ∞ú)**
> >     * **Genomics (Ïú†Ï†ÑÏ≤¥Ìïô)**
> >     * **Patient Engagement (ÌôòÏûê Ï∞∏Ïó¨)**
> > * Ï¶â, Ìó¨Ïä§ÏºÄÏñ¥Ïùò Ï£ºÎèÑÍ∂åÏù¥ 'Îç∞Ïù¥ÌÑ∞Î•º Í∞ÄÏßÑ Í∏∞ÏóÖ'ÏúºÎ°ú ÎÑòÏñ¥Í∞ÄÍ≥† ÏûàÎã§Îäî Ï¶ùÍ±∞ÏûÖÎãàÎã§.
>
> > [!WARNING] PAGE 11-12: ÌòÑÏû¨ ÏùòÌïôÏùò ÌïúÍ≥Ñ (One Treatment Fits All)
> > 11ÌéòÏù¥ÏßÄ ÎèÑÏãùÏùÑ Î¥ÖÏãúÎã§. **"Current Medicine: One Treatment Fits All"**.
> > * ÎòëÍ∞ôÏùÄ ÏïΩ(Pill)ÏùÑ Î™®Îì† ÌôòÏûê(Ï¥àÎ°ù, Îπ®Í∞ï, ÌååÎûë ÏÑûÏó¨ ÏûàÎäî Í∑∏Î£π)ÏóêÍ≤å Ï§çÎãàÎã§.
> > * **Í≤∞Í≥º:**
> >     * ÏùºÎ∂ÄÎäî **Effect (Ìö®Í≥º ÏûàÏùå)**.
> >     * ÏùºÎ∂ÄÎäî **No effect (Ìö®Í≥º ÏóÜÏùå)** - Îèà ÎÇ≠ÎπÑÏ£†.
> >     * Ïã¨ÏßÄÏñ¥ ÏùºÎ∂ÄÎäî **Adverse effects (Î∂ÄÏûëÏö©)** - Ïù¥Í≤å Ï†úÏùº ÏúÑÌóòÌï©ÎãàÎã§.
> > * 12ÌéòÏù¥ÏßÄÎèÑ Í∞ôÏùÄ Îß•ÎùΩÏûÖÎãàÎã§. "Conventional approach"Îäî ÏßÑÎã®Ïù¥ Îä¶Ïñ¥ÏßÄÍ±∞ÎÇò(delayed), Ïò§ÏßÑ(mis-diagnosis)Ïù¥ ÏÉùÍ≤® ÏπòÎ£å Ìö®Ïú®Ïù¥ ÎÇÆÏäµÎãàÎã§.
>
> > [!IMPORTANT] PAGE 13: ÎØ∏Îûò ÏùòÌïô (Personalized Diagnostics)
> > 13ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ 11ÌéòÏù¥ÏßÄÏôÄ Î∞òÎåÄÏûÖÎãàÎã§. ÏàúÏÑúÍ∞Ä Î∞îÎÄùÎãàÎã§.
> > * **ÏÑ†(ÂÖà) ÏßÑÎã®:** ÏπòÎ£å Ï†ÑÏóê **Blood, DNA, Urine, Tissue Analysis**Î•º Î®ºÏ†Ä ÏàòÌñâÌï©ÎãàÎã§.
> > * **ÌõÑ(Âæå) Î∂ÑÎ•ò:** ÌôòÏûêÎì§ÏùÑ Îπ®Í∞ï, ÎÖ∏Îûë, ÌååÎûë Í∑∏Î£πÏúºÎ°ú **ÎØ∏Î¶¨ ÎÇòÎàïÎãàÎã§(Stratification)**.
> > * **Í≤∞Í≥º:** Í∞Å Í∑∏Î£πÏóê ÎßûÎäî ÏïΩÏùÑ Ìà¨Ïó¨ÌïòÎãàÍπå, Î™®Îì† ÌôòÏûêÏóêÍ≤åÏÑú **Effect (Ìö®Í≥º)**Í∞Ä ÎÇòÌÉÄÎÇ©ÎãàÎã§. Î∂ÄÏûëÏö©ÏùÄ ÏµúÏÜåÌôîÎêòÍ≥†Ïöî. Ïù¥Í≤å Ï†ïÎ∞ÄÏùòÌïôÏùò Í∂ÅÍ∑πÏ†Å Î™©ÌëúÏûÖÎãàÎã§.

> [!NOTE] Pages 14-21: P4 MedicineÍ≥º ÏãúÏä§ÌÖú ÏùòÌïô (Systems Medicine)
> Ïûê, Ï†ïÎ∞ÄÏùòÌïôÏùÑ Îã§Î•∏ ÎßêÎ°ú **'P4 Medicine'**Ïù¥ÎùºÍ≥†ÎèÑ Ìï©ÎãàÎã§. Ïù¥ 4Í∞ÄÏßÄ PÍ∞Ä Î≠îÏßÄ Î™®Î•¥Î©¥ Ïù¥ ÏàòÏóÖ ÌóõÎì§ÏùÄ Í≤ÅÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ Î∞©ÎåÄÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïñ¥ÎñªÍ≤å ÏöîÎ¶¨Ìï¥ÏÑú ÏûÑÏÉÅÏóê Ï†ÅÏö©ÌïòÎäîÏßÄ, Í∑∏ Î≥µÏû°Ìïú Í≥ºÏ†ïÏùÑ ÌïòÎÇòÏî© Î∂ÑÌï¥Ìï¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 14: P4 MedicineÏùò Ï†ïÏùò (ÏïîÍ∏∞ ÌïÑÏàò!)
> > 14ÌéòÏù¥ÏßÄ, ÏïÑÏ£º Ï§ëÏöîÌïú ÏïΩÏñ¥Í∞Ä ÎÇòÏòµÎãàÎã§. **P4 Medicine**.
> > 1.  **Predictive (ÏòàÏ∏°):** Î∞úÎ≥ë Ï†ÑÏóê ÎØ∏Î¶¨ ÏïàÎã§.
> > 2.  **Preventive (ÏòàÎ∞©):** ÏïÑÌîÑÍ∏∞ Ï†ÑÏóê ÎßâÎäîÎã§.
> > 3.  **Personalized (ÎßûÏ∂§):** ÎÑàÌïúÌÖå Îî± ÎßûÎäî ÏπòÎ£åÎ•º ÌïúÎã§.
> > 4.  **Participatory (Ï∞∏Ïó¨):** ÌôòÏûêÍ∞Ä ÏàòÎèôÏ†ÅÏù∏ Í∞ùÏ≤¥Í∞Ä ÏïÑÎãàÎùº, Îç∞Ïù¥ÌÑ∞ ÏÉùÏÇ∞ÏûêÎ°úÏÑú Ï∞∏Ïó¨ÌïúÎã§.
> >
> > * **ÌïµÏã¨ ÏßàÎ¨∏:** "Îç∞Ïù¥ÌÑ∞Îäî ÎÑòÏ≥êÎÇòÎäîÎç∞(More data), Ïù¥Í±∏ ÏñºÎßàÎÇò Ìö®Ïú®Ï†ÅÏúºÎ°ú ÏÇ¨Ïö©Ìï† Í≤ÉÏù∏Í∞Ä?" -> Í∑∏ Ìï¥ÎãµÏù¥ Î∞îÎ°ú **Systems Medicine**ÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 15: ÏûÑÏÉÅ Ï†ÅÏö© ÏÇ¨Ïù¥ÌÅ¥ (Clinical Deployment)
> > 15ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùò ÏàúÌôò Íµ¨Ï°∞Î•º Î≥¥ÏÑ∏Ïöî. Îç∞Ïù¥ÌÑ∞Í∞Ä Ïñ¥ÎñªÍ≤å ÌùêÎ•¥ÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§.
> > * **Screening (ÏÑ†Î≥Ñ) ‚Üí Diagnosis (ÏßÑÎã®) ‚Üí Staging & Phenotyping (Î≥ëÍ∏∞ ÏÑ§Ï†ï) ‚Üí Therapy & Monitoring (ÏπòÎ£å Î∞è Î™®ÎãàÌÑ∞ÎßÅ)**
> > * Ïù¥ Í≥ºÏ†ïÏóêÏÑú Ïñ¥Îñ§ Îç∞Ïù¥ÌÑ∞Í∞Ä Îì§Ïñ¥Í∞ÄÎÇòÏöî?
> >     * **-omic/biological:** Ïú†Ï†ÑÏ≤¥ Ï†ïÎ≥¥
> >     * **Electronic health records (EHR):** Î≥ëÏõê Í∏∞Î°ù
> >     * **Geospatial & Environmental:** Ïñ¥Îîî ÏÇ¨ÎäîÏßÄ, ÌôòÍ≤ΩÏùÄ Ïñ¥Îñ§ÏßÄ
> >     * **Personal monitoring:** Ïõ®Ïñ¥Îü¨Î∏î Í∏∞Í∏∞ Îç∞Ïù¥ÌÑ∞ Îì±
> > * Ïö∞Ï∏° ÌïòÎã®Ïùò ÏßàÎ¨∏Îì§Ïù¥ ÎÇ†Ïπ¥Î°≠ÏäµÎãàÎã§. "Í≥ºÍ±∞Î†•(History) Ï§ë Î¨¥ÏóáÏùÑ Î≥ºÍπå?", "ÌòÑÏû¨ ÏÉÅÌÉú(Current state)Îäî?", "Í∞úÏûÖ(Intervene) Í∏∞ÌöåÎäî?", "ÎØ∏Îûò ÏúÑÌóò(Risks)ÏùÄ?"
>
> > [!TIP] üí° PAGE 17-18: Îç∞Ïù¥ÌÑ∞Ïùò ÏõêÏ≤ú (Ï°±Î≥¥ ÏÜåÏä§)
> > Ïûê, Ïó¨Í∏∞ Ï†ÅÌòÄ ÏûàÎäî Îç∞Ïù¥ÌÑ∞Î≤†Ïù¥Ïä§ Ïù¥Î¶ÑÎì§, ÎààÏóê ÏùµÌòÄÎëêÏÑ∏Ïöî. ÎÇòÏ§ëÏóê Ïó∞Íµ¨Ìï† Îïå Î¨¥Ï°∞Í±¥ ÏîÅÎãàÎã§.
> >
> > **1. Technology Platforms (17p):**
> > * **Genomics & Transcriptomics:** ÏãúÌÄÄÏã± Îç∞Ïù¥ÌÑ∞ (ACGT...)
> > * **Proteomics & Metabolomics:** Îã®Î∞±Ïßà, ÎåÄÏÇ¨Î¨ºÏßà (MS-data ÏßàÎüâÎ∂ÑÏÑù)
> > * **Imaging:** ÏòÅÏÉÅ Îç∞Ïù¥ÌÑ∞
> >
> > **2. Public Databases (18p) - Î≥ÑÌëú!:**
> > * **TCGA (The Cancer Genome Atlas):** Ïïî Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Ïùò Î≥¥Î¨ºÏ∞ΩÍ≥†ÏûÖÎãàÎã§.
> > * **CCLE (Cancer Cell Line Encyclopedia):** Ïïî ÏÑ∏Ìè¨Ï£º Îç∞Ïù¥ÌÑ∞.
> > * **ClinicalTrials.gov:** ÏûÑÏÉÅÏãúÌóò Ï†ïÎ≥¥.
> > * **PubChem, DrugBank:** ÏïΩÎ¨º ÌôîÌïô Íµ¨Ï°∞ Î∞è ÌÉÄÍ≤ü Ï†ïÎ≥¥.
> > * **TOXNET:** ÎèÖÏÑ± Ï†ïÎ≥¥.
> > * Ïù¥ Îç∞Ïù¥ÌÑ∞Îì§Ïù¥ Îã§ Ïó∞Í≤∞ÎêòÏñ¥Ïïº ÎπÑÎ°úÏÜå 'Ï†ïÎ∞ÄÏùòÌïô'Ïù¥ Îê©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 19: AIÏôÄ Î®∏Ïã†Îü¨ÎãùÏùò Ïó≠Ìï† (ÏïåÍ≥†Î¶¨Ï¶ò Ïù¥Î¶Ñ Ï≤¥ÌÅ¨)
> > 19ÌéòÏù¥ÏßÄ Ïö∞Ï∏° ÌïòÎã®, Íπ®Ïïå Í∞ôÏùÄ Í∏ÄÏî®Î•º Î≥¥ÏÑ∏Ïöî. Îç∞Ïù¥ÌÑ∞Î•º Î∂ÑÏÑùÌïòÎäî ÎèÑÍµ¨Îì§ÏûÖÎãàÎã§.
> > * **Machine Learning (ML):** Í∏∞Í≥ÑÌïôÏäµ.
> > * **Deep Learning (DL):** Îî•Îü¨Îãù.
> > * **Íµ¨Ï≤¥Ï†Å ÏïåÍ≥†Î¶¨Ï¶ò:**
> >     * **SVM (Support Vector Machine)**
> >     * **RF (Random Forest)**
> >     * **LightGBM:** ÏµúÍ∑º ÎßéÏù¥ Ïì∞Ïù¥Îäî Î∂ÄÏä§ÌåÖ Î™®Îç∏Ïù¥Ï£†.
> > * **Í≥ºÏ†ï:** Feature selection(ÌäπÏßï ÏÑ†ÌÉù) ‚Üí Cross validation(ÍµêÏ∞® Í≤ÄÏ¶ù) ‚Üí Hyperparameter tuning(ÌäúÎãù) ‚Üí **Prediction(ÏòàÏ∏°)**. Ïù¥ ÌîÑÎ°úÏÑ∏Ïä§Í∞Ä Î®∏Î¶øÏÜçÏóê ÏûàÏñ¥Ïïº Ìï©ÎãàÎã§.
>
> > [!INFO] PAGE 20-21: Multi-OmicsÏùò ÌÜµÌï© (Integration)
> > 20ÌéòÏù¥ÏßÄ, ÏÇ¨Îûå Î™∏ÏùÑ **Systems Biology** Í¥ÄÏ†êÏóêÏÑú Î≥∏ Í∑∏Î¶ºÏûÖÎãàÎã§.
> > * ÏïΩÎ¨º(Drug A)Ïù¥ Îì§Ïñ¥Í∞ÄÎ©¥ Îã®ÏÑ†Ï†ÅÏù∏ Î∞òÏùëÎßå ÏûàÎäî Í≤å ÏïÑÎãàÎùº, Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨(Network)Î•º Í±¥ÎìúÎ¶ΩÎãàÎã§. Í∑∏ÎûòÏÑú Î∂ÄÏûëÏö©(AEs)ÎèÑ ÏÉùÍ∏∞Í≥†, ÏÉàÎ°úÏö¥ Ï†ÅÏùëÏ¶ù(New indications, Drug repositioning)ÎèÑ Î∞úÍ≤¨ÎêòÎäî Í±∞Ï£†.
> >
> > 21ÌéòÏù¥ÏßÄÍ∞Ä Í≤∞Î°†ÏûÖÎãàÎã§.
> > * **Multi-OMICS:** Genome, Epigenome, Transcriptome, Proteome, Metabolome, Microbiome... Ïù¥ Î™®Îì† Í±∏ Ìï©Ï≥êÏïº Ìï©ÎãàÎã§.
> > * **Integration (ÌÜµÌï©):** Îî∞Î°ú ÎÜÄÎ©¥ Ïì∞Î†àÍ∏∞ÏûÖÎãàÎã§. ÏÑûÏñ¥ÏÑú Î∂ÑÏÑùÌï¥Ïïº Ïú†ÏùòÎØ∏Ìïú **Signatures (ÌäπÏßï)**Í∞Ä ÎÇòÏò§Í≥†, Í∑∏Ï†úÏïº **Therapeutics (ÏπòÎ£åÎ≤ï)**Í∞Ä ÎÇòÏòµÎãàÎã§.

> [!NOTE] Pages 22-31: Ïú†Ï†ÑÏ≤¥Ìïô Í∏∞Ï¥à (Genomics Basics)
> Ïûê, Ïù¥Ï†ú **ÏÉùÎ™ÖÏùò Ïñ∏Ïñ¥(Language of Life)**Î•º Î∞∞Ïö∏ Ï∞®Î°ÄÏûÖÎãàÎã§. Í≥†Îì±ÌïôÍµê ÏÉùÎ¨º ÏãúÍ∞Ñ Í∞ôÎã§Í≥† Î∞©Ïã¨ÌïòÏßÄ ÎßàÏÑ∏Ïöî. Ïó¨Í∏∞ ÎÇòÏò§Îäî **ÏàòÏπò(nm, bp)**Îì§Í≥º **Îç∞Ïù¥ÌÑ∞Ïùò Í∑úÎ™®**Í∞Ä Ï†ïÎ∞ÄÏùòÌïôÏóêÏÑú Ïôú 'ÎπÖÎç∞Ïù¥ÌÑ∞'ÎùºÍ≥† Î∂àÎ¶¨ÎäîÏßÄ Í∑∏ Í∑ºÍ±∞Í∞Ä ÎêòÎãàÍπåÏöî.
>
> > [!INFO] PAGE 22: ÏÉùÎ¨ºÌïôÏ†Å Ï†ïÎ≥¥Ïùò ÌùêÎ¶Ñ (Central Dogma Í∑∏ Ïù¥ÏÉÅ)
> > 22ÌéòÏù¥ÏßÄ Îã§Ïù¥Ïñ¥Í∑∏Îû®ÏùÑ Î≥¥ÏÑ∏Ïöî. Ïö∞Î¶¨Í∞Ä ÏïÑÎäî ÏÑºÌä∏Îü¥ ÎèÑÍ∑∏Îßà(DNA ‚Üí RNA ‚Üí Protein)Í∞Ä Í∏∞Î≥∏Ïù¥ÏßÄÎßå, Í∑∏Î¶ºÏù¥ Ìõ®Ïî¨ Î≥µÏû°ÌïòÏ£†? 
> > * **Feedback Loops:** ÌôîÏÇ¥ÌëúÍ∞Ä Ìïú Î∞©Ìñ•ÏúºÎ°úÎßå Í∞ÄÏßÄ ÏïäÏäµÎãàÎã§. Îã®Î∞±Ïßà(Proteins)Ïù¥ Îã§Ïãú DNAÎÇò RNA Ï°∞Ï†àÏóê Í¥ÄÏó¨ÌïòÍ≥†, **ÌôòÍ≤Ω(Environment)**Ïù¥ ÏÑ∏Ìè¨ ÎåÄÏÇ¨(Cellular metabolism)Ïóê ÏòÅÌñ•ÏùÑ ÎØ∏ÏπòÎäî **ÏàúÌôò Íµ¨Ï°∞**ÏûÑÏùÑ Î™ÖÏã¨ÌïòÏÑ∏Ïöî. 
>
> > [!INFO] PAGE 23-24: Human Genome Project (HGP)
> > 23ÌéòÏù¥ÏßÄÏùò ÏàòÎßéÏùÄ ÏïåÌååÎ≤≥(ACGT...)Í≥º 24ÌéòÏù¥ÏßÄÏùò ÌååÌòï(Peaks) Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Ïù¥Í≤å Î∞îÎ°ú **Sanger Sequencing**Ïùò Í≤∞Í≥ºÎ¨ºÏûÖÎãàÎã§. 
> > * **Human Genome Project:** Ïù∏Í∞ÑÏùò Î™®Îì† DNA Í∏ÄÏûêÎ•º ÏùΩÏñ¥ÎÇ¥Î†§Îäî Í±∞ÎåÄÌïú ÏãúÎèÑÏòÄÏ£†. ÌÅ¥Î¶∞ÌÑ¥ ÎåÄÌÜµÎ†π ÏÇ¨ÏßÑÎèÑ Î≥¥Ïù¥ÎÑ§Ïöî. 
>
> > [!IMPORTANT] PAGE 25: DNA Íµ¨Ï°∞Ïùò ÏàòÏπò (ÏïîÍ∏∞!)
> > 25ÌéòÏù¥ÏßÄ, Ïó¨Í∏∞ **Î≥ÑÌëú** Îã§ÏÑØ Í∞ú ÏπòÏÑ∏Ïöî. DNA Íµ¨Ï°∞Ïùò ÏàòÏπò, ÏãúÌóòÏóê ÎÇ¥Í∏∞ Îî± Ï¢ãÏäµÎãàÎã§.
> > * **Î∞©Ìñ•ÏÑ±:** **5' end (Ïù∏ÏÇ∞Í∏∞)**ÏóêÏÑú **3' end (ÏàòÏÇ∞Í∏∞, OH)**Î°ú Ïù¥Ïñ¥ÏßëÎãàÎã§. Îëê Í∞ÄÎã•ÏùÄ ÏÑúÎ°ú **Ïó≠ÌèâÌñâ(Anti-parallel)**Ìï©ÎãàÎã§. 
> > * **Î∞±Î≥∏(Backbone):** Ïù∏ÏÇ∞(Phosphate) + Îãπ(Deoxyribose)ÏúºÎ°ú Íµ¨ÏÑ±Îê©ÎãàÎã§. 
> > * **Ï£ºÏöî ÏàòÏπò:**
> >     * **ÏßÄÎ¶Ñ (Width):** **2 nm** 
> >     * **ÎÇòÏÑ† Ìïú Î∞îÌÄ¥ (One turn):** **3.4 nm** 
> >     * **ÏóºÍ∏∞ ÏÇ¨Ïù¥ Í±∞Î¶¨ (Distance between bases):** **0.34 nm** 
> > * **Groove:** ÎÑìÏùÄ **Major groove**ÏôÄ Ï¢ÅÏùÄ **Minor groove**Í∞Ä ÏûàÏäµÎãàÎã§. ÎÇòÏ§ëÏóê Îã®Î∞±ÏßàÏù¥ Ïó¨Í∏∞ ÎÅºÏñ¥Îì§Ïñ¥Í∞ÄÏÑú Í≤∞Ìï©Ìï©ÎãàÎã§. 
>
> > [!INFO] PAGE 28: Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Ïùò ÌÅ¨Í∏∞ (ÎπÑÏú†)
> > 28ÌéòÏù¥ÏßÄ, Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Í∞Ä ÏñºÎßàÎÇò Î∞©ÎåÄÌïúÏßÄ ÎπÑÏú†Î•º Îì§Ïñ¥ ÏÑ§Î™ÖÌï©ÎãàÎã§.
> > * **Ï†ÑÏ≤¥ Ïö©Îüâ:** Ïù∏Í∞Ñ DNAÎäî ÏïΩ **64Ïñµ Í∞ú(6.4 billion)**Ïùò Î¨∏ÏûêÎ°ú ÎêòÏñ¥ ÏûàÏäµÎãàÎã§. 
> > * **Ï±ÖÏúºÎ°ú ÏπòÎ©¥:** 500ÌéòÏù¥ÏßÄÏßúÎ¶¨ Ï±Ö **4,200Í∂å** Î∂ÑÎüâÏûÖÎãàÎã§. Ïñ¥ÎßàÏñ¥ÎßàÌïòÏ£†. 
> > * **ÏÑúÎπÑÏä§ ÎπÑÍµê:**
> >     * **Veritas (Whole Genome):** 4,200Í∂å Ï†ÑÏ≤¥Î•º ÏùΩÏñ¥Ï§çÎãàÎã§. 
> >     * **23andMe (SNP genotyping):** Ï†ÑÏ≤¥Ïùò **1% ÎØ∏Îßå**Îßå Î¥ÖÎãàÎã§. Ï±ÖÏúºÎ°ú ÏπòÎ©¥ Í≤®Ïö∞ **180ÌéòÏù¥ÏßÄ** ÏùΩÎäî ÏÖàÏù¥Ï£†. Ïù¥ Ï∞®Ïù¥Î•º ÏïÑÎäî Í≤å Ï§ëÏöîÌï©ÎãàÎã§. 
>
> > [!INFO] PAGE 30-31: ÏÉùÎ™ÖÏùò Í≥ÑÏ∏µ Íµ¨Ï°∞ÏôÄ ÏóºÏÉâÏ≤¥
> > * **Í≥ÑÏ∏µ (30p):** Macromolecule(DNA) ‚Üí Organelle ‚Üí Cell ‚Üí Tissue ‚Üí Organ ‚Üí Organism ÏàúÏÑúÎ°ú Î≥µÏû°Ìï¥ÏßëÎãàÎã§. 
> > * **ÏóºÏÉâÏ≤¥ (31p):** Ïù∏Í∞ÑÏùÄ **23Ïåç(23 pairs)**Ïùò ÏóºÏÉâÏ≤¥Î•º Í∞ÄÏßëÎãàÎã§. (Ï¥ù 46Í∞ú) 
> > * **ÏÉÅÎèô ÏóºÏÉâÏ≤¥ (Homologous pairs):** Î∂ÄÎ™®Î°úÎ∂ÄÌÑ∞ Í∞ÅÍ∞Å ÌïòÎÇòÏî© Î¨ºÎ†§Î∞õÏùÄ Ìïú ÏåçÏûÖÎãàÎã§.
> >     * **Allele (ÎåÄÎ¶ΩÏú†Ï†ÑÏûê):** Í∞ôÏùÄ ÏúÑÏπòÏóê ÏûàÎäî Ïú†Ï†ÑÏûê Î≤ÑÏ†ÑÏùÑ ÎßêÌï©ÎãàÎã§. Í∑∏Î¶ºÏùò **Allele A**ÏôÄ **Allele a**Î•º Î≥¥ÏÑ∏Ïöî. Ïù¥Í≤å ÌòïÏßà(Ïòà: Î®∏Î¶¨ÏÉâ)ÏùÑ Í≤∞Ï†ïÌï©ÎãàÎã§. 

> [!NOTE] Pages 32-40: Ïú†Ï†ÑÏûê Î∞úÌòÑÍ≥º ÏûÑÏÉÅ ÏãúÌÄÄÏã± Í∏∞Ïà†
> Ïûê, DNAÏóê Ï†ÅÌûå Ï†ïÎ≥¥Í∞Ä Ïñ¥ÎñªÍ≤å Ïö∞Î¶¨ ÎààÏóê Î≥¥Ïù¥Îäî ÌäπÏßï(Phenotype)ÏúºÎ°ú ÎÇòÌÉÄÎÇòÎäîÏßÄ, Í∑∏Î¶¨Í≥† Í∑∏ Ï†ïÎ≥¥Î•º ÏùΩÏñ¥ÎÇ¥Îäî Í∏∞Ïà†ÏóêÎäî Ïñ¥Îñ§ Í≤ÉÎì§Ïù¥ ÏûàÎäîÏßÄ 'Ìï¥ÏÉÅÎèÑ'Î≥ÑÎ°ú ÎúØÏñ¥Î¥ÖÏãúÎã§. ÌäπÌûà **39ÌéòÏù¥ÏßÄ**Îäî ÏûÑÏÉÅ ÏãúÌóòÏù¥ÎÇò Íµ≠Í∞ÄÍ≥†ÏãúÏóêÎèÑ Îã®Í≥®Î°ú ÎÇòÏò§Îäî Í∞úÎÖêÏù¥Îãà Îàà ÌÅ¨Í≤å Îú®ÏÑ∏Ïöî.
>
> > [!INFO] PAGE 32-33: GenotypeÏóêÏÑú PhenotypeÍπåÏßÄ (Layer Íµ¨Ï°∞)
> > 32ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùò Îã§ÏñëÌïú ÏÇ¨ÎûåÎì§ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å Îã§ **Phenotype(ÌëúÌòÑÌòï)**ÏûÖÎãàÎã§.
> > * **ÌïµÏã¨ ÏßàÎ¨∏ (33p):** ÎèÑÎåÄÏ≤¥ Ïñ¥Îñ§ Î¨ºÎ¶¨Ï†Å Î©îÏª§ÎãàÏ¶òÏù¥ Ïö∞Î¶¨Ïùò Ïô∏Î™®ÏôÄ Í∏∞Îä•ÏùÑ Í≤∞Ï†ïÌï†ÍπåÏöî?
> > * **Ï†ïÎ≥¥Ïùò Í≥ÑÏ∏µ (Level):**
> >     * **Genome (Ïú†Ï†ÑÏ≤¥)**: Í∞ÄÏû• Î∞ëÎ∞îÎã• ÏÑ§Í≥ÑÎèÑ.
> >     * **Epigenome (ÌõÑÏÑ±Ïú†Ï†ÑÏ≤¥)**: ÏÑ§Í≥ÑÎèÑÏùò Ïä§ÏúÑÏπò.
> >     * **Transcriptome (Ï†ÑÏÇ¨Ï≤¥)**: Î≥µÏÇ¨Îêú Î™ÖÎ†πÏÑú.
> >     * **Proteome (Îã®Î∞±ÏßàÏ≤¥)**: Ïã§Ï†ú ÏùºÍæº.
> >     * **Metabolome (ÎåÄÏÇ¨Ï≤¥)**: ÏùºÍæºÏù¥ ÎßåÎì† Í≤∞Í≥ºÎ¨º.
> >     * **Phenome (ÌëúÌòÑÌòïÏ≤¥)**: ÏµúÏ¢ÖÏ†ÅÏù∏ ÏÉùÎ¨ºÌïôÏ†Å ÌäπÏßï.
> > * Ïù¥ Î™®Îì† **Biologic Process(ÏÉùÎ¨ºÌïôÏ†Å Í≥ºÏ†ï)**Í∞Ä Ïó∞Í≤∞ÎêòÏñ¥Ïïº ÎπÑÎ°úÏÜå 'ÎÇò'ÎùºÎäî ÏÇ¨ÎûåÏù¥ ÏÑ§Î™ÖÎê©ÎãàÎã§. 
>
> > [!INFO] PAGE 34-37: Ïú†Ï†ÑÏûê(Gene)ÏôÄ Î∞úÌòÑ(Expression)
> > 34ÌéòÏù¥ÏßÄ, 'Ïú†Ï†ÑÏûê'Ïùò Ï†ïÏùòÎ•º Î∂ÑÏûêÏ†Å Í¥ÄÏ†êÏóêÏÑú ÌôïÏã§Ìûà Ìï©ÏãúÎã§.
> > * **Ï†ïÏùò:** Îã®Î∞±ÏßàÏù¥ÎÇò RNAÎ•º ÏΩîÎî©ÌïòÎäî DNA Ï°∞Í∞Å + **"Ïñ∏Ï†ú, Ïñ¥ÎîîÏÑú, ÏñºÎßàÎÇò(when, where, what amounts)"** ÎßåÎì§ÏßÄ Í≤∞Ï†ïÌïòÎäî Î™ÖÎ†πÏñ¥ÍπåÏßÄ Ìè¨Ìï®ÏûÖÎãàÎã§. 
> > * **Expression (36p):**
> >     * **Transcription (Ï†ÑÏÇ¨):** Ìïµ(Nucleus) ÏïàÏóêÏÑú DNA ‚Üí mRNA. (ÏÑ±ÏàôÌïú mRNAÍ∞Ä Îê®) 
> >     * **Translation (Î≤àÏó≠):** ÏÑ∏Ìè¨Ïßà(Cytoplasm)Î°ú ÎÇòÏôÄÏÑú mRNA ‚Üí Protein. 
>
> > [!IMPORTANT] PAGE 39: Clinical Sequencing Ï¢ÖÎ•ò (Ï°±Î≥¥ ÏïºÎßà! ‚òÖ)
> > Ïûê, Ïó¨Í∏∞ **Î≥ÑÌëú 5Í∞ú** Î∞ïÏúºÏÑ∏Ïöî. Î≥ëÏõêÏóêÏÑú "Ïú†Ï†ÑÏûê Í≤ÄÏÇ¨Ìï©ÏãúÎã§" Ìï† Îïå Îã§ Í∞ôÏùÄ Í≤å ÏïÑÎãôÎãàÎã§. Í∞Å Î∞©Î≤ïÏù¥ **Î¨¥ÏóáÏùÑ(Target)** Î≥¥Í≥† **Ïñ¥Îñ§ ÎèåÏó∞Î≥ÄÏù¥(Application)**Î•º Ïû°ÎäîÏßÄ Îß§Ïπ≠Ìï¥Ïïº Ìï©ÎãàÎã§.
> >
> > 1.  **Whole Genome Sequencing (WGS, Ï†ÑÏû• Ïú†Ï†ÑÏ≤¥):**
> >     * **Î≤îÏúÑ:** DNA Ï†ÑÏ≤¥.
> >     * **Ïû°Îäî Í≤É:** **Structural variants (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥)**, Point mutations, Copy number variation (CNV). Îã§ Ïû°ÏäµÎãàÎã§. 
> > 2.  **Whole-Exome Sequencing (WES):**
> >     * **Î≤îÏúÑ:** **Exon baits**Î•º Ïç®ÏÑú Îã®Î∞±Ïßà ÎßåÎìúÎäî **1% (Exon)**Îßå Î¥ÖÎãàÎã§. Í∞ÄÏÑ±ÎπÑÍ∞Ä Ï¢ãÏ£†.
> >     * **Ïû°Îäî Í≤É:** Point mutations, CNV. (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥Îäî Ïûò Î™ª Î¥ÖÎãàÎã§) 
> > 3.  **PCR Amplicon (Targeted Panel):**
> >     * **Î≤îÏúÑ:** ÌäπÏ†ï Ïú†Ï†ÑÏûêÎßå Ï¶ùÌè≠.
> >     * **Ïû°Îäî Í≤É:** Point mutations, Deletions. ÌäπÏ†ï ÏßàÎ≥ë ÌÉÄÍ≤üÌåÖÌï† Îïå ÏîÅÎãàÎã§. 
> > 4.  **Transcriptome (RNA-seq):**
> >     * **Î≤îÏúÑ:** RNA Ï†ÑÏ≤¥.
> >     * **Ïû°Îäî Í≤É:** **Gene expression (Î∞úÌòÑÎüâ)**, **Gene fusions (ÏúµÌï© Ïú†Ï†ÑÏûê)**, Splice variants. 
>
> > [!INFO] PAGE 40: Genotype LayerÎ≥Ñ Î≥ÄÏù¥ Ï¢ÖÎ•ò (Ïö©Ïñ¥ Ï†ïÎ¶¨)
> > 40ÌéòÏù¥ÏßÄ ÌëúÎäî ÏïûÏùò ÎÇ¥Ïö©ÏùÑ Ï†ïÎ¶¨Ìïú Í≤ÅÎãàÎã§. Í∞Å Î†àÎ≤®ÏóêÏÑú ÏùºÏñ¥ÎÇòÎäî **Event** Ïö©Ïñ¥Î•º Ïô∏Ïö∞ÏÑ∏Ïöî.
> > * **Genome:** SNP (Îã®Ïùº ÏóºÍ∏∞ Îã§ÌòïÏÑ±), InDel (ÏÇΩÏûÖ/Í≤∞Ïã§), CNV (Î≥µÏ†úÏàò Î≥ÄÏù¥), SV (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥). 
> > * **Transcriptome:** Gene expression Î≥ÄÌôî, Alternative splicing(ÏÑ†ÌÉùÏ†Å Ïä§ÌîåÎùºÏù¥Ïã±). 
> > * **Proteome:** PTM (Post-translational modification, Î≤àÏó≠ ÌõÑ Î≥ÄÌòï). 

> [!NOTE] Pages 41-51: Ï†ÑÏÇ¨ Ï°∞Ï†àÍ≥º Îã®Î∞±ÏßàÏ≤¥ (Regulation & Proteome)
> Ïûê, DNAÏóê Ï†ïÎ≥¥Í∞Ä ÏûàÎã§Í≥† ÎÅùÏù¥ ÏïÑÎãôÎãàÎã§. Í∑∏Í±∏ ÏùΩÏñ¥ÎÇ¥Í≥†(Transcription), Í∞ÄÍ≥µÌïòÍ≥†(Splicing), Îã®Î∞±ÏßàÎ°ú ÎßåÎì§Í≥†(Translation), Îòê ÏàòÏ†ï(PTM)Ìï¥Ïïº ÎπÑÎ°úÏÜå Í∏∞Îä•Ïù¥ ÏÉùÍπÅÎãàÎã§. Ïù¥ Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨Í∞Ä Í≥†Ïû• ÎÇòÎ©¥ Í∑∏Í≤å Î∞îÎ°ú 'Ïïî'Ïù¥Í≥† 'ÏßàÎ≥ë'ÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 41-43: Ï†ÑÏÇ¨ ÎÑ§Ìä∏ÏõåÌÅ¨ÏôÄ Chromatin (Ï°∞Ï†àÏùò ÏãúÏûë)
> > 41ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. ÏÑ∏Ìè¨Ìïµ(Nucleus)ÏóêÏÑú ÏùºÏñ¥ÎÇòÎäî ÏùºÎì§ÏûÖÎãàÎã§.
> > * **Transcriptional networks (Ï†ÑÏÇ¨ ÎÑ§Ìä∏ÏõåÌÅ¨):**
> >     * **Transcription Factors (TF):** Ï†ÑÏÇ¨Î•º ÏãúÏûëÌïòÎäî Ïó¥Ïá†ÏûÖÎãàÎã§. 
> >     * **Cofactors & Chromatin regulation:** TFÎ•º ÎèÑÏôÄÏ£ºÍ±∞ÎÇò Î∞©Ìï¥ÌïòÎäî ÏπúÍµ¨Îì§Ïù¥Ï£†. 
> >     * **DNA Methylation & Histone Modification:** DNAÎ•º Í∞êÍ≥† ÏûàÎäî Ïã§Ìå®(Histone)Î•º Ï°∞Ïù¥Í±∞ÎÇò ÌíÄÏñ¥ÏÑú Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌï©ÎãàÎã§. (EpigeneticsÏùò ÌïµÏã¨) 
> > * **42ÌéòÏù¥ÏßÄ Íµ¨Ï°∞:** DNAÎäî Í∑∏ÎÉ• ÏûàÎäî Í≤å ÏïÑÎãàÎùº **Histone**Ïóê Í∞êÍ≤® **Nucleosome**ÏùÑ ÌòïÏÑ±Ìï©ÎãàÎã§. Ï†ÑÏÇ¨Í∞Ä ÏùºÏñ¥ÎÇòÎ†§Î©¥ Ïù¥ Íµ¨Ï°∞Í∞Ä ÌíÄÎ†§Ïïº ÌïòÎäîÎç∞, Í∑∏ Ïó¥Î¶∞ Î∂ÄÏúÑÎ•º **DNase I hypersensitive sites**ÎùºÍ≥† Ìï©ÎãàÎã§. "Ïó¨Í∏∞Í∞Ä ÌôúÏÑ± Î∂ÄÏúÑÎã§"ÎùºÎäî ÎúªÏù¥Ï£†. 
> > * **43ÌéòÏù¥ÏßÄ ÏõêÍ±∞Î¶¨ Ï°∞Ï†à:** **Long-range regulatory elements**Î•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏûê Î∞îÎ°ú ÏòÜÏù¥ ÏïÑÎãàÎùº ÏïÑÏ£º Î©ÄÎ¶¨ Îñ®Ïñ¥ÏßÑ Í≥≥ÏóêÏÑúÎèÑ Ï°∞Ï†à Ïã†Ìò∏Î•º Î≥¥ÎÉÖÎãàÎã§. DNAÍ∞Ä Í≥†Î¶¨Ï≤òÎüº ÌúòÏñ¥Ï†∏ÏÑú(Looping) ÎßåÎÇòÎäî Í≤ÅÎãàÎã§. 
>
> > [!INFO] PAGE 44-45: Ï†ÑÏÇ¨ Îã®ÏúÑÏùò Ìï¥Î∂Ä (Anatomy of Transcription)
> > 44ÌéòÏù¥ÏßÄ, Ïú†Ï†ÑÏûêÏùò Íµ¨Ï°∞Î•º ÎúØÏñ¥Î¥ÖÏãúÎã§. Ïö©Ïñ¥ Ï†ïÌôïÌûà ÏïÑÏÖîÏïº Ìï©ÎãàÎã§.
> > * **Promoter (Cis-regulatory region):** Ï†ÑÏÇ¨ ÏãúÏûë ÏúÑÏπòÎ•º Ïû°ÏïÑÏ£ºÎäî Í≥≥. **Basal (core) promoter**ÏôÄ **Module (Enhancer)**Î°ú ÎÇòÎâ©ÎãàÎã§. 
> > * **Transcription Unit:** Ïã§Ï†ú Î≥µÏÇ¨ÎêòÎäî Íµ¨Í∞Ñ. **Exon(ÎÇ®Îäî Î∂ÄÎ∂Ñ)**Í≥º **Intron(Î≤ÑÎ†§ÏßÄÎäî Î∂ÄÎ∂Ñ)**, Í∑∏Î¶¨Í≥† ÏñëÎÅùÏùò **UTR (Untranslated Region)**Ïù¥ ÏûàÏäµÎãàÎã§. 
> > * **45ÌéòÏù¥ÏßÄ Looping:** ÏïÑÍπå ÎßêÌïú ÏõêÍ±∞Î¶¨ Ï°∞Ï†àÏù¥ Ïñ¥ÎñªÍ≤å ÏùºÏñ¥ÎÇòÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§. **Looping factors**Í∞Ä DNAÎ•º ÌúòÍ≤å ÎßåÎì§Ïñ¥ Î©ÄÎ¶¨ ÏûàÎäî EnhancerÎ•º Promoter Í∑ºÏ≤òÎ°ú ÎÅåÍ≥† ÏòµÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 46: p53 Íµ¨Ï°∞ ÏÉÅÏÑ∏ (ÏïºÎßà/Í∏∞Ï∂ú Ìè¨Ïù∏Ìä∏ ‚òÖ)
> > Ïûê, ÏùòÎåÄÏÉùÏù¥ÎùºÎ©¥ **p53** Î™®Î•¥Î©¥ Í∞ÑÏ≤©ÏûÖÎãàÎã§. 'Ïú†Ï†ÑÏ≤¥Ïùò ÏàòÌò∏Ïûê'Ï£†. 46ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ ÌòÑÎØ∏Í≤Ω Î≥¥ÎìØ Î≥¥ÏÑ∏Ïöî.
> > * **Íµ¨Ï°∞Ï†Å ÌäπÏßï:**
> >     * **DNA-binding domain:** DNAÏôÄ ÏßÅÏ†ë Í≤∞Ìï©ÌïòÎäî Î∂ÄÏúÑ. Ïó¨Í∏∞Ïóê **Zinc atom (ÏïÑÏó∞ ÏõêÏûê)**Ïù¥ **Stabilizer(ÏïàÏ†ïÌôîÏ†ú)**Î°ú Î∞ïÌòÄ ÏûàÏäµÎãàÎã§. 
> >     * **Tetramerization domain:** p53ÏùÄ ÌòºÏûê Ïùº Ïïà Ìï©ÎãàÎã§. 4Í∞úÍ∞Ä Î≠âÏ≥êÏÑú(Tetramer) ÏùºÌï©ÎãàÎã§. 
> >     * **Transcription domain:** Ï†ÑÏÇ¨Î•º ÌôúÏÑ±ÌôîÌïòÎäî Î∂ÄÏúÑ. 
> > * **ÏûÑÏÉÅ Ïó∞Í≥Ñ:** ÏïîÌôòÏûêÏóêÏÑú p53 Î≥ÄÏù¥Í∞Ä Î∞úÍ≤¨ÎêòÎ©¥, Ï£ºÎ°ú Ï†Ä **DNA-binding domain**Ïù¥ ÎßùÍ∞ÄÏ†∏ÏÑú DNAÎ•º Î™ª Ïû°Í≤å ÎêòÎäî Í≤ΩÏö∞Í∞Ä ÎßéÏäµÎãàÎã§.
> >   ![Pasted image 20251209101527.png](/img/user/%ED%95%99%EC%97%85/%EC%98%88%202-2/%EB%B6%84%EC%9E%90%EC%9C%A0%EC%A0%84%ED%95%99/%EC%82%AC%EC%A0%84%EC%A0%95%EB%A6%AC%EB%B3%B8/%EA%B8%B0%EB%A7%90/%EB%8F%99%EB%B4%89%EC%9D%B4%EB%AF%B8%EC%A7%80/Pasted%20image%2020251209101527.png)
>
> > [!INFO] PAGE 47-48: SplicingÍ≥º Ï†ÑÏÇ¨Ïùò Î≥µÏû°ÏÑ±
> > 47ÌéòÏù¥ÏßÄÎ•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏûê ÌïòÎÇò(Gene 1)ÏóêÏÑú ÌôîÏÇ¥ÌëúÍ∞Ä Ïó¨Îü¨ Í∞ú ÎÇòÏò§Ï£†?
> > * **Alternative Splicing:** ÏóëÏÜêÏùÑ Ïñ¥ÎñªÍ≤å Ï°∞Î¶ΩÌïòÎäêÎÉêÏóê Îî∞Îùº ÌïòÎÇòÏùò Ïú†Ï†ÑÏûêÏóêÏÑú Ïó¨Îü¨ Ï¢ÖÎ•òÏùò mRNA(Transcripts)Í∞Ä ÎÇòÏòµÎãàÎã§.
> > * **Reverse Strand Transcripts:** Ïã¨ÏßÄÏñ¥ Î∞òÎåÄ Í∞ÄÎã•ÏóêÏÑúÎèÑ Ï†ÑÏÇ¨Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. 
> > * 48ÌéòÏù¥ÏßÄÎäî Îçî Î≥µÏû°Ìï©ÎãàÎã§. **tiRNA, PASR, ncRNA** Í∞ôÏùÄ ÎπÑÏïîÌò∏Ìôî RNAÎì§ÎèÑ ÏóÑÏ≤≠ÎÇòÍ≤å ÏèüÏïÑÏ†∏ ÎÇòÏòµÎãàÎã§. Ïö∞Î¶¨ Î™∏ÏùÄ ÏÉùÍ∞ÅÎ≥¥Îã§ Ìõ®Ïî¨ ÏàòÎã§Ïä§ÎüΩÏäµÎãàÎã§. 
>
> > [!INFO] PAGE 49-51: ProteomeÍ≥º PTM (Î≤àÏó≠ ÌõÑ Î≥ÄÌòï)
> > 49ÌéòÏù¥ÏßÄ Ïö∞Ï∏°ÏùÑ Î≥¥ÏÑ∏Ïöî. Îã®Î∞±ÏßàÏù¥ ÎßåÎì§Ïñ¥ÏßÑ ÌõÑ(Translation)ÏóêÎèÑ ÎÅùÏù¥ ÏïÑÎãôÎãàÎã§. **Post-translational modifications (PTM)**Ïù¥ ÏùºÏñ¥ÎÇ©ÎãàÎã§.
> > * **Ï¢ÖÎ•ò (Ïô∏Ïö∞ÏÑ∏Ïöî):**
> >     * **Phosphorylation (Ïù∏ÏÇ∞Ìôî):** Ïä§ÏúÑÏπò Ïó≠Ìï† (Í∞ÄÏû• Ï§ëÏöî). 
> >     * **Glycosylation (ÎãπÌôî):** ÎãπÏùÑ Î∂ôÏûÑ. 
> >     * **Acetylation (ÏïÑÏÑ∏Ìã∏Ìôî)** 
> >     * **Ubiquitination (Ïú†ÎπÑÌÄ¥Ìã¥Ìôî):** Î∂ÑÌï¥ Ïã†Ìò∏. 
> >     * **SUMOylation:** Îã®Î∞±Ïßà Í∏∞Îä• Ï°∞Ï†à. 
> > * **Í≤∞Î°† (50-51p):** Ïú†Ï†ÑÏûêÎäî ÌïòÎÇòÏßÄÎßå, SplicingÍ≥º PTMÏùÑ Í±∞ÏπòÎ©¥ ÏàòÏã≠, ÏàòÎ∞± Í∞ÄÏßÄÏùò **Mature proteins**Í∞Ä ÏÉùÍπÅÎãàÎã§. Í∑∏ÎûòÏÑú ProteomeÏù¥ GenomeÎ≥¥Îã§ Ìõ®Ïî¨ Î≥µÏû°Ìïú Í≤ÅÎãàÎã§. 

> [!NOTE] Pages 52-59: ÎåÄÏÇ¨Ï≤¥ÏôÄ ÌëúÌòÑÌòï (Metabolome & Phenotype)
> Ïûê, DNAÏóêÏÑú ÏãúÏûëÎêú Ïó¨Ï†ïÏù¥ ÎìúÎîîÏñ¥ Ïö∞Î¶¨ Î™∏Ïùò Ïã§Ï†ú Í∏∞Îä•Ïù∏ 'ÎåÄÏÇ¨'ÏôÄ 'ÌëúÌòÑÌòï'Ïóê ÎèÑÎã¨ÌñàÏäµÎãàÎã§. Ïú†Ï†ÑÏûêÍ∞Ä ÏïÑÎ¨¥Î¶¨ Ï¢ãÏïÑÎèÑ ÌôòÍ≤ΩÏù¥ ÎÇòÏÅòÎ©¥ Î≥ëÏù¥ ÏÉùÍ∏∞Îäî ÏõêÎ¶¨, Í∑∏Î¶¨Í≥† Ïïî ÌôòÏûêÏùò ÏÑ∏Ìè¨Î•º ÎñºÏñ¥ÎÇ¥ÏÑú Ïã§Ï†úÎ°ú ÏïΩÏùÑ Ï≥êÎ≥¥Îäî(Functional Assay) ÏµúÏã† Í∏∞Î≤ïÍπåÏßÄ ÏîπÏñ¥Î®πÏñ¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 53: Ïã†Ìò∏ Ï†ÑÎã¨Í≥º ÎåÄÏÇ¨ Í≤ΩÎ°ú (ÌöåÎ°úÎèÑ Î∂ÑÏÑù)
> > 53ÌéòÏù¥ÏßÄ Ï¢åÏ∏° Í∑∏Î¶º, ÏïÑÏ£º Ï†ÑÌòïÏ†ÅÏù∏ **ÏÑ∏Ìè¨ Ïã†Ìò∏ Ï†ÑÎã¨(Signaling Pathway)** ÌöåÎ°úÎèÑÏûÖÎãàÎã§. ÏàúÏÑúÎ•º Ïô∏Ïö∞ÏÑ∏Ïöî.
> > 1.  **Sensor (Í∞êÏßÄÍ∏∞):** ÏÑ∏Ìè¨ÎßâÏùò **Ligand + Receptor**Í∞Ä Ïã†Ìò∏Î•º Î∞õÏäµÎãàÎã§.
> > 2.  **Transducer (Î≥ÄÌôòÍ∏∞):** Ïù∏ÏÇ∞Ìôî(P) Îì±ÏùÑ ÌÜµÌï¥ Ïã†Ìò∏Î•º ÏïàÏúºÎ°ú Ï†ÑÎã¨Ìï©ÎãàÎã§.
> > 3.  **Circuit (ÌöåÎ°ú):** ÏÑ∏Ìè¨Ïßà(Cytoplasm) ÎÇ¥Ïùò Î≥µÏû°Ìïú Ïã†Ìò∏ ÎÑ§Ìä∏ÏõåÌÅ¨.
> > 4.  **Actuator (Íµ¨ÎèôÍ∏∞):** Ìïµ(Nucleus)ÏúºÎ°ú Îì§Ïñ¥Í∞Ä **DNA**Ïùò Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌï©ÎãàÎã§.
> >
> > * **Ïö∞Ï∏° Í∑∏Î¶º (Multi-omics flow):**
> >     * **Genome:** Gene 1, 2...
> >     * **Proteome:** Protein A, B, C... Ìö®ÏÜå(Enzyme)Îì§Ïù¥Ï£†.
> >     * **Metabolome:** Ìö®ÏÜåÎì§Ïù¥ Í∏∞Ïßà(a)ÏùÑ ÏÉùÏÇ∞Î¨º(b)Î°ú Î∞îÍøâÎãàÎã§. **Feedback loop** (Ï†êÏÑ† ÌôîÏÇ¥Ìëú)Í∞Ä Ï°¥Ïû¨ÌïòÏó¨ ÎåÄÏÇ¨ ÏÇ∞Î¨ºÏù¥ Îã§Ïãú Ïú†Ï†ÑÏûê Î∞úÌòÑÏùÑ Ï°∞Ï†àÌïòÍ∏∞ÎèÑ Ìï©ÎãàÎã§.
>
> > [!INFO] PAGE 54: Metabolome (ÎåÄÏÇ¨Ï≤¥)Ïùò ÏúÑÏπò
> > 54ÌéòÏù¥ÏßÄ ÌëúÏóêÏÑú Îπ®Í∞Ñ Î∞ïÏä§Î•º Î≥¥ÏÑ∏Ïöî.
> > * **Metabolome:** GenotypeÎ≥¥Îã§Îäî **Phenotype**Ïóê Ìõ®Ïî¨ Í∞ÄÍπùÏäµÎãàÎã§. Ï¶â, **"ÌòÑÏû¨ Î™∏ ÏÉÅÌÉúÎ•º Í∞ÄÏû• Ïã§ÏãúÍ∞ÑÏúºÎ°ú Î∞òÏòÅÌïòÎäî ÏßÄÌëú"**ÏûÖÎãàÎã§. Ïú†Ï†ÑÏûêÎäî ÌÉúÏñ¥ÎÇ† Îïå Í≤∞Ï†ïÎêòÏßÄÎßå, ÎåÄÏÇ¨Ï≤¥Îäî ÏïÑÏπ® Î®πÏóàÎÉê Íµ∂ÏóàÎÉêÏóê Îî∞Îùº Îã¨ÎùºÏßÄÎãàÍπåÏöî. 
>
> > [!IMPORTANT] PAGE 56: Ïú†Ï†ÑÏûêÏôÄ ÌôòÍ≤ΩÏùò ÏÉÅÌò∏ÏûëÏö© (Landscape Model)
> > Ïûê, Ïù¥ Í∑∏Î¶º Ïù¥Ìï¥ Î™ªÌïòÎ©¥ ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïô ÍΩùÏûÖÎãàÎã§. Í≥µÏù¥ Íµ¥Îü¨Í∞ÄÎäî Í≤ΩÎ°ú(Trajectory)Í∞Ä ÏÑ∏Ìè¨Ïùò Ïö¥Î™ÖÏûÖÎãàÎã§.
> > * **a (Phenotypic state):** Í≥µÏù¥ Íµ¥Îü¨ÎÇ¥Î†§ÏôÄ Í≥®ÏßúÍ∏∞(Attractor)Ïù∏ **P1~P5** Ï§ë ÌïòÎÇòÏóê ÏïàÏ∞©Ìï©ÎãàÎã§. Ïù¥Í≤å Ï†ïÏÉÅÏ†ÅÏù∏ Î∂ÑÌôîÏûÖÎãàÎã§. 
> > * **b (Environmental factor):** Ïô∏Î∂Ä ÌôòÍ≤ΩÏù¥ Í≥µÏùÑ Î∞ÄÏñ¥Î≤ÑÎ¶ΩÎãàÎã§. Í∑∏Îü¨Î©¥ ÏõêÎûò Í∞ÄÏïº Ìï† Í∏∏(Trajectory)ÏùÑ Î≤óÏñ¥ÎÇò Îã§Î•∏ ÌëúÌòÑÌòïÏúºÎ°ú Í∞ÄÍ≤å ÎêòÏ£†. 
> > * **c (Genetic factor):** Ïú†Ï†ÑÏûê Î≥ÄÏù¥Í∞Ä ÏÉùÍ∏∞Î©¥? **ÏßÄÌòï(Landscape) ÏûêÏ≤¥**Í∞Ä Î∞îÎÄùÎãàÎã§. Í≥®ÏßúÍ∏∞ Î™®ÏñëÏù¥ Î∞îÎÄåÏñ¥ÏÑú Í≥µÏù¥ ÏóâÎö±Ìïú Í≥≥ÏúºÎ°ú Íµ¥Îü¨Í∞ÄÍ≤å ÎßåÎì≠ÎãàÎã§. 
> > * **d (Noise):** ÌäπÎ≥ÑÌïú ÏöîÏù∏ ÏóÜÏñ¥ÎèÑ ÌôïÎ•†Ï†ÅÏù∏ Ïû°Ïùå(Stochasticity)ÎßåÏúºÎ°úÎèÑ Í≤∞Í≥ºÍ∞Ä Îã¨ÎùºÏßà Ïàò ÏûàÏäµÎãàÎã§. 
>
> > [!TIP] üí° PAGE 57-58: Ï∞®ÏÑ∏ÎåÄ Í∏∞Îä•ÏÑ± Î∂ÑÏÑù (Next-Gen Functional Assays)
> > 57-58ÌéòÏù¥ÏßÄÎäî Ïã§Ï†ú Î≥ëÏõêÏóêÏÑú Ïïî ÌôòÏûê Ï°∞ÏßÅÏùÑ ÎñºÏñ¥ÎÇ¥ÏÑú ÌïòÎäî Í≤ÄÏÇ¨Îì§ÏûÖÎãàÎã§. **"ÌôòÏûê ÎßûÏ∂§Ìòï ÏπòÎ£å(Precision Medicine)"**Ïùò ÏµúÏ†ÑÏÑ†Ïù¥Ï£†.
> >
> > **1. Í≤ÄÏ≤¥ ÌôïÎ≥¥ (57p):**
> > * **Solid tumours (Í≥†ÌòïÏïî):** Biopsy(ÏÉùÍ≤Ä) ÎòêÎäî CTCs(ÏàúÌôò Ï¢ÖÏñë ÏÑ∏Ìè¨).
> > * **Haematological (ÌòàÏï°Ïïî):** Bone marrow biopsy(Í≥®Ïàò ÏÉùÍ≤Ä).
> > * Ïù¥Í±∏Î°ú **Organoids (Ïò§Í∞ÄÎÖ∏Ïù¥Îìú, ÎØ∏Îãà Ïû•Í∏∞)**Î•º ÎßåÎì≠ÎãàÎã§. 
> >
> > **2. ÌïµÏã¨ Î∂ÑÏÑùÎ≤ï (58p - Ïö©Ïñ¥ ÏïîÍ∏∞):**
> > * **Kinase profiling:** Ïù∏ÏÇ∞Ìôî Ìö®ÏÜå ÌôúÏÑ± Ï∏°Ï†ï. 
> > * **Immuno-flow / FACS:** Ìï≠Ï≤¥Î•º Ïù¥Ïö©Ìï¥ Îã®Î∞±Ïßà Î∞úÌòÑ Î∂ÑÏÑù. 
> > * **DBP (Dynamic BH3 Profiling):** ÏÑ∏Ìè¨Í∞Ä ÏñºÎßàÎÇò Ï£ΩÍ∏∞ Ïâ¨Ïö¥ÏßÄ(**Apoptotic priming**) Ï∏°Ï†ï. 
> > * **Cytotoxicity (ÏÑ∏Ìè¨ ÎèÖÏÑ±):** ÏïΩ Ï≥§ÏùÑ Îïå ÏñºÎßàÎÇò Ï£ΩÎÇò? (**ATP levels, MTT** Îì±ÏúºÎ°ú Ï∏°Ï†ï). 
> > * **PDX (Patient-Derived Xenograft):** Ï•ê(Mouse)Ïóê ÌôòÏûê ÏïîÏùÑ Ïù¥ÏãùÌï¥ÏÑú ÌÖåÏä§Ìä∏. Í∞ÄÏû• Ï†ïÌôïÌïòÏßÄÎßå ÎπÑÏã∏Í≥† Ïò§Îûò Í±∏Î¶º. 
>
> > [!INFO] PAGE 59: Phenome (ÌòÑÏÉÅÏ≤¥)Ïùò Íµ¨ÏÑ±
> > 59ÌéòÏù¥ÏßÄ ÎßàÏßÄÎßâ Îã®Í≥ÑÏûÖÎãàÎã§.
> > * Í≤∞Íµ≠ Ïù¥ Î™®Îì† Í≥ºÏ†ïÏùò ÎÅùÏùÄ Î¨¥ÏóáÏù∏Í∞Ä?
> > * **Tumorigenesis (Ï¢ÖÏñë ÌòïÏÑ±)**
> > * **Angiogenesis (ÌòàÍ¥Ä ÏÉùÏÑ±)**
> > * **Metastasis (Ï†ÑÏù¥)**
> > * Ïù¥Îü∞ Í±∞ÏãúÏ†ÅÏù∏ ÌäπÏßïÎì§ÏùÑ **Phenome**Ïù¥ÎùºÍ≥† Î∂ÄÎ¶ÖÎãàÎã§. 

> [!NOTE] Pages 60-66: ÌõÑÏÑ±Ïú†Ï†ÑÌïô ÌòÅÎ™Ö (Epigenomic Revolution)
> Ïûê, DNA ÏóºÍ∏∞ÏÑúÏó¥Ïù¥ Ïö¥Î™ÖÏùò Ï†ÑÎ∂ÄÍ∞Ä ÏïÑÎãôÎãàÎã§. ÎòëÍ∞ôÏùÄ ÏïÖÎ≥¥(DNA)Î•º Í∞ÄÏßÄÍ≥†ÎèÑ Ïó∞Ï£ºÏûê(ÏÑ∏Ìè¨)Ïóê Îî∞Îùº Ïä¨Ìîà Í≥°Ïù¥ ÎêòÍ∏∞ÎèÑ ÌïòÍ≥† Í∏∞ÏÅú Í≥°Ïù¥ ÎêòÍ∏∞ÎèÑ ÌïòÏ£†. Í∑∏Í≤å Î∞îÎ°ú **Epigenetics**ÏûÖÎãàÎã§. Ïó¨Í∏∞ÏÑúÎäî **ChromatinÏùò Íµ¨Ï°∞ Î≥ÄÌôî**ÏôÄ **Histone Code**Î•º Ìï¥ÎèÖÌïòÎäî Í≤å ÌïµÏã¨ÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 60-61: ChromatinÏùò Í∞úÌèêÏôÄ Histone Tail
> > 60ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî.
> > * **Compact DNA (a):** ÍΩÅÍΩÅ Í∞êÍ≤® ÏûàÏäµÎãàÎã§. Ïù¥Îü¨Î©¥ Ï†ÑÏÇ¨ Ïù∏Ïûê(TF)Í∞Ä Ï†ëÍ∑ºÏùÑ Î™ª ÌïòÏ£†. **"Gene Inactive"** ÏÉÅÌÉúÏûÖÎãàÎã§. 
> > * **Relaxed DNA (b):** Íµ¨Ï°∞Í∞Ä ÌíÄÎ†∏ÏäµÎãàÎã§(Alteration of structure). DNAÍ∞Ä ÎÖ∏Ï∂úÎêòÎãà Ï†ÑÏÇ¨(Transcription)Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. **"Gene Active"** ÏÉÅÌÉúÏûÖÎãàÎã§. 
> >
> > 61ÌéòÏù¥ÏßÄÎ•º Î≥¥ÏÑ∏Ïöî. Ïù¥ ChromatinÏùÑ ÎßåÎìúÎäî Ïã§Ìå®Í∞Ä **Histone**Ïù¥Ï£†.
> > * **Íµ¨ÏÑ±:** **H2A, H2B, H3, H4**Í∞Ä Í∞ÅÍ∞Å 2Í∞úÏî© Î™®Ïó¨ 8ÎüâÏ≤¥(Octamer)Î•º Ïù¥Î£πÎãàÎã§. 
> > * **Tail (Íº¨Î¶¨):** Í∑∏Î¶ºÏóê ÏÇêÏ£ΩÏÇêÏ£Ω ÌäÄÏñ¥ÎÇòÏò® ÏÑ†Îì§ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å **Histone Tail**ÏûÖÎãàÎã§. Ïó¨Í∏∞Í∞Ä Î∞îÎ°ú ÌôîÌïôÏ†Å Î≥ÄÌòïÏù¥ ÏùºÏñ¥ÎÇòÎäî **'Ï°∞Ï†à Ïä§ÏúÑÏπò'**ÏûÖÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 62: ÌûàÏä§ÌÜ§ ÏΩîÎìú (Histone Code) ÏÉÅÏÑ∏ Î∂ÑÏÑù (‚òÖÏïîÍ∏∞)
> > 62ÌéòÏù¥ÏßÄ, Íπ®Ïïå Í∞ôÏùÄ ÏïåÌååÎ≤≥Îì§Ïù¥ ÎÇòÏòµÎãàÎã§. Ïù¥Í≤å ÌûàÏä§ÌÜ§ Íº¨Î¶¨Ïùò ÏïÑÎØ∏ÎÖ∏ÏÇ∞ ÏÑúÏó¥ÏûÖÎãàÎã§. ÏãúÌóòÏóê ÎÇòÏòµÎãàÎã§.
> >
> > **1. H3 Tail (ÏúÑÏ™Ω Í∑∏Î¶º):** 
> > * ÏÑúÏó¥ ÏãúÏûë: **N-ARTKQTARKSTGGK...** (Ïù¥Í±∞ ÎààÏóê ÏùµÌûàÏÑ∏Ïöî) 
> > * Ï£ºÏöî Î≥ÄÌòï ÏúÑÏπò (Ïà´ÏûêÎäî ÏïÑÎØ∏ÎÖ∏ÏÇ∞ Î≤àÌò∏):
> >     * **K (Lysine, Î¶¨Ïã†):** Ï£ºÎ°ú **Me (Methylation)**ÏôÄ **Ac (Acetylation)**Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. (Ïòà: K4, K9, K27) 
> >     * **S (Serine, ÏÑ∏Î¶∞):** Ï£ºÎ°ú **P (Phosphorylation, Ïù∏ÏÇ∞Ìôî)**Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. (Ïòà: S10, S28) 
> >
> > **2. H4 Tail (ÏïÑÎûòÏ™Ω Í∑∏Î¶º):** 
> > * ÏÑúÏó¥ ÏãúÏûë: **N-SGRGKGGK...** 
> > * Ïó¨Í∏∞ÎèÑ **Acetylation (Ac)**Ïù¥ ÏûîÎú© Î∂ôÏñ¥ ÏûàÏ£†? (K5, K8, K12, K16 Îì±) 
> >
> > **3. H2A & H2B:**
> > * **Ub (Ubiquitination):** Ïú†ÎπÑÌÄ¥Ìã¥Ïù¥ Î∂ôÍ∏∞ÎèÑ Ìï©ÎãàÎã§. 
> >
> > **[ÍµêÏàòÎãòÏùò ÌåÅ]** "KÏóê AcetylÍ∏∞Í∞Ä Î∂ôÏúºÎ©¥(Acetylation) Ï†ÑÏÇ¨Í∞Ä **Ï¥âÏßÑ**ÎêòÍ≥†, MethylÍ∏∞Í∞Ä Î∂ôÏúºÎ©¥(Methylation) ÏúÑÏπòÏóê Îî∞Îùº Ï¥âÏßÑÎêòÍ∏∞ÎèÑ ÌïòÍ≥† ÏñµÏ†úÎêòÍ∏∞ÎèÑ ÌïúÎã§." Ïù¥ ÏõêÏπôÏùÑ Íº≠ Í∏∞ÏñµÌïòÏÑ∏Ïöî.
>
> > [!IMPORTANT] PAGE 63: DNA Methylation (ÌôîÌïô Íµ¨Ï°∞)
> > 63ÌéòÏù¥ÏßÄ, Ïù¥Î≤àÏóî ÌûàÏä§ÌÜ§Ïù¥ ÏïÑÎãàÎùº DNA ÏßÅÏ†ë Î≥ÄÌòïÏûÖÎãàÎã§.
> > * **ÎåÄÏÉÅ:** **Cytosine (C, ÏãúÌÜ†Ïã†)** ÏóºÍ∏∞. 
> > * **Î≥ÄÌôî:** ÏãúÌÜ†Ïã†Ïùò 5Î≤à ÌÉÑÏÜå ÏúÑÏπòÏóê **Methyl group ($CH_3$)**Ïù¥ Î∂ôÏäµÎãàÎã§.
> > * **Í≤∞Í≥º:** **5-methylcytosine**Ïù¥ Îê©ÎãàÎã§. 
> > * **Í∏∞Îä•:** Ï£ºÎ°ú Ïú†Ï†ÑÏûê Î∞úÌòÑÏùÑ **ÏñµÏ†ú(Silencing)**ÌïòÎäî ÏûêÎ¨ºÏá† Ïó≠Ìï†ÏùÑ Ìï©ÎãàÎã§. Í∑∏Î¶ºÏùò ÌôîÌïô Íµ¨Ï°∞Ïãù($NH_2$ Î∞ëÏóê $H$Í∞Ä $CH_3$Î°ú Î∞îÎÄåÎäî Î∂ÄÎ∂Ñ)ÏùÑ ÌôïÏù∏ÌïòÏÑ∏Ïöî. 
>
> > [!INFO] PAGE 64-66: EpigenomeÏùò ÏúÑÏÉÅÍ≥º ÌÜµÌï©
> > 64ÌéòÏù¥ÏßÄ ÌëúÏùò Îπ®Í∞Ñ Î∞ïÏä§Î•º Î≥¥ÏÑ∏Ïöî.
> > * **EpigenomeÏùò Íµ¨ÏÑ± ÏöîÏÜå:**
> >     1.  **Methylation (DNA Î©îÌã∏Ìôî)** 
> >     2.  **Histone modification (ÌûàÏä§ÌÜ§ Î≥ÄÌòï)** 
> >     3.  **miRNA & LncRNA:** ÎπÑÏïîÌò∏Ìôî RNAÎì§ÎèÑ ÌõÑÏÑ±Ïú†Ï†ÑÌïôÏ†Å Ï°∞Ï†àÏóê Í¥ÄÏó¨Ìï©ÎãàÎã§. 
> >
> > 66ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ Ïù¥ Î™®Îì† Í≤å ÌÜµÌï©Îêú Î™®ÏäµÏûÖÎãàÎã§.
> > * **DNA Methylation**Ïù¥ ÎêòÏñ¥ ÏûàÍ≥†, **Histone**Îì§Ïù¥ Î≠âÏ≥ê ÏûàÏúºÎ©¥(Nucleosome) Ï†ëÍ∑º Î∂àÍ∞Ä.
> > * Î∞òÎ©¥ **DNase I hypersensitive sites**Îäî ÌûàÏä§ÌÜ§Ïù¥ ÏóÜÎäî Ïó¥Î¶∞ Íµ¨Í∞ÑÏúºÎ°ú, Ïó¨Í∏∞Í∞Ä **Functional genomic elements(Í∏∞Îä•Ï†Å Ïú†Ï†ÑÏ≤¥ ÏöîÏÜå)**Í∞Ä ÏûëÎèôÌïòÎäî Í≥≥ÏûÖÎãàÎã§. 

> [!NOTE] Pages 67-73: ÌõÑÏÑ±Ïú†Ï†ÑÌïôÍ≥º ÏßàÎ≥ë, Í∑∏Î¶¨Í≥† ENCODE
> Ïûê, "Ïú†Ï†ÑÏûêÎäî Ïö¥Î™ÖÏù¥ ÏïÑÎãàÎã§"ÎùºÎäî Îßê Îì§Ïñ¥Î¥§Ï£†? Í∑∏ Í≥ºÌïôÏ†Å Í∑ºÍ±∞Í∞Ä Ïó¨Í∏∞ Îã§ ÏûàÏäµÎãàÎã§. ÌôòÍ≤Ω(Îã§Ïù¥Ïñ¥Ìä∏, Ïä§Ìä∏Î†àÏä§)Ïù¥ Ïñ¥ÎñªÍ≤å ÎÇ¥ Ïú†Ï†ÑÏûêÏùò Ïä§ÏúÑÏπòÎ•º Ï°∞ÏûëÌï¥ÏÑú ÏïîÏù¥ÎÇò ÎãπÎá®Î≥ëÏùÑ ÏùºÏúºÌÇ§ÎäîÏßÄ, Í∑∏Î¶¨Í≥† Ïú†Ï†Ñ Ï†ïÎ≥¥Î•º ÎÑòÏñ¥ÏÑ† '4Ï∞®Ïõê Ïú†Ï†Ñ'Ïù¥ Î¨¥ÏóáÏù∏ÏßÄ ÏÇ¥Ìé¥Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 67-68: ENCODE ÌîÑÎ°úÏ†ùÌä∏ (ÌïÑÏàò ÏÉÅÏãù)
> > 67ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ ÏïûÏÑú Î∞∞Ïö¥ Ï†ÑÏÇ¨ Ï°∞Ï†àÏùò Ï¥ùÏ†ïÎ¶¨ÏûÖÎãàÎã§.  Ïù¥ Î≥µÏû°Ìïú Ï°∞Ï†à Î∂ÄÏúÑÎì§ÏùÑ Ï†ÑÎ∂Ä Îã§ ÏßÄÎèÑÏóê ÌëúÏãúÌïòÎ†§Îäî ÏãúÎèÑÍ∞Ä ÏûàÏóàÏúºÎãà, Î∞îÎ°ú **ENCODE**ÏûÖÎãàÎã§.
> > * **Ï†ïÏùò (68p):** **The Encyclopedia of DNA Elements**. 'DNA ÏöîÏÜå Î∞±Í≥ºÏÇ¨Ï†Ñ' ÌîÑÎ°úÏ†ùÌä∏ÏûÖÎãàÎã§. 
> > * **Î™©Ìëú:** Ïù∏Í∞Ñ Í≤åÎÜàÏùò **'Î™®Îì† Í∏∞Îä•Ï†Å ÏöîÏÜå(All functional elements)'**Î•º ÏãùÎ≥ÑÌïòÎäî Í≤É. 
> > * **ÎÇ¥Ïö©:** Îã®ÏàúÌûà Ïú†Ï†ÑÏûêÎßå Ï∞æÎäî Í≤å ÏïÑÎãàÎùº, **Regulatory elements(Ï°∞Ï†à Ïù∏Ïûê)**, **Exon variants**, **Alternative promoters** Îì± 'Í∏∞Îä•'ÏùÑ ÌïòÎäî Î™®Îì† Í≤ÉÏùÑ Ï∞æÏäµÎãàÎã§. 
>
> > [!INFO] PAGE 69: ÌõÑÏÑ±Ïú†Ï†ÑÌïôÏ†Å Ïä§ÏúÑÏπò (Active vs Inactive)
> > 69ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Í∞ôÏùÄ DNAÎùºÎèÑ ÏÉÅÌÉúÍ∞Ä Îã§Î¶ÖÎãàÎã§.
> > * **Inactive (ÎπÑÌôúÏÑ±):** DNAÍ∞Ä **Methylation** ÎêòÏñ¥ ÏûàÍ≥†, HistoneÏù¥ ÍΩâ Î≠âÏ≥êÏÑú(Inaccessible) Ïú†Ï†ÑÏûêÍ∞Ä Í∫ºÏ†∏ ÏûàÏäµÎãàÎã§. 
> > * **Active (ÌôúÏÑ±):** **Histone Modification**Ïóê ÏùòÌï¥ Íµ¨Ï°∞Í∞Ä ÌíÄÎ†§ ÏûàÍ≥†(Accessible), Ïú†Ï†ÑÏûêÍ∞Ä ÏºúÏ†∏ ÏûàÏäµÎãàÎã§. 
> > * **ÌïµÏã¨:** ÏãùÏù¥ÏöîÎ≤ï(Dietary sources) Í∞ôÏùÄ ÌôòÍ≤Ω ÏöîÏù∏Ïù¥ Î©îÌã∏Í∏∞(Methyl group)Î•º Ï†úÍ≥µÌï¥ÏÑú Ïù¥ Ïä§ÏúÑÏπòÎ•º Ï°∞ÏûëÌï† Ïàò ÏûàÎã§Îäî Í≤ÅÎãàÎã§. 
>
> > [!WARNING] PAGE 70: ÌôòÍ≤ΩÍ≥º ÏßàÎ≥ëÏùò Ïó∞Í≤∞Í≥†Î¶¨ (Environment-Disease Link)
> > 70ÌéòÏù¥ÏßÄ, Ïó¨Í∏∞Í∞Ä ÏûÑÏÉÅÏ†ÅÏúºÎ°ú Ï†úÏùº Ï§ëÏöîÌï©ÎãàÎã§. Ïôú ÎÇòÏÅú Í±∞ Î®πÏúºÎ©¥ ÏïîÏóê Í±∏Î¶¥ÍπåÏöî?
> > * **ÏòÅÌñ• ÏöîÏù∏ (Factors):** **Diet(ÏãùÎã®)**, **Aging(ÎÖ∏Ìôî)**, **Drugs**, **Environmental chemicals**, Ïã¨ÏßÄÏñ¥ **Development(Î∞úÎã¨ Í≥ºÏ†ï)**ÍπåÏßÄ. 
> > * **Í∏∞Ï†Ñ:** Ïù¥ ÏöîÏù∏Îì§Ïù¥ **DNA Methylation**Ïù¥ÎÇò **Histone Modification**ÏùÑ Î≥ÄÌôîÏãúÌÇµÎãàÎã§. 
> > * **Í≤∞Í≥º (Health Endpoints):** Ïú†Ï†ÑÏûêÍ∞Ä ÏûòÎ™ª ÏºúÏßÄÍ±∞ÎÇò Í∫ºÏ†∏ÏÑú **Cancer(Ïïî)**, **Autoimmune disease(ÏûêÍ∞ÄÎ©¥Ïó≠ÏßàÌôò)**, **Diabetes(ÎãπÎá®)** Îì±Ïù¥ Î∞úÏÉùÌï©ÎãàÎã§. 
>
> > [!INFO] PAGE 71: Ïú†Ï†ÑÏùò 4Í∞ÄÏßÄ Ï∞®Ïõê (4 Dimensions)
> > 71ÌéòÏù¥ÏßÄ ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏùÄ DNA(Genetic)Î°úÎßå ÎêòÎäî Í≤å ÏïÑÎãôÎãàÎã§. 
> > 1.  **Genetic:** DNA ÏóºÍ∏∞ÏÑúÏó¥.
> > 2.  **Epigenetic:** Chromatin marks, RNA silencing Îì±. (ÏÑ∏Ìè¨ Í∏∞Ïñµ)
> > 3.  **Behavioral:** ÌñâÎèôÏ†Å Ï†ÑÏàò (Îî∞Îùº ÌïòÍ∏∞ Îì±).
> > 4.  **Symbolic:** Ïñ∏Ïñ¥, Î¨∏Ìôî Îì± Ïù∏Í∞Ñ Í≥†Ïú†Ïùò Ï†ÑÏàò.
>
> > [!IMPORTANT] PAGE 72: ÌûàÏä§ÌÜ§ ÎßàÌÅ¨Ïùò Íµ¨Ï≤¥Ï†Å Í∏∞Îä• (Ïã¨Ìôî ‚òÖ)
> > 72ÌéòÏù¥ÏßÄ Ïõê ÏïàÏùò Í∏∞Ìò∏Îì§ÏùÑ Ìï¥ÏÑùÌï¥Ïïº Ìï©ÎãàÎã§. **K(ÎùºÏù¥Ïã†)**Ïóê Î≠êÍ∞Ä Î∂ôÎäêÎÉêÏóê Îî∞Îùº Ïö¥Î™ÖÏù¥ Í∞àÎ¶ΩÎãàÎã§. 
> > * **MeK4 (H3K4me):** Ï£ºÎ°ú **Activation (ÌôúÏÑ±Ìôî)**ÏôÄ Í¥ÄÎ†®Îê©ÎãàÎã§.
> > * **MeK9, MeK27 (H3K9me, H3K27me):** Ï£ºÎ°ú **Repression (ÏñµÏ†ú)**ÏôÄ Í¥ÄÎ†®Îê©ÎãàÎã§. (ÌôîÏÇ¥ÌëúÍ∞Ä ÏñµÏ†ú Î™®ÏñëÏù∏ Í≤É ÌôïÏù∏!) 
> > * **AcK (Acetylation):** Í±∞Ïùò Ìï≠ÏÉÅ **Activation**ÏûÖÎãàÎã§.
> > * **CpG Methylation:** DNA Î©îÌã∏ÌôîÎäî Ï£ºÎ°ú **ÏñµÏ†ú**ÏûÖÎãàÎã§.
> > * Ïù¥Îì§Ïù¥ ÏÑúÎ°ú ÏÉÅÌò∏ÏûëÏö©(Cross-talk)ÌïòÎ©∞ Ï†ïÍµêÌïòÍ≤å Ï°∞Ï†àÌï©ÎãàÎã§.
>
> > [!INFO] PAGE 73: EpigenomeÏùò ÌÜµÌï©Ï†Å ÏúÑÏπò
> > 73ÌéòÏù¥ÏßÄ, Îã§Ïãú ÌïúÎ≤à Ï†ÑÏ≤¥ ÏßÄÎèÑÎ•º Î¥ÖÎãàÎã§.
> > * **Epigenome**ÏùÄ GenomeÍ≥º Transcriptome ÏÇ¨Ïù¥ÏóêÏÑú Ï†ïÎ≥¥Ïùò ÌùêÎ¶ÑÏùÑ ÌÜµÏ†úÌïòÎäî **'Í≤ÄÎ¨∏ÏÜå'** Ïó≠Ìï†ÏùÑ Ìï©ÎãàÎã§. Ïó¨Í∏∞ÏÑú **Tumorigenesis(Ïïî Î∞úÏÉù)** Îì±Ïùò Ïö¥Î™ÖÏù¥ 1Ï∞®Ï†ÅÏúºÎ°ú Í≤∞Ï†ïÎêòÎäî Í≤ÉÏûÖÎãàÎã§. 

> [!NOTE] Pages 74-80: ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïôÏùò ÎèÑÍµ¨ÏôÄ Multi-Omics
> Ïûê, Ïù¥Ï†ú Ïù¥Î°†ÏùÄ Ï∂©Î∂ÑÌï©ÎãàÎã§. Ïã§Ï†úÎ°ú Ïù¥ Î∞©ÎåÄÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïñ¥ÎñªÍ≤å ÎΩëÏïÑÎÇ¥Í≥†(Microarray), Ïñ¥ÎñªÍ≤å Î∂ÑÏÑùÌï¥ÏÑú(AI), ÌôòÏûêÎ•º Î∂ÑÎ•ò(Stratification)ÌïòÎäîÏßÄ, Í∑∏ 'Î¨¥Í∏∞'Îì§ÏùÑ Ï†êÍ≤ÄÌï¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 74: Multi-OmicsÏôÄ AIÏùò Í≤∞Ìï© (ÏïåÍ≥†Î¶¨Ï¶ò Ï≤¥ÌÅ¨)
> > 74ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ Ï†ïÎ∞ÄÏùòÌïôÏùò 'Ï†ÑÌà¨ ÏßÄÎèÑ'ÏûÖÎãàÎã§. 
> > * **Multi-Omics:** Genome, Epigenome, Transcriptome, Proteome, MetabolomeÏùÑ Ï†ÑÎ∂Ä Ìï©Ïπ©ÎãàÎã§.
> > * **AI & Machine Learning:** Ïù¥ Îç∞Ïù¥ÌÑ∞Î•º ÏÇ¨ÎûåÏù¥ ÎààÏúºÎ°ú Î™ª Î¥ÖÎãàÎã§. AIÍ∞Ä ÌïÑÏöîÌïòÏ£†. Ïó¨Í∏∞Ïóê Ïì∞Ïù¥Îäî ÏïåÍ≥†Î¶¨Ï¶ò Ïù¥Î¶ÑÎì§ÏùÑ Íº≠ ÎààÏó¨Í≤®Î≥¥ÏÑ∏Ïöî.
> >     * **SVM (Support Vector Machine)** 
> >     * **DT (Decision Tree)** 
> >     * **RF (Random Forest)** 
> >     * **LightGBM:** ÏµúÍ∑º Îç∞Ïù¥ÌÑ∞ Î∂ÑÏÑù ÎåÄÌöåÏóêÏÑú ÎßéÏù¥ Ïì∞Ïù¥Îäî Í∞ïÎ†•Ìïú Î∂ÄÏä§ÌåÖ Î™®Îç∏ÏûÖÎãàÎã§. 
> >     * **Deep Learning (Îî•Îü¨Îãù):** Ïù¥ÎØ∏ÏßÄÎÇò ÎπÑÏ†ïÌòï Îç∞Ïù¥ÌÑ∞ Î∂ÑÏÑùÏóê Í∞ïÌïòÏ£†. 
> > * **Í≥ºÏ†ï:** Îç∞Ïù¥ÌÑ∞ ÌÜµÌï©(Data Integration) ‚Üí ÌäπÏßï ÏÑ†ÌÉù(Feature Selection) ‚Üí ÏòàÏ∏°(Prediction).
>
> > [!INFO] PAGE 75-76: ÌôòÏûê Ï∏µÌôî (Stratification)ÏôÄ Omics Ï†ïÏùò
> > 75ÌéòÏù¥ÏßÄ, ÏïåÎ°ùÎã¨Î°ùÌïú ÏÇ¨Îûå Í∑∏Î¶º Î≥¥Ïù¥Ï£†? 
> > * Í≥ºÍ±∞Ïóî Îã§ ÎòëÍ∞ôÏùÄ ÏÇ¨Îûå(Average patient) Ï∑®Í∏âÌñàÏßÄÎßå, Ïù¥Ï†úÎäî Îç∞Ïù¥ÌÑ∞Î•º ÌÜµÌï¥ **"Stratification(Ï∏µÌôî)"**Ìï©ÎãàÎã§. Í∑∏Î£πÏùÑ ÎÇòÎààÎã§Îäî ÎúªÏûÖÎãàÎã§. Í∑∏ÎûòÏïº **High effective treatment**Í∞Ä Í∞ÄÎä•ÌïòÎãàÍπåÏöî.
> >
> > 76ÌéòÏù¥ÏßÄ, Ïö©Ïñ¥ Ï†ïÎ¶¨ÌïòÍ≥† Í∞ëÏãúÎã§. 
> > * **Omics:** "-ome"ÏùÄ Ï†ÑÏ≤¥(Complete knowledge)Î•º ÎúªÌï©ÎãàÎã§.
> > * **Transcriptomics:** RNA Ï†ÑÏ≤¥.
> > * **Proteomics:** Îã®Î∞±Ïßà Ï†ÑÏ≤¥.
> > * **Metabolomics:** ÎåÄÏÇ¨Î¨ºÏßà Ï†ÑÏ≤¥.
>
> > [!IMPORTANT] PAGE 77-79: DNA Microarray ÏõêÎ¶¨ (ÏÉÅÏÑ∏ Ïä§Ìéô ÏïîÍ∏∞)
> > 77ÌéòÏù¥ÏßÄ, Ïù¥Í≤å Î∞îÎ°ú ÏàòÎßå Í∞úÏùò Ïú†Ï†ÑÏûêÎ•º Ìïú Î∞©Ïóê Í≤ÄÏÇ¨ÌïòÎäî **DNA Microarray** Ïπ©ÏûÖÎãàÎã§. ÏàòÏπòÎ•º Î≥¥ÏÑ∏Ïöî.
> > * **ÌÅ¨Í∏∞:** Ï†ÑÏ≤¥ Ïπ©ÏùÄ **3cm x 7cm** Ï†ïÎèÑÏûÖÎãàÎã§. Ïä¨ÎùºÏù¥Îìú Í∏ÄÎùºÏä§ ÌÅ¨Í∏∞Ï£†. 
> > * **Spot:** Í∑∏ ÏïàÏóê ÏûëÏùÄ Ï†êÎì§Ïù¥ Ï∞çÌòÄ ÏûàÎäîÎç∞, Í∞Å Ï†êÏùò ÏßÄÎ¶ÑÏùÄ **150¬µm**, Ï†ê ÏÇ¨Ïù¥ Í∞ÑÍ≤©ÏùÄ **300¬µm**ÏûÖÎãàÎã§. 
> > * **ÏõêÎ¶¨:**
> >     1.  Ïπ© ÏúÑÏóê **Probe DNA(ÌÉêÏπ®)**Î•º ÎØ∏Î¶¨ Ïã¨Ïñ¥ÎÜìÏäµÎãàÎã§. (ÏàòÎßå Í∞ú) 
> >     2.  ÌôòÏûêÏùò ÏÉòÌîå(RNA)ÏùÑ Ïó≠Ï†ÑÏÇ¨Ìï¥ÏÑú **Fluorescent tagging(ÌòïÍ¥ë ÌëúÏßÄ)**ÏùÑ Î∂ôÏù∏ DNA(cDNA)Î°ú ÎßåÎì≠ÎãàÎã§. 
> >     3.  Ïπ© ÏúÑÏóê ÎøåÎ¶¨Î©¥, Ïßù(ÏÉÅÎ≥¥Ï†Å ÏÑúÏó¥)Ïù¥ ÎßûÎäî Í≤ÉÎÅºÎ¶¨ Îì§Îü¨Î∂ôÏäµÎãàÎã§. Ïù¥Í±∏ **Hybridization(ÌòºÏÑ±Ìôî)**Ïù¥ÎùºÍ≥† Ìï©ÎãàÎã§. 
> > * **Ìï¥ÏÑù (78p):** 
> >     * ÌäπÏ†ï ÏÉâÍπî(Î≥¥ÌÜµ Îπ®Í∞ï/Ï¥àÎ°ù)Ïù¥ ÎπõÎÇòÎ©¥ Í∑∏ Ïú†Ï†ÑÏûêÍ∞Ä Î∞úÌòÑÎêú Í≤ÉÏûÖÎãàÎã§.
> >     * Îëê ÏÉâÏù¥ ÏÑûÏó¨(ÎÖ∏Îûë) ÎÇòÏò§Î©¥ Îëò Îã§ ÏûàÎäî Í±∞Í≥†Ïöî.
> 
>
> > [!INFO] PAGE 80: HeatmapÍ≥º Ï¢ÖÏñë Î∂ÑÎ•ò (Taxonomy)
> > 80ÌéòÏù¥ÏßÄ, ÎßàÏπò Î™®ÏûêÏù¥ÌÅ¨ Í∞ôÏùÄ Í∑∏Î¶ºÏù¥ **Heatmap**ÏûÖÎãàÎã§. 
> > * **Í∞ÄÎ°úÏ§Ñ:** Ïú†Ï†ÑÏûê ÌïòÎÇòÌïòÎÇò.
> > * **ÏÑ∏Î°úÏ§Ñ:** ÌôòÏûê Ìïú Î™Ö Ìïú Î™Ö.
> > * **ÏÉâÍπî:** Îπ®Í∞ÑÏÉâÏùÄ Î∞úÌòÑ ÎÜíÏùå(High), Ï¥àÎ°ùÏÉâÏùÄ ÎÇÆÏùå(Low)ÏùÑ Ï£ºÎ°ú ÎÇòÌÉÄÎÉÖÎãàÎã§.
> > * **Dendrogram (ÎÇòÎ≠áÍ∞ÄÏßÄ Í∑∏Î¶º):** ÏúÑÏ™ΩÏóê ÏûàÎäî Í∞ÄÏßÄ Í∑∏Î¶ºÏûÖÎãàÎã§. Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥Ïù¥ ÎπÑÏä∑Ìïú ÌôòÏûêÎÅºÎ¶¨ Î¨∂Ïñ¥Ï§çÎãàÎã§(Clustering).
> > * **Í≤∞Í≥º:** ÌôòÏûêÎì§Ïù¥ **A, B, C, D** ÎÑ§ Í∞ÄÏßÄ Í∑∏Î£π(Tumor classes)ÏúºÎ°ú ÍπîÎÅîÌïòÍ≤å ÎÇòÎâòÎäî Í±∞ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å Î∞îÎ°ú Ï†ïÎ∞ÄÏùòÌïôÏùò ÏãúÏûëÏûÖÎãàÎã§.

> [!NOTE] Pages 81-89: ÎÑ§Ìä∏ÏõåÌÅ¨ ÎèôÏó≠Ìïô (Network Dynamics)
> Ïûê, ÏßÄÍ∏àÍπåÏßÄ Î∞∞Ïö¥ Ïú†Ï†ÑÏûê, Îã®Î∞±Ïßà, ÎåÄÏÇ¨Ï≤¥Îì§ÏùÑ Îã§ Ïó∞Í≤∞ÌïòÎ©¥ Ïñ¥ÎñªÍ≤å Îê†ÍπåÏöî? Îã®ÏàúÌïú ÏÑ†(Line)Ïù¥ ÏïÑÎãàÎùº Î≥µÏû°Ìïú **ÎÑ§Ìä∏ÏõåÌÅ¨(Network)**Í∞Ä Îê©ÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ ÎÑ§Ìä∏ÏõåÌÅ¨Ïùò ÏõÄÏßÅÏûÑÏùÑ ÏàòÌïôÏ†ÅÏúºÎ°ú ÌëúÌòÑÌïú Í≤ÉÏù¥ Î∞îÎ°ú **State Space(ÏÉÅÌÉú Í≥µÍ∞Ñ)**ÏûÖÎãàÎã§. Ïù¥ Í∞úÎÖêÏùÑ Ïù¥Ìï¥Ìï¥Ïïº "ÏÑ∏Ìè¨Í∞Ä Î∂ÑÌôîÌïúÎã§"Îäî ÎßêÏùò ÏßÑÏßú ÏùòÎØ∏Î•º ÏïåÍ≤å Îê©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 81: Ï¢ÖÏñëÏùò Ïù¥ÏßàÏÑ± (Tumor Heterogeneity)
> > 81ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Ïïî Îç©Ïñ¥Î¶¨Í∞Ä Îã§ ÎòëÍ∞ôÏùÄ ÏÑ∏Ìè¨Í∞Ä ÏïÑÎãàÎùºÎäî Ï¶ùÍ±∞ÏûÖÎãàÎã§. 
> > * **Clonal Evolution:**
> >     * **Monoclonal:** ÌïòÎÇòÏùò Ï°∞ÏÉÅÏóêÏÑú ÏãúÏûëÌï¥ ÎπÑÏä∑ÌïòÍ≤å ÏûêÎûå.
> >     * **Polyclonal:** Ïó¨Îü¨ Ï°∞ÏÉÅÏù¥ ÏÑûÏó¨ÏÑú ÏïÑÏ£º Îã§ÏñëÌïú(Polygenomic) Ïïî Ï°∞ÏßÅÏùÑ ÌòïÏÑ±. ÏπòÎ£åÍ∞Ä Ïñ¥Î†µÍ≤†Ï£†?
> > * **Cancer Stem Cells (Ïïî Ï§ÑÍ∏∞ÏÑ∏Ìè¨):**
> >     * **Single vs Multiple progenitors:** Ï§ÑÍ∏∞ÏÑ∏Ìè¨ ÌïòÎÇòÏóêÏÑú ÏôîÎÉê, Ïó¨Îü¨ Í∞úÏóêÏÑú ÏôîÎÉêÏóê Îî∞Îùº ÏïîÏùò Î≥µÏû°ÎèÑÍ∞Ä Îã¨ÎùºÏßëÎãàÎã§.
> > * **Í≤∞Î°†:** ÏïîÏùÄ **Polygenomic Tumor**Ïù∏ Í≤ΩÏö∞Í∞Ä ÎßéÏïÑÏÑú, ÏïΩ ÌïòÎÇòÎ°ú(One target) ÏôÑÏπòÍ∞Ä ÌûòÎì† Í≤ÅÎãàÎã§.
>
> > [!INFO] PAGE 82-84: Pathway vs Network View
> > 84ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏù¥ ÌïµÏã¨ÏûÖÎãàÎã§. Í¥ÄÏ†êÏùÑ Î∞îÍæ∏ÏÑ∏Ïöî. 
> > * **Pathway View (A):** $X1 \rightarrow X2$. ÏÑ†ÌòïÏ†ÅÏù¥Í≥† Îã®ÏàúÌï©ÎãàÎã§. "AÏù¥Î©¥ BÎã§"ÎùºÎäî ÏãùÏù¥Ï£†.
> > * **Network View (B):** $X1$Í≥º $X2$Í∞Ä Í±∞ÎåÄÌïú Í±∞ÎØ∏Ï§ÑÏùò ÏùºÎ∂ÄÏùº ÎøêÏûÖÎãàÎã§. $X1$ÏùÑ Í±¥ÎìúÎ¶¨Î©¥ $X2$Îßå Î≥ÄÌïòÎäî Í≤å ÏïÑÎãàÎùº ÎÑ§Ìä∏ÏõåÌÅ¨ Ï†ÑÏ≤¥Í∞Ä Ï∂úÎ†ÅÍ±∞Î¶ΩÎãàÎã§. Ïù¥Í≤å ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïôÏùò Í¥ÄÏ†êÏûÖÎãàÎã§.
> > * 83ÌéòÏù¥ÏßÄÏùò Î≥µÏû°Ìïú ÌôîÏÇ¥Ìëú(Activation/Inhibition)Îì§Ïù¥ Î™®Ïó¨ÏÑú Ïù¥ ÎÑ§Ìä∏ÏõåÌÅ¨Î•º ÎßåÎì≠ÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 85: 3Í≥ÑÏ∏µ ÌÜµÌï© Í≥µÍ∞Ñ (Space Integration)
> > 85ÌéòÏù¥ÏßÄ, 3Í∞úÏùò Ìåê(Layer)Ïù¥ Í≤πÏ≥êÏ†∏ ÏûàÏ£†? 
> > 1.  **Gene Space (Ïú†Ï†ÑÏûê Í≥µÍ∞Ñ):** Gene 1, 2, 3...
> > 2.  **Protein Space (Îã®Î∞±Ïßà Í≥µÍ∞Ñ):** Protein 1, 2, 3...
> > 3.  **Metabolic Space (ÎåÄÏÇ¨ Í≥µÍ∞Ñ):** Metabolite 1, 2...
> > * **Feedback:** Îß® Ïò§Î•∏Ï™Ω ÌôîÏÇ¥ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. **Metabolite 2**Í∞Ä Îã§Ïãú **Gene 4**Ïùò Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌïòÎü¨ ÎÇ¥Î†§Í∞ëÎãàÎã§. Ïù¥Î†áÍ≤å Ï∏µÍ∞Ñ ÏÜåÌÜµÏù¥ ÌôúÎ∞úÌï©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 86-87: ÏÉÅÌÉú Î≤°ÌÑ∞ÏôÄ ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space) - ‚òÖÍ∞úÎÖê ÌïÑÏäπ
> > Ïûê, Ïó¨Í∏∞ ÏßëÏ§ëÌïòÏÑ∏Ïöî. ÏÑ∏Ìè¨Ïùò ÏÉÅÌÉúÎ•º ÏàòÌïôÏúºÎ°ú Ï†ïÏùòÌï©ÎãàÎã§.
> >
> > **1. ÏÉÅÌÉú Î≤°ÌÑ∞ (State Vector, 86p):**
> > * Ïú†Ï†ÑÏûê $N$Í∞úÏùò Î∞úÌòÑÎüâÏùÑ Ïà´ÏûêÎ°ú Ï≠â ÎÇòÏó¥Ìïú Í≤ÅÎãàÎã§. 
> > * Ïãù: $$S = [x_1, x_2, ..., x_N]$$ (Ïòà: $x_1$ÏùÄ Ïú†Ï†ÑÏûê 1Ïùò Î∞úÌòÑÎüâ)
> >
> > **2. ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space, 87p):**
> > * 87ÌéòÏù¥ÏßÄÏùò ÌÅêÎ∏å(Cube) Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. 
> > * **Ï∂ï (Axis):** Í∞Å Ïú†Ï†ÑÏûê($X_1, X_2, X_3$)Í∞Ä $x, y, z$ Ï∂ïÏù¥ Îê©ÎãàÎã§.
> > * **Ï†ê (Point):** ÌäπÏ†ï ÏãúÏ†ê($t_1$)Ïùò ÏÑ∏Ìè¨ ÏÉÅÌÉú($S_1$)Îäî Ïù¥ Í≥µÍ∞Ñ ÏïàÏùò **'Ï†ê ÌïòÎÇò'**Î°ú Ï∞çÌûôÎãàÎã§. (Ïòà: $[3.0, 3.0, 3.0]$)
> > * **Í∂§Ï†Å (Trajectory):** ÏãúÍ∞ÑÏù¥ ÏßÄÎÇ®Ïóê Îî∞Îùº ÏÑ∏Ìè¨Ïùò Ïú†Ï†ÑÏûê Î∞úÌòÑÏù¥ Î≥ÄÌïòÏ£†? Ï†êÏù¥ Ïù¥ÎèôÌïòÎ©¥ÏÑú Í∑∏Î¶¨Îäî ÏÑ†ÏûÖÎãàÎã§.
> > * **Attractor (ÎÅåÍ∞ú):** Îπ®Í∞Ñ Ï†ê($S^*$)ÏùÑ Î≥¥ÏÑ∏Ïöî. Ï†êÎì§Ïù¥ Í≤∞Íµ≠ Ïñ¥ÎîîÎ°ú Î™®Ïù¥ÎÇòÏöî? ÏïàÏ†ïÏ†ÅÏù∏ ÏÉÅÌÉúÎ°ú ÏàòÎ†¥ÌïòÏ£†? Ïù¥ ÎèÑÏ∞©Ï†êÏù¥ Î∞îÎ°ú **"ÏÑ∏Ìè¨ ÌÉÄÏûÖ(Cell Type)"**ÏûÖÎãàÎã§.
> >     * "Ï§ÑÍ∏∞ÏÑ∏Ìè¨Í∞Ä Î∂ÑÌôîÌï¥ÏÑú ÌîºÎ∂ÄÏÑ∏Ìè¨Í∞Ä ÎêêÎã§" = "ÏÉÅÌÉú Í≥µÍ∞ÑÏóêÏÑú Ï†êÏù¥ Ïù¥ÎèôÌï¥ ÌîºÎ∂ÄÏÑ∏Ìè¨ÎùºÎäî AttractorÏóê Îπ†Ï°åÎã§."
>
> > [!INFO] PAGE 88-89: WaddingtonÏùò ÌíçÍ≤Ω (Epigenetic Landscape) ÏàòÌïôÏ†Å Ìï¥ÏÑù
> > 89ÌéòÏù¥ÏßÄ, ÏïÑÍπå Î≥∏ Í≥µ Íµ¥Îü¨Í∞ÄÎäî Í∑∏Î¶ºÏùÑ Îã§Ïãú ÏàòÌïôÏ†ÅÏúºÎ°ú Î¥ÖÎãàÎã§. 
> > * **Basin of attraction (ÎÅåÍ∞ú Ïú†Ïó≠):** Í≥µÏù¥ Íµ¥Îü¨ Îñ®Ïñ¥ÏßÄÎäî Í≥®ÏßúÍ∏∞ÏûÖÎãàÎã§.
> > * **Quasi-potential U:** ÏóêÎÑàÏßÄ Ï§ÄÏúÑ Í∞ôÏùÄ Í≤ÅÎãàÎã§. ÎÇÆÏùÑÏàòÎ°ù ÏïàÏ†ïÏ†ÅÏù¥Ï£†.
> > * **Attractors:** Í≥®ÏßúÍ∏∞ Î∞îÎã•. Ïó¨Í∏∞Ïóê ÏïàÏ∞©ÌïòÎ©¥ **Mature cell types (ÏÑ±Ïàô ÏÑ∏Ìè¨)**Í∞Ä ÎêòÎäî Í≤ÅÎãàÎã§.
> > * **Unused attractors:** ÏßÑÌôîÏ†ÅÏúºÎ°ú ÏµúÏ†ÅÌôîÎêòÏßÄ ÏïäÏùÄ, Î≤ÑÎ†§ÏßÑ ÏõÖÎç©Ïù¥Îì§ÎèÑ Ï°¥Ïû¨Ìï† Ïàò ÏûàÏäµÎãàÎã§. (ÏïîÏÑ∏Ìè¨Í∞Ä Ïó¨Í∏∞Î°ú Í∞à ÏàòÎèÑ ÏûàÏ£†)

> [!NOTE] Pages 90-97: ÎÑ§Ìä∏ÏõåÌÅ¨ ÏùòÌïôÍ≥º Ïã†ÏïΩ Í∞úÎ∞ú (Network Medicine)
> Ïûê, Ïù¥Ï†ú Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨ Ïù¥Î°†Ïù¥ Ïã§Ï†ú ÌôòÏûêÎ•º ÏÇ¥Î¶¨Îäî Í∏∞Ïà†Î°ú Î∞îÎÄùÎãàÎã§. ÌôòÏûêÏùò Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥(Signature)Îßå Î≥¥Í≥†ÎèÑ "Ïù¥ ÌôòÏûêÎäî 5ÎÖÑ Îí§Ïóê ÏÉùÏ°¥Ìï† ÌôïÎ•†Ïù¥ ÎÜíÎã§/ÎÇÆÎã§"Î•º ÎßûÏ∂îÍ≥†, ÎÑ§Ìä∏ÏõåÌÅ¨Ïùò ÌäπÏ†ï Î∂ÄÏúÑÎßå Í≥µÍ≤©ÌïòÎäî Ï†ïÎ∞Ä ÌÉÄÍ≤© ÏïΩÎ¨ºÏùÑ Í∞úÎ∞úÌïòÎäî Í≥ºÏ†ïÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 90: ÏòàÌõÑ ÏòàÏ∏° Î™®Îç∏ (Survival Prediction) - ‚òÖÏûÑÏÉÅ ÌïÑÏàò
> > 90ÌéòÏù¥ÏßÄ Í∑∏Î¶º, Î≥ëÏõêÏóêÏÑú Îß§Ïùº Î≥¥Îäî Îç∞Ïù¥ÌÑ∞ÏûÖÎãàÎã§. Ìï¥ÏÑùÌï† Ï§Ñ ÏïåÏïÑÏïº Ìï©ÎãàÎã§. 
> > 1.  **Heatmap (Ï¢åÏ∏°):** 70Í∞úÏùò **Reporter genes** Î∞úÌòÑ Ìå®ÌÑ¥ÏùÑ Î∂ÑÏÑùÌñàÎçîÎãà, ÌôòÏûêÎì§Ïù¥ Îëê Í∑∏Î£πÏúºÎ°ú ÎÇòÎâ©ÎãàÎã§.
> >     * **Good signature:** ÏòàÌõÑÍ∞Ä Ï¢ãÏùÄ Ìå®ÌÑ¥.
> >     * **Poor signature:** ÏòàÌõÑÍ∞Ä ÎÇòÏÅú Ìå®ÌÑ¥.
> > 2.  **Survival Curve (Ïö∞Ï∏° Í∑∏ÎûòÌîÑ):** Ïù¥Í≤å Í∑∏ Ïú†Î™ÖÌïú **Ïπ¥ÌîåÎûÄ-ÎßàÏù¥Ïñ¥(Kaplan-Meier) ÏÉùÏ°¥ Í≥°ÏÑ†**ÏûÖÎãàÎã§.
> >     * **XÏ∂ï:** ÏãúÍ∞Ñ(Years).
> >     * **YÏ∂ï:** Ï†ÑÏ≤¥ ÏÉùÏ°¥Ïú®(Overall survival, 1.0 = 100%).
> >     * **Ìï¥ÏÑù:** **Poor signature(Îπ®Í∞Ñ ÏÑ†)** ÌôòÏûêÎì§ÏùÄ 2~4ÎÖÑ ÏÇ¨Ïù¥Ïóê Í∏âÍ≤©Ìûà ÏÇ¨ÎßùÌïòÏó¨ ÏÉùÏ°¥Ïú®Ïù¥ 0.2(20%) Î∞ëÏúºÎ°ú Îñ®Ïñ¥ÏßëÎãàÎã§. Î∞òÎ©¥ **Good signature(ÌååÎûÄ ÏÑ†)**Îäî 10ÎÖÑÏù¥ ÏßÄÎÇòÎèÑ ÏÉùÏ°¥Ïú®Ïù¥ ÎÜíÏäµÎãàÎã§.
> >     * **ÏùòÏùò:** "ÎãπÏã†ÏùÄ Poor signatureÎãà Îçî Í≥µÍ≤©Ï†ÅÏù∏ Ìï≠ÏïîÏ†úÎ•º ÏîÅÏãúÎã§"ÎùºÎäî **Clinically useful prediction(ÏûÑÏÉÅÏ†Å ÌåêÎã®)**Ïù¥ Í∞ÄÎä•Ìï¥ÏßëÎãàÎã§.
>
> > [!INFO] PAGE 92-93: ÎÑ§Ìä∏ÏõåÌÅ¨ ÏùòÌïôÏùò Ï†ïÏùò
> > 92ÌéòÏù¥ÏßÄ, **Network Medicine**Ïù¥ÎûÄ? 
> > * Ïù∏Íµ¨ ÏßëÎã®(Population)Ïùò ÍπäÏùÄ ÌëúÌòÑÌòï(Deep phenotyping) Îç∞Ïù¥ÌÑ∞Î•º Î™®ÏïÑÏÑú, Í∞úÏù∏Îì§ÏùÑ **ÎÑ§Ìä∏ÏõåÌÅ¨ ÏßÄÌëú(Network metrics)**Ïóê Îî∞Îùº ÌÅ¥Îü¨Ïä§ÌÑ∞ÎßÅ(Cluster)ÌïòÎäî Í≤ÅÎãàÎã§.
> > * **Ìå®Îü¨Îã§ÏûÑ Î≥ÄÌôî (93p):** 
> >     * Í≥ºÍ±∞: **Average patient (ÌèâÍ∑† ÌôòÏûê)**Î•º ÏúÑÌïú ÏïΩ. (Ïûò Ïïà Îì£Í±∞ÎÇò Î∂ÄÏûëÏö©)
> >     * ÌòÑÏû¨: ÌôòÏûêÏùò **Genetics, Microbes, Chemical composition**Ïóê Îî± ÎßûÏ∂ò(Tailored) ÏïΩ.
>
> > [!IMPORTANT] PAGE 94-97: ÎÑ§Ìä∏ÏõåÌÅ¨ Í∏∞Î∞ò Ïã†ÏïΩ Í∞úÎ∞ú (Network-based Drug Discovery)
> > 94ÌéòÏù¥ÏßÄÎ∂ÄÌÑ∞Îäî Ïã†ÏïΩ Í∞úÎ∞ú ÌîÑÎ°úÏÑ∏Ïä§ÏûÖÎãàÎã§.
> > * **Îç∞Ïù¥ÌÑ∞ ÌÜµÌï© (94p):** DNA/RNA Î≥ÄÏù¥, Îã®Î∞±Ïßà(Proteomics), ÎåÄÏÇ¨Ï≤¥(Metabolite), ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞(Clinical data), Î¨∏Ìóå(Literature)ÏùÑ Îã§ ÏÑûÏñ¥ÏÑú Í±∞ÎåÄÌïú ÌîåÎû´ÌèºÏùÑ ÎßåÎì≠ÎãàÎã§. 
> >
> > * **ÎÑ§Ìä∏ÏõåÌÅ¨ ÌÉÄÍ≤üÌåÖ (95-97p):** Ïù¥ Í∑∏Î¶ºÏùÑ Ïûò Î≥¥ÏÑ∏Ïöî. 
> >     * Ï†ÑÏ≤¥ ÎÑ§Ìä∏ÏõåÌÅ¨ ÏïàÏóê **Disease subtype 1** (ÌååÎûÄÏÉâ ÏòÅÏó≠)Í≥º **Disease subtype 2** (Ï¥àÎ°ùÏÉâ ÏòÅÏó≠)Í∞Ä ÏÑúÎ°ú Îã§Î•∏ ÏúÑÏπòÏóê Ï°¥Ïû¨Ìï©ÎãàÎã§. Ï¶â, Í∞ôÏùÄ Î≥ëÏù¥ÎùºÎèÑ Î∞úÎ≥ë Í∏∞Ï†Ñ(ÎÑ§Ìä∏ÏõåÌÅ¨ Î™®Îìà)Ïù¥ Îã§Î¶ÖÎãàÎã§.
> >     * **Toxicity (ÎèÖÏÑ±):** Îπ®Í∞ÑÏÉâ ÏòÅÏó≠ÏùÄ Í±¥ÎìúÎ¶¨Î©¥ Ïïà ÎêòÎäî Ï§ëÏöîÌïú ÏÉùÎ™Ö Ïú†ÏßÄ Í∏∞Îä•(Ïòà: Ïã¨Ïû• Î∞ïÎèô)Ïùº Ïàò ÏûàÏäµÎãàÎã§.
> >     * **Screening:** **High-throughput screening**ÏùÑ ÌÜµÌï¥ ÏàòÎßå Í∞ÄÏßÄ ÌôîÌï©Î¨ºÏùÑ ÎøåÎ†§Î¥ÖÎãàÎã§.
> >     * **Î™©Ìëú:** Îπ®Í∞ÑÏÉâ(ÎèÖÏÑ±)ÏùÄ ÌîºÌïòÍ≥†, ÎÇ¥ ÌôòÏûêÏùò ÌÉÄÏûÖ(Ïòà: Subtype 2)Ïóê Ìï¥ÎãπÌïòÎäî ÎÑ§Ìä∏ÏõåÌÅ¨Îßå Ï†ïÌôïÌûà ÌÉÄÍ≤©ÌïòÎäî ÏïΩÎ¨ºÏùÑ Ï∞æÎäî Í≤ÉÏûÖÎãàÎã§.

> [!NOTE] Pages 98-113: ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨ÏôÄ ÎîîÏßÄÌÑ∏ Ìó¨Ïä§Ïùò ÎØ∏Îûò
> Ïûê, Ïù¥Ï†ú ÎßàÏßÄÎßâ ÌçºÏ¶êÏùÑ ÎßûÏ∂•ÏãúÎã§. Íµ¨Í∏Ä ÎßµÏù¥ Ïó¨Îü¨ Î†àÏù¥Ïñ¥(ÍµêÌÜµ, ÏúÑÏÑ±, ÏßÄÎèÑ)Î•º Í≤πÏ≥êÏÑú Í∏∏ÏùÑ Î≥¥Ïó¨Ï£ºÎìØ, Ïö∞Î¶¨ Î™∏Ïùò Îç∞Ïù¥ÌÑ∞ÎèÑ Í≤πÏ≥êÏïº Î≥¥ÏûÖÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ Î™®Îì† Í≤ÉÏù¥ IT Í∏∞Ïà†(IoMT)Í≥º Í≤∞Ìï©ÌïòÏó¨ ÏßÑÏ†ïÌïú **'ÌôòÏûê Ï§ëÏã¨ ÏùòÎ£å'**Í∞Ä ÏôÑÏÑ±ÎêòÎäî Í≤ÉÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 98-99: Íµ¨Í∏Ä ÎßµÍ≥º ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨ (Analogy)
> > 98ÌéòÏù¥ÏßÄ, ÏïÑÏ£º ÌõåÎ•≠Ìïú ÎπÑÏú†Í∞Ä ÎÇòÏòµÎãàÎã§. 
> > * **Google Maps:** ÏßÄÎ¶¨Ï†Å ÏúÑÏπò(Geographical Positioning)Î•º Ï§ëÏã¨ÏúºÎ°ú ÍµêÌÜµ, Í±¥Î¨º, ÏúÑÏÑ± ÏÇ¨ÏßÑ Îì± Ïó¨Îü¨ Ï∏µ(Layers)Ïùò Ï†ïÎ≥¥Î•º Í≤πÏ≥êÏÑú Î≥¥Ïó¨Ï§çÎãàÎã§.
> > * **Information Commons (ÏùòÎ£å Ï†ïÎ≥¥ Í≥µÏú†ÏßÄ):** ÎßàÏ∞¨Í∞ÄÏßÄÏûÖÎãàÎã§. **"Í∞úÎ≥Ñ ÌôòÏûê(Individual Patients)"**Î•º Ï§ëÏã¨ÏúºÎ°ú Îã§Ïùå Ï†ïÎ≥¥Îì§ÏùÑ Í≤πÏ≥êÏïº Ìï©ÎãàÎã§.
> >     * **Signs and Symptoms (Ï¶ùÏÉÅ)**
> >     * **Exposome (ÌôòÍ≤Ω ÎÖ∏Ï∂ú)**
> >     * **Genome (Ïú†Ï†ÑÏûê)**
> >     * **Epigenome & Microbiome**
> > * **Í≤∞Î°†:** ÌôòÏûê Ìïú Î™Ö Ìïú Î™ÖÏù¥ ÎßàÏπò Íµ¨Í∏Ä ÎßµÏùò Ï¢åÌëúÏ≤òÎüº, Î™®Îì† Ï†ïÎ≥¥Í∞Ä ÌÜµÌï©Îêú **ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨**Ïùò Ï§ëÏã¨Ïù¥ Îê©ÎãàÎã§.
> 
>
> > [!IMPORTANT] PAGE 100: ÏóëÏä§Ìè¨Ï¢Ä (Exposome) - ÌôòÍ≤ΩÏùò Ï†ïÎüâÌôî (‚òÖ)
> > 100ÌéòÏù¥ÏßÄ, ÌôòÍ≤Ω(Environment)ÏùÑ Îú¨Íµ¨Î¶Ñ Ïû°Îäî ÏñòÍ∏∞Í∞Ä ÏïÑÎãàÎùº Í≥ºÌïôÏ†ÅÏúºÎ°ú Ï†ïÏùòÌï©ÎãàÎã§. Ïù¥Í≤å **Exposome**ÏûÖÎãàÎã§. 
> > * **Ï†ïÏùò:** ÎÇ¥Î∂Ä ÌôîÌïô ÌôòÍ≤Ω(Internal chemical environment)Ïóê ÎèÑÎã¨ÌïòÎäî **Î™®Îì† ÎÖ∏Ï∂úÏùò Ï¥ùÌï©**ÏûÖÎãàÎã§.
> > * **Íµ¨ÏÑ± ÏöîÏÜå:**
> >     * **External (Ïô∏Î∂Ä):** Stress, Lifestyle, Drugs, Diet, Pollution Îì±.
> >     * **Internal (ÎÇ¥Î∂Ä):** Xenobiotics(Ïù¥Î¨ºÏßà), Inflammation(ÏóºÏ¶ù), Oxidative stress(ÏÇ∞Ìôî Ïä§Ìä∏Î†àÏä§), **Gut flora(Ïû•ÎÇ¥ ÎØ∏ÏÉùÎ¨º)**.
> > * **Í≤ÄÏ∂ú:** Ïù¥Îü∞ ÏöîÏù∏Îì§ÏùÄ ÌòàÏï°Ïù¥ÎÇò ÌòàÏ≤≠(Blood or serum)ÏóêÏÑú **Biomarkers(ÏÉùÏ≤¥ÌëúÏßÄÏûê)**Î°ú Í≤ÄÏ∂ú Í∞ÄÎä•Ìï©ÎãàÎã§. Ï¶â, "Ïä§Ìä∏Î†àÏä§ Î∞õÏïòÎã§"Í∞Ä ÏïÑÎãàÎùº "Ïä§Ìä∏Î†àÏä§ ÎßàÏª§ ÏàòÏπòÍ∞Ä XÎã§"ÎùºÍ≥† ÎßêÌï† Ïàò ÏûàÍ≤å Îêú Í±∞Ï£†.
>
> > [!INFO] PAGE 101-104: ÏÉàÎ°úÏö¥ Î∂ÑÎ•ò Ï≤¥Í≥Ñ (Taxonomy)
> > Ïù¥ Ïä¨ÎùºÏù¥ÎìúÎì§ÏùÄ ÌùêÎ¶ÑÎßå Î≥¥Î©¥ Îê©ÎãàÎã§. 
> > * **Information Commons:** ÌôòÏûêÎì§Ïùò Îç∞Ïù¥ÌÑ∞Í∞Ä Î™®Ïó¨ Í≥µÏú†ÏßÄÎ•º ÌòïÏÑ±ÌïòÍ≥†,
> > * **Taxonomic classification:** Í≥ºÍ±∞Ïùò 'Ï¶ùÏÉÅ' Í∏∞Î∞ò Î∂ÑÎ•òÍ∞Ä ÏïÑÎãàÎùº, Î∂ÑÏûêÏ†Å ÏõêÏù∏Ïóê Í∏∞Î∞òÌïú **'ÏßàÎ≥ë Î∂ÑÎ•ò(Taxonomy)'**Í∞Ä ÏÉàÎ°ú Ïì∞Ïù¥Í≤å Îê©ÎãàÎã§. (Ïòà: ÌèêÏïî 1Í∏∞Í∞Ä ÏïÑÎãàÎùº, EGFR Î≥ÄÏù¥ ÏñëÏÑ± ÌèêÏïî)
> > * **Knowledge network-based medicine:** Í≤∞Íµ≠ Î™®Îì† ÏπòÎ£åÎäî Ïù¥ ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨Ïóê Í∏∞Î∞òÌïòÍ≤å Îê©ÎãàÎã§.
>
> > [!INFO] PAGE 105-113: ÎîîÏßÄÌÑ∏ Ìó¨Ïä§ ÌòÅÎ™Ö (Tech Revolution)
> > ÎßàÏßÄÎßâ ÏÑπÏÖòÏûÖÎãàÎã§. Ï†ïÎ∞ÄÏùòÌïôÏùÑ Í∞ÄÎä•ÌïòÍ≤å ÌïòÎäî Í∏∞Ïà†Ï†Å Î∞∞Í≤ΩÏûÖÎãàÎã§. 
> > * **IoMT (Internet of Medical Things):** ÏùòÎ£å ÏÇ¨Î¨º Ïù∏ÌÑ∞ÎÑ∑. Ïõ®Ïñ¥Îü¨Î∏î Í∏∞Í∏∞ Îì±Ïù¥ Ïã§ÏãúÍ∞ÑÏúºÎ°ú ÌôòÏûê Îç∞Ïù¥ÌÑ∞Î•º ÏèüÏïÑÎÉÖÎãàÎã§.
> > * **Big Data & AI:** ÏèüÏïÑÏßÄÎäî Îç∞Ïù¥ÌÑ∞Î•º Î∂ÑÏÑùÌï©ÎãàÎã§.
> > * **Rising of Precision Medicine:** Ïù¥ Î™®Îì† Í≤ÉÏù¥ Ìï©Ï≥êÏ†∏ Ï†ïÎ∞ÄÏùòÌïôÏù¥ Î∂ÄÏÉÅÌïòÍ≥† ÏûàÏäµÎãàÎã§.
> > * **Q & A (113p):** ÏßàÎ¨∏ ÏûàÎÇòÏöî?

, ',
    displayMath: [['$$', '$$'], ['\\[', '\\]']],
    processEscapes: true,
  },
  svg: {
    fontCache: 'global'
  }
};
</script>
<script type="text/javascript" id="MathJax-script" async
  src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-svg.js">
</script>

---

>[!quote] Í≥µÏßÄ
>Î≥∏ ÏûêÎ£åÏùò Ï†ÄÏûëÍ∂åÏùÄ **KAISTUDY**Ïóê ÏûàÏäµÎãàÎã§.

---

> [!abstract]- üìñ Í∞ïÏùò ÌïúÎààÏóê Î≥¥Í∏∞: Precision Medicine & Systems Biology
> **"One Treatment Fits All(Í≥ºÍ±∞)ÏóêÏÑú Data-Driven Algorithm(ÎØ∏Îûò)ÏúºÎ°úÏùò ÏßÑÌôî"**
>
> 1.  **Introduction (Ìå®Îü¨Îã§ÏûÑÏùò Ï†ÑÌôò)**
>     * ÏùòÌïôÏùÄ ÏßÅÍ¥Ä(Intuition)Í≥º Ï¶ùÍ±∞(EBM)Î•º ÎÑòÏñ¥, **ÎπÖÎç∞Ïù¥ÌÑ∞ÏôÄ ÏïåÍ≥†Î¶¨Ï¶ò Í∏∞Î∞òÏùò Ï†ïÎ∞ÄÏùòÌïô(Precision Medicine)**ÏúºÎ°ú Ïù¥Îèô Ï§ëÏûÖÎãàÎã§.
>     * ÌïµÏã¨ÏùÄ ÌôòÏûêÎ•º ÌèâÍ∑†(Average)Ïù¥ ÏïÑÎãå **Ïú†Ï†ÑÏ≤¥(Genes), ÌôòÍ≤Ω(Environment), ÏÉùÌôúÏäµÍ¥Ä(Lifestyle)**Ïù¥ Í≤∞Ìï©Îêú Í≥†Ïú†Ìïú Í∞úÏ≤¥Î°ú Î≥¥Îäî Í≤ÉÏûÖÎãàÎã§.
> 2.  **Omics & Regulation (ÏÉùÎ™ÖÏùò Ïñ∏Ïñ¥ÏôÄ Ï°∞Ï†à)**
>     * Îã®Ïàú DNA ÏÑúÏó¥(Genome)ÎøêÎßå ÏïÑÎãàÎùº, Ïù¥Î•º Ï°∞Ï†àÌïòÎäî **Epigenome(ÌõÑÏÑ±Ïú†Ï†ÑÏ≤¥)**Í≥º Ïã§Ï†ú Í∏∞Îä•ÏùÑ ÏàòÌñâÌïòÎäî Proteome/MetabolomeÏùÑ ÌÜµÌï©Ìï¥Ïïº Ìï©ÎãàÎã§.
>     * ÌäπÌûà **Histone Modification**Í≥º **DNA Methylation**Ïù¥ Ïú†Ï†ÑÏûê Ïä§ÏúÑÏπò(On/Off)Î•º Í≤∞Ï†ïÌïòÎäî ÌïµÏã¨ Í∏∞Ï†ÑÏûÖÎãàÎã§.
> 3.  **Systems & Network (ÌÜµÌï©Ï†Å Î∂ÑÏÑù)**
>     * ÏßàÎ≥ëÏùÄ Îã®Ïùº Ïú†Ï†ÑÏûêÏùò Í≥†Ïû•Ïù¥ ÏïÑÎãàÎùº, **ÎÑ§Ìä∏ÏõåÌÅ¨(Network)Ïùò ÏÑ≠Îèô**ÏûÖÎãàÎã§.
>     * ÏÑ∏Ìè¨Ïùò Ïö¥Î™ÖÏùÄ **ÏÉÅÌÉú Í≥µÍ∞Ñ(State Space)** ÎÇ¥ÏóêÏÑú **ÎÅåÍ∞ú(Attractor)**Î°ú Ïù¥ÎèôÌïòÎäî Í∂§Ï†Å(Trajectory)ÏúºÎ°ú ÏàòÌïôÏ†Å Ï†ïÏùòÍ∞Ä Í∞ÄÎä•Ìï©ÎãàÎã§.
> 4.  **Clinical Application (ÏûÑÏÉÅ Ï†ÅÏö©)**
>     * Í≤∞Íµ≠ Ïù¥ Î™®Îì† Îç∞Ïù¥ÌÑ∞Î•º Ìï©Ï≥ê(Multi-omics Integration), ÌôòÏûêÎ•º Î∂ÑÏûê ÏàòÏ§ÄÏóêÏÑú Ï∏µÌôî(Stratification)ÌïòÍ≥†, **ÎÑ§Ìä∏ÏõåÌÅ¨ Í∏∞Î∞ò Ïã†ÏïΩ(Network Medicine)**ÏùÑ Ï†ÅÏö©ÌïòÏó¨ ÏÉùÏ°¥Ïú®ÏùÑ ÎÜíÏù¥Îäî Í≤ÉÏù¥ Î™©ÌëúÏûÖÎãàÎã§.

> [!example]- üíä ÌïµÏã¨ ÌÇ§ÏõåÎìú & ÏïºÎßà Ï†ïÎ¶¨
>
> ### 1. Precision MedicineÏùò Í∏∞Ï¥à (Data & P4)
> * **Ïò§Î∞îÎßàÏùò 3ÎåÄ Î≥ÄÏàò (2015):** ‚ë† Genes(Ïú†Ï†ÑÏûê) + ‚ë° Environment(ÌôòÍ≤Ω) + ‚ë¢ Lifestyle(ÏÉùÌôúÏäµÍ¥Ä) **(üî•Í∏∞Ï∂ú)**
> * **Îç∞Ïù¥ÌÑ∞ Íµ¨ÏÑ± ÎπÑÏú®:** **Exogenous(ÌôòÍ≤Ω/ÌñâÎèô) 60%** > Genomics 30% > Clinical 10%. (Î≥ëÏõê Îç∞Ïù¥ÌÑ∞Îäî ÎπôÏÇ∞Ïùò ÏùºÍ∞ÅÏûÑ **üî•ÏïºÎßà**)
> * **P4 Medicine:** **P**redictive(ÏòàÏ∏°), **P**reventive(ÏòàÎ∞©), **P**ersonalized(ÎßûÏ∂§), **P**articipatory(Ï∞∏Ïó¨).
>
> ### 2. Clinical Sequencing Í∏∞Ïà† ÎπÑÍµê (vs) **(üî•Ï°±Î≥¥: Ï†ÅÏùëÏ¶ù Íµ¨Î≥Ñ)**
> * **WGS (Whole Genome):** DNA Ï†ÑÏ≤¥(30Ïñµ Ïåç) Î∂ÑÏÑù. Point mutation, Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥(SV), CNV **Î™®Îëê Í≤ÄÏ∂ú Í∞ÄÎä•**.
> * **WES (Whole Exome):** Îã®Î∞±Ïßà ÏΩîÎî© Î∂ÄÏúÑ(**Exon, Ï†ÑÏ≤¥Ïùò 1%**)Îßå ÎÜçÏ∂ï(Baits)ÌïòÏó¨ Î∂ÑÏÑù. Í∞ÄÏÑ±ÎπÑ Ï¢ãÏùå. Point mutation, CNV Í≤ÄÏ∂ú.
> * **Targeted Panel (PCR Amplicon):** ÌäπÏ†ï ÏßàÎ≥ë Í¥ÄÎ†® Ïú†Ï†ÑÏûêÎßå Ï¶ùÌè≠. ÍπäÏùÄ Ìï¥ÏÉÅÎèÑ(Depth) Í∞ÄÎä•.
> * **RNA-seq (Transcriptome):** **Î∞úÌòÑÎüâ(Expression)**, ÏúµÌï© Ïú†Ï†ÑÏûê(Fusion), Splicing variant Í≤ÄÏ∂ú.
>
> ### 3. DNA Íµ¨Ï°∞ & p53 (Concrete Details)
> * **DNA ÏàòÏπò:** ÏßÄÎ¶Ñ **2nm**, Ìïú Î∞îÌÄ¥ **3.4nm**, ÏóºÍ∏∞ ÏÇ¨Ïù¥ **0.34nm**. **(üî•Í∏∞Ï∂ú: Ïà´Ïûê ÏïîÍ∏∞)**
> * **p53 Íµ¨Ï°∞:** **Tetramer(4ÎüâÏ≤¥)**Î°ú ÏûëÎèô. DNA Í≤∞Ìï© Î∂ÄÏúÑÏóê **Zinc atom(ÏïÑÏó∞)**Ïù¥ ÏïàÏ†ïÌôîÏ†úÎ°ú Î∞ïÌòÄ ÏûàÏùå. ÏïîÌôòÏûêÎäî Ï£ºÎ°ú Ïù¥ Í≤∞Ìï© Î∂ÄÏúÑÍ∞Ä ÎßùÍ∞ÄÏßê.
>
> ### 4. Epigenetics: Histone Code & Methylation
> * **Histone Tail:** Ï°∞Ï†àÏùò ÌïµÏã¨. (H3, H4 TailÏù¥ Ï§ëÏöî)
> * **Acetylation (Ac):** Lysine(K)Ïóê Î∂ôÏùå. Ï£ºÎ°ú **Activation (Ï†ÑÏÇ¨ Ï¥âÏßÑ)**. **(üî•ÏïºÎßà)**
> * **Methylation (Me):** Lysine(K)Ïóê Î∂ôÏùå. ÏúÑÏπòÏóê Îî∞Îùº Îã§Î¶Ñ (Ïòà: H3K4=Active, H3K9/27=Repression).
> * **DNA Methylation:** CytosineÏùò 5Î≤à ÌÉÑÏÜåÏóê $CH_3$ Î∂ÄÏ∞© ($5$-mC). Ï£ºÎ°ú **Silencing (Ï†ÑÏÇ¨ ÏñµÏ†ú)**.
>
> ### 5. Systems Biology: State Space & Attractor
> * **ÏÉÅÌÉú Î≤°ÌÑ∞ (State Vector):** $S = [x_1, x_2, ... x_N]$ (Ïú†Ï†ÑÏûê Î∞úÌòÑÎüâÏùò ÏßëÌï©).
> * **ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space):** Ïú†Ï†ÑÏûêÎì§ÏùÑ Ï∂ïÏúºÎ°ú ÌïòÎäî Îã§Ï∞®Ïõê Í≥µÍ∞Ñ. ÏÑ∏Ìè¨ ÏÉÅÌÉúÎäî Ïù¥ Í≥µÍ∞ÑÏùò **'Ï†ê'**ÏúºÎ°ú ÌëúÌòÑÎê®.
> * **Attractor (ÎÅåÍ∞ú):** ÎèôÏ†Å ÏãúÏä§ÌÖúÏù¥ ÏãúÍ∞ÑÏù¥ ÏßÄÎÇò ÏàòÎ†¥ÌïòÎäî ÏïàÏ†ïÎêú ÏÉÅÌÉú. ÏÉùÎ¨ºÌïôÏ†ÅÏúºÎ°ú **"Cell Type(Î∂ÑÌôîÎêú ÏÑ∏Ìè¨)"**ÏùÑ ÏùòÎØ∏Ìï®. **(üî•Í∞úÎÖê ÌïÑÏäπ)**
> * **Landscape Model:** Í≥µ(ÏÑ∏Ìè¨)Ïù¥ Í≥®ÏßúÍ∏∞(Attractor)Î°ú Íµ¥Îü¨Îñ®Ïñ¥ÏßÄÎäî Í≥ºÏ†ï = Î∂ÑÌôî(Differentiation). Ïú†Ï†ÑÏûê Î≥ÄÏù¥Îäî ÏßÄÌòï ÏûêÏ≤¥Î•º Î∞îÍøà.
>
> ### 6. Network Medicine & Survival Analysis
> * **Kaplan-Meier Curve:** XÏ∂ï(ÏãúÍ∞Ñ) vs YÏ∂ï(ÏÉùÏ°¥Ïú®). Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥(Signature)Ïóê Îî∞Îùº **Good vs Poor ÏòàÌõÑ Í∑∏Î£π**ÏùÑ ÎÇòÎàå Ïàò ÏûàÏùå. **(üî•ÏûÑÏÉÅ Ìï¥ÏÑù)**
> * **Drug Discovery:** ÏßàÎ≥ë ÎÑ§Ìä∏ÏõåÌÅ¨(Disease module)Î•º ÌÉÄÍ≤©ÌïòÎêò, ÌïÑÏàò ÏÉùÏ°¥ Ïú†Ï†ÑÏûê(Toxicity)Îäî Í±¥ÎìúÎ¶¨ÏßÄ ÏïäÎäî ÏïΩÎ¨ºÏùÑ Ï∞æÎäî Í≥ºÏ†ï.

---

> [!NOTE] Pages 1-7: Precision MedicineÏùò ÌÉúÎèôÍ≥º Big Data
> Ïûê, Ïù¥ Í∞ïÏùòÏùò ÏÑúÎßâÏûÖÎãàÎã§. Ïôú ÏßÄÍ∏à Ïù¥ ÏãúÏ†êÏóê 'Ï†ïÎ∞ÄÏùòÌïô(Precision Medicine)'Ïù¥ ÌôîÎëêÍ∞Ä ÎêòÎäîÏßÄ, Í∑∏Î¶¨Í≥† Í∑∏ Í∏∞Î∞òÏù¥ ÎêòÎäî **Big Data**Í∞Ä ÎèÑÎåÄÏ≤¥ Ïñ¥Îäê Ï†ïÎèÑ Í∑úÎ™®Ïù∏ÏßÄ Ïà´ÏûêÎ°ú ÌôïÏã§ÌïòÍ≤å Í∞êÏùÑ Ïû°Í≥† Í∞ÄÏïº Ìï©ÎãàÎã§. Ïò§Î∞îÎßà ÎåÄÌÜµÎ†πÏù¥ Ïñ∏Í∏âÌïú Ï†ïÏùòÎ∂ÄÌÑ∞ Îç∞Ïù¥ÌÑ∞Ïùò Íµ¨Ï≤¥Ï†ÅÏù∏ ÎπÑÏú®(%)ÍπåÏßÄ ÍººÍººÌûà Î¥ÖÏãúÎã§.
>
> > [!INFO] PAGE 1-2: Í∞úÎÖêÏùò ÏãúÏûë (Gianrico Farrugia)
> > 1ÌéòÏù¥ÏßÄ ÌëúÏßÄÎ•º ÎÑòÍ≤® 2ÌéòÏù¥ÏßÄÎ•º Î¥ÖÏãúÎã§. **Gianrico Farrugia**Ïùò ÏΩîÎ©òÌä∏Í∞Ä ÎÇòÏòµÎãàÎã§.
> > * ÌïµÏã¨ÏùÄ **"Treat the person as an individual"**ÏûÖÎãàÎã§. ÌôòÏûêÎ•º 'Í∑∏Î£π'Ïùò ÏùºÎ∂ÄÎ°ú Î≥¥Îäî Í≤å ÏïÑÎãàÎùº, Í∑∏ ÏÇ¨Îûå Í≥†Ïú†Ïùò **Genetic material(Ïú†Ï†Ñ Î¨ºÏßà)**Ïóê Í∏∞Î∞òÌï¥ ÏπòÎ£åÌïòÍ≤†Îã§Îäî Í±∞Ï£†. 
> > * Ïù¥Í≤å Î∞îÎ°ú **Individualized, Personalized, Precise**Ìïú ÏùòÎ£åÏùò Ï†ïÏùòÏûÖÎãàÎã§. Í∑∏ÎÉ• Ï¢ãÏùÄ Îßê Í∞ôÏßÄÎßå, 'Ïú†Ï†Ñ Î¨ºÏßà Í∏∞Î∞ò'Ïù¥ÎùºÎäî Ï†ÑÏ†ú Ï°∞Í±¥ÏùÑ Íº≠ Í∏∞ÏñµÌïòÏÑ∏Ïöî. 
>
> > [!IMPORTANT] PAGE 3-5: Precision Medicine Initiative (Ïò§Î∞îÎßà, 2015)
> > 3ÌéòÏù¥ÏßÄ ÏßÄÎèÑ Í∑∏Î¶ºÍ≥º 4ÌéòÏù¥ÏßÄ Ïò§Î∞îÎßà ÏÇ¨ÏßÑ Î≥¥Ïù¥Ï£†? **2015ÎÖÑ Ïó∞ÎëêÍµêÏÑú(State of the Union Address)**ÏóêÏÑú Î∞úÌëúÌïú ÎÇ¥Ïö©ÏûÖÎãàÎã§. 
> >
> > **1. Ï†ïÏùò (3p):** 
> > * ÏßàÎ≥ë ÏòàÎ∞©Í≥º ÏπòÎ£åÏóê ÏûàÏñ¥ÏÑú **ÏÑ∏ Í∞ÄÏßÄ Î≥ÄÏàò**Î•º Í≥†Î†§Ìï©ÎãàÎã§. Ïù¥Í±∞ ÏãúÌóòÏóê ÎÇòÏò§Î©¥ Î¨¥Ï°∞Í±¥ Ïç®Ïïº Ìï©ÎãàÎã§.
> >     1.  **Genes (Ïú†Ï†ÑÏûê)**
> >     2.  **Environment (ÌôòÍ≤Ω)**
> >     3.  **Lifestyle (ÏÉùÌôúÏäµÍ¥Ä)**
> >
> > **2. Íµ¨Ï≤¥Ï†Å Î™©Ìëú (5p):** 
> > * Îã®ÏàúÌûà ÏïΩÎßå Í∞úÎ∞úÌïòÎäî Í≤å ÏïÑÎãôÎãàÎã§.
> > * **100Îßå Î™Ö(1 million)** Ïù¥ÏÉÅÏùò ÎØ∏Íµ≠Ïù∏ ÏûêÏõêÎ¥âÏÇ¨ÏûêÎ°ú Íµ¨ÏÑ±Îêú Ïó∞Íµ¨ ÎÑ§Ìä∏ÏõåÌÅ¨ Íµ¨Ï∂ï. (Ïä§ÏºÄÏùºÏù¥ Îã§Î¶ÖÎãàÎã§, Ïà´Ïûê Ï≤¥ÌÅ¨!)
> > * ÌôòÏûêÍ∞Ä ÏûêÏã†Ïùò Í±¥Í∞ï Ï†ïÎ≥¥Ïóê Ï†ëÍ∑ºÌïòÏó¨ ÏπòÎ£åÏóê **ÌòëÎ†•(Collaborate)**ÌïòÍ≤å Ìï®.
> > * ÏÉàÎ°úÏö¥ ÏùòÎ£å Í∏∞Ïà†ÏùÑ ÏãúÏû•Ïóê Îçî **Îπ†Î•¥Í≤å(Faster)** ÎèÑÏûÖ.
>
> > [!INFO] PAGE 6: Ïôú ÏßÄÍ∏àÏù∏Í∞Ä? (Why Now?)
> > 6ÌéòÏù¥ÏßÄ ÌÖçÏä§Ìä∏Î•º Î≥¥ÏÑ∏Ïöî. Ïôú ÌïòÌïÑ ÏßÄÍ∏à Ï†ïÎ∞ÄÏùòÌïôÏùºÍπåÏöî? ÏÑ∏ Í∞ÄÏßÄ Í∏∞Ïà†Ï†Å Î∞∞Í≤ΩÏù¥ ÏûàÏäµÎãàÎã§. 
> > 1.  **Sequencing:** Ïù∏Í∞Ñ Ïú†Ï†ÑÏ≤¥(Human Genome) Î∂ÑÏÑù ÎπÑÏö©Í≥º ÏãúÍ∞ÑÏù¥ ÌöçÍ∏∞Ï†ÅÏúºÎ°ú Ï§ÑÏóàÏ£†.
> > 2.  **Improved Technologies:** ÏÉùÏùòÌïô Î∂ÑÏÑù(Biomedical analysis) Í∏∞Ïà†Ïùò Ìñ•ÏÉÅ.
> > 3.  **New Tools:** ÎåÄÏö©Îüâ Îç∞Ïù¥ÌÑ∞ÏÖã(Large datasets)ÏùÑ Îã§Î£∞ Ïàò ÏûàÎäî ÎèÑÍµ¨(Ïª¥Ìì®ÌåÖ ÌååÏõå, AI Îì±)Ïùò Îì±Ïû•.
>
> > [!IMPORTANT] PAGE 7: Ìó¨Ïä§ÏºÄÏñ¥ Îç∞Ïù¥ÌÑ∞Ïùò Ïã§Ï≤¥ (ÏàòÏπò ÏïîÍ∏∞!)
> > Ïûê, Ïó¨Í∏∞ **Î≥ÑÌëú** ÏπòÏÑ∏Ïöî. Ìó¨Ïä§ÏºÄÏñ¥ ÎπÖÎç∞Ïù¥ÌÑ∞Ïùò Íµ¨ÏÑ± ÎπÑÏú®Í≥º Ïö©ÎüâÏù¥ Íµ¨Ï≤¥Ï†ÅÏúºÎ°ú ÎÇòÏòµÎãàÎã§. ÌâÅÏ≥êÏÑú 'ÎßéÎã§'Í≥† ÌïòÎ©¥ ÏùòÎåÄÏÉù ÏïÑÎãàÏ£†. ÏàòÏπòÎ•º Î≥¥ÏÑ∏Ïöî.
> >
> > **1. Í±¥Í∞ï Í≤∞Ï†ï ÏöîÏù∏ (Determinants of Health) ÎπÑÏú®:** 
> > * **Exogenous data (Ïô∏Ïù∏ÏÑ± Îç∞Ïù¥ÌÑ∞):** ÌñâÎèô, ÏÇ¨ÌöåÍ≤ΩÏ†úÏ†Å, ÌôòÍ≤ΩÏ†Å ÏöîÏù∏. Î¨¥Î†§ **60%**Î•º Ï∞®ÏßÄÌï©ÎãàÎã§.
> > * **Genomics data (Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞):** **30%**. ÏÉùÍ∞ÅÎ≥¥Îã§ ÎπÑÏ§ëÏù¥ ÌÅ¨Ï£†?
> > * **Clinical data (ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞):** Í≤®Ïö∞ **10%**. Î≥ëÏõêÏóêÏÑú ÎÇòÏò§Îäî Îç∞Ïù¥ÌÑ∞Îäî ÎπôÏÇ∞Ïùò ÏùºÍ∞ÅÏù¥ÎùºÎäî Í≤ÅÎãàÎã§.
> >
> > **2. ÌèâÏÉù ÏÉùÏÑ±ÎêòÎäî Îç∞Ïù¥ÌÑ∞ Ïñë (Data per lifetime):** 
> > * Ï¥ùÎüâ: **1100 Terabytes (TB)**
> > * Exogenous: **1100 TB** (Í±∞Ïùò ÎåÄÎ∂ÄÎ∂Ñ)
> > * Genomics: **6 TB**
> > * Clinical: **0.4 TB** (ÏïÑÏ£º ÎØ∏ÎØ∏Ìï®)
> >
> > **3. ÎπÖÎç∞Ïù¥ÌÑ∞Ïùò 4V:** 
> > * **Volume (Ïñë)**, **Variety (Îã§ÏñëÏÑ±)**, **Velocity (ÏÜçÎèÑ)**, **Veracity (Ï†ïÌôïÏÑ±)**.
> > * ÌäπÌûà ÌïòÎã®Ïóê Î≥¥Î©¥ 2020ÎÖÑ Í∏∞Ï§ÄÏúºÎ°ú ÏùòÎ£å Îç∞Ïù¥ÌÑ∞Îäî **73ÏùºÎßàÎã§ 2Î∞∞**Î°ú Ï¶ùÍ∞ÄÌïúÎã§Í≥† ÎêòÏñ¥ ÏûàÏäµÎãàÎã§. Í∏àÏúµ(Finance) Î∂ÑÏïºÎ≥¥Îã§ Îç∞Ïù¥ÌÑ∞Í∞Ä Îçî ÎßéÏïÑÏöî. 

> [!NOTE] Pages 8-13: ÏùòÎ£å Ìå®Îü¨Îã§ÏûÑÏùò ÎåÄÏ†ÑÌôò (Paradigm Shift)
> Ïûê, Ïù¥Ï†ú ÏùòÌïôÏùò Ïó≠ÏÇ¨Î•º 3Îã®Í≥ÑÎ°ú ÎÇòÎà†ÏÑú Î®∏Î¶øÏÜçÏóê ÏßëÏñ¥ÎÑ£ÏùçÏãúÎã§. Í≥ºÍ±∞Ïùò ÏùòÏÇ¨Îì§ÏùÄ 'ÏßÅÍ¥Ä'Ïóê ÏùòÏ°¥ÌñàÏßÄÎßå, ÎØ∏ÎûòÏùò ÏùòÏÇ¨Îì§ÏùÄ **'ÏïåÍ≥†Î¶¨Ï¶ò'**ÏùÑ Îã§Î§ÑÏïº Ìï©ÎãàÎã§. Ïù¥ ÌååÌä∏Ïùò ÌïµÏã¨ÏùÄ **"One Treatment Fits All(Îã®Ïùº ÏπòÎ£å)"Ïùò Î™∞ÎùΩ**Í≥º **"Personalized(ÎßûÏ∂§Ìòï)"Ïùò Î∂ÄÏÉÅ**ÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 8: Ìå®Îü¨Îã§ÏûÑ 3Îã®Í≥Ñ (ÏãúÌóò ÏïºÎßà!)
> > 8ÌéòÏù¥ÏßÄ ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. ÏùòÌïôÏùÄ Ïù¥Î†áÍ≤å ÏßÑÌôîÌñàÏäµÎãàÎã§. Í∞Å Îã®Í≥ÑÏùò ÌÇ§ÏõåÎìúÎ•º Î∞òÎìúÏãú Îß§Ïπ≠ÏãúÌÇ§ÏÑ∏Ïöî.
> >
> > 1.  **Yesterday (Í≥ºÍ±∞):**
> >     * Í∏∞Î∞ò: **Symptom-based (Ï¶ùÏÉÅ Í∏∞Î∞ò)**
> >     * Î∞©Ïãù: **Intuition Medicine (ÏßÅÍ¥Ä ÏùòÌïô)** - ÏùòÏÇ¨Ïùò 'Í∞ê'Ïóê ÏùòÏ°¥ÌñàÏ£†.
> > 2.  **Today (ÌòÑÏû¨):**
> >     * Í∏∞Î∞ò: **Pattern-based (Ìå®ÌÑ¥ Í∏∞Î∞ò)**
> >     * Î∞©Ïãù: **Evidence-based Medicine (Ï¶ùÍ±∞ Í∏∞Î∞ò ÏùòÌïô, EBM)** - ÏûÑÏÉÅÏãúÌóò ÌÜµÍ≥ÑÍ∞Ä ÏôïÏù¥ÏóàÏäµÎãàÎã§.
> > 3.  **Tomorrow (ÎØ∏Îûò):**
> >     * Í∏∞Î∞ò: **Algorithm-based (ÏïåÍ≥†Î¶¨Ï¶ò Í∏∞Î∞ò)** - Ïó¨Í∏∞Í∞Ä ÌïµÏã¨ÏûÖÎãàÎã§.
> >     * Î∞©Ïãù: **Precision Medicine (Ï†ïÎ∞Ä ÏùòÌïô)** - Îç∞Ïù¥ÌÑ∞Í∞Ä ÏπòÎ£åÎ•º Í≤∞Ï†ïÌï©ÎãàÎã§.
>
> > [!INFO] PAGE 9: ÏÉàÎ°úÏö¥ ÌîåÎ†àÏù¥Ïñ¥Îì§ (IT Giants)
> > 9ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Î≥ëÏõê Î°úÍ≥†Í∞Ä ÏïÑÎãôÎãàÎã§. **Google Health, Google DeepMind, IBM Watson Health, Human Longevity Inc.** Í∞ôÏùÄ IT Í∏∞ÏóÖÎì§Ïù¥Ï£†.
> > * Ïù¥Îì§Ïù¥ ÎÖ∏Î¶¨Îäî Î∂ÑÏïºÍ∞Ä ÏïÑÎûò Ìä∏Î¶¨Ïóê ÎÇòÏòµÎãàÎã§:
> >     * **Oncology (Ï¢ÖÏñëÌïô)**
> >     * **Drug Discovery (Ïã†ÏïΩ Í∞úÎ∞ú)**
> >     * **Genomics (Ïú†Ï†ÑÏ≤¥Ìïô)**
> >     * **Patient Engagement (ÌôòÏûê Ï∞∏Ïó¨)**
> > * Ï¶â, Ìó¨Ïä§ÏºÄÏñ¥Ïùò Ï£ºÎèÑÍ∂åÏù¥ 'Îç∞Ïù¥ÌÑ∞Î•º Í∞ÄÏßÑ Í∏∞ÏóÖ'ÏúºÎ°ú ÎÑòÏñ¥Í∞ÄÍ≥† ÏûàÎã§Îäî Ï¶ùÍ±∞ÏûÖÎãàÎã§.
>
> > [!WARNING] PAGE 11-12: ÌòÑÏû¨ ÏùòÌïôÏùò ÌïúÍ≥Ñ (One Treatment Fits All)
> > 11ÌéòÏù¥ÏßÄ ÎèÑÏãùÏùÑ Î¥ÖÏãúÎã§. **"Current Medicine: One Treatment Fits All"**.
> > * ÎòëÍ∞ôÏùÄ ÏïΩ(Pill)ÏùÑ Î™®Îì† ÌôòÏûê(Ï¥àÎ°ù, Îπ®Í∞ï, ÌååÎûë ÏÑûÏó¨ ÏûàÎäî Í∑∏Î£π)ÏóêÍ≤å Ï§çÎãàÎã§.
> > * **Í≤∞Í≥º:**
> >     * ÏùºÎ∂ÄÎäî **Effect (Ìö®Í≥º ÏûàÏùå)**.
> >     * ÏùºÎ∂ÄÎäî **No effect (Ìö®Í≥º ÏóÜÏùå)** - Îèà ÎÇ≠ÎπÑÏ£†.
> >     * Ïã¨ÏßÄÏñ¥ ÏùºÎ∂ÄÎäî **Adverse effects (Î∂ÄÏûëÏö©)** - Ïù¥Í≤å Ï†úÏùº ÏúÑÌóòÌï©ÎãàÎã§.
> > * 12ÌéòÏù¥ÏßÄÎèÑ Í∞ôÏùÄ Îß•ÎùΩÏûÖÎãàÎã§. "Conventional approach"Îäî ÏßÑÎã®Ïù¥ Îä¶Ïñ¥ÏßÄÍ±∞ÎÇò(delayed), Ïò§ÏßÑ(mis-diagnosis)Ïù¥ ÏÉùÍ≤® ÏπòÎ£å Ìö®Ïú®Ïù¥ ÎÇÆÏäµÎãàÎã§.
>
> > [!IMPORTANT] PAGE 13: ÎØ∏Îûò ÏùòÌïô (Personalized Diagnostics)
> > 13ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ 11ÌéòÏù¥ÏßÄÏôÄ Î∞òÎåÄÏûÖÎãàÎã§. ÏàúÏÑúÍ∞Ä Î∞îÎÄùÎãàÎã§.
> > * **ÏÑ†(ÂÖà) ÏßÑÎã®:** ÏπòÎ£å Ï†ÑÏóê **Blood, DNA, Urine, Tissue Analysis**Î•º Î®ºÏ†Ä ÏàòÌñâÌï©ÎãàÎã§.
> > * **ÌõÑ(Âæå) Î∂ÑÎ•ò:** ÌôòÏûêÎì§ÏùÑ Îπ®Í∞ï, ÎÖ∏Îûë, ÌååÎûë Í∑∏Î£πÏúºÎ°ú **ÎØ∏Î¶¨ ÎÇòÎàïÎãàÎã§(Stratification)**.
> > * **Í≤∞Í≥º:** Í∞Å Í∑∏Î£πÏóê ÎßûÎäî ÏïΩÏùÑ Ìà¨Ïó¨ÌïòÎãàÍπå, Î™®Îì† ÌôòÏûêÏóêÍ≤åÏÑú **Effect (Ìö®Í≥º)**Í∞Ä ÎÇòÌÉÄÎÇ©ÎãàÎã§. Î∂ÄÏûëÏö©ÏùÄ ÏµúÏÜåÌôîÎêòÍ≥†Ïöî. Ïù¥Í≤å Ï†ïÎ∞ÄÏùòÌïôÏùò Í∂ÅÍ∑πÏ†Å Î™©ÌëúÏûÖÎãàÎã§.

> [!NOTE] Pages 14-21: P4 MedicineÍ≥º ÏãúÏä§ÌÖú ÏùòÌïô (Systems Medicine)
> Ïûê, Ï†ïÎ∞ÄÏùòÌïôÏùÑ Îã§Î•∏ ÎßêÎ°ú **'P4 Medicine'**Ïù¥ÎùºÍ≥†ÎèÑ Ìï©ÎãàÎã§. Ïù¥ 4Í∞ÄÏßÄ PÍ∞Ä Î≠îÏßÄ Î™®Î•¥Î©¥ Ïù¥ ÏàòÏóÖ ÌóõÎì§ÏùÄ Í≤ÅÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ Î∞©ÎåÄÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïñ¥ÎñªÍ≤å ÏöîÎ¶¨Ìï¥ÏÑú ÏûÑÏÉÅÏóê Ï†ÅÏö©ÌïòÎäîÏßÄ, Í∑∏ Î≥µÏû°Ìïú Í≥ºÏ†ïÏùÑ ÌïòÎÇòÏî© Î∂ÑÌï¥Ìï¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 14: P4 MedicineÏùò Ï†ïÏùò (ÏïîÍ∏∞ ÌïÑÏàò!)
> > 14ÌéòÏù¥ÏßÄ, ÏïÑÏ£º Ï§ëÏöîÌïú ÏïΩÏñ¥Í∞Ä ÎÇòÏòµÎãàÎã§. **P4 Medicine**.
> > 1.  **Predictive (ÏòàÏ∏°):** Î∞úÎ≥ë Ï†ÑÏóê ÎØ∏Î¶¨ ÏïàÎã§.
> > 2.  **Preventive (ÏòàÎ∞©):** ÏïÑÌîÑÍ∏∞ Ï†ÑÏóê ÎßâÎäîÎã§.
> > 3.  **Personalized (ÎßûÏ∂§):** ÎÑàÌïúÌÖå Îî± ÎßûÎäî ÏπòÎ£åÎ•º ÌïúÎã§.
> > 4.  **Participatory (Ï∞∏Ïó¨):** ÌôòÏûêÍ∞Ä ÏàòÎèôÏ†ÅÏù∏ Í∞ùÏ≤¥Í∞Ä ÏïÑÎãàÎùº, Îç∞Ïù¥ÌÑ∞ ÏÉùÏÇ∞ÏûêÎ°úÏÑú Ï∞∏Ïó¨ÌïúÎã§.
> >
> > * **ÌïµÏã¨ ÏßàÎ¨∏:** "Îç∞Ïù¥ÌÑ∞Îäî ÎÑòÏ≥êÎÇòÎäîÎç∞(More data), Ïù¥Í±∏ ÏñºÎßàÎÇò Ìö®Ïú®Ï†ÅÏúºÎ°ú ÏÇ¨Ïö©Ìï† Í≤ÉÏù∏Í∞Ä?" -> Í∑∏ Ìï¥ÎãµÏù¥ Î∞îÎ°ú **Systems Medicine**ÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 15: ÏûÑÏÉÅ Ï†ÅÏö© ÏÇ¨Ïù¥ÌÅ¥ (Clinical Deployment)
> > 15ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùò ÏàúÌôò Íµ¨Ï°∞Î•º Î≥¥ÏÑ∏Ïöî. Îç∞Ïù¥ÌÑ∞Í∞Ä Ïñ¥ÎñªÍ≤å ÌùêÎ•¥ÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§.
> > * **Screening (ÏÑ†Î≥Ñ) ‚Üí Diagnosis (ÏßÑÎã®) ‚Üí Staging & Phenotyping (Î≥ëÍ∏∞ ÏÑ§Ï†ï) ‚Üí Therapy & Monitoring (ÏπòÎ£å Î∞è Î™®ÎãàÌÑ∞ÎßÅ)**
> > * Ïù¥ Í≥ºÏ†ïÏóêÏÑú Ïñ¥Îñ§ Îç∞Ïù¥ÌÑ∞Í∞Ä Îì§Ïñ¥Í∞ÄÎÇòÏöî?
> >     * **-omic/biological:** Ïú†Ï†ÑÏ≤¥ Ï†ïÎ≥¥
> >     * **Electronic health records (EHR):** Î≥ëÏõê Í∏∞Î°ù
> >     * **Geospatial & Environmental:** Ïñ¥Îîî ÏÇ¨ÎäîÏßÄ, ÌôòÍ≤ΩÏùÄ Ïñ¥Îñ§ÏßÄ
> >     * **Personal monitoring:** Ïõ®Ïñ¥Îü¨Î∏î Í∏∞Í∏∞ Îç∞Ïù¥ÌÑ∞ Îì±
> > * Ïö∞Ï∏° ÌïòÎã®Ïùò ÏßàÎ¨∏Îì§Ïù¥ ÎÇ†Ïπ¥Î°≠ÏäµÎãàÎã§. "Í≥ºÍ±∞Î†•(History) Ï§ë Î¨¥ÏóáÏùÑ Î≥ºÍπå?", "ÌòÑÏû¨ ÏÉÅÌÉú(Current state)Îäî?", "Í∞úÏûÖ(Intervene) Í∏∞ÌöåÎäî?", "ÎØ∏Îûò ÏúÑÌóò(Risks)ÏùÄ?"
>
> > [!TIP] üí° PAGE 17-18: Îç∞Ïù¥ÌÑ∞Ïùò ÏõêÏ≤ú (Ï°±Î≥¥ ÏÜåÏä§)
> > Ïûê, Ïó¨Í∏∞ Ï†ÅÌòÄ ÏûàÎäî Îç∞Ïù¥ÌÑ∞Î≤†Ïù¥Ïä§ Ïù¥Î¶ÑÎì§, ÎààÏóê ÏùµÌòÄÎëêÏÑ∏Ïöî. ÎÇòÏ§ëÏóê Ïó∞Íµ¨Ìï† Îïå Î¨¥Ï°∞Í±¥ ÏîÅÎãàÎã§.
> >
> > **1. Technology Platforms (17p):**
> > * **Genomics & Transcriptomics:** ÏãúÌÄÄÏã± Îç∞Ïù¥ÌÑ∞ (ACGT...)
> > * **Proteomics & Metabolomics:** Îã®Î∞±Ïßà, ÎåÄÏÇ¨Î¨ºÏßà (MS-data ÏßàÎüâÎ∂ÑÏÑù)
> > * **Imaging:** ÏòÅÏÉÅ Îç∞Ïù¥ÌÑ∞
> >
> > **2. Public Databases (18p) - Î≥ÑÌëú!:**
> > * **TCGA (The Cancer Genome Atlas):** Ïïî Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Ïùò Î≥¥Î¨ºÏ∞ΩÍ≥†ÏûÖÎãàÎã§.
> > * **CCLE (Cancer Cell Line Encyclopedia):** Ïïî ÏÑ∏Ìè¨Ï£º Îç∞Ïù¥ÌÑ∞.
> > * **ClinicalTrials.gov:** ÏûÑÏÉÅÏãúÌóò Ï†ïÎ≥¥.
> > * **PubChem, DrugBank:** ÏïΩÎ¨º ÌôîÌïô Íµ¨Ï°∞ Î∞è ÌÉÄÍ≤ü Ï†ïÎ≥¥.
> > * **TOXNET:** ÎèÖÏÑ± Ï†ïÎ≥¥.
> > * Ïù¥ Îç∞Ïù¥ÌÑ∞Îì§Ïù¥ Îã§ Ïó∞Í≤∞ÎêòÏñ¥Ïïº ÎπÑÎ°úÏÜå 'Ï†ïÎ∞ÄÏùòÌïô'Ïù¥ Îê©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 19: AIÏôÄ Î®∏Ïã†Îü¨ÎãùÏùò Ïó≠Ìï† (ÏïåÍ≥†Î¶¨Ï¶ò Ïù¥Î¶Ñ Ï≤¥ÌÅ¨)
> > 19ÌéòÏù¥ÏßÄ Ïö∞Ï∏° ÌïòÎã®, Íπ®Ïïå Í∞ôÏùÄ Í∏ÄÏî®Î•º Î≥¥ÏÑ∏Ïöî. Îç∞Ïù¥ÌÑ∞Î•º Î∂ÑÏÑùÌïòÎäî ÎèÑÍµ¨Îì§ÏûÖÎãàÎã§.
> > * **Machine Learning (ML):** Í∏∞Í≥ÑÌïôÏäµ.
> > * **Deep Learning (DL):** Îî•Îü¨Îãù.
> > * **Íµ¨Ï≤¥Ï†Å ÏïåÍ≥†Î¶¨Ï¶ò:**
> >     * **SVM (Support Vector Machine)**
> >     * **RF (Random Forest)**
> >     * **LightGBM:** ÏµúÍ∑º ÎßéÏù¥ Ïì∞Ïù¥Îäî Î∂ÄÏä§ÌåÖ Î™®Îç∏Ïù¥Ï£†.
> > * **Í≥ºÏ†ï:** Feature selection(ÌäπÏßï ÏÑ†ÌÉù) ‚Üí Cross validation(ÍµêÏ∞® Í≤ÄÏ¶ù) ‚Üí Hyperparameter tuning(ÌäúÎãù) ‚Üí **Prediction(ÏòàÏ∏°)**. Ïù¥ ÌîÑÎ°úÏÑ∏Ïä§Í∞Ä Î®∏Î¶øÏÜçÏóê ÏûàÏñ¥Ïïº Ìï©ÎãàÎã§.
>
> > [!INFO] PAGE 20-21: Multi-OmicsÏùò ÌÜµÌï© (Integration)
> > 20ÌéòÏù¥ÏßÄ, ÏÇ¨Îûå Î™∏ÏùÑ **Systems Biology** Í¥ÄÏ†êÏóêÏÑú Î≥∏ Í∑∏Î¶ºÏûÖÎãàÎã§.
> > * ÏïΩÎ¨º(Drug A)Ïù¥ Îì§Ïñ¥Í∞ÄÎ©¥ Îã®ÏÑ†Ï†ÅÏù∏ Î∞òÏùëÎßå ÏûàÎäî Í≤å ÏïÑÎãàÎùº, Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨(Network)Î•º Í±¥ÎìúÎ¶ΩÎãàÎã§. Í∑∏ÎûòÏÑú Î∂ÄÏûëÏö©(AEs)ÎèÑ ÏÉùÍ∏∞Í≥†, ÏÉàÎ°úÏö¥ Ï†ÅÏùëÏ¶ù(New indications, Drug repositioning)ÎèÑ Î∞úÍ≤¨ÎêòÎäî Í±∞Ï£†.
> >
> > 21ÌéòÏù¥ÏßÄÍ∞Ä Í≤∞Î°†ÏûÖÎãàÎã§.
> > * **Multi-OMICS:** Genome, Epigenome, Transcriptome, Proteome, Metabolome, Microbiome... Ïù¥ Î™®Îì† Í±∏ Ìï©Ï≥êÏïº Ìï©ÎãàÎã§.
> > * **Integration (ÌÜµÌï©):** Îî∞Î°ú ÎÜÄÎ©¥ Ïì∞Î†àÍ∏∞ÏûÖÎãàÎã§. ÏÑûÏñ¥ÏÑú Î∂ÑÏÑùÌï¥Ïïº Ïú†ÏùòÎØ∏Ìïú **Signatures (ÌäπÏßï)**Í∞Ä ÎÇòÏò§Í≥†, Í∑∏Ï†úÏïº **Therapeutics (ÏπòÎ£åÎ≤ï)**Í∞Ä ÎÇòÏòµÎãàÎã§.

> [!NOTE] Pages 22-31: Ïú†Ï†ÑÏ≤¥Ìïô Í∏∞Ï¥à (Genomics Basics)
> Ïûê, Ïù¥Ï†ú **ÏÉùÎ™ÖÏùò Ïñ∏Ïñ¥(Language of Life)**Î•º Î∞∞Ïö∏ Ï∞®Î°ÄÏûÖÎãàÎã§. Í≥†Îì±ÌïôÍµê ÏÉùÎ¨º ÏãúÍ∞Ñ Í∞ôÎã§Í≥† Î∞©Ïã¨ÌïòÏßÄ ÎßàÏÑ∏Ïöî. Ïó¨Í∏∞ ÎÇòÏò§Îäî **ÏàòÏπò(nm, bp)**Îì§Í≥º **Îç∞Ïù¥ÌÑ∞Ïùò Í∑úÎ™®**Í∞Ä Ï†ïÎ∞ÄÏùòÌïôÏóêÏÑú Ïôú 'ÎπÖÎç∞Ïù¥ÌÑ∞'ÎùºÍ≥† Î∂àÎ¶¨ÎäîÏßÄ Í∑∏ Í∑ºÍ±∞Í∞Ä ÎêòÎãàÍπåÏöî.
>
> > [!INFO] PAGE 22: ÏÉùÎ¨ºÌïôÏ†Å Ï†ïÎ≥¥Ïùò ÌùêÎ¶Ñ (Central Dogma Í∑∏ Ïù¥ÏÉÅ)
> > 22ÌéòÏù¥ÏßÄ Îã§Ïù¥Ïñ¥Í∑∏Îû®ÏùÑ Î≥¥ÏÑ∏Ïöî. Ïö∞Î¶¨Í∞Ä ÏïÑÎäî ÏÑºÌä∏Îü¥ ÎèÑÍ∑∏Îßà(DNA ‚Üí RNA ‚Üí Protein)Í∞Ä Í∏∞Î≥∏Ïù¥ÏßÄÎßå, Í∑∏Î¶ºÏù¥ Ìõ®Ïî¨ Î≥µÏû°ÌïòÏ£†? 
> > * **Feedback Loops:** ÌôîÏÇ¥ÌëúÍ∞Ä Ìïú Î∞©Ìñ•ÏúºÎ°úÎßå Í∞ÄÏßÄ ÏïäÏäµÎãàÎã§. Îã®Î∞±Ïßà(Proteins)Ïù¥ Îã§Ïãú DNAÎÇò RNA Ï°∞Ï†àÏóê Í¥ÄÏó¨ÌïòÍ≥†, **ÌôòÍ≤Ω(Environment)**Ïù¥ ÏÑ∏Ìè¨ ÎåÄÏÇ¨(Cellular metabolism)Ïóê ÏòÅÌñ•ÏùÑ ÎØ∏ÏπòÎäî **ÏàúÌôò Íµ¨Ï°∞**ÏûÑÏùÑ Î™ÖÏã¨ÌïòÏÑ∏Ïöî. 
>
> > [!INFO] PAGE 23-24: Human Genome Project (HGP)
> > 23ÌéòÏù¥ÏßÄÏùò ÏàòÎßéÏùÄ ÏïåÌååÎ≤≥(ACGT...)Í≥º 24ÌéòÏù¥ÏßÄÏùò ÌååÌòï(Peaks) Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Ïù¥Í≤å Î∞îÎ°ú **Sanger Sequencing**Ïùò Í≤∞Í≥ºÎ¨ºÏûÖÎãàÎã§. 
> > * **Human Genome Project:** Ïù∏Í∞ÑÏùò Î™®Îì† DNA Í∏ÄÏûêÎ•º ÏùΩÏñ¥ÎÇ¥Î†§Îäî Í±∞ÎåÄÌïú ÏãúÎèÑÏòÄÏ£†. ÌÅ¥Î¶∞ÌÑ¥ ÎåÄÌÜµÎ†π ÏÇ¨ÏßÑÎèÑ Î≥¥Ïù¥ÎÑ§Ïöî. 
>
> > [!IMPORTANT] PAGE 25: DNA Íµ¨Ï°∞Ïùò ÏàòÏπò (ÏïîÍ∏∞!)
> > 25ÌéòÏù¥ÏßÄ, Ïó¨Í∏∞ **Î≥ÑÌëú** Îã§ÏÑØ Í∞ú ÏπòÏÑ∏Ïöî. DNA Íµ¨Ï°∞Ïùò ÏàòÏπò, ÏãúÌóòÏóê ÎÇ¥Í∏∞ Îî± Ï¢ãÏäµÎãàÎã§.
> > * **Î∞©Ìñ•ÏÑ±:** **5' end (Ïù∏ÏÇ∞Í∏∞)**ÏóêÏÑú **3' end (ÏàòÏÇ∞Í∏∞, OH)**Î°ú Ïù¥Ïñ¥ÏßëÎãàÎã§. Îëê Í∞ÄÎã•ÏùÄ ÏÑúÎ°ú **Ïó≠ÌèâÌñâ(Anti-parallel)**Ìï©ÎãàÎã§. 
> > * **Î∞±Î≥∏(Backbone):** Ïù∏ÏÇ∞(Phosphate) + Îãπ(Deoxyribose)ÏúºÎ°ú Íµ¨ÏÑ±Îê©ÎãàÎã§. 
> > * **Ï£ºÏöî ÏàòÏπò:**
> >     * **ÏßÄÎ¶Ñ (Width):** **2 nm** 
> >     * **ÎÇòÏÑ† Ìïú Î∞îÌÄ¥ (One turn):** **3.4 nm** 
> >     * **ÏóºÍ∏∞ ÏÇ¨Ïù¥ Í±∞Î¶¨ (Distance between bases):** **0.34 nm** 
> > * **Groove:** ÎÑìÏùÄ **Major groove**ÏôÄ Ï¢ÅÏùÄ **Minor groove**Í∞Ä ÏûàÏäµÎãàÎã§. ÎÇòÏ§ëÏóê Îã®Î∞±ÏßàÏù¥ Ïó¨Í∏∞ ÎÅºÏñ¥Îì§Ïñ¥Í∞ÄÏÑú Í≤∞Ìï©Ìï©ÎãàÎã§. 
>
> > [!INFO] PAGE 28: Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Ïùò ÌÅ¨Í∏∞ (ÎπÑÏú†)
> > 28ÌéòÏù¥ÏßÄ, Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Í∞Ä ÏñºÎßàÎÇò Î∞©ÎåÄÌïúÏßÄ ÎπÑÏú†Î•º Îì§Ïñ¥ ÏÑ§Î™ÖÌï©ÎãàÎã§.
> > * **Ï†ÑÏ≤¥ Ïö©Îüâ:** Ïù∏Í∞Ñ DNAÎäî ÏïΩ **64Ïñµ Í∞ú(6.4 billion)**Ïùò Î¨∏ÏûêÎ°ú ÎêòÏñ¥ ÏûàÏäµÎãàÎã§. 
> > * **Ï±ÖÏúºÎ°ú ÏπòÎ©¥:** 500ÌéòÏù¥ÏßÄÏßúÎ¶¨ Ï±Ö **4,200Í∂å** Î∂ÑÎüâÏûÖÎãàÎã§. Ïñ¥ÎßàÏñ¥ÎßàÌïòÏ£†. 
> > * **ÏÑúÎπÑÏä§ ÎπÑÍµê:**
> >     * **Veritas (Whole Genome):** 4,200Í∂å Ï†ÑÏ≤¥Î•º ÏùΩÏñ¥Ï§çÎãàÎã§. 
> >     * **23andMe (SNP genotyping):** Ï†ÑÏ≤¥Ïùò **1% ÎØ∏Îßå**Îßå Î¥ÖÎãàÎã§. Ï±ÖÏúºÎ°ú ÏπòÎ©¥ Í≤®Ïö∞ **180ÌéòÏù¥ÏßÄ** ÏùΩÎäî ÏÖàÏù¥Ï£†. Ïù¥ Ï∞®Ïù¥Î•º ÏïÑÎäî Í≤å Ï§ëÏöîÌï©ÎãàÎã§. 
>
> > [!INFO] PAGE 30-31: ÏÉùÎ™ÖÏùò Í≥ÑÏ∏µ Íµ¨Ï°∞ÏôÄ ÏóºÏÉâÏ≤¥
> > * **Í≥ÑÏ∏µ (30p):** Macromolecule(DNA) ‚Üí Organelle ‚Üí Cell ‚Üí Tissue ‚Üí Organ ‚Üí Organism ÏàúÏÑúÎ°ú Î≥µÏû°Ìï¥ÏßëÎãàÎã§. 
> > * **ÏóºÏÉâÏ≤¥ (31p):** Ïù∏Í∞ÑÏùÄ **23Ïåç(23 pairs)**Ïùò ÏóºÏÉâÏ≤¥Î•º Í∞ÄÏßëÎãàÎã§. (Ï¥ù 46Í∞ú) 
> > * **ÏÉÅÎèô ÏóºÏÉâÏ≤¥ (Homologous pairs):** Î∂ÄÎ™®Î°úÎ∂ÄÌÑ∞ Í∞ÅÍ∞Å ÌïòÎÇòÏî© Î¨ºÎ†§Î∞õÏùÄ Ìïú ÏåçÏûÖÎãàÎã§.
> >     * **Allele (ÎåÄÎ¶ΩÏú†Ï†ÑÏûê):** Í∞ôÏùÄ ÏúÑÏπòÏóê ÏûàÎäî Ïú†Ï†ÑÏûê Î≤ÑÏ†ÑÏùÑ ÎßêÌï©ÎãàÎã§. Í∑∏Î¶ºÏùò **Allele A**ÏôÄ **Allele a**Î•º Î≥¥ÏÑ∏Ïöî. Ïù¥Í≤å ÌòïÏßà(Ïòà: Î®∏Î¶¨ÏÉâ)ÏùÑ Í≤∞Ï†ïÌï©ÎãàÎã§. 

> [!NOTE] Pages 32-40: Ïú†Ï†ÑÏûê Î∞úÌòÑÍ≥º ÏûÑÏÉÅ ÏãúÌÄÄÏã± Í∏∞Ïà†
> Ïûê, DNAÏóê Ï†ÅÌûå Ï†ïÎ≥¥Í∞Ä Ïñ¥ÎñªÍ≤å Ïö∞Î¶¨ ÎààÏóê Î≥¥Ïù¥Îäî ÌäπÏßï(Phenotype)ÏúºÎ°ú ÎÇòÌÉÄÎÇòÎäîÏßÄ, Í∑∏Î¶¨Í≥† Í∑∏ Ï†ïÎ≥¥Î•º ÏùΩÏñ¥ÎÇ¥Îäî Í∏∞Ïà†ÏóêÎäî Ïñ¥Îñ§ Í≤ÉÎì§Ïù¥ ÏûàÎäîÏßÄ 'Ìï¥ÏÉÅÎèÑ'Î≥ÑÎ°ú ÎúØÏñ¥Î¥ÖÏãúÎã§. ÌäπÌûà **39ÌéòÏù¥ÏßÄ**Îäî ÏûÑÏÉÅ ÏãúÌóòÏù¥ÎÇò Íµ≠Í∞ÄÍ≥†ÏãúÏóêÎèÑ Îã®Í≥®Î°ú ÎÇòÏò§Îäî Í∞úÎÖêÏù¥Îãà Îàà ÌÅ¨Í≤å Îú®ÏÑ∏Ïöî.
>
> > [!INFO] PAGE 32-33: GenotypeÏóêÏÑú PhenotypeÍπåÏßÄ (Layer Íµ¨Ï°∞)
> > 32ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùò Îã§ÏñëÌïú ÏÇ¨ÎûåÎì§ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å Îã§ **Phenotype(ÌëúÌòÑÌòï)**ÏûÖÎãàÎã§.
> > * **ÌïµÏã¨ ÏßàÎ¨∏ (33p):** ÎèÑÎåÄÏ≤¥ Ïñ¥Îñ§ Î¨ºÎ¶¨Ï†Å Î©îÏª§ÎãàÏ¶òÏù¥ Ïö∞Î¶¨Ïùò Ïô∏Î™®ÏôÄ Í∏∞Îä•ÏùÑ Í≤∞Ï†ïÌï†ÍπåÏöî?
> > * **Ï†ïÎ≥¥Ïùò Í≥ÑÏ∏µ (Level):**
> >     * **Genome (Ïú†Ï†ÑÏ≤¥)**: Í∞ÄÏû• Î∞ëÎ∞îÎã• ÏÑ§Í≥ÑÎèÑ.
> >     * **Epigenome (ÌõÑÏÑ±Ïú†Ï†ÑÏ≤¥)**: ÏÑ§Í≥ÑÎèÑÏùò Ïä§ÏúÑÏπò.
> >     * **Transcriptome (Ï†ÑÏÇ¨Ï≤¥)**: Î≥µÏÇ¨Îêú Î™ÖÎ†πÏÑú.
> >     * **Proteome (Îã®Î∞±ÏßàÏ≤¥)**: Ïã§Ï†ú ÏùºÍæº.
> >     * **Metabolome (ÎåÄÏÇ¨Ï≤¥)**: ÏùºÍæºÏù¥ ÎßåÎì† Í≤∞Í≥ºÎ¨º.
> >     * **Phenome (ÌëúÌòÑÌòïÏ≤¥)**: ÏµúÏ¢ÖÏ†ÅÏù∏ ÏÉùÎ¨ºÌïôÏ†Å ÌäπÏßï.
> > * Ïù¥ Î™®Îì† **Biologic Process(ÏÉùÎ¨ºÌïôÏ†Å Í≥ºÏ†ï)**Í∞Ä Ïó∞Í≤∞ÎêòÏñ¥Ïïº ÎπÑÎ°úÏÜå 'ÎÇò'ÎùºÎäî ÏÇ¨ÎûåÏù¥ ÏÑ§Î™ÖÎê©ÎãàÎã§. 
>
> > [!INFO] PAGE 34-37: Ïú†Ï†ÑÏûê(Gene)ÏôÄ Î∞úÌòÑ(Expression)
> > 34ÌéòÏù¥ÏßÄ, 'Ïú†Ï†ÑÏûê'Ïùò Ï†ïÏùòÎ•º Î∂ÑÏûêÏ†Å Í¥ÄÏ†êÏóêÏÑú ÌôïÏã§Ìûà Ìï©ÏãúÎã§.
> > * **Ï†ïÏùò:** Îã®Î∞±ÏßàÏù¥ÎÇò RNAÎ•º ÏΩîÎî©ÌïòÎäî DNA Ï°∞Í∞Å + **"Ïñ∏Ï†ú, Ïñ¥ÎîîÏÑú, ÏñºÎßàÎÇò(when, where, what amounts)"** ÎßåÎì§ÏßÄ Í≤∞Ï†ïÌïòÎäî Î™ÖÎ†πÏñ¥ÍπåÏßÄ Ìè¨Ìï®ÏûÖÎãàÎã§. 
> > * **Expression (36p):**
> >     * **Transcription (Ï†ÑÏÇ¨):** Ìïµ(Nucleus) ÏïàÏóêÏÑú DNA ‚Üí mRNA. (ÏÑ±ÏàôÌïú mRNAÍ∞Ä Îê®) 
> >     * **Translation (Î≤àÏó≠):** ÏÑ∏Ìè¨Ïßà(Cytoplasm)Î°ú ÎÇòÏôÄÏÑú mRNA ‚Üí Protein. 
>
> > [!IMPORTANT] PAGE 39: Clinical Sequencing Ï¢ÖÎ•ò (Ï°±Î≥¥ ÏïºÎßà! ‚òÖ)
> > Ïûê, Ïó¨Í∏∞ **Î≥ÑÌëú 5Í∞ú** Î∞ïÏúºÏÑ∏Ïöî. Î≥ëÏõêÏóêÏÑú "Ïú†Ï†ÑÏûê Í≤ÄÏÇ¨Ìï©ÏãúÎã§" Ìï† Îïå Îã§ Í∞ôÏùÄ Í≤å ÏïÑÎãôÎãàÎã§. Í∞Å Î∞©Î≤ïÏù¥ **Î¨¥ÏóáÏùÑ(Target)** Î≥¥Í≥† **Ïñ¥Îñ§ ÎèåÏó∞Î≥ÄÏù¥(Application)**Î•º Ïû°ÎäîÏßÄ Îß§Ïπ≠Ìï¥Ïïº Ìï©ÎãàÎã§.
> >
> > 1.  **Whole Genome Sequencing (WGS, Ï†ÑÏû• Ïú†Ï†ÑÏ≤¥):**
> >     * **Î≤îÏúÑ:** DNA Ï†ÑÏ≤¥.
> >     * **Ïû°Îäî Í≤É:** **Structural variants (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥)**, Point mutations, Copy number variation (CNV). Îã§ Ïû°ÏäµÎãàÎã§. 
> > 2.  **Whole-Exome Sequencing (WES):**
> >     * **Î≤îÏúÑ:** **Exon baits**Î•º Ïç®ÏÑú Îã®Î∞±Ïßà ÎßåÎìúÎäî **1% (Exon)**Îßå Î¥ÖÎãàÎã§. Í∞ÄÏÑ±ÎπÑÍ∞Ä Ï¢ãÏ£†.
> >     * **Ïû°Îäî Í≤É:** Point mutations, CNV. (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥Îäî Ïûò Î™ª Î¥ÖÎãàÎã§) 
> > 3.  **PCR Amplicon (Targeted Panel):**
> >     * **Î≤îÏúÑ:** ÌäπÏ†ï Ïú†Ï†ÑÏûêÎßå Ï¶ùÌè≠.
> >     * **Ïû°Îäî Í≤É:** Point mutations, Deletions. ÌäπÏ†ï ÏßàÎ≥ë ÌÉÄÍ≤üÌåÖÌï† Îïå ÏîÅÎãàÎã§. 
> > 4.  **Transcriptome (RNA-seq):**
> >     * **Î≤îÏúÑ:** RNA Ï†ÑÏ≤¥.
> >     * **Ïû°Îäî Í≤É:** **Gene expression (Î∞úÌòÑÎüâ)**, **Gene fusions (ÏúµÌï© Ïú†Ï†ÑÏûê)**, Splice variants. 
>
> > [!INFO] PAGE 40: Genotype LayerÎ≥Ñ Î≥ÄÏù¥ Ï¢ÖÎ•ò (Ïö©Ïñ¥ Ï†ïÎ¶¨)
> > 40ÌéòÏù¥ÏßÄ ÌëúÎäî ÏïûÏùò ÎÇ¥Ïö©ÏùÑ Ï†ïÎ¶¨Ìïú Í≤ÅÎãàÎã§. Í∞Å Î†àÎ≤®ÏóêÏÑú ÏùºÏñ¥ÎÇòÎäî **Event** Ïö©Ïñ¥Î•º Ïô∏Ïö∞ÏÑ∏Ïöî.
> > * **Genome:** SNP (Îã®Ïùº ÏóºÍ∏∞ Îã§ÌòïÏÑ±), InDel (ÏÇΩÏûÖ/Í≤∞Ïã§), CNV (Î≥µÏ†úÏàò Î≥ÄÏù¥), SV (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥). 
> > * **Transcriptome:** Gene expression Î≥ÄÌôî, Alternative splicing(ÏÑ†ÌÉùÏ†Å Ïä§ÌîåÎùºÏù¥Ïã±). 
> > * **Proteome:** PTM (Post-translational modification, Î≤àÏó≠ ÌõÑ Î≥ÄÌòï). 

> [!NOTE] Pages 41-51: Ï†ÑÏÇ¨ Ï°∞Ï†àÍ≥º Îã®Î∞±ÏßàÏ≤¥ (Regulation & Proteome)
> Ïûê, DNAÏóê Ï†ïÎ≥¥Í∞Ä ÏûàÎã§Í≥† ÎÅùÏù¥ ÏïÑÎãôÎãàÎã§. Í∑∏Í±∏ ÏùΩÏñ¥ÎÇ¥Í≥†(Transcription), Í∞ÄÍ≥µÌïòÍ≥†(Splicing), Îã®Î∞±ÏßàÎ°ú ÎßåÎì§Í≥†(Translation), Îòê ÏàòÏ†ï(PTM)Ìï¥Ïïº ÎπÑÎ°úÏÜå Í∏∞Îä•Ïù¥ ÏÉùÍπÅÎãàÎã§. Ïù¥ Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨Í∞Ä Í≥†Ïû• ÎÇòÎ©¥ Í∑∏Í≤å Î∞îÎ°ú 'Ïïî'Ïù¥Í≥† 'ÏßàÎ≥ë'ÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 41-43: Ï†ÑÏÇ¨ ÎÑ§Ìä∏ÏõåÌÅ¨ÏôÄ Chromatin (Ï°∞Ï†àÏùò ÏãúÏûë)
> > 41ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. ÏÑ∏Ìè¨Ìïµ(Nucleus)ÏóêÏÑú ÏùºÏñ¥ÎÇòÎäî ÏùºÎì§ÏûÖÎãàÎã§.
> > * **Transcriptional networks (Ï†ÑÏÇ¨ ÎÑ§Ìä∏ÏõåÌÅ¨):**
> >     * **Transcription Factors (TF):** Ï†ÑÏÇ¨Î•º ÏãúÏûëÌïòÎäî Ïó¥Ïá†ÏûÖÎãàÎã§. 
> >     * **Cofactors & Chromatin regulation:** TFÎ•º ÎèÑÏôÄÏ£ºÍ±∞ÎÇò Î∞©Ìï¥ÌïòÎäî ÏπúÍµ¨Îì§Ïù¥Ï£†. 
> >     * **DNA Methylation & Histone Modification:** DNAÎ•º Í∞êÍ≥† ÏûàÎäî Ïã§Ìå®(Histone)Î•º Ï°∞Ïù¥Í±∞ÎÇò ÌíÄÏñ¥ÏÑú Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌï©ÎãàÎã§. (EpigeneticsÏùò ÌïµÏã¨) 
> > * **42ÌéòÏù¥ÏßÄ Íµ¨Ï°∞:** DNAÎäî Í∑∏ÎÉ• ÏûàÎäî Í≤å ÏïÑÎãàÎùº **Histone**Ïóê Í∞êÍ≤® **Nucleosome**ÏùÑ ÌòïÏÑ±Ìï©ÎãàÎã§. Ï†ÑÏÇ¨Í∞Ä ÏùºÏñ¥ÎÇòÎ†§Î©¥ Ïù¥ Íµ¨Ï°∞Í∞Ä ÌíÄÎ†§Ïïº ÌïòÎäîÎç∞, Í∑∏ Ïó¥Î¶∞ Î∂ÄÏúÑÎ•º **DNase I hypersensitive sites**ÎùºÍ≥† Ìï©ÎãàÎã§. "Ïó¨Í∏∞Í∞Ä ÌôúÏÑ± Î∂ÄÏúÑÎã§"ÎùºÎäî ÎúªÏù¥Ï£†. 
> > * **43ÌéòÏù¥ÏßÄ ÏõêÍ±∞Î¶¨ Ï°∞Ï†à:** **Long-range regulatory elements**Î•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏûê Î∞îÎ°ú ÏòÜÏù¥ ÏïÑÎãàÎùº ÏïÑÏ£º Î©ÄÎ¶¨ Îñ®Ïñ¥ÏßÑ Í≥≥ÏóêÏÑúÎèÑ Ï°∞Ï†à Ïã†Ìò∏Î•º Î≥¥ÎÉÖÎãàÎã§. DNAÍ∞Ä Í≥†Î¶¨Ï≤òÎüº ÌúòÏñ¥Ï†∏ÏÑú(Looping) ÎßåÎÇòÎäî Í≤ÅÎãàÎã§. 
>
> > [!INFO] PAGE 44-45: Ï†ÑÏÇ¨ Îã®ÏúÑÏùò Ìï¥Î∂Ä (Anatomy of Transcription)
> > 44ÌéòÏù¥ÏßÄ, Ïú†Ï†ÑÏûêÏùò Íµ¨Ï°∞Î•º ÎúØÏñ¥Î¥ÖÏãúÎã§. Ïö©Ïñ¥ Ï†ïÌôïÌûà ÏïÑÏÖîÏïº Ìï©ÎãàÎã§.
> > * **Promoter (Cis-regulatory region):** Ï†ÑÏÇ¨ ÏãúÏûë ÏúÑÏπòÎ•º Ïû°ÏïÑÏ£ºÎäî Í≥≥. **Basal (core) promoter**ÏôÄ **Module (Enhancer)**Î°ú ÎÇòÎâ©ÎãàÎã§. 
> > * **Transcription Unit:** Ïã§Ï†ú Î≥µÏÇ¨ÎêòÎäî Íµ¨Í∞Ñ. **Exon(ÎÇ®Îäî Î∂ÄÎ∂Ñ)**Í≥º **Intron(Î≤ÑÎ†§ÏßÄÎäî Î∂ÄÎ∂Ñ)**, Í∑∏Î¶¨Í≥† ÏñëÎÅùÏùò **UTR (Untranslated Region)**Ïù¥ ÏûàÏäµÎãàÎã§. 
> > * **45ÌéòÏù¥ÏßÄ Looping:** ÏïÑÍπå ÎßêÌïú ÏõêÍ±∞Î¶¨ Ï°∞Ï†àÏù¥ Ïñ¥ÎñªÍ≤å ÏùºÏñ¥ÎÇòÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§. **Looping factors**Í∞Ä DNAÎ•º ÌúòÍ≤å ÎßåÎì§Ïñ¥ Î©ÄÎ¶¨ ÏûàÎäî EnhancerÎ•º Promoter Í∑ºÏ≤òÎ°ú ÎÅåÍ≥† ÏòµÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 46: p53 Íµ¨Ï°∞ ÏÉÅÏÑ∏ (ÏïºÎßà/Í∏∞Ï∂ú Ìè¨Ïù∏Ìä∏ ‚òÖ)
> > Ïûê, ÏùòÎåÄÏÉùÏù¥ÎùºÎ©¥ **p53** Î™®Î•¥Î©¥ Í∞ÑÏ≤©ÏûÖÎãàÎã§. 'Ïú†Ï†ÑÏ≤¥Ïùò ÏàòÌò∏Ïûê'Ï£†. 46ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ ÌòÑÎØ∏Í≤Ω Î≥¥ÎìØ Î≥¥ÏÑ∏Ïöî.
> > * **Íµ¨Ï°∞Ï†Å ÌäπÏßï:**
> >     * **DNA-binding domain:** DNAÏôÄ ÏßÅÏ†ë Í≤∞Ìï©ÌïòÎäî Î∂ÄÏúÑ. Ïó¨Í∏∞Ïóê **Zinc atom (ÏïÑÏó∞ ÏõêÏûê)**Ïù¥ **Stabilizer(ÏïàÏ†ïÌôîÏ†ú)**Î°ú Î∞ïÌòÄ ÏûàÏäµÎãàÎã§. 
> >     * **Tetramerization domain:** p53ÏùÄ ÌòºÏûê Ïùº Ïïà Ìï©ÎãàÎã§. 4Í∞úÍ∞Ä Î≠âÏ≥êÏÑú(Tetramer) ÏùºÌï©ÎãàÎã§. 
> >     * **Transcription domain:** Ï†ÑÏÇ¨Î•º ÌôúÏÑ±ÌôîÌïòÎäî Î∂ÄÏúÑ. 
> > * **ÏûÑÏÉÅ Ïó∞Í≥Ñ:** ÏïîÌôòÏûêÏóêÏÑú p53 Î≥ÄÏù¥Í∞Ä Î∞úÍ≤¨ÎêòÎ©¥, Ï£ºÎ°ú Ï†Ä **DNA-binding domain**Ïù¥ ÎßùÍ∞ÄÏ†∏ÏÑú DNAÎ•º Î™ª Ïû°Í≤å ÎêòÎäî Í≤ΩÏö∞Í∞Ä ÎßéÏäµÎãàÎã§.
> >   ![Pasted image 20251209101527.png](/img/user/%ED%95%99%EC%97%85/%EC%98%88%202-2/%EB%B6%84%EC%9E%90%EC%9C%A0%EC%A0%84%ED%95%99/%EC%82%AC%EC%A0%84%EC%A0%95%EB%A6%AC%EB%B3%B8/%EA%B8%B0%EB%A7%90/%EB%8F%99%EB%B4%89%EC%9D%B4%EB%AF%B8%EC%A7%80/Pasted%20image%2020251209101527.png)
>
> > [!INFO] PAGE 47-48: SplicingÍ≥º Ï†ÑÏÇ¨Ïùò Î≥µÏû°ÏÑ±
> > 47ÌéòÏù¥ÏßÄÎ•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏûê ÌïòÎÇò(Gene 1)ÏóêÏÑú ÌôîÏÇ¥ÌëúÍ∞Ä Ïó¨Îü¨ Í∞ú ÎÇòÏò§Ï£†?
> > * **Alternative Splicing:** ÏóëÏÜêÏùÑ Ïñ¥ÎñªÍ≤å Ï°∞Î¶ΩÌïòÎäêÎÉêÏóê Îî∞Îùº ÌïòÎÇòÏùò Ïú†Ï†ÑÏûêÏóêÏÑú Ïó¨Îü¨ Ï¢ÖÎ•òÏùò mRNA(Transcripts)Í∞Ä ÎÇòÏòµÎãàÎã§.
> > * **Reverse Strand Transcripts:** Ïã¨ÏßÄÏñ¥ Î∞òÎåÄ Í∞ÄÎã•ÏóêÏÑúÎèÑ Ï†ÑÏÇ¨Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. 
> > * 48ÌéòÏù¥ÏßÄÎäî Îçî Î≥µÏû°Ìï©ÎãàÎã§. **tiRNA, PASR, ncRNA** Í∞ôÏùÄ ÎπÑÏïîÌò∏Ìôî RNAÎì§ÎèÑ ÏóÑÏ≤≠ÎÇòÍ≤å ÏèüÏïÑÏ†∏ ÎÇòÏòµÎãàÎã§. Ïö∞Î¶¨ Î™∏ÏùÄ ÏÉùÍ∞ÅÎ≥¥Îã§ Ìõ®Ïî¨ ÏàòÎã§Ïä§ÎüΩÏäµÎãàÎã§. 
>
> > [!INFO] PAGE 49-51: ProteomeÍ≥º PTM (Î≤àÏó≠ ÌõÑ Î≥ÄÌòï)
> > 49ÌéòÏù¥ÏßÄ Ïö∞Ï∏°ÏùÑ Î≥¥ÏÑ∏Ïöî. Îã®Î∞±ÏßàÏù¥ ÎßåÎì§Ïñ¥ÏßÑ ÌõÑ(Translation)ÏóêÎèÑ ÎÅùÏù¥ ÏïÑÎãôÎãàÎã§. **Post-translational modifications (PTM)**Ïù¥ ÏùºÏñ¥ÎÇ©ÎãàÎã§.
> > * **Ï¢ÖÎ•ò (Ïô∏Ïö∞ÏÑ∏Ïöî):**
> >     * **Phosphorylation (Ïù∏ÏÇ∞Ìôî):** Ïä§ÏúÑÏπò Ïó≠Ìï† (Í∞ÄÏû• Ï§ëÏöî). 
> >     * **Glycosylation (ÎãπÌôî):** ÎãπÏùÑ Î∂ôÏûÑ. 
> >     * **Acetylation (ÏïÑÏÑ∏Ìã∏Ìôî)** 
> >     * **Ubiquitination (Ïú†ÎπÑÌÄ¥Ìã¥Ìôî):** Î∂ÑÌï¥ Ïã†Ìò∏. 
> >     * **SUMOylation:** Îã®Î∞±Ïßà Í∏∞Îä• Ï°∞Ï†à. 
> > * **Í≤∞Î°† (50-51p):** Ïú†Ï†ÑÏûêÎäî ÌïòÎÇòÏßÄÎßå, SplicingÍ≥º PTMÏùÑ Í±∞ÏπòÎ©¥ ÏàòÏã≠, ÏàòÎ∞± Í∞ÄÏßÄÏùò **Mature proteins**Í∞Ä ÏÉùÍπÅÎãàÎã§. Í∑∏ÎûòÏÑú ProteomeÏù¥ GenomeÎ≥¥Îã§ Ìõ®Ïî¨ Î≥µÏû°Ìïú Í≤ÅÎãàÎã§. 

> [!NOTE] Pages 52-59: ÎåÄÏÇ¨Ï≤¥ÏôÄ ÌëúÌòÑÌòï (Metabolome & Phenotype)
> Ïûê, DNAÏóêÏÑú ÏãúÏûëÎêú Ïó¨Ï†ïÏù¥ ÎìúÎîîÏñ¥ Ïö∞Î¶¨ Î™∏Ïùò Ïã§Ï†ú Í∏∞Îä•Ïù∏ 'ÎåÄÏÇ¨'ÏôÄ 'ÌëúÌòÑÌòï'Ïóê ÎèÑÎã¨ÌñàÏäµÎãàÎã§. Ïú†Ï†ÑÏûêÍ∞Ä ÏïÑÎ¨¥Î¶¨ Ï¢ãÏïÑÎèÑ ÌôòÍ≤ΩÏù¥ ÎÇòÏÅòÎ©¥ Î≥ëÏù¥ ÏÉùÍ∏∞Îäî ÏõêÎ¶¨, Í∑∏Î¶¨Í≥† Ïïî ÌôòÏûêÏùò ÏÑ∏Ìè¨Î•º ÎñºÏñ¥ÎÇ¥ÏÑú Ïã§Ï†úÎ°ú ÏïΩÏùÑ Ï≥êÎ≥¥Îäî(Functional Assay) ÏµúÏã† Í∏∞Î≤ïÍπåÏßÄ ÏîπÏñ¥Î®πÏñ¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 53: Ïã†Ìò∏ Ï†ÑÎã¨Í≥º ÎåÄÏÇ¨ Í≤ΩÎ°ú (ÌöåÎ°úÎèÑ Î∂ÑÏÑù)
> > 53ÌéòÏù¥ÏßÄ Ï¢åÏ∏° Í∑∏Î¶º, ÏïÑÏ£º Ï†ÑÌòïÏ†ÅÏù∏ **ÏÑ∏Ìè¨ Ïã†Ìò∏ Ï†ÑÎã¨(Signaling Pathway)** ÌöåÎ°úÎèÑÏûÖÎãàÎã§. ÏàúÏÑúÎ•º Ïô∏Ïö∞ÏÑ∏Ïöî.
> > 1.  **Sensor (Í∞êÏßÄÍ∏∞):** ÏÑ∏Ìè¨ÎßâÏùò **Ligand + Receptor**Í∞Ä Ïã†Ìò∏Î•º Î∞õÏäµÎãàÎã§.
> > 2.  **Transducer (Î≥ÄÌôòÍ∏∞):** Ïù∏ÏÇ∞Ìôî(P) Îì±ÏùÑ ÌÜµÌï¥ Ïã†Ìò∏Î•º ÏïàÏúºÎ°ú Ï†ÑÎã¨Ìï©ÎãàÎã§.
> > 3.  **Circuit (ÌöåÎ°ú):** ÏÑ∏Ìè¨Ïßà(Cytoplasm) ÎÇ¥Ïùò Î≥µÏû°Ìïú Ïã†Ìò∏ ÎÑ§Ìä∏ÏõåÌÅ¨.
> > 4.  **Actuator (Íµ¨ÎèôÍ∏∞):** Ìïµ(Nucleus)ÏúºÎ°ú Îì§Ïñ¥Í∞Ä **DNA**Ïùò Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌï©ÎãàÎã§.
> >
> > * **Ïö∞Ï∏° Í∑∏Î¶º (Multi-omics flow):**
> >     * **Genome:** Gene 1, 2...
> >     * **Proteome:** Protein A, B, C... Ìö®ÏÜå(Enzyme)Îì§Ïù¥Ï£†.
> >     * **Metabolome:** Ìö®ÏÜåÎì§Ïù¥ Í∏∞Ïßà(a)ÏùÑ ÏÉùÏÇ∞Î¨º(b)Î°ú Î∞îÍøâÎãàÎã§. **Feedback loop** (Ï†êÏÑ† ÌôîÏÇ¥Ìëú)Í∞Ä Ï°¥Ïû¨ÌïòÏó¨ ÎåÄÏÇ¨ ÏÇ∞Î¨ºÏù¥ Îã§Ïãú Ïú†Ï†ÑÏûê Î∞úÌòÑÏùÑ Ï°∞Ï†àÌïòÍ∏∞ÎèÑ Ìï©ÎãàÎã§.
>
> > [!INFO] PAGE 54: Metabolome (ÎåÄÏÇ¨Ï≤¥)Ïùò ÏúÑÏπò
> > 54ÌéòÏù¥ÏßÄ ÌëúÏóêÏÑú Îπ®Í∞Ñ Î∞ïÏä§Î•º Î≥¥ÏÑ∏Ïöî.
> > * **Metabolome:** GenotypeÎ≥¥Îã§Îäî **Phenotype**Ïóê Ìõ®Ïî¨ Í∞ÄÍπùÏäµÎãàÎã§. Ï¶â, **"ÌòÑÏû¨ Î™∏ ÏÉÅÌÉúÎ•º Í∞ÄÏû• Ïã§ÏãúÍ∞ÑÏúºÎ°ú Î∞òÏòÅÌïòÎäî ÏßÄÌëú"**ÏûÖÎãàÎã§. Ïú†Ï†ÑÏûêÎäî ÌÉúÏñ¥ÎÇ† Îïå Í≤∞Ï†ïÎêòÏßÄÎßå, ÎåÄÏÇ¨Ï≤¥Îäî ÏïÑÏπ® Î®πÏóàÎÉê Íµ∂ÏóàÎÉêÏóê Îî∞Îùº Îã¨ÎùºÏßÄÎãàÍπåÏöî. 
>
> > [!IMPORTANT] PAGE 56: Ïú†Ï†ÑÏûêÏôÄ ÌôòÍ≤ΩÏùò ÏÉÅÌò∏ÏûëÏö© (Landscape Model)
> > Ïûê, Ïù¥ Í∑∏Î¶º Ïù¥Ìï¥ Î™ªÌïòÎ©¥ ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïô ÍΩùÏûÖÎãàÎã§. Í≥µÏù¥ Íµ¥Îü¨Í∞ÄÎäî Í≤ΩÎ°ú(Trajectory)Í∞Ä ÏÑ∏Ìè¨Ïùò Ïö¥Î™ÖÏûÖÎãàÎã§.
> > * **a (Phenotypic state):** Í≥µÏù¥ Íµ¥Îü¨ÎÇ¥Î†§ÏôÄ Í≥®ÏßúÍ∏∞(Attractor)Ïù∏ **P1~P5** Ï§ë ÌïòÎÇòÏóê ÏïàÏ∞©Ìï©ÎãàÎã§. Ïù¥Í≤å Ï†ïÏÉÅÏ†ÅÏù∏ Î∂ÑÌôîÏûÖÎãàÎã§. 
> > * **b (Environmental factor):** Ïô∏Î∂Ä ÌôòÍ≤ΩÏù¥ Í≥µÏùÑ Î∞ÄÏñ¥Î≤ÑÎ¶ΩÎãàÎã§. Í∑∏Îü¨Î©¥ ÏõêÎûò Í∞ÄÏïº Ìï† Í∏∏(Trajectory)ÏùÑ Î≤óÏñ¥ÎÇò Îã§Î•∏ ÌëúÌòÑÌòïÏúºÎ°ú Í∞ÄÍ≤å ÎêòÏ£†. 
> > * **c (Genetic factor):** Ïú†Ï†ÑÏûê Î≥ÄÏù¥Í∞Ä ÏÉùÍ∏∞Î©¥? **ÏßÄÌòï(Landscape) ÏûêÏ≤¥**Í∞Ä Î∞îÎÄùÎãàÎã§. Í≥®ÏßúÍ∏∞ Î™®ÏñëÏù¥ Î∞îÎÄåÏñ¥ÏÑú Í≥µÏù¥ ÏóâÎö±Ìïú Í≥≥ÏúºÎ°ú Íµ¥Îü¨Í∞ÄÍ≤å ÎßåÎì≠ÎãàÎã§. 
> > * **d (Noise):** ÌäπÎ≥ÑÌïú ÏöîÏù∏ ÏóÜÏñ¥ÎèÑ ÌôïÎ•†Ï†ÅÏù∏ Ïû°Ïùå(Stochasticity)ÎßåÏúºÎ°úÎèÑ Í≤∞Í≥ºÍ∞Ä Îã¨ÎùºÏßà Ïàò ÏûàÏäµÎãàÎã§. 
>
> > [!TIP] üí° PAGE 57-58: Ï∞®ÏÑ∏ÎåÄ Í∏∞Îä•ÏÑ± Î∂ÑÏÑù (Next-Gen Functional Assays)
> > 57-58ÌéòÏù¥ÏßÄÎäî Ïã§Ï†ú Î≥ëÏõêÏóêÏÑú Ïïî ÌôòÏûê Ï°∞ÏßÅÏùÑ ÎñºÏñ¥ÎÇ¥ÏÑú ÌïòÎäî Í≤ÄÏÇ¨Îì§ÏûÖÎãàÎã§. **"ÌôòÏûê ÎßûÏ∂§Ìòï ÏπòÎ£å(Precision Medicine)"**Ïùò ÏµúÏ†ÑÏÑ†Ïù¥Ï£†.
> >
> > **1. Í≤ÄÏ≤¥ ÌôïÎ≥¥ (57p):**
> > * **Solid tumours (Í≥†ÌòïÏïî):** Biopsy(ÏÉùÍ≤Ä) ÎòêÎäî CTCs(ÏàúÌôò Ï¢ÖÏñë ÏÑ∏Ìè¨).
> > * **Haematological (ÌòàÏï°Ïïî):** Bone marrow biopsy(Í≥®Ïàò ÏÉùÍ≤Ä).
> > * Ïù¥Í±∏Î°ú **Organoids (Ïò§Í∞ÄÎÖ∏Ïù¥Îìú, ÎØ∏Îãà Ïû•Í∏∞)**Î•º ÎßåÎì≠ÎãàÎã§. 
> >
> > **2. ÌïµÏã¨ Î∂ÑÏÑùÎ≤ï (58p - Ïö©Ïñ¥ ÏïîÍ∏∞):**
> > * **Kinase profiling:** Ïù∏ÏÇ∞Ìôî Ìö®ÏÜå ÌôúÏÑ± Ï∏°Ï†ï. 
> > * **Immuno-flow / FACS:** Ìï≠Ï≤¥Î•º Ïù¥Ïö©Ìï¥ Îã®Î∞±Ïßà Î∞úÌòÑ Î∂ÑÏÑù. 
> > * **DBP (Dynamic BH3 Profiling):** ÏÑ∏Ìè¨Í∞Ä ÏñºÎßàÎÇò Ï£ΩÍ∏∞ Ïâ¨Ïö¥ÏßÄ(**Apoptotic priming**) Ï∏°Ï†ï. 
> > * **Cytotoxicity (ÏÑ∏Ìè¨ ÎèÖÏÑ±):** ÏïΩ Ï≥§ÏùÑ Îïå ÏñºÎßàÎÇò Ï£ΩÎÇò? (**ATP levels, MTT** Îì±ÏúºÎ°ú Ï∏°Ï†ï). 
> > * **PDX (Patient-Derived Xenograft):** Ï•ê(Mouse)Ïóê ÌôòÏûê ÏïîÏùÑ Ïù¥ÏãùÌï¥ÏÑú ÌÖåÏä§Ìä∏. Í∞ÄÏû• Ï†ïÌôïÌïòÏßÄÎßå ÎπÑÏã∏Í≥† Ïò§Îûò Í±∏Î¶º. 
>
> > [!INFO] PAGE 59: Phenome (ÌòÑÏÉÅÏ≤¥)Ïùò Íµ¨ÏÑ±
> > 59ÌéòÏù¥ÏßÄ ÎßàÏßÄÎßâ Îã®Í≥ÑÏûÖÎãàÎã§.
> > * Í≤∞Íµ≠ Ïù¥ Î™®Îì† Í≥ºÏ†ïÏùò ÎÅùÏùÄ Î¨¥ÏóáÏù∏Í∞Ä?
> > * **Tumorigenesis (Ï¢ÖÏñë ÌòïÏÑ±)**
> > * **Angiogenesis (ÌòàÍ¥Ä ÏÉùÏÑ±)**
> > * **Metastasis (Ï†ÑÏù¥)**
> > * Ïù¥Îü∞ Í±∞ÏãúÏ†ÅÏù∏ ÌäπÏßïÎì§ÏùÑ **Phenome**Ïù¥ÎùºÍ≥† Î∂ÄÎ¶ÖÎãàÎã§. 

> [!NOTE] Pages 60-66: ÌõÑÏÑ±Ïú†Ï†ÑÌïô ÌòÅÎ™Ö (Epigenomic Revolution)
> Ïûê, DNA ÏóºÍ∏∞ÏÑúÏó¥Ïù¥ Ïö¥Î™ÖÏùò Ï†ÑÎ∂ÄÍ∞Ä ÏïÑÎãôÎãàÎã§. ÎòëÍ∞ôÏùÄ ÏïÖÎ≥¥(DNA)Î•º Í∞ÄÏßÄÍ≥†ÎèÑ Ïó∞Ï£ºÏûê(ÏÑ∏Ìè¨)Ïóê Îî∞Îùº Ïä¨Ìîà Í≥°Ïù¥ ÎêòÍ∏∞ÎèÑ ÌïòÍ≥† Í∏∞ÏÅú Í≥°Ïù¥ ÎêòÍ∏∞ÎèÑ ÌïòÏ£†. Í∑∏Í≤å Î∞îÎ°ú **Epigenetics**ÏûÖÎãàÎã§. Ïó¨Í∏∞ÏÑúÎäî **ChromatinÏùò Íµ¨Ï°∞ Î≥ÄÌôî**ÏôÄ **Histone Code**Î•º Ìï¥ÎèÖÌïòÎäî Í≤å ÌïµÏã¨ÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 60-61: ChromatinÏùò Í∞úÌèêÏôÄ Histone Tail
> > 60ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî.
> > * **Compact DNA (a):** ÍΩÅÍΩÅ Í∞êÍ≤® ÏûàÏäµÎãàÎã§. Ïù¥Îü¨Î©¥ Ï†ÑÏÇ¨ Ïù∏Ïûê(TF)Í∞Ä Ï†ëÍ∑ºÏùÑ Î™ª ÌïòÏ£†. **"Gene Inactive"** ÏÉÅÌÉúÏûÖÎãàÎã§. 
> > * **Relaxed DNA (b):** Íµ¨Ï°∞Í∞Ä ÌíÄÎ†∏ÏäµÎãàÎã§(Alteration of structure). DNAÍ∞Ä ÎÖ∏Ï∂úÎêòÎãà Ï†ÑÏÇ¨(Transcription)Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. **"Gene Active"** ÏÉÅÌÉúÏûÖÎãàÎã§. 
> >
> > 61ÌéòÏù¥ÏßÄÎ•º Î≥¥ÏÑ∏Ïöî. Ïù¥ ChromatinÏùÑ ÎßåÎìúÎäî Ïã§Ìå®Í∞Ä **Histone**Ïù¥Ï£†.
> > * **Íµ¨ÏÑ±:** **H2A, H2B, H3, H4**Í∞Ä Í∞ÅÍ∞Å 2Í∞úÏî© Î™®Ïó¨ 8ÎüâÏ≤¥(Octamer)Î•º Ïù¥Î£πÎãàÎã§. 
> > * **Tail (Íº¨Î¶¨):** Í∑∏Î¶ºÏóê ÏÇêÏ£ΩÏÇêÏ£Ω ÌäÄÏñ¥ÎÇòÏò® ÏÑ†Îì§ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å **Histone Tail**ÏûÖÎãàÎã§. Ïó¨Í∏∞Í∞Ä Î∞îÎ°ú ÌôîÌïôÏ†Å Î≥ÄÌòïÏù¥ ÏùºÏñ¥ÎÇòÎäî **'Ï°∞Ï†à Ïä§ÏúÑÏπò'**ÏûÖÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 62: ÌûàÏä§ÌÜ§ ÏΩîÎìú (Histone Code) ÏÉÅÏÑ∏ Î∂ÑÏÑù (‚òÖÏïîÍ∏∞)
> > 62ÌéòÏù¥ÏßÄ, Íπ®Ïïå Í∞ôÏùÄ ÏïåÌååÎ≤≥Îì§Ïù¥ ÎÇòÏòµÎãàÎã§. Ïù¥Í≤å ÌûàÏä§ÌÜ§ Íº¨Î¶¨Ïùò ÏïÑÎØ∏ÎÖ∏ÏÇ∞ ÏÑúÏó¥ÏûÖÎãàÎã§. ÏãúÌóòÏóê ÎÇòÏòµÎãàÎã§.
> >
> > **1. H3 Tail (ÏúÑÏ™Ω Í∑∏Î¶º):** 
> > * ÏÑúÏó¥ ÏãúÏûë: **N-ARTKQTARKSTGGK...** (Ïù¥Í±∞ ÎààÏóê ÏùµÌûàÏÑ∏Ïöî) 
> > * Ï£ºÏöî Î≥ÄÌòï ÏúÑÏπò (Ïà´ÏûêÎäî ÏïÑÎØ∏ÎÖ∏ÏÇ∞ Î≤àÌò∏):
> >     * **K (Lysine, Î¶¨Ïã†):** Ï£ºÎ°ú **Me (Methylation)**ÏôÄ **Ac (Acetylation)**Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. (Ïòà: K4, K9, K27) 
> >     * **S (Serine, ÏÑ∏Î¶∞):** Ï£ºÎ°ú **P (Phosphorylation, Ïù∏ÏÇ∞Ìôî)**Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. (Ïòà: S10, S28) 
> >
> > **2. H4 Tail (ÏïÑÎûòÏ™Ω Í∑∏Î¶º):** 
> > * ÏÑúÏó¥ ÏãúÏûë: **N-SGRGKGGK...** 
> > * Ïó¨Í∏∞ÎèÑ **Acetylation (Ac)**Ïù¥ ÏûîÎú© Î∂ôÏñ¥ ÏûàÏ£†? (K5, K8, K12, K16 Îì±) 
> >
> > **3. H2A & H2B:**
> > * **Ub (Ubiquitination):** Ïú†ÎπÑÌÄ¥Ìã¥Ïù¥ Î∂ôÍ∏∞ÎèÑ Ìï©ÎãàÎã§. 
> >
> > **[ÍµêÏàòÎãòÏùò ÌåÅ]** "KÏóê AcetylÍ∏∞Í∞Ä Î∂ôÏúºÎ©¥(Acetylation) Ï†ÑÏÇ¨Í∞Ä **Ï¥âÏßÑ**ÎêòÍ≥†, MethylÍ∏∞Í∞Ä Î∂ôÏúºÎ©¥(Methylation) ÏúÑÏπòÏóê Îî∞Îùº Ï¥âÏßÑÎêòÍ∏∞ÎèÑ ÌïòÍ≥† ÏñµÏ†úÎêòÍ∏∞ÎèÑ ÌïúÎã§." Ïù¥ ÏõêÏπôÏùÑ Íº≠ Í∏∞ÏñµÌïòÏÑ∏Ïöî.
>
> > [!IMPORTANT] PAGE 63: DNA Methylation (ÌôîÌïô Íµ¨Ï°∞)
> > 63ÌéòÏù¥ÏßÄ, Ïù¥Î≤àÏóî ÌûàÏä§ÌÜ§Ïù¥ ÏïÑÎãàÎùº DNA ÏßÅÏ†ë Î≥ÄÌòïÏûÖÎãàÎã§.
> > * **ÎåÄÏÉÅ:** **Cytosine (C, ÏãúÌÜ†Ïã†)** ÏóºÍ∏∞. 
> > * **Î≥ÄÌôî:** ÏãúÌÜ†Ïã†Ïùò 5Î≤à ÌÉÑÏÜå ÏúÑÏπòÏóê **Methyl group ($CH_3$)**Ïù¥ Î∂ôÏäµÎãàÎã§.
> > * **Í≤∞Í≥º:** **5-methylcytosine**Ïù¥ Îê©ÎãàÎã§. 
> > * **Í∏∞Îä•:** Ï£ºÎ°ú Ïú†Ï†ÑÏûê Î∞úÌòÑÏùÑ **ÏñµÏ†ú(Silencing)**ÌïòÎäî ÏûêÎ¨ºÏá† Ïó≠Ìï†ÏùÑ Ìï©ÎãàÎã§. Í∑∏Î¶ºÏùò ÌôîÌïô Íµ¨Ï°∞Ïãù($NH_2$ Î∞ëÏóê $H$Í∞Ä $CH_3$Î°ú Î∞îÎÄåÎäî Î∂ÄÎ∂Ñ)ÏùÑ ÌôïÏù∏ÌïòÏÑ∏Ïöî. 
>
> > [!INFO] PAGE 64-66: EpigenomeÏùò ÏúÑÏÉÅÍ≥º ÌÜµÌï©
> > 64ÌéòÏù¥ÏßÄ ÌëúÏùò Îπ®Í∞Ñ Î∞ïÏä§Î•º Î≥¥ÏÑ∏Ïöî.
> > * **EpigenomeÏùò Íµ¨ÏÑ± ÏöîÏÜå:**
> >     1.  **Methylation (DNA Î©îÌã∏Ìôî)** 
> >     2.  **Histone modification (ÌûàÏä§ÌÜ§ Î≥ÄÌòï)** 
> >     3.  **miRNA & LncRNA:** ÎπÑÏïîÌò∏Ìôî RNAÎì§ÎèÑ ÌõÑÏÑ±Ïú†Ï†ÑÌïôÏ†Å Ï°∞Ï†àÏóê Í¥ÄÏó¨Ìï©ÎãàÎã§. 
> >
> > 66ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ Ïù¥ Î™®Îì† Í≤å ÌÜµÌï©Îêú Î™®ÏäµÏûÖÎãàÎã§.
> > * **DNA Methylation**Ïù¥ ÎêòÏñ¥ ÏûàÍ≥†, **Histone**Îì§Ïù¥ Î≠âÏ≥ê ÏûàÏúºÎ©¥(Nucleosome) Ï†ëÍ∑º Î∂àÍ∞Ä.
> > * Î∞òÎ©¥ **DNase I hypersensitive sites**Îäî ÌûàÏä§ÌÜ§Ïù¥ ÏóÜÎäî Ïó¥Î¶∞ Íµ¨Í∞ÑÏúºÎ°ú, Ïó¨Í∏∞Í∞Ä **Functional genomic elements(Í∏∞Îä•Ï†Å Ïú†Ï†ÑÏ≤¥ ÏöîÏÜå)**Í∞Ä ÏûëÎèôÌïòÎäî Í≥≥ÏûÖÎãàÎã§. 

> [!NOTE] Pages 67-73: ÌõÑÏÑ±Ïú†Ï†ÑÌïôÍ≥º ÏßàÎ≥ë, Í∑∏Î¶¨Í≥† ENCODE
> Ïûê, "Ïú†Ï†ÑÏûêÎäî Ïö¥Î™ÖÏù¥ ÏïÑÎãàÎã§"ÎùºÎäî Îßê Îì§Ïñ¥Î¥§Ï£†? Í∑∏ Í≥ºÌïôÏ†Å Í∑ºÍ±∞Í∞Ä Ïó¨Í∏∞ Îã§ ÏûàÏäµÎãàÎã§. ÌôòÍ≤Ω(Îã§Ïù¥Ïñ¥Ìä∏, Ïä§Ìä∏Î†àÏä§)Ïù¥ Ïñ¥ÎñªÍ≤å ÎÇ¥ Ïú†Ï†ÑÏûêÏùò Ïä§ÏúÑÏπòÎ•º Ï°∞ÏûëÌï¥ÏÑú ÏïîÏù¥ÎÇò ÎãπÎá®Î≥ëÏùÑ ÏùºÏúºÌÇ§ÎäîÏßÄ, Í∑∏Î¶¨Í≥† Ïú†Ï†Ñ Ï†ïÎ≥¥Î•º ÎÑòÏñ¥ÏÑ† '4Ï∞®Ïõê Ïú†Ï†Ñ'Ïù¥ Î¨¥ÏóáÏù∏ÏßÄ ÏÇ¥Ìé¥Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 67-68: ENCODE ÌîÑÎ°úÏ†ùÌä∏ (ÌïÑÏàò ÏÉÅÏãù)
> > 67ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ ÏïûÏÑú Î∞∞Ïö¥ Ï†ÑÏÇ¨ Ï°∞Ï†àÏùò Ï¥ùÏ†ïÎ¶¨ÏûÖÎãàÎã§.  Ïù¥ Î≥µÏû°Ìïú Ï°∞Ï†à Î∂ÄÏúÑÎì§ÏùÑ Ï†ÑÎ∂Ä Îã§ ÏßÄÎèÑÏóê ÌëúÏãúÌïòÎ†§Îäî ÏãúÎèÑÍ∞Ä ÏûàÏóàÏúºÎãà, Î∞îÎ°ú **ENCODE**ÏûÖÎãàÎã§.
> > * **Ï†ïÏùò (68p):** **The Encyclopedia of DNA Elements**. 'DNA ÏöîÏÜå Î∞±Í≥ºÏÇ¨Ï†Ñ' ÌîÑÎ°úÏ†ùÌä∏ÏûÖÎãàÎã§. 
> > * **Î™©Ìëú:** Ïù∏Í∞Ñ Í≤åÎÜàÏùò **'Î™®Îì† Í∏∞Îä•Ï†Å ÏöîÏÜå(All functional elements)'**Î•º ÏãùÎ≥ÑÌïòÎäî Í≤É. 
> > * **ÎÇ¥Ïö©:** Îã®ÏàúÌûà Ïú†Ï†ÑÏûêÎßå Ï∞æÎäî Í≤å ÏïÑÎãàÎùº, **Regulatory elements(Ï°∞Ï†à Ïù∏Ïûê)**, **Exon variants**, **Alternative promoters** Îì± 'Í∏∞Îä•'ÏùÑ ÌïòÎäî Î™®Îì† Í≤ÉÏùÑ Ï∞æÏäµÎãàÎã§. 
>
> > [!INFO] PAGE 69: ÌõÑÏÑ±Ïú†Ï†ÑÌïôÏ†Å Ïä§ÏúÑÏπò (Active vs Inactive)
> > 69ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Í∞ôÏùÄ DNAÎùºÎèÑ ÏÉÅÌÉúÍ∞Ä Îã§Î¶ÖÎãàÎã§.
> > * **Inactive (ÎπÑÌôúÏÑ±):** DNAÍ∞Ä **Methylation** ÎêòÏñ¥ ÏûàÍ≥†, HistoneÏù¥ ÍΩâ Î≠âÏ≥êÏÑú(Inaccessible) Ïú†Ï†ÑÏûêÍ∞Ä Í∫ºÏ†∏ ÏûàÏäµÎãàÎã§. 
> > * **Active (ÌôúÏÑ±):** **Histone Modification**Ïóê ÏùòÌï¥ Íµ¨Ï°∞Í∞Ä ÌíÄÎ†§ ÏûàÍ≥†(Accessible), Ïú†Ï†ÑÏûêÍ∞Ä ÏºúÏ†∏ ÏûàÏäµÎãàÎã§. 
> > * **ÌïµÏã¨:** ÏãùÏù¥ÏöîÎ≤ï(Dietary sources) Í∞ôÏùÄ ÌôòÍ≤Ω ÏöîÏù∏Ïù¥ Î©îÌã∏Í∏∞(Methyl group)Î•º Ï†úÍ≥µÌï¥ÏÑú Ïù¥ Ïä§ÏúÑÏπòÎ•º Ï°∞ÏûëÌï† Ïàò ÏûàÎã§Îäî Í≤ÅÎãàÎã§. 
>
> > [!WARNING] PAGE 70: ÌôòÍ≤ΩÍ≥º ÏßàÎ≥ëÏùò Ïó∞Í≤∞Í≥†Î¶¨ (Environment-Disease Link)
> > 70ÌéòÏù¥ÏßÄ, Ïó¨Í∏∞Í∞Ä ÏûÑÏÉÅÏ†ÅÏúºÎ°ú Ï†úÏùº Ï§ëÏöîÌï©ÎãàÎã§. Ïôú ÎÇòÏÅú Í±∞ Î®πÏúºÎ©¥ ÏïîÏóê Í±∏Î¶¥ÍπåÏöî?
> > * **ÏòÅÌñ• ÏöîÏù∏ (Factors):** **Diet(ÏãùÎã®)**, **Aging(ÎÖ∏Ìôî)**, **Drugs**, **Environmental chemicals**, Ïã¨ÏßÄÏñ¥ **Development(Î∞úÎã¨ Í≥ºÏ†ï)**ÍπåÏßÄ. 
> > * **Í∏∞Ï†Ñ:** Ïù¥ ÏöîÏù∏Îì§Ïù¥ **DNA Methylation**Ïù¥ÎÇò **Histone Modification**ÏùÑ Î≥ÄÌôîÏãúÌÇµÎãàÎã§. 
> > * **Í≤∞Í≥º (Health Endpoints):** Ïú†Ï†ÑÏûêÍ∞Ä ÏûòÎ™ª ÏºúÏßÄÍ±∞ÎÇò Í∫ºÏ†∏ÏÑú **Cancer(Ïïî)**, **Autoimmune disease(ÏûêÍ∞ÄÎ©¥Ïó≠ÏßàÌôò)**, **Diabetes(ÎãπÎá®)** Îì±Ïù¥ Î∞úÏÉùÌï©ÎãàÎã§. 
>
> > [!INFO] PAGE 71: Ïú†Ï†ÑÏùò 4Í∞ÄÏßÄ Ï∞®Ïõê (4 Dimensions)
> > 71ÌéòÏù¥ÏßÄ ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏùÄ DNA(Genetic)Î°úÎßå ÎêòÎäî Í≤å ÏïÑÎãôÎãàÎã§. 
> > 1.  **Genetic:** DNA ÏóºÍ∏∞ÏÑúÏó¥.
> > 2.  **Epigenetic:** Chromatin marks, RNA silencing Îì±. (ÏÑ∏Ìè¨ Í∏∞Ïñµ)
> > 3.  **Behavioral:** ÌñâÎèôÏ†Å Ï†ÑÏàò (Îî∞Îùº ÌïòÍ∏∞ Îì±).
> > 4.  **Symbolic:** Ïñ∏Ïñ¥, Î¨∏Ìôî Îì± Ïù∏Í∞Ñ Í≥†Ïú†Ïùò Ï†ÑÏàò.
>
> > [!IMPORTANT] PAGE 72: ÌûàÏä§ÌÜ§ ÎßàÌÅ¨Ïùò Íµ¨Ï≤¥Ï†Å Í∏∞Îä• (Ïã¨Ìôî ‚òÖ)
> > 72ÌéòÏù¥ÏßÄ Ïõê ÏïàÏùò Í∏∞Ìò∏Îì§ÏùÑ Ìï¥ÏÑùÌï¥Ïïº Ìï©ÎãàÎã§. **K(ÎùºÏù¥Ïã†)**Ïóê Î≠êÍ∞Ä Î∂ôÎäêÎÉêÏóê Îî∞Îùº Ïö¥Î™ÖÏù¥ Í∞àÎ¶ΩÎãàÎã§. 
> > * **MeK4 (H3K4me):** Ï£ºÎ°ú **Activation (ÌôúÏÑ±Ìôî)**ÏôÄ Í¥ÄÎ†®Îê©ÎãàÎã§.
> > * **MeK9, MeK27 (H3K9me, H3K27me):** Ï£ºÎ°ú **Repression (ÏñµÏ†ú)**ÏôÄ Í¥ÄÎ†®Îê©ÎãàÎã§. (ÌôîÏÇ¥ÌëúÍ∞Ä ÏñµÏ†ú Î™®ÏñëÏù∏ Í≤É ÌôïÏù∏!) 
> > * **AcK (Acetylation):** Í±∞Ïùò Ìï≠ÏÉÅ **Activation**ÏûÖÎãàÎã§.
> > * **CpG Methylation:** DNA Î©îÌã∏ÌôîÎäî Ï£ºÎ°ú **ÏñµÏ†ú**ÏûÖÎãàÎã§.
> > * Ïù¥Îì§Ïù¥ ÏÑúÎ°ú ÏÉÅÌò∏ÏûëÏö©(Cross-talk)ÌïòÎ©∞ Ï†ïÍµêÌïòÍ≤å Ï°∞Ï†àÌï©ÎãàÎã§.
>
> > [!INFO] PAGE 73: EpigenomeÏùò ÌÜµÌï©Ï†Å ÏúÑÏπò
> > 73ÌéòÏù¥ÏßÄ, Îã§Ïãú ÌïúÎ≤à Ï†ÑÏ≤¥ ÏßÄÎèÑÎ•º Î¥ÖÎãàÎã§.
> > * **Epigenome**ÏùÄ GenomeÍ≥º Transcriptome ÏÇ¨Ïù¥ÏóêÏÑú Ï†ïÎ≥¥Ïùò ÌùêÎ¶ÑÏùÑ ÌÜµÏ†úÌïòÎäî **'Í≤ÄÎ¨∏ÏÜå'** Ïó≠Ìï†ÏùÑ Ìï©ÎãàÎã§. Ïó¨Í∏∞ÏÑú **Tumorigenesis(Ïïî Î∞úÏÉù)** Îì±Ïùò Ïö¥Î™ÖÏù¥ 1Ï∞®Ï†ÅÏúºÎ°ú Í≤∞Ï†ïÎêòÎäî Í≤ÉÏûÖÎãàÎã§. 

> [!NOTE] Pages 74-80: ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïôÏùò ÎèÑÍµ¨ÏôÄ Multi-Omics
> Ïûê, Ïù¥Ï†ú Ïù¥Î°†ÏùÄ Ï∂©Î∂ÑÌï©ÎãàÎã§. Ïã§Ï†úÎ°ú Ïù¥ Î∞©ÎåÄÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïñ¥ÎñªÍ≤å ÎΩëÏïÑÎÇ¥Í≥†(Microarray), Ïñ¥ÎñªÍ≤å Î∂ÑÏÑùÌï¥ÏÑú(AI), ÌôòÏûêÎ•º Î∂ÑÎ•ò(Stratification)ÌïòÎäîÏßÄ, Í∑∏ 'Î¨¥Í∏∞'Îì§ÏùÑ Ï†êÍ≤ÄÌï¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 74: Multi-OmicsÏôÄ AIÏùò Í≤∞Ìï© (ÏïåÍ≥†Î¶¨Ï¶ò Ï≤¥ÌÅ¨)
> > 74ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ Ï†ïÎ∞ÄÏùòÌïôÏùò 'Ï†ÑÌà¨ ÏßÄÎèÑ'ÏûÖÎãàÎã§. 
> > * **Multi-Omics:** Genome, Epigenome, Transcriptome, Proteome, MetabolomeÏùÑ Ï†ÑÎ∂Ä Ìï©Ïπ©ÎãàÎã§.
> > * **AI & Machine Learning:** Ïù¥ Îç∞Ïù¥ÌÑ∞Î•º ÏÇ¨ÎûåÏù¥ ÎààÏúºÎ°ú Î™ª Î¥ÖÎãàÎã§. AIÍ∞Ä ÌïÑÏöîÌïòÏ£†. Ïó¨Í∏∞Ïóê Ïì∞Ïù¥Îäî ÏïåÍ≥†Î¶¨Ï¶ò Ïù¥Î¶ÑÎì§ÏùÑ Íº≠ ÎààÏó¨Í≤®Î≥¥ÏÑ∏Ïöî.
> >     * **SVM (Support Vector Machine)** 
> >     * **DT (Decision Tree)** 
> >     * **RF (Random Forest)** 
> >     * **LightGBM:** ÏµúÍ∑º Îç∞Ïù¥ÌÑ∞ Î∂ÑÏÑù ÎåÄÌöåÏóêÏÑú ÎßéÏù¥ Ïì∞Ïù¥Îäî Í∞ïÎ†•Ìïú Î∂ÄÏä§ÌåÖ Î™®Îç∏ÏûÖÎãàÎã§. 
> >     * **Deep Learning (Îî•Îü¨Îãù):** Ïù¥ÎØ∏ÏßÄÎÇò ÎπÑÏ†ïÌòï Îç∞Ïù¥ÌÑ∞ Î∂ÑÏÑùÏóê Í∞ïÌïòÏ£†. 
> > * **Í≥ºÏ†ï:** Îç∞Ïù¥ÌÑ∞ ÌÜµÌï©(Data Integration) ‚Üí ÌäπÏßï ÏÑ†ÌÉù(Feature Selection) ‚Üí ÏòàÏ∏°(Prediction).
>
> > [!INFO] PAGE 75-76: ÌôòÏûê Ï∏µÌôî (Stratification)ÏôÄ Omics Ï†ïÏùò
> > 75ÌéòÏù¥ÏßÄ, ÏïåÎ°ùÎã¨Î°ùÌïú ÏÇ¨Îûå Í∑∏Î¶º Î≥¥Ïù¥Ï£†? 
> > * Í≥ºÍ±∞Ïóî Îã§ ÎòëÍ∞ôÏùÄ ÏÇ¨Îûå(Average patient) Ï∑®Í∏âÌñàÏßÄÎßå, Ïù¥Ï†úÎäî Îç∞Ïù¥ÌÑ∞Î•º ÌÜµÌï¥ **"Stratification(Ï∏µÌôî)"**Ìï©ÎãàÎã§. Í∑∏Î£πÏùÑ ÎÇòÎààÎã§Îäî ÎúªÏûÖÎãàÎã§. Í∑∏ÎûòÏïº **High effective treatment**Í∞Ä Í∞ÄÎä•ÌïòÎãàÍπåÏöî.
> >
> > 76ÌéòÏù¥ÏßÄ, Ïö©Ïñ¥ Ï†ïÎ¶¨ÌïòÍ≥† Í∞ëÏãúÎã§. 
> > * **Omics:** "-ome"ÏùÄ Ï†ÑÏ≤¥(Complete knowledge)Î•º ÎúªÌï©ÎãàÎã§.
> > * **Transcriptomics:** RNA Ï†ÑÏ≤¥.
> > * **Proteomics:** Îã®Î∞±Ïßà Ï†ÑÏ≤¥.
> > * **Metabolomics:** ÎåÄÏÇ¨Î¨ºÏßà Ï†ÑÏ≤¥.
>
> > [!IMPORTANT] PAGE 77-79: DNA Microarray ÏõêÎ¶¨ (ÏÉÅÏÑ∏ Ïä§Ìéô ÏïîÍ∏∞)
> > 77ÌéòÏù¥ÏßÄ, Ïù¥Í≤å Î∞îÎ°ú ÏàòÎßå Í∞úÏùò Ïú†Ï†ÑÏûêÎ•º Ìïú Î∞©Ïóê Í≤ÄÏÇ¨ÌïòÎäî **DNA Microarray** Ïπ©ÏûÖÎãàÎã§. ÏàòÏπòÎ•º Î≥¥ÏÑ∏Ïöî.
> > * **ÌÅ¨Í∏∞:** Ï†ÑÏ≤¥ Ïπ©ÏùÄ **3cm x 7cm** Ï†ïÎèÑÏûÖÎãàÎã§. Ïä¨ÎùºÏù¥Îìú Í∏ÄÎùºÏä§ ÌÅ¨Í∏∞Ï£†. 
> > * **Spot:** Í∑∏ ÏïàÏóê ÏûëÏùÄ Ï†êÎì§Ïù¥ Ï∞çÌòÄ ÏûàÎäîÎç∞, Í∞Å Ï†êÏùò ÏßÄÎ¶ÑÏùÄ **150¬µm**, Ï†ê ÏÇ¨Ïù¥ Í∞ÑÍ≤©ÏùÄ **300¬µm**ÏûÖÎãàÎã§. 
> > * **ÏõêÎ¶¨:**
> >     1.  Ïπ© ÏúÑÏóê **Probe DNA(ÌÉêÏπ®)**Î•º ÎØ∏Î¶¨ Ïã¨Ïñ¥ÎÜìÏäµÎãàÎã§. (ÏàòÎßå Í∞ú) 
> >     2.  ÌôòÏûêÏùò ÏÉòÌîå(RNA)ÏùÑ Ïó≠Ï†ÑÏÇ¨Ìï¥ÏÑú **Fluorescent tagging(ÌòïÍ¥ë ÌëúÏßÄ)**ÏùÑ Î∂ôÏù∏ DNA(cDNA)Î°ú ÎßåÎì≠ÎãàÎã§. 
> >     3.  Ïπ© ÏúÑÏóê ÎøåÎ¶¨Î©¥, Ïßù(ÏÉÅÎ≥¥Ï†Å ÏÑúÏó¥)Ïù¥ ÎßûÎäî Í≤ÉÎÅºÎ¶¨ Îì§Îü¨Î∂ôÏäµÎãàÎã§. Ïù¥Í±∏ **Hybridization(ÌòºÏÑ±Ìôî)**Ïù¥ÎùºÍ≥† Ìï©ÎãàÎã§. 
> > * **Ìï¥ÏÑù (78p):** 
> >     * ÌäπÏ†ï ÏÉâÍπî(Î≥¥ÌÜµ Îπ®Í∞ï/Ï¥àÎ°ù)Ïù¥ ÎπõÎÇòÎ©¥ Í∑∏ Ïú†Ï†ÑÏûêÍ∞Ä Î∞úÌòÑÎêú Í≤ÉÏûÖÎãàÎã§.
> >     * Îëê ÏÉâÏù¥ ÏÑûÏó¨(ÎÖ∏Îûë) ÎÇòÏò§Î©¥ Îëò Îã§ ÏûàÎäî Í±∞Í≥†Ïöî.
> 
>
> > [!INFO] PAGE 80: HeatmapÍ≥º Ï¢ÖÏñë Î∂ÑÎ•ò (Taxonomy)
> > 80ÌéòÏù¥ÏßÄ, ÎßàÏπò Î™®ÏûêÏù¥ÌÅ¨ Í∞ôÏùÄ Í∑∏Î¶ºÏù¥ **Heatmap**ÏûÖÎãàÎã§. 
> > * **Í∞ÄÎ°úÏ§Ñ:** Ïú†Ï†ÑÏûê ÌïòÎÇòÌïòÎÇò.
> > * **ÏÑ∏Î°úÏ§Ñ:** ÌôòÏûê Ìïú Î™Ö Ìïú Î™Ö.
> > * **ÏÉâÍπî:** Îπ®Í∞ÑÏÉâÏùÄ Î∞úÌòÑ ÎÜíÏùå(High), Ï¥àÎ°ùÏÉâÏùÄ ÎÇÆÏùå(Low)ÏùÑ Ï£ºÎ°ú ÎÇòÌÉÄÎÉÖÎãàÎã§.
> > * **Dendrogram (ÎÇòÎ≠áÍ∞ÄÏßÄ Í∑∏Î¶º):** ÏúÑÏ™ΩÏóê ÏûàÎäî Í∞ÄÏßÄ Í∑∏Î¶ºÏûÖÎãàÎã§. Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥Ïù¥ ÎπÑÏä∑Ìïú ÌôòÏûêÎÅºÎ¶¨ Î¨∂Ïñ¥Ï§çÎãàÎã§(Clustering).
> > * **Í≤∞Í≥º:** ÌôòÏûêÎì§Ïù¥ **A, B, C, D** ÎÑ§ Í∞ÄÏßÄ Í∑∏Î£π(Tumor classes)ÏúºÎ°ú ÍπîÎÅîÌïòÍ≤å ÎÇòÎâòÎäî Í±∞ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å Î∞îÎ°ú Ï†ïÎ∞ÄÏùòÌïôÏùò ÏãúÏûëÏûÖÎãàÎã§.

> [!NOTE] Pages 81-89: ÎÑ§Ìä∏ÏõåÌÅ¨ ÎèôÏó≠Ìïô (Network Dynamics)
> Ïûê, ÏßÄÍ∏àÍπåÏßÄ Î∞∞Ïö¥ Ïú†Ï†ÑÏûê, Îã®Î∞±Ïßà, ÎåÄÏÇ¨Ï≤¥Îì§ÏùÑ Îã§ Ïó∞Í≤∞ÌïòÎ©¥ Ïñ¥ÎñªÍ≤å Îê†ÍπåÏöî? Îã®ÏàúÌïú ÏÑ†(Line)Ïù¥ ÏïÑÎãàÎùº Î≥µÏû°Ìïú **ÎÑ§Ìä∏ÏõåÌÅ¨(Network)**Í∞Ä Îê©ÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ ÎÑ§Ìä∏ÏõåÌÅ¨Ïùò ÏõÄÏßÅÏûÑÏùÑ ÏàòÌïôÏ†ÅÏúºÎ°ú ÌëúÌòÑÌïú Í≤ÉÏù¥ Î∞îÎ°ú **State Space(ÏÉÅÌÉú Í≥µÍ∞Ñ)**ÏûÖÎãàÎã§. Ïù¥ Í∞úÎÖêÏùÑ Ïù¥Ìï¥Ìï¥Ïïº "ÏÑ∏Ìè¨Í∞Ä Î∂ÑÌôîÌïúÎã§"Îäî ÎßêÏùò ÏßÑÏßú ÏùòÎØ∏Î•º ÏïåÍ≤å Îê©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 81: Ï¢ÖÏñëÏùò Ïù¥ÏßàÏÑ± (Tumor Heterogeneity)
> > 81ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Ïïî Îç©Ïñ¥Î¶¨Í∞Ä Îã§ ÎòëÍ∞ôÏùÄ ÏÑ∏Ìè¨Í∞Ä ÏïÑÎãàÎùºÎäî Ï¶ùÍ±∞ÏûÖÎãàÎã§. 
> > * **Clonal Evolution:**
> >     * **Monoclonal:** ÌïòÎÇòÏùò Ï°∞ÏÉÅÏóêÏÑú ÏãúÏûëÌï¥ ÎπÑÏä∑ÌïòÍ≤å ÏûêÎûå.
> >     * **Polyclonal:** Ïó¨Îü¨ Ï°∞ÏÉÅÏù¥ ÏÑûÏó¨ÏÑú ÏïÑÏ£º Îã§ÏñëÌïú(Polygenomic) Ïïî Ï°∞ÏßÅÏùÑ ÌòïÏÑ±. ÏπòÎ£åÍ∞Ä Ïñ¥Î†µÍ≤†Ï£†?
> > * **Cancer Stem Cells (Ïïî Ï§ÑÍ∏∞ÏÑ∏Ìè¨):**
> >     * **Single vs Multiple progenitors:** Ï§ÑÍ∏∞ÏÑ∏Ìè¨ ÌïòÎÇòÏóêÏÑú ÏôîÎÉê, Ïó¨Îü¨ Í∞úÏóêÏÑú ÏôîÎÉêÏóê Îî∞Îùº ÏïîÏùò Î≥µÏû°ÎèÑÍ∞Ä Îã¨ÎùºÏßëÎãàÎã§.
> > * **Í≤∞Î°†:** ÏïîÏùÄ **Polygenomic Tumor**Ïù∏ Í≤ΩÏö∞Í∞Ä ÎßéÏïÑÏÑú, ÏïΩ ÌïòÎÇòÎ°ú(One target) ÏôÑÏπòÍ∞Ä ÌûòÎì† Í≤ÅÎãàÎã§.
>
> > [!INFO] PAGE 82-84: Pathway vs Network View
> > 84ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏù¥ ÌïµÏã¨ÏûÖÎãàÎã§. Í¥ÄÏ†êÏùÑ Î∞îÍæ∏ÏÑ∏Ïöî. 
> > * **Pathway View (A):** $X1 \rightarrow X2$. ÏÑ†ÌòïÏ†ÅÏù¥Í≥† Îã®ÏàúÌï©ÎãàÎã§. "AÏù¥Î©¥ BÎã§"ÎùºÎäî ÏãùÏù¥Ï£†.
> > * **Network View (B):** $X1$Í≥º $X2$Í∞Ä Í±∞ÎåÄÌïú Í±∞ÎØ∏Ï§ÑÏùò ÏùºÎ∂ÄÏùº ÎøêÏûÖÎãàÎã§. $X1$ÏùÑ Í±¥ÎìúÎ¶¨Î©¥ $X2$Îßå Î≥ÄÌïòÎäî Í≤å ÏïÑÎãàÎùº ÎÑ§Ìä∏ÏõåÌÅ¨ Ï†ÑÏ≤¥Í∞Ä Ï∂úÎ†ÅÍ±∞Î¶ΩÎãàÎã§. Ïù¥Í≤å ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïôÏùò Í¥ÄÏ†êÏûÖÎãàÎã§.
> > * 83ÌéòÏù¥ÏßÄÏùò Î≥µÏû°Ìïú ÌôîÏÇ¥Ìëú(Activation/Inhibition)Îì§Ïù¥ Î™®Ïó¨ÏÑú Ïù¥ ÎÑ§Ìä∏ÏõåÌÅ¨Î•º ÎßåÎì≠ÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 85: 3Í≥ÑÏ∏µ ÌÜµÌï© Í≥µÍ∞Ñ (Space Integration)
> > 85ÌéòÏù¥ÏßÄ, 3Í∞úÏùò Ìåê(Layer)Ïù¥ Í≤πÏ≥êÏ†∏ ÏûàÏ£†? 
> > 1.  **Gene Space (Ïú†Ï†ÑÏûê Í≥µÍ∞Ñ):** Gene 1, 2, 3...
> > 2.  **Protein Space (Îã®Î∞±Ïßà Í≥µÍ∞Ñ):** Protein 1, 2, 3...
> > 3.  **Metabolic Space (ÎåÄÏÇ¨ Í≥µÍ∞Ñ):** Metabolite 1, 2...
> > * **Feedback:** Îß® Ïò§Î•∏Ï™Ω ÌôîÏÇ¥ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. **Metabolite 2**Í∞Ä Îã§Ïãú **Gene 4**Ïùò Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌïòÎü¨ ÎÇ¥Î†§Í∞ëÎãàÎã§. Ïù¥Î†áÍ≤å Ï∏µÍ∞Ñ ÏÜåÌÜµÏù¥ ÌôúÎ∞úÌï©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 86-87: ÏÉÅÌÉú Î≤°ÌÑ∞ÏôÄ ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space) - ‚òÖÍ∞úÎÖê ÌïÑÏäπ
> > Ïûê, Ïó¨Í∏∞ ÏßëÏ§ëÌïòÏÑ∏Ïöî. ÏÑ∏Ìè¨Ïùò ÏÉÅÌÉúÎ•º ÏàòÌïôÏúºÎ°ú Ï†ïÏùòÌï©ÎãàÎã§.
> >
> > **1. ÏÉÅÌÉú Î≤°ÌÑ∞ (State Vector, 86p):**
> > * Ïú†Ï†ÑÏûê $N$Í∞úÏùò Î∞úÌòÑÎüâÏùÑ Ïà´ÏûêÎ°ú Ï≠â ÎÇòÏó¥Ìïú Í≤ÅÎãàÎã§. 
> > * Ïãù: $$S = [x_1, x_2, ..., x_N]$$ (Ïòà: $x_1$ÏùÄ Ïú†Ï†ÑÏûê 1Ïùò Î∞úÌòÑÎüâ)
> >
> > **2. ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space, 87p):**
> > * 87ÌéòÏù¥ÏßÄÏùò ÌÅêÎ∏å(Cube) Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. 
> > * **Ï∂ï (Axis):** Í∞Å Ïú†Ï†ÑÏûê($X_1, X_2, X_3$)Í∞Ä $x, y, z$ Ï∂ïÏù¥ Îê©ÎãàÎã§.
> > * **Ï†ê (Point):** ÌäπÏ†ï ÏãúÏ†ê($t_1$)Ïùò ÏÑ∏Ìè¨ ÏÉÅÌÉú($S_1$)Îäî Ïù¥ Í≥µÍ∞Ñ ÏïàÏùò **'Ï†ê ÌïòÎÇò'**Î°ú Ï∞çÌûôÎãàÎã§. (Ïòà: $[3.0, 3.0, 3.0]$)
> > * **Í∂§Ï†Å (Trajectory):** ÏãúÍ∞ÑÏù¥ ÏßÄÎÇ®Ïóê Îî∞Îùº ÏÑ∏Ìè¨Ïùò Ïú†Ï†ÑÏûê Î∞úÌòÑÏù¥ Î≥ÄÌïòÏ£†? Ï†êÏù¥ Ïù¥ÎèôÌïòÎ©¥ÏÑú Í∑∏Î¶¨Îäî ÏÑ†ÏûÖÎãàÎã§.
> > * **Attractor (ÎÅåÍ∞ú):** Îπ®Í∞Ñ Ï†ê($S^*$)ÏùÑ Î≥¥ÏÑ∏Ïöî. Ï†êÎì§Ïù¥ Í≤∞Íµ≠ Ïñ¥ÎîîÎ°ú Î™®Ïù¥ÎÇòÏöî? ÏïàÏ†ïÏ†ÅÏù∏ ÏÉÅÌÉúÎ°ú ÏàòÎ†¥ÌïòÏ£†? Ïù¥ ÎèÑÏ∞©Ï†êÏù¥ Î∞îÎ°ú **"ÏÑ∏Ìè¨ ÌÉÄÏûÖ(Cell Type)"**ÏûÖÎãàÎã§.
> >     * "Ï§ÑÍ∏∞ÏÑ∏Ìè¨Í∞Ä Î∂ÑÌôîÌï¥ÏÑú ÌîºÎ∂ÄÏÑ∏Ìè¨Í∞Ä ÎêêÎã§" = "ÏÉÅÌÉú Í≥µÍ∞ÑÏóêÏÑú Ï†êÏù¥ Ïù¥ÎèôÌï¥ ÌîºÎ∂ÄÏÑ∏Ìè¨ÎùºÎäî AttractorÏóê Îπ†Ï°åÎã§."
>
> > [!INFO] PAGE 88-89: WaddingtonÏùò ÌíçÍ≤Ω (Epigenetic Landscape) ÏàòÌïôÏ†Å Ìï¥ÏÑù
> > 89ÌéòÏù¥ÏßÄ, ÏïÑÍπå Î≥∏ Í≥µ Íµ¥Îü¨Í∞ÄÎäî Í∑∏Î¶ºÏùÑ Îã§Ïãú ÏàòÌïôÏ†ÅÏúºÎ°ú Î¥ÖÎãàÎã§. 
> > * **Basin of attraction (ÎÅåÍ∞ú Ïú†Ïó≠):** Í≥µÏù¥ Íµ¥Îü¨ Îñ®Ïñ¥ÏßÄÎäî Í≥®ÏßúÍ∏∞ÏûÖÎãàÎã§.
> > * **Quasi-potential U:** ÏóêÎÑàÏßÄ Ï§ÄÏúÑ Í∞ôÏùÄ Í≤ÅÎãàÎã§. ÎÇÆÏùÑÏàòÎ°ù ÏïàÏ†ïÏ†ÅÏù¥Ï£†.
> > * **Attractors:** Í≥®ÏßúÍ∏∞ Î∞îÎã•. Ïó¨Í∏∞Ïóê ÏïàÏ∞©ÌïòÎ©¥ **Mature cell types (ÏÑ±Ïàô ÏÑ∏Ìè¨)**Í∞Ä ÎêòÎäî Í≤ÅÎãàÎã§.
> > * **Unused attractors:** ÏßÑÌôîÏ†ÅÏúºÎ°ú ÏµúÏ†ÅÌôîÎêòÏßÄ ÏïäÏùÄ, Î≤ÑÎ†§ÏßÑ ÏõÖÎç©Ïù¥Îì§ÎèÑ Ï°¥Ïû¨Ìï† Ïàò ÏûàÏäµÎãàÎã§. (ÏïîÏÑ∏Ìè¨Í∞Ä Ïó¨Í∏∞Î°ú Í∞à ÏàòÎèÑ ÏûàÏ£†)

> [!NOTE] Pages 90-97: ÎÑ§Ìä∏ÏõåÌÅ¨ ÏùòÌïôÍ≥º Ïã†ÏïΩ Í∞úÎ∞ú (Network Medicine)
> Ïûê, Ïù¥Ï†ú Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨ Ïù¥Î°†Ïù¥ Ïã§Ï†ú ÌôòÏûêÎ•º ÏÇ¥Î¶¨Îäî Í∏∞Ïà†Î°ú Î∞îÎÄùÎãàÎã§. ÌôòÏûêÏùò Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥(Signature)Îßå Î≥¥Í≥†ÎèÑ "Ïù¥ ÌôòÏûêÎäî 5ÎÖÑ Îí§Ïóê ÏÉùÏ°¥Ìï† ÌôïÎ•†Ïù¥ ÎÜíÎã§/ÎÇÆÎã§"Î•º ÎßûÏ∂îÍ≥†, ÎÑ§Ìä∏ÏõåÌÅ¨Ïùò ÌäπÏ†ï Î∂ÄÏúÑÎßå Í≥µÍ≤©ÌïòÎäî Ï†ïÎ∞Ä ÌÉÄÍ≤© ÏïΩÎ¨ºÏùÑ Í∞úÎ∞úÌïòÎäî Í≥ºÏ†ïÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 90: ÏòàÌõÑ ÏòàÏ∏° Î™®Îç∏ (Survival Prediction) - ‚òÖÏûÑÏÉÅ ÌïÑÏàò
> > 90ÌéòÏù¥ÏßÄ Í∑∏Î¶º, Î≥ëÏõêÏóêÏÑú Îß§Ïùº Î≥¥Îäî Îç∞Ïù¥ÌÑ∞ÏûÖÎãàÎã§. Ìï¥ÏÑùÌï† Ï§Ñ ÏïåÏïÑÏïº Ìï©ÎãàÎã§. 
> > 1.  **Heatmap (Ï¢åÏ∏°):** 70Í∞úÏùò **Reporter genes** Î∞úÌòÑ Ìå®ÌÑ¥ÏùÑ Î∂ÑÏÑùÌñàÎçîÎãà, ÌôòÏûêÎì§Ïù¥ Îëê Í∑∏Î£πÏúºÎ°ú ÎÇòÎâ©ÎãàÎã§.
> >     * **Good signature:** ÏòàÌõÑÍ∞Ä Ï¢ãÏùÄ Ìå®ÌÑ¥.
> >     * **Poor signature:** ÏòàÌõÑÍ∞Ä ÎÇòÏÅú Ìå®ÌÑ¥.
> > 2.  **Survival Curve (Ïö∞Ï∏° Í∑∏ÎûòÌîÑ):** Ïù¥Í≤å Í∑∏ Ïú†Î™ÖÌïú **Ïπ¥ÌîåÎûÄ-ÎßàÏù¥Ïñ¥(Kaplan-Meier) ÏÉùÏ°¥ Í≥°ÏÑ†**ÏûÖÎãàÎã§.
> >     * **XÏ∂ï:** ÏãúÍ∞Ñ(Years).
> >     * **YÏ∂ï:** Ï†ÑÏ≤¥ ÏÉùÏ°¥Ïú®(Overall survival, 1.0 = 100%).
> >     * **Ìï¥ÏÑù:** **Poor signature(Îπ®Í∞Ñ ÏÑ†)** ÌôòÏûêÎì§ÏùÄ 2~4ÎÖÑ ÏÇ¨Ïù¥Ïóê Í∏âÍ≤©Ìûà ÏÇ¨ÎßùÌïòÏó¨ ÏÉùÏ°¥Ïú®Ïù¥ 0.2(20%) Î∞ëÏúºÎ°ú Îñ®Ïñ¥ÏßëÎãàÎã§. Î∞òÎ©¥ **Good signature(ÌååÎûÄ ÏÑ†)**Îäî 10ÎÖÑÏù¥ ÏßÄÎÇòÎèÑ ÏÉùÏ°¥Ïú®Ïù¥ ÎÜíÏäµÎãàÎã§.
> >     * **ÏùòÏùò:** "ÎãπÏã†ÏùÄ Poor signatureÎãà Îçî Í≥µÍ≤©Ï†ÅÏù∏ Ìï≠ÏïîÏ†úÎ•º ÏîÅÏãúÎã§"ÎùºÎäî **Clinically useful prediction(ÏûÑÏÉÅÏ†Å ÌåêÎã®)**Ïù¥ Í∞ÄÎä•Ìï¥ÏßëÎãàÎã§.
>
> > [!INFO] PAGE 92-93: ÎÑ§Ìä∏ÏõåÌÅ¨ ÏùòÌïôÏùò Ï†ïÏùò
> > 92ÌéòÏù¥ÏßÄ, **Network Medicine**Ïù¥ÎûÄ? 
> > * Ïù∏Íµ¨ ÏßëÎã®(Population)Ïùò ÍπäÏùÄ ÌëúÌòÑÌòï(Deep phenotyping) Îç∞Ïù¥ÌÑ∞Î•º Î™®ÏïÑÏÑú, Í∞úÏù∏Îì§ÏùÑ **ÎÑ§Ìä∏ÏõåÌÅ¨ ÏßÄÌëú(Network metrics)**Ïóê Îî∞Îùº ÌÅ¥Îü¨Ïä§ÌÑ∞ÎßÅ(Cluster)ÌïòÎäî Í≤ÅÎãàÎã§.
> > * **Ìå®Îü¨Îã§ÏûÑ Î≥ÄÌôî (93p):** 
> >     * Í≥ºÍ±∞: **Average patient (ÌèâÍ∑† ÌôòÏûê)**Î•º ÏúÑÌïú ÏïΩ. (Ïûò Ïïà Îì£Í±∞ÎÇò Î∂ÄÏûëÏö©)
> >     * ÌòÑÏû¨: ÌôòÏûêÏùò **Genetics, Microbes, Chemical composition**Ïóê Îî± ÎßûÏ∂ò(Tailored) ÏïΩ.
>
> > [!IMPORTANT] PAGE 94-97: ÎÑ§Ìä∏ÏõåÌÅ¨ Í∏∞Î∞ò Ïã†ÏïΩ Í∞úÎ∞ú (Network-based Drug Discovery)
> > 94ÌéòÏù¥ÏßÄÎ∂ÄÌÑ∞Îäî Ïã†ÏïΩ Í∞úÎ∞ú ÌîÑÎ°úÏÑ∏Ïä§ÏûÖÎãàÎã§.
> > * **Îç∞Ïù¥ÌÑ∞ ÌÜµÌï© (94p):** DNA/RNA Î≥ÄÏù¥, Îã®Î∞±Ïßà(Proteomics), ÎåÄÏÇ¨Ï≤¥(Metabolite), ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞(Clinical data), Î¨∏Ìóå(Literature)ÏùÑ Îã§ ÏÑûÏñ¥ÏÑú Í±∞ÎåÄÌïú ÌîåÎû´ÌèºÏùÑ ÎßåÎì≠ÎãàÎã§. 
> >
> > * **ÎÑ§Ìä∏ÏõåÌÅ¨ ÌÉÄÍ≤üÌåÖ (95-97p):** Ïù¥ Í∑∏Î¶ºÏùÑ Ïûò Î≥¥ÏÑ∏Ïöî. 
> >     * Ï†ÑÏ≤¥ ÎÑ§Ìä∏ÏõåÌÅ¨ ÏïàÏóê **Disease subtype 1** (ÌååÎûÄÏÉâ ÏòÅÏó≠)Í≥º **Disease subtype 2** (Ï¥àÎ°ùÏÉâ ÏòÅÏó≠)Í∞Ä ÏÑúÎ°ú Îã§Î•∏ ÏúÑÏπòÏóê Ï°¥Ïû¨Ìï©ÎãàÎã§. Ï¶â, Í∞ôÏùÄ Î≥ëÏù¥ÎùºÎèÑ Î∞úÎ≥ë Í∏∞Ï†Ñ(ÎÑ§Ìä∏ÏõåÌÅ¨ Î™®Îìà)Ïù¥ Îã§Î¶ÖÎãàÎã§.
> >     * **Toxicity (ÎèÖÏÑ±):** Îπ®Í∞ÑÏÉâ ÏòÅÏó≠ÏùÄ Í±¥ÎìúÎ¶¨Î©¥ Ïïà ÎêòÎäî Ï§ëÏöîÌïú ÏÉùÎ™Ö Ïú†ÏßÄ Í∏∞Îä•(Ïòà: Ïã¨Ïû• Î∞ïÎèô)Ïùº Ïàò ÏûàÏäµÎãàÎã§.
> >     * **Screening:** **High-throughput screening**ÏùÑ ÌÜµÌï¥ ÏàòÎßå Í∞ÄÏßÄ ÌôîÌï©Î¨ºÏùÑ ÎøåÎ†§Î¥ÖÎãàÎã§.
> >     * **Î™©Ìëú:** Îπ®Í∞ÑÏÉâ(ÎèÖÏÑ±)ÏùÄ ÌîºÌïòÍ≥†, ÎÇ¥ ÌôòÏûêÏùò ÌÉÄÏûÖ(Ïòà: Subtype 2)Ïóê Ìï¥ÎãπÌïòÎäî ÎÑ§Ìä∏ÏõåÌÅ¨Îßå Ï†ïÌôïÌûà ÌÉÄÍ≤©ÌïòÎäî ÏïΩÎ¨ºÏùÑ Ï∞æÎäî Í≤ÉÏûÖÎãàÎã§.

> [!NOTE] Pages 98-113: ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨ÏôÄ ÎîîÏßÄÌÑ∏ Ìó¨Ïä§Ïùò ÎØ∏Îûò
> Ïûê, Ïù¥Ï†ú ÎßàÏßÄÎßâ ÌçºÏ¶êÏùÑ ÎßûÏ∂•ÏãúÎã§. Íµ¨Í∏Ä ÎßµÏù¥ Ïó¨Îü¨ Î†àÏù¥Ïñ¥(ÍµêÌÜµ, ÏúÑÏÑ±, ÏßÄÎèÑ)Î•º Í≤πÏ≥êÏÑú Í∏∏ÏùÑ Î≥¥Ïó¨Ï£ºÎìØ, Ïö∞Î¶¨ Î™∏Ïùò Îç∞Ïù¥ÌÑ∞ÎèÑ Í≤πÏ≥êÏïº Î≥¥ÏûÖÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ Î™®Îì† Í≤ÉÏù¥ IT Í∏∞Ïà†(IoMT)Í≥º Í≤∞Ìï©ÌïòÏó¨ ÏßÑÏ†ïÌïú **'ÌôòÏûê Ï§ëÏã¨ ÏùòÎ£å'**Í∞Ä ÏôÑÏÑ±ÎêòÎäî Í≤ÉÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 98-99: Íµ¨Í∏Ä ÎßµÍ≥º ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨ (Analogy)
> > 98ÌéòÏù¥ÏßÄ, ÏïÑÏ£º ÌõåÎ•≠Ìïú ÎπÑÏú†Í∞Ä ÎÇòÏòµÎãàÎã§. 
> > * **Google Maps:** ÏßÄÎ¶¨Ï†Å ÏúÑÏπò(Geographical Positioning)Î•º Ï§ëÏã¨ÏúºÎ°ú ÍµêÌÜµ, Í±¥Î¨º, ÏúÑÏÑ± ÏÇ¨ÏßÑ Îì± Ïó¨Îü¨ Ï∏µ(Layers)Ïùò Ï†ïÎ≥¥Î•º Í≤πÏ≥êÏÑú Î≥¥Ïó¨Ï§çÎãàÎã§.
> > * **Information Commons (ÏùòÎ£å Ï†ïÎ≥¥ Í≥µÏú†ÏßÄ):** ÎßàÏ∞¨Í∞ÄÏßÄÏûÖÎãàÎã§. **"Í∞úÎ≥Ñ ÌôòÏûê(Individual Patients)"**Î•º Ï§ëÏã¨ÏúºÎ°ú Îã§Ïùå Ï†ïÎ≥¥Îì§ÏùÑ Í≤πÏ≥êÏïº Ìï©ÎãàÎã§.
> >     * **Signs and Symptoms (Ï¶ùÏÉÅ)**
> >     * **Exposome (ÌôòÍ≤Ω ÎÖ∏Ï∂ú)**
> >     * **Genome (Ïú†Ï†ÑÏûê)**
> >     * **Epigenome & Microbiome**
> > * **Í≤∞Î°†:** ÌôòÏûê Ìïú Î™Ö Ìïú Î™ÖÏù¥ ÎßàÏπò Íµ¨Í∏Ä ÎßµÏùò Ï¢åÌëúÏ≤òÎüº, Î™®Îì† Ï†ïÎ≥¥Í∞Ä ÌÜµÌï©Îêú **ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨**Ïùò Ï§ëÏã¨Ïù¥ Îê©ÎãàÎã§.
> 
>
> > [!IMPORTANT] PAGE 100: ÏóëÏä§Ìè¨Ï¢Ä (Exposome) - ÌôòÍ≤ΩÏùò Ï†ïÎüâÌôî (‚òÖ)
> > 100ÌéòÏù¥ÏßÄ, ÌôòÍ≤Ω(Environment)ÏùÑ Îú¨Íµ¨Î¶Ñ Ïû°Îäî ÏñòÍ∏∞Í∞Ä ÏïÑÎãàÎùº Í≥ºÌïôÏ†ÅÏúºÎ°ú Ï†ïÏùòÌï©ÎãàÎã§. Ïù¥Í≤å **Exposome**ÏûÖÎãàÎã§. 
> > * **Ï†ïÏùò:** ÎÇ¥Î∂Ä ÌôîÌïô ÌôòÍ≤Ω(Internal chemical environment)Ïóê ÎèÑÎã¨ÌïòÎäî **Î™®Îì† ÎÖ∏Ï∂úÏùò Ï¥ùÌï©**ÏûÖÎãàÎã§.
> > * **Íµ¨ÏÑ± ÏöîÏÜå:**
> >     * **External (Ïô∏Î∂Ä):** Stress, Lifestyle, Drugs, Diet, Pollution Îì±.
> >     * **Internal (ÎÇ¥Î∂Ä):** Xenobiotics(Ïù¥Î¨ºÏßà), Inflammation(ÏóºÏ¶ù), Oxidative stress(ÏÇ∞Ìôî Ïä§Ìä∏Î†àÏä§), **Gut flora(Ïû•ÎÇ¥ ÎØ∏ÏÉùÎ¨º)**.
> > * **Í≤ÄÏ∂ú:** Ïù¥Îü∞ ÏöîÏù∏Îì§ÏùÄ ÌòàÏï°Ïù¥ÎÇò ÌòàÏ≤≠(Blood or serum)ÏóêÏÑú **Biomarkers(ÏÉùÏ≤¥ÌëúÏßÄÏûê)**Î°ú Í≤ÄÏ∂ú Í∞ÄÎä•Ìï©ÎãàÎã§. Ï¶â, "Ïä§Ìä∏Î†àÏä§ Î∞õÏïòÎã§"Í∞Ä ÏïÑÎãàÎùº "Ïä§Ìä∏Î†àÏä§ ÎßàÏª§ ÏàòÏπòÍ∞Ä XÎã§"ÎùºÍ≥† ÎßêÌï† Ïàò ÏûàÍ≤å Îêú Í±∞Ï£†.
>
> > [!INFO] PAGE 101-104: ÏÉàÎ°úÏö¥ Î∂ÑÎ•ò Ï≤¥Í≥Ñ (Taxonomy)
> > Ïù¥ Ïä¨ÎùºÏù¥ÎìúÎì§ÏùÄ ÌùêÎ¶ÑÎßå Î≥¥Î©¥ Îê©ÎãàÎã§. 
> > * **Information Commons:** ÌôòÏûêÎì§Ïùò Îç∞Ïù¥ÌÑ∞Í∞Ä Î™®Ïó¨ Í≥µÏú†ÏßÄÎ•º ÌòïÏÑ±ÌïòÍ≥†,
> > * **Taxonomic classification:** Í≥ºÍ±∞Ïùò 'Ï¶ùÏÉÅ' Í∏∞Î∞ò Î∂ÑÎ•òÍ∞Ä ÏïÑÎãàÎùº, Î∂ÑÏûêÏ†Å ÏõêÏù∏Ïóê Í∏∞Î∞òÌïú **'ÏßàÎ≥ë Î∂ÑÎ•ò(Taxonomy)'**Í∞Ä ÏÉàÎ°ú Ïì∞Ïù¥Í≤å Îê©ÎãàÎã§. (Ïòà: ÌèêÏïî 1Í∏∞Í∞Ä ÏïÑÎãàÎùº, EGFR Î≥ÄÏù¥ ÏñëÏÑ± ÌèêÏïî)
> > * **Knowledge network-based medicine:** Í≤∞Íµ≠ Î™®Îì† ÏπòÎ£åÎäî Ïù¥ ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨Ïóê Í∏∞Î∞òÌïòÍ≤å Îê©ÎãàÎã§.
>
> > [!INFO] PAGE 105-113: ÎîîÏßÄÌÑ∏ Ìó¨Ïä§ ÌòÅÎ™Ö (Tech Revolution)
> > ÎßàÏßÄÎßâ ÏÑπÏÖòÏûÖÎãàÎã§. Ï†ïÎ∞ÄÏùòÌïôÏùÑ Í∞ÄÎä•ÌïòÍ≤å ÌïòÎäî Í∏∞Ïà†Ï†Å Î∞∞Í≤ΩÏûÖÎãàÎã§. 
> > * **IoMT (Internet of Medical Things):** ÏùòÎ£å ÏÇ¨Î¨º Ïù∏ÌÑ∞ÎÑ∑. Ïõ®Ïñ¥Îü¨Î∏î Í∏∞Í∏∞ Îì±Ïù¥ Ïã§ÏãúÍ∞ÑÏúºÎ°ú ÌôòÏûê Îç∞Ïù¥ÌÑ∞Î•º ÏèüÏïÑÎÉÖÎãàÎã§.
> > * **Big Data & AI:** ÏèüÏïÑÏßÄÎäî Îç∞Ïù¥ÌÑ∞Î•º Î∂ÑÏÑùÌï©ÎãàÎã§.
> > * **Rising of Precision Medicine:** Ïù¥ Î™®Îì† Í≤ÉÏù¥ Ìï©Ï≥êÏ†∏ Ï†ïÎ∞ÄÏùòÌïôÏù¥ Î∂ÄÏÉÅÌïòÍ≥† ÏûàÏäµÎãàÎã§.
> > * **Q & A (113p):** ÏßàÎ¨∏ ÏûàÎÇòÏöî?

], ['\\(', '\\)']],
    displayMath: [['$$', '$$'], ['\\[', '\\]']],
    processEscapes: true,
  },
  svg: {
    fontCache: 'global'
  }
};
</script>
<script type="text/javascript" id="MathJax-script" async
  src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-svg.js">
</script>

---

>[!quote] Í≥µÏßÄ
>Î≥∏ ÏûêÎ£åÏùò Ï†ÄÏûëÍ∂åÏùÄ **KAISTUDY**Ïóê ÏûàÏäµÎãàÎã§.

---

> [!abstract]- üìñ Í∞ïÏùò ÌïúÎààÏóê Î≥¥Í∏∞: Precision Medicine & Systems Biology
> **"One Treatment Fits All(Í≥ºÍ±∞)ÏóêÏÑú Data-Driven Algorithm(ÎØ∏Îûò)ÏúºÎ°úÏùò ÏßÑÌôî"**
>
> 1.  **Introduction (Ìå®Îü¨Îã§ÏûÑÏùò Ï†ÑÌôò)**
>     * ÏùòÌïôÏùÄ ÏßÅÍ¥Ä(Intuition)Í≥º Ï¶ùÍ±∞(EBM)Î•º ÎÑòÏñ¥, **ÎπÖÎç∞Ïù¥ÌÑ∞ÏôÄ ÏïåÍ≥†Î¶¨Ï¶ò Í∏∞Î∞òÏùò Ï†ïÎ∞ÄÏùòÌïô(Precision Medicine)**ÏúºÎ°ú Ïù¥Îèô Ï§ëÏûÖÎãàÎã§.
>     * ÌïµÏã¨ÏùÄ ÌôòÏûêÎ•º ÌèâÍ∑†(Average)Ïù¥ ÏïÑÎãå **Ïú†Ï†ÑÏ≤¥(Genes), ÌôòÍ≤Ω(Environment), ÏÉùÌôúÏäµÍ¥Ä(Lifestyle)**Ïù¥ Í≤∞Ìï©Îêú Í≥†Ïú†Ìïú Í∞úÏ≤¥Î°ú Î≥¥Îäî Í≤ÉÏûÖÎãàÎã§.
> 2.  **Omics & Regulation (ÏÉùÎ™ÖÏùò Ïñ∏Ïñ¥ÏôÄ Ï°∞Ï†à)**
>     * Îã®Ïàú DNA ÏÑúÏó¥(Genome)ÎøêÎßå ÏïÑÎãàÎùº, Ïù¥Î•º Ï°∞Ï†àÌïòÎäî **Epigenome(ÌõÑÏÑ±Ïú†Ï†ÑÏ≤¥)**Í≥º Ïã§Ï†ú Í∏∞Îä•ÏùÑ ÏàòÌñâÌïòÎäî Proteome/MetabolomeÏùÑ ÌÜµÌï©Ìï¥Ïïº Ìï©ÎãàÎã§.
>     * ÌäπÌûà **Histone Modification**Í≥º **DNA Methylation**Ïù¥ Ïú†Ï†ÑÏûê Ïä§ÏúÑÏπò(On/Off)Î•º Í≤∞Ï†ïÌïòÎäî ÌïµÏã¨ Í∏∞Ï†ÑÏûÖÎãàÎã§.
> 3.  **Systems & Network (ÌÜµÌï©Ï†Å Î∂ÑÏÑù)**
>     * ÏßàÎ≥ëÏùÄ Îã®Ïùº Ïú†Ï†ÑÏûêÏùò Í≥†Ïû•Ïù¥ ÏïÑÎãàÎùº, **ÎÑ§Ìä∏ÏõåÌÅ¨(Network)Ïùò ÏÑ≠Îèô**ÏûÖÎãàÎã§.
>     * ÏÑ∏Ìè¨Ïùò Ïö¥Î™ÖÏùÄ **ÏÉÅÌÉú Í≥µÍ∞Ñ(State Space)** ÎÇ¥ÏóêÏÑú **ÎÅåÍ∞ú(Attractor)**Î°ú Ïù¥ÎèôÌïòÎäî Í∂§Ï†Å(Trajectory)ÏúºÎ°ú ÏàòÌïôÏ†Å Ï†ïÏùòÍ∞Ä Í∞ÄÎä•Ìï©ÎãàÎã§.
> 4.  **Clinical Application (ÏûÑÏÉÅ Ï†ÅÏö©)**
>     * Í≤∞Íµ≠ Ïù¥ Î™®Îì† Îç∞Ïù¥ÌÑ∞Î•º Ìï©Ï≥ê(Multi-omics Integration), ÌôòÏûêÎ•º Î∂ÑÏûê ÏàòÏ§ÄÏóêÏÑú Ï∏µÌôî(Stratification)ÌïòÍ≥†, **ÎÑ§Ìä∏ÏõåÌÅ¨ Í∏∞Î∞ò Ïã†ÏïΩ(Network Medicine)**ÏùÑ Ï†ÅÏö©ÌïòÏó¨ ÏÉùÏ°¥Ïú®ÏùÑ ÎÜíÏù¥Îäî Í≤ÉÏù¥ Î™©ÌëúÏûÖÎãàÎã§.

> [!example]- üíä ÌïµÏã¨ ÌÇ§ÏõåÎìú & ÏïºÎßà Ï†ïÎ¶¨
>
> ### 1. Precision MedicineÏùò Í∏∞Ï¥à (Data & P4)
> * **Ïò§Î∞îÎßàÏùò 3ÎåÄ Î≥ÄÏàò (2015):** ‚ë† Genes(Ïú†Ï†ÑÏûê) + ‚ë° Environment(ÌôòÍ≤Ω) + ‚ë¢ Lifestyle(ÏÉùÌôúÏäµÍ¥Ä) **(üî•Í∏∞Ï∂ú)**
> * **Îç∞Ïù¥ÌÑ∞ Íµ¨ÏÑ± ÎπÑÏú®:** **Exogenous(ÌôòÍ≤Ω/ÌñâÎèô) 60%** > Genomics 30% > Clinical 10%. (Î≥ëÏõê Îç∞Ïù¥ÌÑ∞Îäî ÎπôÏÇ∞Ïùò ÏùºÍ∞ÅÏûÑ **üî•ÏïºÎßà**)
> * **P4 Medicine:** **P**redictive(ÏòàÏ∏°), **P**reventive(ÏòàÎ∞©), **P**ersonalized(ÎßûÏ∂§), **P**articipatory(Ï∞∏Ïó¨).
>
> ### 2. Clinical Sequencing Í∏∞Ïà† ÎπÑÍµê (vs) **(üî•Ï°±Î≥¥: Ï†ÅÏùëÏ¶ù Íµ¨Î≥Ñ)**
> * **WGS (Whole Genome):** DNA Ï†ÑÏ≤¥(30Ïñµ Ïåç) Î∂ÑÏÑù. Point mutation, Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥(SV), CNV **Î™®Îëê Í≤ÄÏ∂ú Í∞ÄÎä•**.
> * **WES (Whole Exome):** Îã®Î∞±Ïßà ÏΩîÎî© Î∂ÄÏúÑ(**Exon, Ï†ÑÏ≤¥Ïùò 1%**)Îßå ÎÜçÏ∂ï(Baits)ÌïòÏó¨ Î∂ÑÏÑù. Í∞ÄÏÑ±ÎπÑ Ï¢ãÏùå. Point mutation, CNV Í≤ÄÏ∂ú.
> * **Targeted Panel (PCR Amplicon):** ÌäπÏ†ï ÏßàÎ≥ë Í¥ÄÎ†® Ïú†Ï†ÑÏûêÎßå Ï¶ùÌè≠. ÍπäÏùÄ Ìï¥ÏÉÅÎèÑ(Depth) Í∞ÄÎä•.
> * **RNA-seq (Transcriptome):** **Î∞úÌòÑÎüâ(Expression)**, ÏúµÌï© Ïú†Ï†ÑÏûê(Fusion), Splicing variant Í≤ÄÏ∂ú.
>
> ### 3. DNA Íµ¨Ï°∞ & p53 (Concrete Details)
> * **DNA ÏàòÏπò:** ÏßÄÎ¶Ñ **2nm**, Ìïú Î∞îÌÄ¥ **3.4nm**, ÏóºÍ∏∞ ÏÇ¨Ïù¥ **0.34nm**. **(üî•Í∏∞Ï∂ú: Ïà´Ïûê ÏïîÍ∏∞)**
> * **p53 Íµ¨Ï°∞:** **Tetramer(4ÎüâÏ≤¥)**Î°ú ÏûëÎèô. DNA Í≤∞Ìï© Î∂ÄÏúÑÏóê **Zinc atom(ÏïÑÏó∞)**Ïù¥ ÏïàÏ†ïÌôîÏ†úÎ°ú Î∞ïÌòÄ ÏûàÏùå. ÏïîÌôòÏûêÎäî Ï£ºÎ°ú Ïù¥ Í≤∞Ìï© Î∂ÄÏúÑÍ∞Ä ÎßùÍ∞ÄÏßê.
>
> ### 4. Epigenetics: Histone Code & Methylation
> * **Histone Tail:** Ï°∞Ï†àÏùò ÌïµÏã¨. (H3, H4 TailÏù¥ Ï§ëÏöî)
> * **Acetylation (Ac):** Lysine(K)Ïóê Î∂ôÏùå. Ï£ºÎ°ú **Activation (Ï†ÑÏÇ¨ Ï¥âÏßÑ)**. **(üî•ÏïºÎßà)**
> * **Methylation (Me):** Lysine(K)Ïóê Î∂ôÏùå. ÏúÑÏπòÏóê Îî∞Îùº Îã§Î¶Ñ (Ïòà: H3K4=Active, H3K9/27=Repression).
> * **DNA Methylation:** CytosineÏùò 5Î≤à ÌÉÑÏÜåÏóê $CH_3$ Î∂ÄÏ∞© ($5$-mC). Ï£ºÎ°ú **Silencing (Ï†ÑÏÇ¨ ÏñµÏ†ú)**.
>
> ### 5. Systems Biology: State Space & Attractor
> * **ÏÉÅÌÉú Î≤°ÌÑ∞ (State Vector):** $S = [x_1, x_2, ... x_N]$ (Ïú†Ï†ÑÏûê Î∞úÌòÑÎüâÏùò ÏßëÌï©).
> * **ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space):** Ïú†Ï†ÑÏûêÎì§ÏùÑ Ï∂ïÏúºÎ°ú ÌïòÎäî Îã§Ï∞®Ïõê Í≥µÍ∞Ñ. ÏÑ∏Ìè¨ ÏÉÅÌÉúÎäî Ïù¥ Í≥µÍ∞ÑÏùò **'Ï†ê'**ÏúºÎ°ú ÌëúÌòÑÎê®.
> * **Attractor (ÎÅåÍ∞ú):** ÎèôÏ†Å ÏãúÏä§ÌÖúÏù¥ ÏãúÍ∞ÑÏù¥ ÏßÄÎÇò ÏàòÎ†¥ÌïòÎäî ÏïàÏ†ïÎêú ÏÉÅÌÉú. ÏÉùÎ¨ºÌïôÏ†ÅÏúºÎ°ú **"Cell Type(Î∂ÑÌôîÎêú ÏÑ∏Ìè¨)"**ÏùÑ ÏùòÎØ∏Ìï®. **(üî•Í∞úÎÖê ÌïÑÏäπ)**
> * **Landscape Model:** Í≥µ(ÏÑ∏Ìè¨)Ïù¥ Í≥®ÏßúÍ∏∞(Attractor)Î°ú Íµ¥Îü¨Îñ®Ïñ¥ÏßÄÎäî Í≥ºÏ†ï = Î∂ÑÌôî(Differentiation). Ïú†Ï†ÑÏûê Î≥ÄÏù¥Îäî ÏßÄÌòï ÏûêÏ≤¥Î•º Î∞îÍøà.
>
> ### 6. Network Medicine & Survival Analysis
> * **Kaplan-Meier Curve:** XÏ∂ï(ÏãúÍ∞Ñ) vs YÏ∂ï(ÏÉùÏ°¥Ïú®). Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥(Signature)Ïóê Îî∞Îùº **Good vs Poor ÏòàÌõÑ Í∑∏Î£π**ÏùÑ ÎÇòÎàå Ïàò ÏûàÏùå. **(üî•ÏûÑÏÉÅ Ìï¥ÏÑù)**
> * **Drug Discovery:** ÏßàÎ≥ë ÎÑ§Ìä∏ÏõåÌÅ¨(Disease module)Î•º ÌÉÄÍ≤©ÌïòÎêò, ÌïÑÏàò ÏÉùÏ°¥ Ïú†Ï†ÑÏûê(Toxicity)Îäî Í±¥ÎìúÎ¶¨ÏßÄ ÏïäÎäî ÏïΩÎ¨ºÏùÑ Ï∞æÎäî Í≥ºÏ†ï.

---

> [!NOTE] Pages 1-7: Precision MedicineÏùò ÌÉúÎèôÍ≥º Big Data
> Ïûê, Ïù¥ Í∞ïÏùòÏùò ÏÑúÎßâÏûÖÎãàÎã§. Ïôú ÏßÄÍ∏à Ïù¥ ÏãúÏ†êÏóê 'Ï†ïÎ∞ÄÏùòÌïô(Precision Medicine)'Ïù¥ ÌôîÎëêÍ∞Ä ÎêòÎäîÏßÄ, Í∑∏Î¶¨Í≥† Í∑∏ Í∏∞Î∞òÏù¥ ÎêòÎäî **Big Data**Í∞Ä ÎèÑÎåÄÏ≤¥ Ïñ¥Îäê Ï†ïÎèÑ Í∑úÎ™®Ïù∏ÏßÄ Ïà´ÏûêÎ°ú ÌôïÏã§ÌïòÍ≤å Í∞êÏùÑ Ïû°Í≥† Í∞ÄÏïº Ìï©ÎãàÎã§. Ïò§Î∞îÎßà ÎåÄÌÜµÎ†πÏù¥ Ïñ∏Í∏âÌïú Ï†ïÏùòÎ∂ÄÌÑ∞ Îç∞Ïù¥ÌÑ∞Ïùò Íµ¨Ï≤¥Ï†ÅÏù∏ ÎπÑÏú®(%)ÍπåÏßÄ ÍººÍººÌûà Î¥ÖÏãúÎã§.
>
> > [!INFO] PAGE 1-2: Í∞úÎÖêÏùò ÏãúÏûë (Gianrico Farrugia)
> > 1ÌéòÏù¥ÏßÄ ÌëúÏßÄÎ•º ÎÑòÍ≤® 2ÌéòÏù¥ÏßÄÎ•º Î¥ÖÏãúÎã§. **Gianrico Farrugia**Ïùò ÏΩîÎ©òÌä∏Í∞Ä ÎÇòÏòµÎãàÎã§.
> > * ÌïµÏã¨ÏùÄ **"Treat the person as an individual"**ÏûÖÎãàÎã§. ÌôòÏûêÎ•º 'Í∑∏Î£π'Ïùò ÏùºÎ∂ÄÎ°ú Î≥¥Îäî Í≤å ÏïÑÎãàÎùº, Í∑∏ ÏÇ¨Îûå Í≥†Ïú†Ïùò **Genetic material(Ïú†Ï†Ñ Î¨ºÏßà)**Ïóê Í∏∞Î∞òÌï¥ ÏπòÎ£åÌïòÍ≤†Îã§Îäî Í±∞Ï£†. 
> > * Ïù¥Í≤å Î∞îÎ°ú **Individualized, Personalized, Precise**Ìïú ÏùòÎ£åÏùò Ï†ïÏùòÏûÖÎãàÎã§. Í∑∏ÎÉ• Ï¢ãÏùÄ Îßê Í∞ôÏßÄÎßå, 'Ïú†Ï†Ñ Î¨ºÏßà Í∏∞Î∞ò'Ïù¥ÎùºÎäî Ï†ÑÏ†ú Ï°∞Í±¥ÏùÑ Íº≠ Í∏∞ÏñµÌïòÏÑ∏Ïöî. 
>
> > [!IMPORTANT] PAGE 3-5: Precision Medicine Initiative (Ïò§Î∞îÎßà, 2015)
> > 3ÌéòÏù¥ÏßÄ ÏßÄÎèÑ Í∑∏Î¶ºÍ≥º 4ÌéòÏù¥ÏßÄ Ïò§Î∞îÎßà ÏÇ¨ÏßÑ Î≥¥Ïù¥Ï£†? **2015ÎÖÑ Ïó∞ÎëêÍµêÏÑú(State of the Union Address)**ÏóêÏÑú Î∞úÌëúÌïú ÎÇ¥Ïö©ÏûÖÎãàÎã§. 
> >
> > **1. Ï†ïÏùò (3p):** 
> > * ÏßàÎ≥ë ÏòàÎ∞©Í≥º ÏπòÎ£åÏóê ÏûàÏñ¥ÏÑú **ÏÑ∏ Í∞ÄÏßÄ Î≥ÄÏàò**Î•º Í≥†Î†§Ìï©ÎãàÎã§. Ïù¥Í±∞ ÏãúÌóòÏóê ÎÇòÏò§Î©¥ Î¨¥Ï°∞Í±¥ Ïç®Ïïº Ìï©ÎãàÎã§.
> >     1.  **Genes (Ïú†Ï†ÑÏûê)**
> >     2.  **Environment (ÌôòÍ≤Ω)**
> >     3.  **Lifestyle (ÏÉùÌôúÏäµÍ¥Ä)**
> >
> > **2. Íµ¨Ï≤¥Ï†Å Î™©Ìëú (5p):** 
> > * Îã®ÏàúÌûà ÏïΩÎßå Í∞úÎ∞úÌïòÎäî Í≤å ÏïÑÎãôÎãàÎã§.
> > * **100Îßå Î™Ö(1 million)** Ïù¥ÏÉÅÏùò ÎØ∏Íµ≠Ïù∏ ÏûêÏõêÎ¥âÏÇ¨ÏûêÎ°ú Íµ¨ÏÑ±Îêú Ïó∞Íµ¨ ÎÑ§Ìä∏ÏõåÌÅ¨ Íµ¨Ï∂ï. (Ïä§ÏºÄÏùºÏù¥ Îã§Î¶ÖÎãàÎã§, Ïà´Ïûê Ï≤¥ÌÅ¨!)
> > * ÌôòÏûêÍ∞Ä ÏûêÏã†Ïùò Í±¥Í∞ï Ï†ïÎ≥¥Ïóê Ï†ëÍ∑ºÌïòÏó¨ ÏπòÎ£åÏóê **ÌòëÎ†•(Collaborate)**ÌïòÍ≤å Ìï®.
> > * ÏÉàÎ°úÏö¥ ÏùòÎ£å Í∏∞Ïà†ÏùÑ ÏãúÏû•Ïóê Îçî **Îπ†Î•¥Í≤å(Faster)** ÎèÑÏûÖ.
>
> > [!INFO] PAGE 6: Ïôú ÏßÄÍ∏àÏù∏Í∞Ä? (Why Now?)
> > 6ÌéòÏù¥ÏßÄ ÌÖçÏä§Ìä∏Î•º Î≥¥ÏÑ∏Ïöî. Ïôú ÌïòÌïÑ ÏßÄÍ∏à Ï†ïÎ∞ÄÏùòÌïôÏùºÍπåÏöî? ÏÑ∏ Í∞ÄÏßÄ Í∏∞Ïà†Ï†Å Î∞∞Í≤ΩÏù¥ ÏûàÏäµÎãàÎã§. 
> > 1.  **Sequencing:** Ïù∏Í∞Ñ Ïú†Ï†ÑÏ≤¥(Human Genome) Î∂ÑÏÑù ÎπÑÏö©Í≥º ÏãúÍ∞ÑÏù¥ ÌöçÍ∏∞Ï†ÅÏúºÎ°ú Ï§ÑÏóàÏ£†.
> > 2.  **Improved Technologies:** ÏÉùÏùòÌïô Î∂ÑÏÑù(Biomedical analysis) Í∏∞Ïà†Ïùò Ìñ•ÏÉÅ.
> > 3.  **New Tools:** ÎåÄÏö©Îüâ Îç∞Ïù¥ÌÑ∞ÏÖã(Large datasets)ÏùÑ Îã§Î£∞ Ïàò ÏûàÎäî ÎèÑÍµ¨(Ïª¥Ìì®ÌåÖ ÌååÏõå, AI Îì±)Ïùò Îì±Ïû•.
>
> > [!IMPORTANT] PAGE 7: Ìó¨Ïä§ÏºÄÏñ¥ Îç∞Ïù¥ÌÑ∞Ïùò Ïã§Ï≤¥ (ÏàòÏπò ÏïîÍ∏∞!)
> > Ïûê, Ïó¨Í∏∞ **Î≥ÑÌëú** ÏπòÏÑ∏Ïöî. Ìó¨Ïä§ÏºÄÏñ¥ ÎπÖÎç∞Ïù¥ÌÑ∞Ïùò Íµ¨ÏÑ± ÎπÑÏú®Í≥º Ïö©ÎüâÏù¥ Íµ¨Ï≤¥Ï†ÅÏúºÎ°ú ÎÇòÏòµÎãàÎã§. ÌâÅÏ≥êÏÑú 'ÎßéÎã§'Í≥† ÌïòÎ©¥ ÏùòÎåÄÏÉù ÏïÑÎãàÏ£†. ÏàòÏπòÎ•º Î≥¥ÏÑ∏Ïöî.
> >
> > **1. Í±¥Í∞ï Í≤∞Ï†ï ÏöîÏù∏ (Determinants of Health) ÎπÑÏú®:** 
> > * **Exogenous data (Ïô∏Ïù∏ÏÑ± Îç∞Ïù¥ÌÑ∞):** ÌñâÎèô, ÏÇ¨ÌöåÍ≤ΩÏ†úÏ†Å, ÌôòÍ≤ΩÏ†Å ÏöîÏù∏. Î¨¥Î†§ **60%**Î•º Ï∞®ÏßÄÌï©ÎãàÎã§.
> > * **Genomics data (Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞):** **30%**. ÏÉùÍ∞ÅÎ≥¥Îã§ ÎπÑÏ§ëÏù¥ ÌÅ¨Ï£†?
> > * **Clinical data (ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞):** Í≤®Ïö∞ **10%**. Î≥ëÏõêÏóêÏÑú ÎÇòÏò§Îäî Îç∞Ïù¥ÌÑ∞Îäî ÎπôÏÇ∞Ïùò ÏùºÍ∞ÅÏù¥ÎùºÎäî Í≤ÅÎãàÎã§.
> >
> > **2. ÌèâÏÉù ÏÉùÏÑ±ÎêòÎäî Îç∞Ïù¥ÌÑ∞ Ïñë (Data per lifetime):** 
> > * Ï¥ùÎüâ: **1100 Terabytes (TB)**
> > * Exogenous: **1100 TB** (Í±∞Ïùò ÎåÄÎ∂ÄÎ∂Ñ)
> > * Genomics: **6 TB**
> > * Clinical: **0.4 TB** (ÏïÑÏ£º ÎØ∏ÎØ∏Ìï®)
> >
> > **3. ÎπÖÎç∞Ïù¥ÌÑ∞Ïùò 4V:** 
> > * **Volume (Ïñë)**, **Variety (Îã§ÏñëÏÑ±)**, **Velocity (ÏÜçÎèÑ)**, **Veracity (Ï†ïÌôïÏÑ±)**.
> > * ÌäπÌûà ÌïòÎã®Ïóê Î≥¥Î©¥ 2020ÎÖÑ Í∏∞Ï§ÄÏúºÎ°ú ÏùòÎ£å Îç∞Ïù¥ÌÑ∞Îäî **73ÏùºÎßàÎã§ 2Î∞∞**Î°ú Ï¶ùÍ∞ÄÌïúÎã§Í≥† ÎêòÏñ¥ ÏûàÏäµÎãàÎã§. Í∏àÏúµ(Finance) Î∂ÑÏïºÎ≥¥Îã§ Îç∞Ïù¥ÌÑ∞Í∞Ä Îçî ÎßéÏïÑÏöî. 

> [!NOTE] Pages 8-13: ÏùòÎ£å Ìå®Îü¨Îã§ÏûÑÏùò ÎåÄÏ†ÑÌôò (Paradigm Shift)
> Ïûê, Ïù¥Ï†ú ÏùòÌïôÏùò Ïó≠ÏÇ¨Î•º 3Îã®Í≥ÑÎ°ú ÎÇòÎà†ÏÑú Î®∏Î¶øÏÜçÏóê ÏßëÏñ¥ÎÑ£ÏùçÏãúÎã§. Í≥ºÍ±∞Ïùò ÏùòÏÇ¨Îì§ÏùÄ 'ÏßÅÍ¥Ä'Ïóê ÏùòÏ°¥ÌñàÏßÄÎßå, ÎØ∏ÎûòÏùò ÏùòÏÇ¨Îì§ÏùÄ **'ÏïåÍ≥†Î¶¨Ï¶ò'**ÏùÑ Îã§Î§ÑÏïº Ìï©ÎãàÎã§. Ïù¥ ÌååÌä∏Ïùò ÌïµÏã¨ÏùÄ **"One Treatment Fits All(Îã®Ïùº ÏπòÎ£å)"Ïùò Î™∞ÎùΩ**Í≥º **"Personalized(ÎßûÏ∂§Ìòï)"Ïùò Î∂ÄÏÉÅ**ÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 8: Ìå®Îü¨Îã§ÏûÑ 3Îã®Í≥Ñ (ÏãúÌóò ÏïºÎßà!)
> > 8ÌéòÏù¥ÏßÄ ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. ÏùòÌïôÏùÄ Ïù¥Î†áÍ≤å ÏßÑÌôîÌñàÏäµÎãàÎã§. Í∞Å Îã®Í≥ÑÏùò ÌÇ§ÏõåÎìúÎ•º Î∞òÎìúÏãú Îß§Ïπ≠ÏãúÌÇ§ÏÑ∏Ïöî.
> >
> > 1.  **Yesterday (Í≥ºÍ±∞):**
> >     * Í∏∞Î∞ò: **Symptom-based (Ï¶ùÏÉÅ Í∏∞Î∞ò)**
> >     * Î∞©Ïãù: **Intuition Medicine (ÏßÅÍ¥Ä ÏùòÌïô)** - ÏùòÏÇ¨Ïùò 'Í∞ê'Ïóê ÏùòÏ°¥ÌñàÏ£†.
> > 2.  **Today (ÌòÑÏû¨):**
> >     * Í∏∞Î∞ò: **Pattern-based (Ìå®ÌÑ¥ Í∏∞Î∞ò)**
> >     * Î∞©Ïãù: **Evidence-based Medicine (Ï¶ùÍ±∞ Í∏∞Î∞ò ÏùòÌïô, EBM)** - ÏûÑÏÉÅÏãúÌóò ÌÜµÍ≥ÑÍ∞Ä ÏôïÏù¥ÏóàÏäµÎãàÎã§.
> > 3.  **Tomorrow (ÎØ∏Îûò):**
> >     * Í∏∞Î∞ò: **Algorithm-based (ÏïåÍ≥†Î¶¨Ï¶ò Í∏∞Î∞ò)** - Ïó¨Í∏∞Í∞Ä ÌïµÏã¨ÏûÖÎãàÎã§.
> >     * Î∞©Ïãù: **Precision Medicine (Ï†ïÎ∞Ä ÏùòÌïô)** - Îç∞Ïù¥ÌÑ∞Í∞Ä ÏπòÎ£åÎ•º Í≤∞Ï†ïÌï©ÎãàÎã§.
>
> > [!INFO] PAGE 9: ÏÉàÎ°úÏö¥ ÌîåÎ†àÏù¥Ïñ¥Îì§ (IT Giants)
> > 9ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Î≥ëÏõê Î°úÍ≥†Í∞Ä ÏïÑÎãôÎãàÎã§. **Google Health, Google DeepMind, IBM Watson Health, Human Longevity Inc.** Í∞ôÏùÄ IT Í∏∞ÏóÖÎì§Ïù¥Ï£†.
> > * Ïù¥Îì§Ïù¥ ÎÖ∏Î¶¨Îäî Î∂ÑÏïºÍ∞Ä ÏïÑÎûò Ìä∏Î¶¨Ïóê ÎÇòÏòµÎãàÎã§:
> >     * **Oncology (Ï¢ÖÏñëÌïô)**
> >     * **Drug Discovery (Ïã†ÏïΩ Í∞úÎ∞ú)**
> >     * **Genomics (Ïú†Ï†ÑÏ≤¥Ìïô)**
> >     * **Patient Engagement (ÌôòÏûê Ï∞∏Ïó¨)**
> > * Ï¶â, Ìó¨Ïä§ÏºÄÏñ¥Ïùò Ï£ºÎèÑÍ∂åÏù¥ 'Îç∞Ïù¥ÌÑ∞Î•º Í∞ÄÏßÑ Í∏∞ÏóÖ'ÏúºÎ°ú ÎÑòÏñ¥Í∞ÄÍ≥† ÏûàÎã§Îäî Ï¶ùÍ±∞ÏûÖÎãàÎã§.
>
> > [!WARNING] PAGE 11-12: ÌòÑÏû¨ ÏùòÌïôÏùò ÌïúÍ≥Ñ (One Treatment Fits All)
> > 11ÌéòÏù¥ÏßÄ ÎèÑÏãùÏùÑ Î¥ÖÏãúÎã§. **"Current Medicine: One Treatment Fits All"**.
> > * ÎòëÍ∞ôÏùÄ ÏïΩ(Pill)ÏùÑ Î™®Îì† ÌôòÏûê(Ï¥àÎ°ù, Îπ®Í∞ï, ÌååÎûë ÏÑûÏó¨ ÏûàÎäî Í∑∏Î£π)ÏóêÍ≤å Ï§çÎãàÎã§.
> > * **Í≤∞Í≥º:**
> >     * ÏùºÎ∂ÄÎäî **Effect (Ìö®Í≥º ÏûàÏùå)**.
> >     * ÏùºÎ∂ÄÎäî **No effect (Ìö®Í≥º ÏóÜÏùå)** - Îèà ÎÇ≠ÎπÑÏ£†.
> >     * Ïã¨ÏßÄÏñ¥ ÏùºÎ∂ÄÎäî **Adverse effects (Î∂ÄÏûëÏö©)** - Ïù¥Í≤å Ï†úÏùº ÏúÑÌóòÌï©ÎãàÎã§.
> > * 12ÌéòÏù¥ÏßÄÎèÑ Í∞ôÏùÄ Îß•ÎùΩÏûÖÎãàÎã§. "Conventional approach"Îäî ÏßÑÎã®Ïù¥ Îä¶Ïñ¥ÏßÄÍ±∞ÎÇò(delayed), Ïò§ÏßÑ(mis-diagnosis)Ïù¥ ÏÉùÍ≤® ÏπòÎ£å Ìö®Ïú®Ïù¥ ÎÇÆÏäµÎãàÎã§.
>
> > [!IMPORTANT] PAGE 13: ÎØ∏Îûò ÏùòÌïô (Personalized Diagnostics)
> > 13ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ 11ÌéòÏù¥ÏßÄÏôÄ Î∞òÎåÄÏûÖÎãàÎã§. ÏàúÏÑúÍ∞Ä Î∞îÎÄùÎãàÎã§.
> > * **ÏÑ†(ÂÖà) ÏßÑÎã®:** ÏπòÎ£å Ï†ÑÏóê **Blood, DNA, Urine, Tissue Analysis**Î•º Î®ºÏ†Ä ÏàòÌñâÌï©ÎãàÎã§.
> > * **ÌõÑ(Âæå) Î∂ÑÎ•ò:** ÌôòÏûêÎì§ÏùÑ Îπ®Í∞ï, ÎÖ∏Îûë, ÌååÎûë Í∑∏Î£πÏúºÎ°ú **ÎØ∏Î¶¨ ÎÇòÎàïÎãàÎã§(Stratification)**.
> > * **Í≤∞Í≥º:** Í∞Å Í∑∏Î£πÏóê ÎßûÎäî ÏïΩÏùÑ Ìà¨Ïó¨ÌïòÎãàÍπå, Î™®Îì† ÌôòÏûêÏóêÍ≤åÏÑú **Effect (Ìö®Í≥º)**Í∞Ä ÎÇòÌÉÄÎÇ©ÎãàÎã§. Î∂ÄÏûëÏö©ÏùÄ ÏµúÏÜåÌôîÎêòÍ≥†Ïöî. Ïù¥Í≤å Ï†ïÎ∞ÄÏùòÌïôÏùò Í∂ÅÍ∑πÏ†Å Î™©ÌëúÏûÖÎãàÎã§.

> [!NOTE] Pages 14-21: P4 MedicineÍ≥º ÏãúÏä§ÌÖú ÏùòÌïô (Systems Medicine)
> Ïûê, Ï†ïÎ∞ÄÏùòÌïôÏùÑ Îã§Î•∏ ÎßêÎ°ú **'P4 Medicine'**Ïù¥ÎùºÍ≥†ÎèÑ Ìï©ÎãàÎã§. Ïù¥ 4Í∞ÄÏßÄ PÍ∞Ä Î≠îÏßÄ Î™®Î•¥Î©¥ Ïù¥ ÏàòÏóÖ ÌóõÎì§ÏùÄ Í≤ÅÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ Î∞©ÎåÄÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïñ¥ÎñªÍ≤å ÏöîÎ¶¨Ìï¥ÏÑú ÏûÑÏÉÅÏóê Ï†ÅÏö©ÌïòÎäîÏßÄ, Í∑∏ Î≥µÏû°Ìïú Í≥ºÏ†ïÏùÑ ÌïòÎÇòÏî© Î∂ÑÌï¥Ìï¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 14: P4 MedicineÏùò Ï†ïÏùò (ÏïîÍ∏∞ ÌïÑÏàò!)
> > 14ÌéòÏù¥ÏßÄ, ÏïÑÏ£º Ï§ëÏöîÌïú ÏïΩÏñ¥Í∞Ä ÎÇòÏòµÎãàÎã§. **P4 Medicine**.
> > 1.  **Predictive (ÏòàÏ∏°):** Î∞úÎ≥ë Ï†ÑÏóê ÎØ∏Î¶¨ ÏïàÎã§.
> > 2.  **Preventive (ÏòàÎ∞©):** ÏïÑÌîÑÍ∏∞ Ï†ÑÏóê ÎßâÎäîÎã§.
> > 3.  **Personalized (ÎßûÏ∂§):** ÎÑàÌïúÌÖå Îî± ÎßûÎäî ÏπòÎ£åÎ•º ÌïúÎã§.
> > 4.  **Participatory (Ï∞∏Ïó¨):** ÌôòÏûêÍ∞Ä ÏàòÎèôÏ†ÅÏù∏ Í∞ùÏ≤¥Í∞Ä ÏïÑÎãàÎùº, Îç∞Ïù¥ÌÑ∞ ÏÉùÏÇ∞ÏûêÎ°úÏÑú Ï∞∏Ïó¨ÌïúÎã§.
> >
> > * **ÌïµÏã¨ ÏßàÎ¨∏:** "Îç∞Ïù¥ÌÑ∞Îäî ÎÑòÏ≥êÎÇòÎäîÎç∞(More data), Ïù¥Í±∏ ÏñºÎßàÎÇò Ìö®Ïú®Ï†ÅÏúºÎ°ú ÏÇ¨Ïö©Ìï† Í≤ÉÏù∏Í∞Ä?" -> Í∑∏ Ìï¥ÎãµÏù¥ Î∞îÎ°ú **Systems Medicine**ÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 15: ÏûÑÏÉÅ Ï†ÅÏö© ÏÇ¨Ïù¥ÌÅ¥ (Clinical Deployment)
> > 15ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùò ÏàúÌôò Íµ¨Ï°∞Î•º Î≥¥ÏÑ∏Ïöî. Îç∞Ïù¥ÌÑ∞Í∞Ä Ïñ¥ÎñªÍ≤å ÌùêÎ•¥ÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§.
> > * **Screening (ÏÑ†Î≥Ñ) ‚Üí Diagnosis (ÏßÑÎã®) ‚Üí Staging & Phenotyping (Î≥ëÍ∏∞ ÏÑ§Ï†ï) ‚Üí Therapy & Monitoring (ÏπòÎ£å Î∞è Î™®ÎãàÌÑ∞ÎßÅ)**
> > * Ïù¥ Í≥ºÏ†ïÏóêÏÑú Ïñ¥Îñ§ Îç∞Ïù¥ÌÑ∞Í∞Ä Îì§Ïñ¥Í∞ÄÎÇòÏöî?
> >     * **-omic/biological:** Ïú†Ï†ÑÏ≤¥ Ï†ïÎ≥¥
> >     * **Electronic health records (EHR):** Î≥ëÏõê Í∏∞Î°ù
> >     * **Geospatial & Environmental:** Ïñ¥Îîî ÏÇ¨ÎäîÏßÄ, ÌôòÍ≤ΩÏùÄ Ïñ¥Îñ§ÏßÄ
> >     * **Personal monitoring:** Ïõ®Ïñ¥Îü¨Î∏î Í∏∞Í∏∞ Îç∞Ïù¥ÌÑ∞ Îì±
> > * Ïö∞Ï∏° ÌïòÎã®Ïùò ÏßàÎ¨∏Îì§Ïù¥ ÎÇ†Ïπ¥Î°≠ÏäµÎãàÎã§. "Í≥ºÍ±∞Î†•(History) Ï§ë Î¨¥ÏóáÏùÑ Î≥ºÍπå?", "ÌòÑÏû¨ ÏÉÅÌÉú(Current state)Îäî?", "Í∞úÏûÖ(Intervene) Í∏∞ÌöåÎäî?", "ÎØ∏Îûò ÏúÑÌóò(Risks)ÏùÄ?"
>
> > [!TIP] üí° PAGE 17-18: Îç∞Ïù¥ÌÑ∞Ïùò ÏõêÏ≤ú (Ï°±Î≥¥ ÏÜåÏä§)
> > Ïûê, Ïó¨Í∏∞ Ï†ÅÌòÄ ÏûàÎäî Îç∞Ïù¥ÌÑ∞Î≤†Ïù¥Ïä§ Ïù¥Î¶ÑÎì§, ÎààÏóê ÏùµÌòÄÎëêÏÑ∏Ïöî. ÎÇòÏ§ëÏóê Ïó∞Íµ¨Ìï† Îïå Î¨¥Ï°∞Í±¥ ÏîÅÎãàÎã§.
> >
> > **1. Technology Platforms (17p):**
> > * **Genomics & Transcriptomics:** ÏãúÌÄÄÏã± Îç∞Ïù¥ÌÑ∞ (ACGT...)
> > * **Proteomics & Metabolomics:** Îã®Î∞±Ïßà, ÎåÄÏÇ¨Î¨ºÏßà (MS-data ÏßàÎüâÎ∂ÑÏÑù)
> > * **Imaging:** ÏòÅÏÉÅ Îç∞Ïù¥ÌÑ∞
> >
> > **2. Public Databases (18p) - Î≥ÑÌëú!:**
> > * **TCGA (The Cancer Genome Atlas):** Ïïî Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Ïùò Î≥¥Î¨ºÏ∞ΩÍ≥†ÏûÖÎãàÎã§.
> > * **CCLE (Cancer Cell Line Encyclopedia):** Ïïî ÏÑ∏Ìè¨Ï£º Îç∞Ïù¥ÌÑ∞.
> > * **ClinicalTrials.gov:** ÏûÑÏÉÅÏãúÌóò Ï†ïÎ≥¥.
> > * **PubChem, DrugBank:** ÏïΩÎ¨º ÌôîÌïô Íµ¨Ï°∞ Î∞è ÌÉÄÍ≤ü Ï†ïÎ≥¥.
> > * **TOXNET:** ÎèÖÏÑ± Ï†ïÎ≥¥.
> > * Ïù¥ Îç∞Ïù¥ÌÑ∞Îì§Ïù¥ Îã§ Ïó∞Í≤∞ÎêòÏñ¥Ïïº ÎπÑÎ°úÏÜå 'Ï†ïÎ∞ÄÏùòÌïô'Ïù¥ Îê©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 19: AIÏôÄ Î®∏Ïã†Îü¨ÎãùÏùò Ïó≠Ìï† (ÏïåÍ≥†Î¶¨Ï¶ò Ïù¥Î¶Ñ Ï≤¥ÌÅ¨)
> > 19ÌéòÏù¥ÏßÄ Ïö∞Ï∏° ÌïòÎã®, Íπ®Ïïå Í∞ôÏùÄ Í∏ÄÏî®Î•º Î≥¥ÏÑ∏Ïöî. Îç∞Ïù¥ÌÑ∞Î•º Î∂ÑÏÑùÌïòÎäî ÎèÑÍµ¨Îì§ÏûÖÎãàÎã§.
> > * **Machine Learning (ML):** Í∏∞Í≥ÑÌïôÏäµ.
> > * **Deep Learning (DL):** Îî•Îü¨Îãù.
> > * **Íµ¨Ï≤¥Ï†Å ÏïåÍ≥†Î¶¨Ï¶ò:**
> >     * **SVM (Support Vector Machine)**
> >     * **RF (Random Forest)**
> >     * **LightGBM:** ÏµúÍ∑º ÎßéÏù¥ Ïì∞Ïù¥Îäî Î∂ÄÏä§ÌåÖ Î™®Îç∏Ïù¥Ï£†.
> > * **Í≥ºÏ†ï:** Feature selection(ÌäπÏßï ÏÑ†ÌÉù) ‚Üí Cross validation(ÍµêÏ∞® Í≤ÄÏ¶ù) ‚Üí Hyperparameter tuning(ÌäúÎãù) ‚Üí **Prediction(ÏòàÏ∏°)**. Ïù¥ ÌîÑÎ°úÏÑ∏Ïä§Í∞Ä Î®∏Î¶øÏÜçÏóê ÏûàÏñ¥Ïïº Ìï©ÎãàÎã§.
>
> > [!INFO] PAGE 20-21: Multi-OmicsÏùò ÌÜµÌï© (Integration)
> > 20ÌéòÏù¥ÏßÄ, ÏÇ¨Îûå Î™∏ÏùÑ **Systems Biology** Í¥ÄÏ†êÏóêÏÑú Î≥∏ Í∑∏Î¶ºÏûÖÎãàÎã§.
> > * ÏïΩÎ¨º(Drug A)Ïù¥ Îì§Ïñ¥Í∞ÄÎ©¥ Îã®ÏÑ†Ï†ÅÏù∏ Î∞òÏùëÎßå ÏûàÎäî Í≤å ÏïÑÎãàÎùº, Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨(Network)Î•º Í±¥ÎìúÎ¶ΩÎãàÎã§. Í∑∏ÎûòÏÑú Î∂ÄÏûëÏö©(AEs)ÎèÑ ÏÉùÍ∏∞Í≥†, ÏÉàÎ°úÏö¥ Ï†ÅÏùëÏ¶ù(New indications, Drug repositioning)ÎèÑ Î∞úÍ≤¨ÎêòÎäî Í±∞Ï£†.
> >
> > 21ÌéòÏù¥ÏßÄÍ∞Ä Í≤∞Î°†ÏûÖÎãàÎã§.
> > * **Multi-OMICS:** Genome, Epigenome, Transcriptome, Proteome, Metabolome, Microbiome... Ïù¥ Î™®Îì† Í±∏ Ìï©Ï≥êÏïº Ìï©ÎãàÎã§.
> > * **Integration (ÌÜµÌï©):** Îî∞Î°ú ÎÜÄÎ©¥ Ïì∞Î†àÍ∏∞ÏûÖÎãàÎã§. ÏÑûÏñ¥ÏÑú Î∂ÑÏÑùÌï¥Ïïº Ïú†ÏùòÎØ∏Ìïú **Signatures (ÌäπÏßï)**Í∞Ä ÎÇòÏò§Í≥†, Í∑∏Ï†úÏïº **Therapeutics (ÏπòÎ£åÎ≤ï)**Í∞Ä ÎÇòÏòµÎãàÎã§.

> [!NOTE] Pages 22-31: Ïú†Ï†ÑÏ≤¥Ìïô Í∏∞Ï¥à (Genomics Basics)
> Ïûê, Ïù¥Ï†ú **ÏÉùÎ™ÖÏùò Ïñ∏Ïñ¥(Language of Life)**Î•º Î∞∞Ïö∏ Ï∞®Î°ÄÏûÖÎãàÎã§. Í≥†Îì±ÌïôÍµê ÏÉùÎ¨º ÏãúÍ∞Ñ Í∞ôÎã§Í≥† Î∞©Ïã¨ÌïòÏßÄ ÎßàÏÑ∏Ïöî. Ïó¨Í∏∞ ÎÇòÏò§Îäî **ÏàòÏπò(nm, bp)**Îì§Í≥º **Îç∞Ïù¥ÌÑ∞Ïùò Í∑úÎ™®**Í∞Ä Ï†ïÎ∞ÄÏùòÌïôÏóêÏÑú Ïôú 'ÎπÖÎç∞Ïù¥ÌÑ∞'ÎùºÍ≥† Î∂àÎ¶¨ÎäîÏßÄ Í∑∏ Í∑ºÍ±∞Í∞Ä ÎêòÎãàÍπåÏöî.
>
> > [!INFO] PAGE 22: ÏÉùÎ¨ºÌïôÏ†Å Ï†ïÎ≥¥Ïùò ÌùêÎ¶Ñ (Central Dogma Í∑∏ Ïù¥ÏÉÅ)
> > 22ÌéòÏù¥ÏßÄ Îã§Ïù¥Ïñ¥Í∑∏Îû®ÏùÑ Î≥¥ÏÑ∏Ïöî. Ïö∞Î¶¨Í∞Ä ÏïÑÎäî ÏÑºÌä∏Îü¥ ÎèÑÍ∑∏Îßà(DNA ‚Üí RNA ‚Üí Protein)Í∞Ä Í∏∞Î≥∏Ïù¥ÏßÄÎßå, Í∑∏Î¶ºÏù¥ Ìõ®Ïî¨ Î≥µÏû°ÌïòÏ£†? 
> > * **Feedback Loops:** ÌôîÏÇ¥ÌëúÍ∞Ä Ìïú Î∞©Ìñ•ÏúºÎ°úÎßå Í∞ÄÏßÄ ÏïäÏäµÎãàÎã§. Îã®Î∞±Ïßà(Proteins)Ïù¥ Îã§Ïãú DNAÎÇò RNA Ï°∞Ï†àÏóê Í¥ÄÏó¨ÌïòÍ≥†, **ÌôòÍ≤Ω(Environment)**Ïù¥ ÏÑ∏Ìè¨ ÎåÄÏÇ¨(Cellular metabolism)Ïóê ÏòÅÌñ•ÏùÑ ÎØ∏ÏπòÎäî **ÏàúÌôò Íµ¨Ï°∞**ÏûÑÏùÑ Î™ÖÏã¨ÌïòÏÑ∏Ïöî. 
>
> > [!INFO] PAGE 23-24: Human Genome Project (HGP)
> > 23ÌéòÏù¥ÏßÄÏùò ÏàòÎßéÏùÄ ÏïåÌååÎ≤≥(ACGT...)Í≥º 24ÌéòÏù¥ÏßÄÏùò ÌååÌòï(Peaks) Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Ïù¥Í≤å Î∞îÎ°ú **Sanger Sequencing**Ïùò Í≤∞Í≥ºÎ¨ºÏûÖÎãàÎã§. 
> > * **Human Genome Project:** Ïù∏Í∞ÑÏùò Î™®Îì† DNA Í∏ÄÏûêÎ•º ÏùΩÏñ¥ÎÇ¥Î†§Îäî Í±∞ÎåÄÌïú ÏãúÎèÑÏòÄÏ£†. ÌÅ¥Î¶∞ÌÑ¥ ÎåÄÌÜµÎ†π ÏÇ¨ÏßÑÎèÑ Î≥¥Ïù¥ÎÑ§Ïöî. 
>
> > [!IMPORTANT] PAGE 25: DNA Íµ¨Ï°∞Ïùò ÏàòÏπò (ÏïîÍ∏∞!)
> > 25ÌéòÏù¥ÏßÄ, Ïó¨Í∏∞ **Î≥ÑÌëú** Îã§ÏÑØ Í∞ú ÏπòÏÑ∏Ïöî. DNA Íµ¨Ï°∞Ïùò ÏàòÏπò, ÏãúÌóòÏóê ÎÇ¥Í∏∞ Îî± Ï¢ãÏäµÎãàÎã§.
> > * **Î∞©Ìñ•ÏÑ±:** **5' end (Ïù∏ÏÇ∞Í∏∞)**ÏóêÏÑú **3' end (ÏàòÏÇ∞Í∏∞, OH)**Î°ú Ïù¥Ïñ¥ÏßëÎãàÎã§. Îëê Í∞ÄÎã•ÏùÄ ÏÑúÎ°ú **Ïó≠ÌèâÌñâ(Anti-parallel)**Ìï©ÎãàÎã§. 
> > * **Î∞±Î≥∏(Backbone):** Ïù∏ÏÇ∞(Phosphate) + Îãπ(Deoxyribose)ÏúºÎ°ú Íµ¨ÏÑ±Îê©ÎãàÎã§. 
> > * **Ï£ºÏöî ÏàòÏπò:**
> >     * **ÏßÄÎ¶Ñ (Width):** **2 nm** 
> >     * **ÎÇòÏÑ† Ìïú Î∞îÌÄ¥ (One turn):** **3.4 nm** 
> >     * **ÏóºÍ∏∞ ÏÇ¨Ïù¥ Í±∞Î¶¨ (Distance between bases):** **0.34 nm** 
> > * **Groove:** ÎÑìÏùÄ **Major groove**ÏôÄ Ï¢ÅÏùÄ **Minor groove**Í∞Ä ÏûàÏäµÎãàÎã§. ÎÇòÏ§ëÏóê Îã®Î∞±ÏßàÏù¥ Ïó¨Í∏∞ ÎÅºÏñ¥Îì§Ïñ¥Í∞ÄÏÑú Í≤∞Ìï©Ìï©ÎãàÎã§. 
>
> > [!INFO] PAGE 28: Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Ïùò ÌÅ¨Í∏∞ (ÎπÑÏú†)
> > 28ÌéòÏù¥ÏßÄ, Ïú†Ï†ÑÏ≤¥ Îç∞Ïù¥ÌÑ∞Í∞Ä ÏñºÎßàÎÇò Î∞©ÎåÄÌïúÏßÄ ÎπÑÏú†Î•º Îì§Ïñ¥ ÏÑ§Î™ÖÌï©ÎãàÎã§.
> > * **Ï†ÑÏ≤¥ Ïö©Îüâ:** Ïù∏Í∞Ñ DNAÎäî ÏïΩ **64Ïñµ Í∞ú(6.4 billion)**Ïùò Î¨∏ÏûêÎ°ú ÎêòÏñ¥ ÏûàÏäµÎãàÎã§. 
> > * **Ï±ÖÏúºÎ°ú ÏπòÎ©¥:** 500ÌéòÏù¥ÏßÄÏßúÎ¶¨ Ï±Ö **4,200Í∂å** Î∂ÑÎüâÏûÖÎãàÎã§. Ïñ¥ÎßàÏñ¥ÎßàÌïòÏ£†. 
> > * **ÏÑúÎπÑÏä§ ÎπÑÍµê:**
> >     * **Veritas (Whole Genome):** 4,200Í∂å Ï†ÑÏ≤¥Î•º ÏùΩÏñ¥Ï§çÎãàÎã§. 
> >     * **23andMe (SNP genotyping):** Ï†ÑÏ≤¥Ïùò **1% ÎØ∏Îßå**Îßå Î¥ÖÎãàÎã§. Ï±ÖÏúºÎ°ú ÏπòÎ©¥ Í≤®Ïö∞ **180ÌéòÏù¥ÏßÄ** ÏùΩÎäî ÏÖàÏù¥Ï£†. Ïù¥ Ï∞®Ïù¥Î•º ÏïÑÎäî Í≤å Ï§ëÏöîÌï©ÎãàÎã§. 
>
> > [!INFO] PAGE 30-31: ÏÉùÎ™ÖÏùò Í≥ÑÏ∏µ Íµ¨Ï°∞ÏôÄ ÏóºÏÉâÏ≤¥
> > * **Í≥ÑÏ∏µ (30p):** Macromolecule(DNA) ‚Üí Organelle ‚Üí Cell ‚Üí Tissue ‚Üí Organ ‚Üí Organism ÏàúÏÑúÎ°ú Î≥µÏû°Ìï¥ÏßëÎãàÎã§. 
> > * **ÏóºÏÉâÏ≤¥ (31p):** Ïù∏Í∞ÑÏùÄ **23Ïåç(23 pairs)**Ïùò ÏóºÏÉâÏ≤¥Î•º Í∞ÄÏßëÎãàÎã§. (Ï¥ù 46Í∞ú) 
> > * **ÏÉÅÎèô ÏóºÏÉâÏ≤¥ (Homologous pairs):** Î∂ÄÎ™®Î°úÎ∂ÄÌÑ∞ Í∞ÅÍ∞Å ÌïòÎÇòÏî© Î¨ºÎ†§Î∞õÏùÄ Ìïú ÏåçÏûÖÎãàÎã§.
> >     * **Allele (ÎåÄÎ¶ΩÏú†Ï†ÑÏûê):** Í∞ôÏùÄ ÏúÑÏπòÏóê ÏûàÎäî Ïú†Ï†ÑÏûê Î≤ÑÏ†ÑÏùÑ ÎßêÌï©ÎãàÎã§. Í∑∏Î¶ºÏùò **Allele A**ÏôÄ **Allele a**Î•º Î≥¥ÏÑ∏Ïöî. Ïù¥Í≤å ÌòïÏßà(Ïòà: Î®∏Î¶¨ÏÉâ)ÏùÑ Í≤∞Ï†ïÌï©ÎãàÎã§. 

> [!NOTE] Pages 32-40: Ïú†Ï†ÑÏûê Î∞úÌòÑÍ≥º ÏûÑÏÉÅ ÏãúÌÄÄÏã± Í∏∞Ïà†
> Ïûê, DNAÏóê Ï†ÅÌûå Ï†ïÎ≥¥Í∞Ä Ïñ¥ÎñªÍ≤å Ïö∞Î¶¨ ÎààÏóê Î≥¥Ïù¥Îäî ÌäπÏßï(Phenotype)ÏúºÎ°ú ÎÇòÌÉÄÎÇòÎäîÏßÄ, Í∑∏Î¶¨Í≥† Í∑∏ Ï†ïÎ≥¥Î•º ÏùΩÏñ¥ÎÇ¥Îäî Í∏∞Ïà†ÏóêÎäî Ïñ¥Îñ§ Í≤ÉÎì§Ïù¥ ÏûàÎäîÏßÄ 'Ìï¥ÏÉÅÎèÑ'Î≥ÑÎ°ú ÎúØÏñ¥Î¥ÖÏãúÎã§. ÌäπÌûà **39ÌéòÏù¥ÏßÄ**Îäî ÏûÑÏÉÅ ÏãúÌóòÏù¥ÎÇò Íµ≠Í∞ÄÍ≥†ÏãúÏóêÎèÑ Îã®Í≥®Î°ú ÎÇòÏò§Îäî Í∞úÎÖêÏù¥Îãà Îàà ÌÅ¨Í≤å Îú®ÏÑ∏Ïöî.
>
> > [!INFO] PAGE 32-33: GenotypeÏóêÏÑú PhenotypeÍπåÏßÄ (Layer Íµ¨Ï°∞)
> > 32ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùò Îã§ÏñëÌïú ÏÇ¨ÎûåÎì§ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å Îã§ **Phenotype(ÌëúÌòÑÌòï)**ÏûÖÎãàÎã§.
> > * **ÌïµÏã¨ ÏßàÎ¨∏ (33p):** ÎèÑÎåÄÏ≤¥ Ïñ¥Îñ§ Î¨ºÎ¶¨Ï†Å Î©îÏª§ÎãàÏ¶òÏù¥ Ïö∞Î¶¨Ïùò Ïô∏Î™®ÏôÄ Í∏∞Îä•ÏùÑ Í≤∞Ï†ïÌï†ÍπåÏöî?
> > * **Ï†ïÎ≥¥Ïùò Í≥ÑÏ∏µ (Level):**
> >     * **Genome (Ïú†Ï†ÑÏ≤¥)**: Í∞ÄÏû• Î∞ëÎ∞îÎã• ÏÑ§Í≥ÑÎèÑ.
> >     * **Epigenome (ÌõÑÏÑ±Ïú†Ï†ÑÏ≤¥)**: ÏÑ§Í≥ÑÎèÑÏùò Ïä§ÏúÑÏπò.
> >     * **Transcriptome (Ï†ÑÏÇ¨Ï≤¥)**: Î≥µÏÇ¨Îêú Î™ÖÎ†πÏÑú.
> >     * **Proteome (Îã®Î∞±ÏßàÏ≤¥)**: Ïã§Ï†ú ÏùºÍæº.
> >     * **Metabolome (ÎåÄÏÇ¨Ï≤¥)**: ÏùºÍæºÏù¥ ÎßåÎì† Í≤∞Í≥ºÎ¨º.
> >     * **Phenome (ÌëúÌòÑÌòïÏ≤¥)**: ÏµúÏ¢ÖÏ†ÅÏù∏ ÏÉùÎ¨ºÌïôÏ†Å ÌäπÏßï.
> > * Ïù¥ Î™®Îì† **Biologic Process(ÏÉùÎ¨ºÌïôÏ†Å Í≥ºÏ†ï)**Í∞Ä Ïó∞Í≤∞ÎêòÏñ¥Ïïº ÎπÑÎ°úÏÜå 'ÎÇò'ÎùºÎäî ÏÇ¨ÎûåÏù¥ ÏÑ§Î™ÖÎê©ÎãàÎã§. 
>
> > [!INFO] PAGE 34-37: Ïú†Ï†ÑÏûê(Gene)ÏôÄ Î∞úÌòÑ(Expression)
> > 34ÌéòÏù¥ÏßÄ, 'Ïú†Ï†ÑÏûê'Ïùò Ï†ïÏùòÎ•º Î∂ÑÏûêÏ†Å Í¥ÄÏ†êÏóêÏÑú ÌôïÏã§Ìûà Ìï©ÏãúÎã§.
> > * **Ï†ïÏùò:** Îã®Î∞±ÏßàÏù¥ÎÇò RNAÎ•º ÏΩîÎî©ÌïòÎäî DNA Ï°∞Í∞Å + **"Ïñ∏Ï†ú, Ïñ¥ÎîîÏÑú, ÏñºÎßàÎÇò(when, where, what amounts)"** ÎßåÎì§ÏßÄ Í≤∞Ï†ïÌïòÎäî Î™ÖÎ†πÏñ¥ÍπåÏßÄ Ìè¨Ìï®ÏûÖÎãàÎã§. 
> > * **Expression (36p):**
> >     * **Transcription (Ï†ÑÏÇ¨):** Ìïµ(Nucleus) ÏïàÏóêÏÑú DNA ‚Üí mRNA. (ÏÑ±ÏàôÌïú mRNAÍ∞Ä Îê®) 
> >     * **Translation (Î≤àÏó≠):** ÏÑ∏Ìè¨Ïßà(Cytoplasm)Î°ú ÎÇòÏôÄÏÑú mRNA ‚Üí Protein. 
>
> > [!IMPORTANT] PAGE 39: Clinical Sequencing Ï¢ÖÎ•ò (Ï°±Î≥¥ ÏïºÎßà! ‚òÖ)
> > Ïûê, Ïó¨Í∏∞ **Î≥ÑÌëú 5Í∞ú** Î∞ïÏúºÏÑ∏Ïöî. Î≥ëÏõêÏóêÏÑú "Ïú†Ï†ÑÏûê Í≤ÄÏÇ¨Ìï©ÏãúÎã§" Ìï† Îïå Îã§ Í∞ôÏùÄ Í≤å ÏïÑÎãôÎãàÎã§. Í∞Å Î∞©Î≤ïÏù¥ **Î¨¥ÏóáÏùÑ(Target)** Î≥¥Í≥† **Ïñ¥Îñ§ ÎèåÏó∞Î≥ÄÏù¥(Application)**Î•º Ïû°ÎäîÏßÄ Îß§Ïπ≠Ìï¥Ïïº Ìï©ÎãàÎã§.
> >
> > 1.  **Whole Genome Sequencing (WGS, Ï†ÑÏû• Ïú†Ï†ÑÏ≤¥):**
> >     * **Î≤îÏúÑ:** DNA Ï†ÑÏ≤¥.
> >     * **Ïû°Îäî Í≤É:** **Structural variants (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥)**, Point mutations, Copy number variation (CNV). Îã§ Ïû°ÏäµÎãàÎã§. 
> > 2.  **Whole-Exome Sequencing (WES):**
> >     * **Î≤îÏúÑ:** **Exon baits**Î•º Ïç®ÏÑú Îã®Î∞±Ïßà ÎßåÎìúÎäî **1% (Exon)**Îßå Î¥ÖÎãàÎã§. Í∞ÄÏÑ±ÎπÑÍ∞Ä Ï¢ãÏ£†.
> >     * **Ïû°Îäî Í≤É:** Point mutations, CNV. (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥Îäî Ïûò Î™ª Î¥ÖÎãàÎã§) 
> > 3.  **PCR Amplicon (Targeted Panel):**
> >     * **Î≤îÏúÑ:** ÌäπÏ†ï Ïú†Ï†ÑÏûêÎßå Ï¶ùÌè≠.
> >     * **Ïû°Îäî Í≤É:** Point mutations, Deletions. ÌäπÏ†ï ÏßàÎ≥ë ÌÉÄÍ≤üÌåÖÌï† Îïå ÏîÅÎãàÎã§. 
> > 4.  **Transcriptome (RNA-seq):**
> >     * **Î≤îÏúÑ:** RNA Ï†ÑÏ≤¥.
> >     * **Ïû°Îäî Í≤É:** **Gene expression (Î∞úÌòÑÎüâ)**, **Gene fusions (ÏúµÌï© Ïú†Ï†ÑÏûê)**, Splice variants. 
>
> > [!INFO] PAGE 40: Genotype LayerÎ≥Ñ Î≥ÄÏù¥ Ï¢ÖÎ•ò (Ïö©Ïñ¥ Ï†ïÎ¶¨)
> > 40ÌéòÏù¥ÏßÄ ÌëúÎäî ÏïûÏùò ÎÇ¥Ïö©ÏùÑ Ï†ïÎ¶¨Ìïú Í≤ÅÎãàÎã§. Í∞Å Î†àÎ≤®ÏóêÏÑú ÏùºÏñ¥ÎÇòÎäî **Event** Ïö©Ïñ¥Î•º Ïô∏Ïö∞ÏÑ∏Ïöî.
> > * **Genome:** SNP (Îã®Ïùº ÏóºÍ∏∞ Îã§ÌòïÏÑ±), InDel (ÏÇΩÏûÖ/Í≤∞Ïã§), CNV (Î≥µÏ†úÏàò Î≥ÄÏù¥), SV (Íµ¨Ï°∞Ï†Å Î≥ÄÏù¥). 
> > * **Transcriptome:** Gene expression Î≥ÄÌôî, Alternative splicing(ÏÑ†ÌÉùÏ†Å Ïä§ÌîåÎùºÏù¥Ïã±). 
> > * **Proteome:** PTM (Post-translational modification, Î≤àÏó≠ ÌõÑ Î≥ÄÌòï). 

> [!NOTE] Pages 41-51: Ï†ÑÏÇ¨ Ï°∞Ï†àÍ≥º Îã®Î∞±ÏßàÏ≤¥ (Regulation & Proteome)
> Ïûê, DNAÏóê Ï†ïÎ≥¥Í∞Ä ÏûàÎã§Í≥† ÎÅùÏù¥ ÏïÑÎãôÎãàÎã§. Í∑∏Í±∏ ÏùΩÏñ¥ÎÇ¥Í≥†(Transcription), Í∞ÄÍ≥µÌïòÍ≥†(Splicing), Îã®Î∞±ÏßàÎ°ú ÎßåÎì§Í≥†(Translation), Îòê ÏàòÏ†ï(PTM)Ìï¥Ïïº ÎπÑÎ°úÏÜå Í∏∞Îä•Ïù¥ ÏÉùÍπÅÎãàÎã§. Ïù¥ Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨Í∞Ä Í≥†Ïû• ÎÇòÎ©¥ Í∑∏Í≤å Î∞îÎ°ú 'Ïïî'Ïù¥Í≥† 'ÏßàÎ≥ë'ÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 41-43: Ï†ÑÏÇ¨ ÎÑ§Ìä∏ÏõåÌÅ¨ÏôÄ Chromatin (Ï°∞Ï†àÏùò ÏãúÏûë)
> > 41ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. ÏÑ∏Ìè¨Ìïµ(Nucleus)ÏóêÏÑú ÏùºÏñ¥ÎÇòÎäî ÏùºÎì§ÏûÖÎãàÎã§.
> > * **Transcriptional networks (Ï†ÑÏÇ¨ ÎÑ§Ìä∏ÏõåÌÅ¨):**
> >     * **Transcription Factors (TF):** Ï†ÑÏÇ¨Î•º ÏãúÏûëÌïòÎäî Ïó¥Ïá†ÏûÖÎãàÎã§. 
> >     * **Cofactors & Chromatin regulation:** TFÎ•º ÎèÑÏôÄÏ£ºÍ±∞ÎÇò Î∞©Ìï¥ÌïòÎäî ÏπúÍµ¨Îì§Ïù¥Ï£†. 
> >     * **DNA Methylation & Histone Modification:** DNAÎ•º Í∞êÍ≥† ÏûàÎäî Ïã§Ìå®(Histone)Î•º Ï°∞Ïù¥Í±∞ÎÇò ÌíÄÏñ¥ÏÑú Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌï©ÎãàÎã§. (EpigeneticsÏùò ÌïµÏã¨) 
> > * **42ÌéòÏù¥ÏßÄ Íµ¨Ï°∞:** DNAÎäî Í∑∏ÎÉ• ÏûàÎäî Í≤å ÏïÑÎãàÎùº **Histone**Ïóê Í∞êÍ≤® **Nucleosome**ÏùÑ ÌòïÏÑ±Ìï©ÎãàÎã§. Ï†ÑÏÇ¨Í∞Ä ÏùºÏñ¥ÎÇòÎ†§Î©¥ Ïù¥ Íµ¨Ï°∞Í∞Ä ÌíÄÎ†§Ïïº ÌïòÎäîÎç∞, Í∑∏ Ïó¥Î¶∞ Î∂ÄÏúÑÎ•º **DNase I hypersensitive sites**ÎùºÍ≥† Ìï©ÎãàÎã§. "Ïó¨Í∏∞Í∞Ä ÌôúÏÑ± Î∂ÄÏúÑÎã§"ÎùºÎäî ÎúªÏù¥Ï£†. 
> > * **43ÌéòÏù¥ÏßÄ ÏõêÍ±∞Î¶¨ Ï°∞Ï†à:** **Long-range regulatory elements**Î•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏûê Î∞îÎ°ú ÏòÜÏù¥ ÏïÑÎãàÎùº ÏïÑÏ£º Î©ÄÎ¶¨ Îñ®Ïñ¥ÏßÑ Í≥≥ÏóêÏÑúÎèÑ Ï°∞Ï†à Ïã†Ìò∏Î•º Î≥¥ÎÉÖÎãàÎã§. DNAÍ∞Ä Í≥†Î¶¨Ï≤òÎüº ÌúòÏñ¥Ï†∏ÏÑú(Looping) ÎßåÎÇòÎäî Í≤ÅÎãàÎã§. 
>
> > [!INFO] PAGE 44-45: Ï†ÑÏÇ¨ Îã®ÏúÑÏùò Ìï¥Î∂Ä (Anatomy of Transcription)
> > 44ÌéòÏù¥ÏßÄ, Ïú†Ï†ÑÏûêÏùò Íµ¨Ï°∞Î•º ÎúØÏñ¥Î¥ÖÏãúÎã§. Ïö©Ïñ¥ Ï†ïÌôïÌûà ÏïÑÏÖîÏïº Ìï©ÎãàÎã§.
> > * **Promoter (Cis-regulatory region):** Ï†ÑÏÇ¨ ÏãúÏûë ÏúÑÏπòÎ•º Ïû°ÏïÑÏ£ºÎäî Í≥≥. **Basal (core) promoter**ÏôÄ **Module (Enhancer)**Î°ú ÎÇòÎâ©ÎãàÎã§. 
> > * **Transcription Unit:** Ïã§Ï†ú Î≥µÏÇ¨ÎêòÎäî Íµ¨Í∞Ñ. **Exon(ÎÇ®Îäî Î∂ÄÎ∂Ñ)**Í≥º **Intron(Î≤ÑÎ†§ÏßÄÎäî Î∂ÄÎ∂Ñ)**, Í∑∏Î¶¨Í≥† ÏñëÎÅùÏùò **UTR (Untranslated Region)**Ïù¥ ÏûàÏäµÎãàÎã§. 
> > * **45ÌéòÏù¥ÏßÄ Looping:** ÏïÑÍπå ÎßêÌïú ÏõêÍ±∞Î¶¨ Ï°∞Ï†àÏù¥ Ïñ¥ÎñªÍ≤å ÏùºÏñ¥ÎÇòÎäîÏßÄ Î≥¥Ïó¨Ï§çÎãàÎã§. **Looping factors**Í∞Ä DNAÎ•º ÌúòÍ≤å ÎßåÎì§Ïñ¥ Î©ÄÎ¶¨ ÏûàÎäî EnhancerÎ•º Promoter Í∑ºÏ≤òÎ°ú ÎÅåÍ≥† ÏòµÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 46: p53 Íµ¨Ï°∞ ÏÉÅÏÑ∏ (ÏïºÎßà/Í∏∞Ï∂ú Ìè¨Ïù∏Ìä∏ ‚òÖ)
> > Ïûê, ÏùòÎåÄÏÉùÏù¥ÎùºÎ©¥ **p53** Î™®Î•¥Î©¥ Í∞ÑÏ≤©ÏûÖÎãàÎã§. 'Ïú†Ï†ÑÏ≤¥Ïùò ÏàòÌò∏Ïûê'Ï£†. 46ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ ÌòÑÎØ∏Í≤Ω Î≥¥ÎìØ Î≥¥ÏÑ∏Ïöî.
> > * **Íµ¨Ï°∞Ï†Å ÌäπÏßï:**
> >     * **DNA-binding domain:** DNAÏôÄ ÏßÅÏ†ë Í≤∞Ìï©ÌïòÎäî Î∂ÄÏúÑ. Ïó¨Í∏∞Ïóê **Zinc atom (ÏïÑÏó∞ ÏõêÏûê)**Ïù¥ **Stabilizer(ÏïàÏ†ïÌôîÏ†ú)**Î°ú Î∞ïÌòÄ ÏûàÏäµÎãàÎã§. 
> >     * **Tetramerization domain:** p53ÏùÄ ÌòºÏûê Ïùº Ïïà Ìï©ÎãàÎã§. 4Í∞úÍ∞Ä Î≠âÏ≥êÏÑú(Tetramer) ÏùºÌï©ÎãàÎã§. 
> >     * **Transcription domain:** Ï†ÑÏÇ¨Î•º ÌôúÏÑ±ÌôîÌïòÎäî Î∂ÄÏúÑ. 
> > * **ÏûÑÏÉÅ Ïó∞Í≥Ñ:** ÏïîÌôòÏûêÏóêÏÑú p53 Î≥ÄÏù¥Í∞Ä Î∞úÍ≤¨ÎêòÎ©¥, Ï£ºÎ°ú Ï†Ä **DNA-binding domain**Ïù¥ ÎßùÍ∞ÄÏ†∏ÏÑú DNAÎ•º Î™ª Ïû°Í≤å ÎêòÎäî Í≤ΩÏö∞Í∞Ä ÎßéÏäµÎãàÎã§.
> >   ![Pasted image 20251209101527.png](/img/user/%ED%95%99%EC%97%85/%EC%98%88%202-2/%EB%B6%84%EC%9E%90%EC%9C%A0%EC%A0%84%ED%95%99/%EC%82%AC%EC%A0%84%EC%A0%95%EB%A6%AC%EB%B3%B8/%EA%B8%B0%EB%A7%90/%EB%8F%99%EB%B4%89%EC%9D%B4%EB%AF%B8%EC%A7%80/Pasted%20image%2020251209101527.png)
>
> > [!INFO] PAGE 47-48: SplicingÍ≥º Ï†ÑÏÇ¨Ïùò Î≥µÏû°ÏÑ±
> > 47ÌéòÏù¥ÏßÄÎ•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏûê ÌïòÎÇò(Gene 1)ÏóêÏÑú ÌôîÏÇ¥ÌëúÍ∞Ä Ïó¨Îü¨ Í∞ú ÎÇòÏò§Ï£†?
> > * **Alternative Splicing:** ÏóëÏÜêÏùÑ Ïñ¥ÎñªÍ≤å Ï°∞Î¶ΩÌïòÎäêÎÉêÏóê Îî∞Îùº ÌïòÎÇòÏùò Ïú†Ï†ÑÏûêÏóêÏÑú Ïó¨Îü¨ Ï¢ÖÎ•òÏùò mRNA(Transcripts)Í∞Ä ÎÇòÏòµÎãàÎã§.
> > * **Reverse Strand Transcripts:** Ïã¨ÏßÄÏñ¥ Î∞òÎåÄ Í∞ÄÎã•ÏóêÏÑúÎèÑ Ï†ÑÏÇ¨Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. 
> > * 48ÌéòÏù¥ÏßÄÎäî Îçî Î≥µÏû°Ìï©ÎãàÎã§. **tiRNA, PASR, ncRNA** Í∞ôÏùÄ ÎπÑÏïîÌò∏Ìôî RNAÎì§ÎèÑ ÏóÑÏ≤≠ÎÇòÍ≤å ÏèüÏïÑÏ†∏ ÎÇòÏòµÎãàÎã§. Ïö∞Î¶¨ Î™∏ÏùÄ ÏÉùÍ∞ÅÎ≥¥Îã§ Ìõ®Ïî¨ ÏàòÎã§Ïä§ÎüΩÏäµÎãàÎã§. 
>
> > [!INFO] PAGE 49-51: ProteomeÍ≥º PTM (Î≤àÏó≠ ÌõÑ Î≥ÄÌòï)
> > 49ÌéòÏù¥ÏßÄ Ïö∞Ï∏°ÏùÑ Î≥¥ÏÑ∏Ïöî. Îã®Î∞±ÏßàÏù¥ ÎßåÎì§Ïñ¥ÏßÑ ÌõÑ(Translation)ÏóêÎèÑ ÎÅùÏù¥ ÏïÑÎãôÎãàÎã§. **Post-translational modifications (PTM)**Ïù¥ ÏùºÏñ¥ÎÇ©ÎãàÎã§.
> > * **Ï¢ÖÎ•ò (Ïô∏Ïö∞ÏÑ∏Ïöî):**
> >     * **Phosphorylation (Ïù∏ÏÇ∞Ìôî):** Ïä§ÏúÑÏπò Ïó≠Ìï† (Í∞ÄÏû• Ï§ëÏöî). 
> >     * **Glycosylation (ÎãπÌôî):** ÎãπÏùÑ Î∂ôÏûÑ. 
> >     * **Acetylation (ÏïÑÏÑ∏Ìã∏Ìôî)** 
> >     * **Ubiquitination (Ïú†ÎπÑÌÄ¥Ìã¥Ìôî):** Î∂ÑÌï¥ Ïã†Ìò∏. 
> >     * **SUMOylation:** Îã®Î∞±Ïßà Í∏∞Îä• Ï°∞Ï†à. 
> > * **Í≤∞Î°† (50-51p):** Ïú†Ï†ÑÏûêÎäî ÌïòÎÇòÏßÄÎßå, SplicingÍ≥º PTMÏùÑ Í±∞ÏπòÎ©¥ ÏàòÏã≠, ÏàòÎ∞± Í∞ÄÏßÄÏùò **Mature proteins**Í∞Ä ÏÉùÍπÅÎãàÎã§. Í∑∏ÎûòÏÑú ProteomeÏù¥ GenomeÎ≥¥Îã§ Ìõ®Ïî¨ Î≥µÏû°Ìïú Í≤ÅÎãàÎã§. 

> [!NOTE] Pages 52-59: ÎåÄÏÇ¨Ï≤¥ÏôÄ ÌëúÌòÑÌòï (Metabolome & Phenotype)
> Ïûê, DNAÏóêÏÑú ÏãúÏûëÎêú Ïó¨Ï†ïÏù¥ ÎìúÎîîÏñ¥ Ïö∞Î¶¨ Î™∏Ïùò Ïã§Ï†ú Í∏∞Îä•Ïù∏ 'ÎåÄÏÇ¨'ÏôÄ 'ÌëúÌòÑÌòï'Ïóê ÎèÑÎã¨ÌñàÏäµÎãàÎã§. Ïú†Ï†ÑÏûêÍ∞Ä ÏïÑÎ¨¥Î¶¨ Ï¢ãÏïÑÎèÑ ÌôòÍ≤ΩÏù¥ ÎÇòÏÅòÎ©¥ Î≥ëÏù¥ ÏÉùÍ∏∞Îäî ÏõêÎ¶¨, Í∑∏Î¶¨Í≥† Ïïî ÌôòÏûêÏùò ÏÑ∏Ìè¨Î•º ÎñºÏñ¥ÎÇ¥ÏÑú Ïã§Ï†úÎ°ú ÏïΩÏùÑ Ï≥êÎ≥¥Îäî(Functional Assay) ÏµúÏã† Í∏∞Î≤ïÍπåÏßÄ ÏîπÏñ¥Î®πÏñ¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 53: Ïã†Ìò∏ Ï†ÑÎã¨Í≥º ÎåÄÏÇ¨ Í≤ΩÎ°ú (ÌöåÎ°úÎèÑ Î∂ÑÏÑù)
> > 53ÌéòÏù¥ÏßÄ Ï¢åÏ∏° Í∑∏Î¶º, ÏïÑÏ£º Ï†ÑÌòïÏ†ÅÏù∏ **ÏÑ∏Ìè¨ Ïã†Ìò∏ Ï†ÑÎã¨(Signaling Pathway)** ÌöåÎ°úÎèÑÏûÖÎãàÎã§. ÏàúÏÑúÎ•º Ïô∏Ïö∞ÏÑ∏Ïöî.
> > 1.  **Sensor (Í∞êÏßÄÍ∏∞):** ÏÑ∏Ìè¨ÎßâÏùò **Ligand + Receptor**Í∞Ä Ïã†Ìò∏Î•º Î∞õÏäµÎãàÎã§.
> > 2.  **Transducer (Î≥ÄÌôòÍ∏∞):** Ïù∏ÏÇ∞Ìôî(P) Îì±ÏùÑ ÌÜµÌï¥ Ïã†Ìò∏Î•º ÏïàÏúºÎ°ú Ï†ÑÎã¨Ìï©ÎãàÎã§.
> > 3.  **Circuit (ÌöåÎ°ú):** ÏÑ∏Ìè¨Ïßà(Cytoplasm) ÎÇ¥Ïùò Î≥µÏû°Ìïú Ïã†Ìò∏ ÎÑ§Ìä∏ÏõåÌÅ¨.
> > 4.  **Actuator (Íµ¨ÎèôÍ∏∞):** Ìïµ(Nucleus)ÏúºÎ°ú Îì§Ïñ¥Í∞Ä **DNA**Ïùò Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌï©ÎãàÎã§.
> >
> > * **Ïö∞Ï∏° Í∑∏Î¶º (Multi-omics flow):**
> >     * **Genome:** Gene 1, 2...
> >     * **Proteome:** Protein A, B, C... Ìö®ÏÜå(Enzyme)Îì§Ïù¥Ï£†.
> >     * **Metabolome:** Ìö®ÏÜåÎì§Ïù¥ Í∏∞Ïßà(a)ÏùÑ ÏÉùÏÇ∞Î¨º(b)Î°ú Î∞îÍøâÎãàÎã§. **Feedback loop** (Ï†êÏÑ† ÌôîÏÇ¥Ìëú)Í∞Ä Ï°¥Ïû¨ÌïòÏó¨ ÎåÄÏÇ¨ ÏÇ∞Î¨ºÏù¥ Îã§Ïãú Ïú†Ï†ÑÏûê Î∞úÌòÑÏùÑ Ï°∞Ï†àÌïòÍ∏∞ÎèÑ Ìï©ÎãàÎã§.
>
> > [!INFO] PAGE 54: Metabolome (ÎåÄÏÇ¨Ï≤¥)Ïùò ÏúÑÏπò
> > 54ÌéòÏù¥ÏßÄ ÌëúÏóêÏÑú Îπ®Í∞Ñ Î∞ïÏä§Î•º Î≥¥ÏÑ∏Ïöî.
> > * **Metabolome:** GenotypeÎ≥¥Îã§Îäî **Phenotype**Ïóê Ìõ®Ïî¨ Í∞ÄÍπùÏäµÎãàÎã§. Ï¶â, **"ÌòÑÏû¨ Î™∏ ÏÉÅÌÉúÎ•º Í∞ÄÏû• Ïã§ÏãúÍ∞ÑÏúºÎ°ú Î∞òÏòÅÌïòÎäî ÏßÄÌëú"**ÏûÖÎãàÎã§. Ïú†Ï†ÑÏûêÎäî ÌÉúÏñ¥ÎÇ† Îïå Í≤∞Ï†ïÎêòÏßÄÎßå, ÎåÄÏÇ¨Ï≤¥Îäî ÏïÑÏπ® Î®πÏóàÎÉê Íµ∂ÏóàÎÉêÏóê Îî∞Îùº Îã¨ÎùºÏßÄÎãàÍπåÏöî. 
>
> > [!IMPORTANT] PAGE 56: Ïú†Ï†ÑÏûêÏôÄ ÌôòÍ≤ΩÏùò ÏÉÅÌò∏ÏûëÏö© (Landscape Model)
> > Ïûê, Ïù¥ Í∑∏Î¶º Ïù¥Ìï¥ Î™ªÌïòÎ©¥ ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïô ÍΩùÏûÖÎãàÎã§. Í≥µÏù¥ Íµ¥Îü¨Í∞ÄÎäî Í≤ΩÎ°ú(Trajectory)Í∞Ä ÏÑ∏Ìè¨Ïùò Ïö¥Î™ÖÏûÖÎãàÎã§.
> > * **a (Phenotypic state):** Í≥µÏù¥ Íµ¥Îü¨ÎÇ¥Î†§ÏôÄ Í≥®ÏßúÍ∏∞(Attractor)Ïù∏ **P1~P5** Ï§ë ÌïòÎÇòÏóê ÏïàÏ∞©Ìï©ÎãàÎã§. Ïù¥Í≤å Ï†ïÏÉÅÏ†ÅÏù∏ Î∂ÑÌôîÏûÖÎãàÎã§. 
> > * **b (Environmental factor):** Ïô∏Î∂Ä ÌôòÍ≤ΩÏù¥ Í≥µÏùÑ Î∞ÄÏñ¥Î≤ÑÎ¶ΩÎãàÎã§. Í∑∏Îü¨Î©¥ ÏõêÎûò Í∞ÄÏïº Ìï† Í∏∏(Trajectory)ÏùÑ Î≤óÏñ¥ÎÇò Îã§Î•∏ ÌëúÌòÑÌòïÏúºÎ°ú Í∞ÄÍ≤å ÎêòÏ£†. 
> > * **c (Genetic factor):** Ïú†Ï†ÑÏûê Î≥ÄÏù¥Í∞Ä ÏÉùÍ∏∞Î©¥? **ÏßÄÌòï(Landscape) ÏûêÏ≤¥**Í∞Ä Î∞îÎÄùÎãàÎã§. Í≥®ÏßúÍ∏∞ Î™®ÏñëÏù¥ Î∞îÎÄåÏñ¥ÏÑú Í≥µÏù¥ ÏóâÎö±Ìïú Í≥≥ÏúºÎ°ú Íµ¥Îü¨Í∞ÄÍ≤å ÎßåÎì≠ÎãàÎã§. 
> > * **d (Noise):** ÌäπÎ≥ÑÌïú ÏöîÏù∏ ÏóÜÏñ¥ÎèÑ ÌôïÎ•†Ï†ÅÏù∏ Ïû°Ïùå(Stochasticity)ÎßåÏúºÎ°úÎèÑ Í≤∞Í≥ºÍ∞Ä Îã¨ÎùºÏßà Ïàò ÏûàÏäµÎãàÎã§. 
>
> > [!TIP] üí° PAGE 57-58: Ï∞®ÏÑ∏ÎåÄ Í∏∞Îä•ÏÑ± Î∂ÑÏÑù (Next-Gen Functional Assays)
> > 57-58ÌéòÏù¥ÏßÄÎäî Ïã§Ï†ú Î≥ëÏõêÏóêÏÑú Ïïî ÌôòÏûê Ï°∞ÏßÅÏùÑ ÎñºÏñ¥ÎÇ¥ÏÑú ÌïòÎäî Í≤ÄÏÇ¨Îì§ÏûÖÎãàÎã§. **"ÌôòÏûê ÎßûÏ∂§Ìòï ÏπòÎ£å(Precision Medicine)"**Ïùò ÏµúÏ†ÑÏÑ†Ïù¥Ï£†.
> >
> > **1. Í≤ÄÏ≤¥ ÌôïÎ≥¥ (57p):**
> > * **Solid tumours (Í≥†ÌòïÏïî):** Biopsy(ÏÉùÍ≤Ä) ÎòêÎäî CTCs(ÏàúÌôò Ï¢ÖÏñë ÏÑ∏Ìè¨).
> > * **Haematological (ÌòàÏï°Ïïî):** Bone marrow biopsy(Í≥®Ïàò ÏÉùÍ≤Ä).
> > * Ïù¥Í±∏Î°ú **Organoids (Ïò§Í∞ÄÎÖ∏Ïù¥Îìú, ÎØ∏Îãà Ïû•Í∏∞)**Î•º ÎßåÎì≠ÎãàÎã§. 
> >
> > **2. ÌïµÏã¨ Î∂ÑÏÑùÎ≤ï (58p - Ïö©Ïñ¥ ÏïîÍ∏∞):**
> > * **Kinase profiling:** Ïù∏ÏÇ∞Ìôî Ìö®ÏÜå ÌôúÏÑ± Ï∏°Ï†ï. 
> > * **Immuno-flow / FACS:** Ìï≠Ï≤¥Î•º Ïù¥Ïö©Ìï¥ Îã®Î∞±Ïßà Î∞úÌòÑ Î∂ÑÏÑù. 
> > * **DBP (Dynamic BH3 Profiling):** ÏÑ∏Ìè¨Í∞Ä ÏñºÎßàÎÇò Ï£ΩÍ∏∞ Ïâ¨Ïö¥ÏßÄ(**Apoptotic priming**) Ï∏°Ï†ï. 
> > * **Cytotoxicity (ÏÑ∏Ìè¨ ÎèÖÏÑ±):** ÏïΩ Ï≥§ÏùÑ Îïå ÏñºÎßàÎÇò Ï£ΩÎÇò? (**ATP levels, MTT** Îì±ÏúºÎ°ú Ï∏°Ï†ï). 
> > * **PDX (Patient-Derived Xenograft):** Ï•ê(Mouse)Ïóê ÌôòÏûê ÏïîÏùÑ Ïù¥ÏãùÌï¥ÏÑú ÌÖåÏä§Ìä∏. Í∞ÄÏû• Ï†ïÌôïÌïòÏßÄÎßå ÎπÑÏã∏Í≥† Ïò§Îûò Í±∏Î¶º. 
>
> > [!INFO] PAGE 59: Phenome (ÌòÑÏÉÅÏ≤¥)Ïùò Íµ¨ÏÑ±
> > 59ÌéòÏù¥ÏßÄ ÎßàÏßÄÎßâ Îã®Í≥ÑÏûÖÎãàÎã§.
> > * Í≤∞Íµ≠ Ïù¥ Î™®Îì† Í≥ºÏ†ïÏùò ÎÅùÏùÄ Î¨¥ÏóáÏù∏Í∞Ä?
> > * **Tumorigenesis (Ï¢ÖÏñë ÌòïÏÑ±)**
> > * **Angiogenesis (ÌòàÍ¥Ä ÏÉùÏÑ±)**
> > * **Metastasis (Ï†ÑÏù¥)**
> > * Ïù¥Îü∞ Í±∞ÏãúÏ†ÅÏù∏ ÌäπÏßïÎì§ÏùÑ **Phenome**Ïù¥ÎùºÍ≥† Î∂ÄÎ¶ÖÎãàÎã§. 

> [!NOTE] Pages 60-66: ÌõÑÏÑ±Ïú†Ï†ÑÌïô ÌòÅÎ™Ö (Epigenomic Revolution)
> Ïûê, DNA ÏóºÍ∏∞ÏÑúÏó¥Ïù¥ Ïö¥Î™ÖÏùò Ï†ÑÎ∂ÄÍ∞Ä ÏïÑÎãôÎãàÎã§. ÎòëÍ∞ôÏùÄ ÏïÖÎ≥¥(DNA)Î•º Í∞ÄÏßÄÍ≥†ÎèÑ Ïó∞Ï£ºÏûê(ÏÑ∏Ìè¨)Ïóê Îî∞Îùº Ïä¨Ìîà Í≥°Ïù¥ ÎêòÍ∏∞ÎèÑ ÌïòÍ≥† Í∏∞ÏÅú Í≥°Ïù¥ ÎêòÍ∏∞ÎèÑ ÌïòÏ£†. Í∑∏Í≤å Î∞îÎ°ú **Epigenetics**ÏûÖÎãàÎã§. Ïó¨Í∏∞ÏÑúÎäî **ChromatinÏùò Íµ¨Ï°∞ Î≥ÄÌôî**ÏôÄ **Histone Code**Î•º Ìï¥ÎèÖÌïòÎäî Í≤å ÌïµÏã¨ÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 60-61: ChromatinÏùò Í∞úÌèêÏôÄ Histone Tail
> > 60ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî.
> > * **Compact DNA (a):** ÍΩÅÍΩÅ Í∞êÍ≤® ÏûàÏäµÎãàÎã§. Ïù¥Îü¨Î©¥ Ï†ÑÏÇ¨ Ïù∏Ïûê(TF)Í∞Ä Ï†ëÍ∑ºÏùÑ Î™ª ÌïòÏ£†. **"Gene Inactive"** ÏÉÅÌÉúÏûÖÎãàÎã§. 
> > * **Relaxed DNA (b):** Íµ¨Ï°∞Í∞Ä ÌíÄÎ†∏ÏäµÎãàÎã§(Alteration of structure). DNAÍ∞Ä ÎÖ∏Ï∂úÎêòÎãà Ï†ÑÏÇ¨(Transcription)Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. **"Gene Active"** ÏÉÅÌÉúÏûÖÎãàÎã§. 
> >
> > 61ÌéòÏù¥ÏßÄÎ•º Î≥¥ÏÑ∏Ïöî. Ïù¥ ChromatinÏùÑ ÎßåÎìúÎäî Ïã§Ìå®Í∞Ä **Histone**Ïù¥Ï£†.
> > * **Íµ¨ÏÑ±:** **H2A, H2B, H3, H4**Í∞Ä Í∞ÅÍ∞Å 2Í∞úÏî© Î™®Ïó¨ 8ÎüâÏ≤¥(Octamer)Î•º Ïù¥Î£πÎãàÎã§. 
> > * **Tail (Íº¨Î¶¨):** Í∑∏Î¶ºÏóê ÏÇêÏ£ΩÏÇêÏ£Ω ÌäÄÏñ¥ÎÇòÏò® ÏÑ†Îì§ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å **Histone Tail**ÏûÖÎãàÎã§. Ïó¨Í∏∞Í∞Ä Î∞îÎ°ú ÌôîÌïôÏ†Å Î≥ÄÌòïÏù¥ ÏùºÏñ¥ÎÇòÎäî **'Ï°∞Ï†à Ïä§ÏúÑÏπò'**ÏûÖÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 62: ÌûàÏä§ÌÜ§ ÏΩîÎìú (Histone Code) ÏÉÅÏÑ∏ Î∂ÑÏÑù (‚òÖÏïîÍ∏∞)
> > 62ÌéòÏù¥ÏßÄ, Íπ®Ïïå Í∞ôÏùÄ ÏïåÌååÎ≤≥Îì§Ïù¥ ÎÇòÏòµÎãàÎã§. Ïù¥Í≤å ÌûàÏä§ÌÜ§ Íº¨Î¶¨Ïùò ÏïÑÎØ∏ÎÖ∏ÏÇ∞ ÏÑúÏó¥ÏûÖÎãàÎã§. ÏãúÌóòÏóê ÎÇòÏòµÎãàÎã§.
> >
> > **1. H3 Tail (ÏúÑÏ™Ω Í∑∏Î¶º):** 
> > * ÏÑúÏó¥ ÏãúÏûë: **N-ARTKQTARKSTGGK...** (Ïù¥Í±∞ ÎààÏóê ÏùµÌûàÏÑ∏Ïöî) 
> > * Ï£ºÏöî Î≥ÄÌòï ÏúÑÏπò (Ïà´ÏûêÎäî ÏïÑÎØ∏ÎÖ∏ÏÇ∞ Î≤àÌò∏):
> >     * **K (Lysine, Î¶¨Ïã†):** Ï£ºÎ°ú **Me (Methylation)**ÏôÄ **Ac (Acetylation)**Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. (Ïòà: K4, K9, K27) 
> >     * **S (Serine, ÏÑ∏Î¶∞):** Ï£ºÎ°ú **P (Phosphorylation, Ïù∏ÏÇ∞Ìôî)**Í∞Ä ÏùºÏñ¥ÎÇ©ÎãàÎã§. (Ïòà: S10, S28) 
> >
> > **2. H4 Tail (ÏïÑÎûòÏ™Ω Í∑∏Î¶º):** 
> > * ÏÑúÏó¥ ÏãúÏûë: **N-SGRGKGGK...** 
> > * Ïó¨Í∏∞ÎèÑ **Acetylation (Ac)**Ïù¥ ÏûîÎú© Î∂ôÏñ¥ ÏûàÏ£†? (K5, K8, K12, K16 Îì±) 
> >
> > **3. H2A & H2B:**
> > * **Ub (Ubiquitination):** Ïú†ÎπÑÌÄ¥Ìã¥Ïù¥ Î∂ôÍ∏∞ÎèÑ Ìï©ÎãàÎã§. 
> >
> > **[ÍµêÏàòÎãòÏùò ÌåÅ]** "KÏóê AcetylÍ∏∞Í∞Ä Î∂ôÏúºÎ©¥(Acetylation) Ï†ÑÏÇ¨Í∞Ä **Ï¥âÏßÑ**ÎêòÍ≥†, MethylÍ∏∞Í∞Ä Î∂ôÏúºÎ©¥(Methylation) ÏúÑÏπòÏóê Îî∞Îùº Ï¥âÏßÑÎêòÍ∏∞ÎèÑ ÌïòÍ≥† ÏñµÏ†úÎêòÍ∏∞ÎèÑ ÌïúÎã§." Ïù¥ ÏõêÏπôÏùÑ Íº≠ Í∏∞ÏñµÌïòÏÑ∏Ïöî.
>
> > [!IMPORTANT] PAGE 63: DNA Methylation (ÌôîÌïô Íµ¨Ï°∞)
> > 63ÌéòÏù¥ÏßÄ, Ïù¥Î≤àÏóî ÌûàÏä§ÌÜ§Ïù¥ ÏïÑÎãàÎùº DNA ÏßÅÏ†ë Î≥ÄÌòïÏûÖÎãàÎã§.
> > * **ÎåÄÏÉÅ:** **Cytosine (C, ÏãúÌÜ†Ïã†)** ÏóºÍ∏∞. 
> > * **Î≥ÄÌôî:** ÏãúÌÜ†Ïã†Ïùò 5Î≤à ÌÉÑÏÜå ÏúÑÏπòÏóê **Methyl group ($CH_3$)**Ïù¥ Î∂ôÏäµÎãàÎã§.
> > * **Í≤∞Í≥º:** **5-methylcytosine**Ïù¥ Îê©ÎãàÎã§. 
> > * **Í∏∞Îä•:** Ï£ºÎ°ú Ïú†Ï†ÑÏûê Î∞úÌòÑÏùÑ **ÏñµÏ†ú(Silencing)**ÌïòÎäî ÏûêÎ¨ºÏá† Ïó≠Ìï†ÏùÑ Ìï©ÎãàÎã§. Í∑∏Î¶ºÏùò ÌôîÌïô Íµ¨Ï°∞Ïãù($NH_2$ Î∞ëÏóê $H$Í∞Ä $CH_3$Î°ú Î∞îÎÄåÎäî Î∂ÄÎ∂Ñ)ÏùÑ ÌôïÏù∏ÌïòÏÑ∏Ïöî. 
>
> > [!INFO] PAGE 64-66: EpigenomeÏùò ÏúÑÏÉÅÍ≥º ÌÜµÌï©
> > 64ÌéòÏù¥ÏßÄ ÌëúÏùò Îπ®Í∞Ñ Î∞ïÏä§Î•º Î≥¥ÏÑ∏Ïöî.
> > * **EpigenomeÏùò Íµ¨ÏÑ± ÏöîÏÜå:**
> >     1.  **Methylation (DNA Î©îÌã∏Ìôî)** 
> >     2.  **Histone modification (ÌûàÏä§ÌÜ§ Î≥ÄÌòï)** 
> >     3.  **miRNA & LncRNA:** ÎπÑÏïîÌò∏Ìôî RNAÎì§ÎèÑ ÌõÑÏÑ±Ïú†Ï†ÑÌïôÏ†Å Ï°∞Ï†àÏóê Í¥ÄÏó¨Ìï©ÎãàÎã§. 
> >
> > 66ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ Ïù¥ Î™®Îì† Í≤å ÌÜµÌï©Îêú Î™®ÏäµÏûÖÎãàÎã§.
> > * **DNA Methylation**Ïù¥ ÎêòÏñ¥ ÏûàÍ≥†, **Histone**Îì§Ïù¥ Î≠âÏ≥ê ÏûàÏúºÎ©¥(Nucleosome) Ï†ëÍ∑º Î∂àÍ∞Ä.
> > * Î∞òÎ©¥ **DNase I hypersensitive sites**Îäî ÌûàÏä§ÌÜ§Ïù¥ ÏóÜÎäî Ïó¥Î¶∞ Íµ¨Í∞ÑÏúºÎ°ú, Ïó¨Í∏∞Í∞Ä **Functional genomic elements(Í∏∞Îä•Ï†Å Ïú†Ï†ÑÏ≤¥ ÏöîÏÜå)**Í∞Ä ÏûëÎèôÌïòÎäî Í≥≥ÏûÖÎãàÎã§. 

> [!NOTE] Pages 67-73: ÌõÑÏÑ±Ïú†Ï†ÑÌïôÍ≥º ÏßàÎ≥ë, Í∑∏Î¶¨Í≥† ENCODE
> Ïûê, "Ïú†Ï†ÑÏûêÎäî Ïö¥Î™ÖÏù¥ ÏïÑÎãàÎã§"ÎùºÎäî Îßê Îì§Ïñ¥Î¥§Ï£†? Í∑∏ Í≥ºÌïôÏ†Å Í∑ºÍ±∞Í∞Ä Ïó¨Í∏∞ Îã§ ÏûàÏäµÎãàÎã§. ÌôòÍ≤Ω(Îã§Ïù¥Ïñ¥Ìä∏, Ïä§Ìä∏Î†àÏä§)Ïù¥ Ïñ¥ÎñªÍ≤å ÎÇ¥ Ïú†Ï†ÑÏûêÏùò Ïä§ÏúÑÏπòÎ•º Ï°∞ÏûëÌï¥ÏÑú ÏïîÏù¥ÎÇò ÎãπÎá®Î≥ëÏùÑ ÏùºÏúºÌÇ§ÎäîÏßÄ, Í∑∏Î¶¨Í≥† Ïú†Ï†Ñ Ï†ïÎ≥¥Î•º ÎÑòÏñ¥ÏÑ† '4Ï∞®Ïõê Ïú†Ï†Ñ'Ïù¥ Î¨¥ÏóáÏù∏ÏßÄ ÏÇ¥Ìé¥Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 67-68: ENCODE ÌîÑÎ°úÏ†ùÌä∏ (ÌïÑÏàò ÏÉÅÏãù)
> > 67ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ ÏïûÏÑú Î∞∞Ïö¥ Ï†ÑÏÇ¨ Ï°∞Ï†àÏùò Ï¥ùÏ†ïÎ¶¨ÏûÖÎãàÎã§.  Ïù¥ Î≥µÏû°Ìïú Ï°∞Ï†à Î∂ÄÏúÑÎì§ÏùÑ Ï†ÑÎ∂Ä Îã§ ÏßÄÎèÑÏóê ÌëúÏãúÌïòÎ†§Îäî ÏãúÎèÑÍ∞Ä ÏûàÏóàÏúºÎãà, Î∞îÎ°ú **ENCODE**ÏûÖÎãàÎã§.
> > * **Ï†ïÏùò (68p):** **The Encyclopedia of DNA Elements**. 'DNA ÏöîÏÜå Î∞±Í≥ºÏÇ¨Ï†Ñ' ÌîÑÎ°úÏ†ùÌä∏ÏûÖÎãàÎã§. 
> > * **Î™©Ìëú:** Ïù∏Í∞Ñ Í≤åÎÜàÏùò **'Î™®Îì† Í∏∞Îä•Ï†Å ÏöîÏÜå(All functional elements)'**Î•º ÏãùÎ≥ÑÌïòÎäî Í≤É. 
> > * **ÎÇ¥Ïö©:** Îã®ÏàúÌûà Ïú†Ï†ÑÏûêÎßå Ï∞æÎäî Í≤å ÏïÑÎãàÎùº, **Regulatory elements(Ï°∞Ï†à Ïù∏Ïûê)**, **Exon variants**, **Alternative promoters** Îì± 'Í∏∞Îä•'ÏùÑ ÌïòÎäî Î™®Îì† Í≤ÉÏùÑ Ï∞æÏäµÎãàÎã§. 
>
> > [!INFO] PAGE 69: ÌõÑÏÑ±Ïú†Ï†ÑÌïôÏ†Å Ïä§ÏúÑÏπò (Active vs Inactive)
> > 69ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Í∞ôÏùÄ DNAÎùºÎèÑ ÏÉÅÌÉúÍ∞Ä Îã§Î¶ÖÎãàÎã§.
> > * **Inactive (ÎπÑÌôúÏÑ±):** DNAÍ∞Ä **Methylation** ÎêòÏñ¥ ÏûàÍ≥†, HistoneÏù¥ ÍΩâ Î≠âÏ≥êÏÑú(Inaccessible) Ïú†Ï†ÑÏûêÍ∞Ä Í∫ºÏ†∏ ÏûàÏäµÎãàÎã§. 
> > * **Active (ÌôúÏÑ±):** **Histone Modification**Ïóê ÏùòÌï¥ Íµ¨Ï°∞Í∞Ä ÌíÄÎ†§ ÏûàÍ≥†(Accessible), Ïú†Ï†ÑÏûêÍ∞Ä ÏºúÏ†∏ ÏûàÏäµÎãàÎã§. 
> > * **ÌïµÏã¨:** ÏãùÏù¥ÏöîÎ≤ï(Dietary sources) Í∞ôÏùÄ ÌôòÍ≤Ω ÏöîÏù∏Ïù¥ Î©îÌã∏Í∏∞(Methyl group)Î•º Ï†úÍ≥µÌï¥ÏÑú Ïù¥ Ïä§ÏúÑÏπòÎ•º Ï°∞ÏûëÌï† Ïàò ÏûàÎã§Îäî Í≤ÅÎãàÎã§. 
>
> > [!WARNING] PAGE 70: ÌôòÍ≤ΩÍ≥º ÏßàÎ≥ëÏùò Ïó∞Í≤∞Í≥†Î¶¨ (Environment-Disease Link)
> > 70ÌéòÏù¥ÏßÄ, Ïó¨Í∏∞Í∞Ä ÏûÑÏÉÅÏ†ÅÏúºÎ°ú Ï†úÏùº Ï§ëÏöîÌï©ÎãàÎã§. Ïôú ÎÇòÏÅú Í±∞ Î®πÏúºÎ©¥ ÏïîÏóê Í±∏Î¶¥ÍπåÏöî?
> > * **ÏòÅÌñ• ÏöîÏù∏ (Factors):** **Diet(ÏãùÎã®)**, **Aging(ÎÖ∏Ìôî)**, **Drugs**, **Environmental chemicals**, Ïã¨ÏßÄÏñ¥ **Development(Î∞úÎã¨ Í≥ºÏ†ï)**ÍπåÏßÄ. 
> > * **Í∏∞Ï†Ñ:** Ïù¥ ÏöîÏù∏Îì§Ïù¥ **DNA Methylation**Ïù¥ÎÇò **Histone Modification**ÏùÑ Î≥ÄÌôîÏãúÌÇµÎãàÎã§. 
> > * **Í≤∞Í≥º (Health Endpoints):** Ïú†Ï†ÑÏûêÍ∞Ä ÏûòÎ™ª ÏºúÏßÄÍ±∞ÎÇò Í∫ºÏ†∏ÏÑú **Cancer(Ïïî)**, **Autoimmune disease(ÏûêÍ∞ÄÎ©¥Ïó≠ÏßàÌôò)**, **Diabetes(ÎãπÎá®)** Îì±Ïù¥ Î∞úÏÉùÌï©ÎãàÎã§. 
>
> > [!INFO] PAGE 71: Ïú†Ï†ÑÏùò 4Í∞ÄÏßÄ Ï∞®Ïõê (4 Dimensions)
> > 71ÌéòÏù¥ÏßÄ ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. Ïú†Ï†ÑÏùÄ DNA(Genetic)Î°úÎßå ÎêòÎäî Í≤å ÏïÑÎãôÎãàÎã§. 
> > 1.  **Genetic:** DNA ÏóºÍ∏∞ÏÑúÏó¥.
> > 2.  **Epigenetic:** Chromatin marks, RNA silencing Îì±. (ÏÑ∏Ìè¨ Í∏∞Ïñµ)
> > 3.  **Behavioral:** ÌñâÎèôÏ†Å Ï†ÑÏàò (Îî∞Îùº ÌïòÍ∏∞ Îì±).
> > 4.  **Symbolic:** Ïñ∏Ïñ¥, Î¨∏Ìôî Îì± Ïù∏Í∞Ñ Í≥†Ïú†Ïùò Ï†ÑÏàò.
>
> > [!IMPORTANT] PAGE 72: ÌûàÏä§ÌÜ§ ÎßàÌÅ¨Ïùò Íµ¨Ï≤¥Ï†Å Í∏∞Îä• (Ïã¨Ìôî ‚òÖ)
> > 72ÌéòÏù¥ÏßÄ Ïõê ÏïàÏùò Í∏∞Ìò∏Îì§ÏùÑ Ìï¥ÏÑùÌï¥Ïïº Ìï©ÎãàÎã§. **K(ÎùºÏù¥Ïã†)**Ïóê Î≠êÍ∞Ä Î∂ôÎäêÎÉêÏóê Îî∞Îùº Ïö¥Î™ÖÏù¥ Í∞àÎ¶ΩÎãàÎã§. 
> > * **MeK4 (H3K4me):** Ï£ºÎ°ú **Activation (ÌôúÏÑ±Ìôî)**ÏôÄ Í¥ÄÎ†®Îê©ÎãàÎã§.
> > * **MeK9, MeK27 (H3K9me, H3K27me):** Ï£ºÎ°ú **Repression (ÏñµÏ†ú)**ÏôÄ Í¥ÄÎ†®Îê©ÎãàÎã§. (ÌôîÏÇ¥ÌëúÍ∞Ä ÏñµÏ†ú Î™®ÏñëÏù∏ Í≤É ÌôïÏù∏!) 
> > * **AcK (Acetylation):** Í±∞Ïùò Ìï≠ÏÉÅ **Activation**ÏûÖÎãàÎã§.
> > * **CpG Methylation:** DNA Î©îÌã∏ÌôîÎäî Ï£ºÎ°ú **ÏñµÏ†ú**ÏûÖÎãàÎã§.
> > * Ïù¥Îì§Ïù¥ ÏÑúÎ°ú ÏÉÅÌò∏ÏûëÏö©(Cross-talk)ÌïòÎ©∞ Ï†ïÍµêÌïòÍ≤å Ï°∞Ï†àÌï©ÎãàÎã§.
>
> > [!INFO] PAGE 73: EpigenomeÏùò ÌÜµÌï©Ï†Å ÏúÑÏπò
> > 73ÌéòÏù¥ÏßÄ, Îã§Ïãú ÌïúÎ≤à Ï†ÑÏ≤¥ ÏßÄÎèÑÎ•º Î¥ÖÎãàÎã§.
> > * **Epigenome**ÏùÄ GenomeÍ≥º Transcriptome ÏÇ¨Ïù¥ÏóêÏÑú Ï†ïÎ≥¥Ïùò ÌùêÎ¶ÑÏùÑ ÌÜµÏ†úÌïòÎäî **'Í≤ÄÎ¨∏ÏÜå'** Ïó≠Ìï†ÏùÑ Ìï©ÎãàÎã§. Ïó¨Í∏∞ÏÑú **Tumorigenesis(Ïïî Î∞úÏÉù)** Îì±Ïùò Ïö¥Î™ÖÏù¥ 1Ï∞®Ï†ÅÏúºÎ°ú Í≤∞Ï†ïÎêòÎäî Í≤ÉÏûÖÎãàÎã§. 

> [!NOTE] Pages 74-80: ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïôÏùò ÎèÑÍµ¨ÏôÄ Multi-Omics
> Ïûê, Ïù¥Ï†ú Ïù¥Î°†ÏùÄ Ï∂©Î∂ÑÌï©ÎãàÎã§. Ïã§Ï†úÎ°ú Ïù¥ Î∞©ÎåÄÌïú Îç∞Ïù¥ÌÑ∞Î•º Ïñ¥ÎñªÍ≤å ÎΩëÏïÑÎÇ¥Í≥†(Microarray), Ïñ¥ÎñªÍ≤å Î∂ÑÏÑùÌï¥ÏÑú(AI), ÌôòÏûêÎ•º Î∂ÑÎ•ò(Stratification)ÌïòÎäîÏßÄ, Í∑∏ 'Î¨¥Í∏∞'Îì§ÏùÑ Ï†êÍ≤ÄÌï¥ Î¥ÖÏãúÎã§.
>
> > [!IMPORTANT] PAGE 74: Multi-OmicsÏôÄ AIÏùò Í≤∞Ìï© (ÏïåÍ≥†Î¶¨Ï¶ò Ï≤¥ÌÅ¨)
> > 74ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÄ Ï†ïÎ∞ÄÏùòÌïôÏùò 'Ï†ÑÌà¨ ÏßÄÎèÑ'ÏûÖÎãàÎã§. 
> > * **Multi-Omics:** Genome, Epigenome, Transcriptome, Proteome, MetabolomeÏùÑ Ï†ÑÎ∂Ä Ìï©Ïπ©ÎãàÎã§.
> > * **AI & Machine Learning:** Ïù¥ Îç∞Ïù¥ÌÑ∞Î•º ÏÇ¨ÎûåÏù¥ ÎààÏúºÎ°ú Î™ª Î¥ÖÎãàÎã§. AIÍ∞Ä ÌïÑÏöîÌïòÏ£†. Ïó¨Í∏∞Ïóê Ïì∞Ïù¥Îäî ÏïåÍ≥†Î¶¨Ï¶ò Ïù¥Î¶ÑÎì§ÏùÑ Íº≠ ÎààÏó¨Í≤®Î≥¥ÏÑ∏Ïöî.
> >     * **SVM (Support Vector Machine)** 
> >     * **DT (Decision Tree)** 
> >     * **RF (Random Forest)** 
> >     * **LightGBM:** ÏµúÍ∑º Îç∞Ïù¥ÌÑ∞ Î∂ÑÏÑù ÎåÄÌöåÏóêÏÑú ÎßéÏù¥ Ïì∞Ïù¥Îäî Í∞ïÎ†•Ìïú Î∂ÄÏä§ÌåÖ Î™®Îç∏ÏûÖÎãàÎã§. 
> >     * **Deep Learning (Îî•Îü¨Îãù):** Ïù¥ÎØ∏ÏßÄÎÇò ÎπÑÏ†ïÌòï Îç∞Ïù¥ÌÑ∞ Î∂ÑÏÑùÏóê Í∞ïÌïòÏ£†. 
> > * **Í≥ºÏ†ï:** Îç∞Ïù¥ÌÑ∞ ÌÜµÌï©(Data Integration) ‚Üí ÌäπÏßï ÏÑ†ÌÉù(Feature Selection) ‚Üí ÏòàÏ∏°(Prediction).
>
> > [!INFO] PAGE 75-76: ÌôòÏûê Ï∏µÌôî (Stratification)ÏôÄ Omics Ï†ïÏùò
> > 75ÌéòÏù¥ÏßÄ, ÏïåÎ°ùÎã¨Î°ùÌïú ÏÇ¨Îûå Í∑∏Î¶º Î≥¥Ïù¥Ï£†? 
> > * Í≥ºÍ±∞Ïóî Îã§ ÎòëÍ∞ôÏùÄ ÏÇ¨Îûå(Average patient) Ï∑®Í∏âÌñàÏßÄÎßå, Ïù¥Ï†úÎäî Îç∞Ïù¥ÌÑ∞Î•º ÌÜµÌï¥ **"Stratification(Ï∏µÌôî)"**Ìï©ÎãàÎã§. Í∑∏Î£πÏùÑ ÎÇòÎààÎã§Îäî ÎúªÏûÖÎãàÎã§. Í∑∏ÎûòÏïº **High effective treatment**Í∞Ä Í∞ÄÎä•ÌïòÎãàÍπåÏöî.
> >
> > 76ÌéòÏù¥ÏßÄ, Ïö©Ïñ¥ Ï†ïÎ¶¨ÌïòÍ≥† Í∞ëÏãúÎã§. 
> > * **Omics:** "-ome"ÏùÄ Ï†ÑÏ≤¥(Complete knowledge)Î•º ÎúªÌï©ÎãàÎã§.
> > * **Transcriptomics:** RNA Ï†ÑÏ≤¥.
> > * **Proteomics:** Îã®Î∞±Ïßà Ï†ÑÏ≤¥.
> > * **Metabolomics:** ÎåÄÏÇ¨Î¨ºÏßà Ï†ÑÏ≤¥.
>
> > [!IMPORTANT] PAGE 77-79: DNA Microarray ÏõêÎ¶¨ (ÏÉÅÏÑ∏ Ïä§Ìéô ÏïîÍ∏∞)
> > 77ÌéòÏù¥ÏßÄ, Ïù¥Í≤å Î∞îÎ°ú ÏàòÎßå Í∞úÏùò Ïú†Ï†ÑÏûêÎ•º Ìïú Î∞©Ïóê Í≤ÄÏÇ¨ÌïòÎäî **DNA Microarray** Ïπ©ÏûÖÎãàÎã§. ÏàòÏπòÎ•º Î≥¥ÏÑ∏Ïöî.
> > * **ÌÅ¨Í∏∞:** Ï†ÑÏ≤¥ Ïπ©ÏùÄ **3cm x 7cm** Ï†ïÎèÑÏûÖÎãàÎã§. Ïä¨ÎùºÏù¥Îìú Í∏ÄÎùºÏä§ ÌÅ¨Í∏∞Ï£†. 
> > * **Spot:** Í∑∏ ÏïàÏóê ÏûëÏùÄ Ï†êÎì§Ïù¥ Ï∞çÌòÄ ÏûàÎäîÎç∞, Í∞Å Ï†êÏùò ÏßÄÎ¶ÑÏùÄ **150¬µm**, Ï†ê ÏÇ¨Ïù¥ Í∞ÑÍ≤©ÏùÄ **300¬µm**ÏûÖÎãàÎã§. 
> > * **ÏõêÎ¶¨:**
> >     1.  Ïπ© ÏúÑÏóê **Probe DNA(ÌÉêÏπ®)**Î•º ÎØ∏Î¶¨ Ïã¨Ïñ¥ÎÜìÏäµÎãàÎã§. (ÏàòÎßå Í∞ú) 
> >     2.  ÌôòÏûêÏùò ÏÉòÌîå(RNA)ÏùÑ Ïó≠Ï†ÑÏÇ¨Ìï¥ÏÑú **Fluorescent tagging(ÌòïÍ¥ë ÌëúÏßÄ)**ÏùÑ Î∂ôÏù∏ DNA(cDNA)Î°ú ÎßåÎì≠ÎãàÎã§. 
> >     3.  Ïπ© ÏúÑÏóê ÎøåÎ¶¨Î©¥, Ïßù(ÏÉÅÎ≥¥Ï†Å ÏÑúÏó¥)Ïù¥ ÎßûÎäî Í≤ÉÎÅºÎ¶¨ Îì§Îü¨Î∂ôÏäµÎãàÎã§. Ïù¥Í±∏ **Hybridization(ÌòºÏÑ±Ìôî)**Ïù¥ÎùºÍ≥† Ìï©ÎãàÎã§. 
> > * **Ìï¥ÏÑù (78p):** 
> >     * ÌäπÏ†ï ÏÉâÍπî(Î≥¥ÌÜµ Îπ®Í∞ï/Ï¥àÎ°ù)Ïù¥ ÎπõÎÇòÎ©¥ Í∑∏ Ïú†Ï†ÑÏûêÍ∞Ä Î∞úÌòÑÎêú Í≤ÉÏûÖÎãàÎã§.
> >     * Îëê ÏÉâÏù¥ ÏÑûÏó¨(ÎÖ∏Îûë) ÎÇòÏò§Î©¥ Îëò Îã§ ÏûàÎäî Í±∞Í≥†Ïöî.
> 
>
> > [!INFO] PAGE 80: HeatmapÍ≥º Ï¢ÖÏñë Î∂ÑÎ•ò (Taxonomy)
> > 80ÌéòÏù¥ÏßÄ, ÎßàÏπò Î™®ÏûêÏù¥ÌÅ¨ Í∞ôÏùÄ Í∑∏Î¶ºÏù¥ **Heatmap**ÏûÖÎãàÎã§. 
> > * **Í∞ÄÎ°úÏ§Ñ:** Ïú†Ï†ÑÏûê ÌïòÎÇòÌïòÎÇò.
> > * **ÏÑ∏Î°úÏ§Ñ:** ÌôòÏûê Ìïú Î™Ö Ìïú Î™Ö.
> > * **ÏÉâÍπî:** Îπ®Í∞ÑÏÉâÏùÄ Î∞úÌòÑ ÎÜíÏùå(High), Ï¥àÎ°ùÏÉâÏùÄ ÎÇÆÏùå(Low)ÏùÑ Ï£ºÎ°ú ÎÇòÌÉÄÎÉÖÎãàÎã§.
> > * **Dendrogram (ÎÇòÎ≠áÍ∞ÄÏßÄ Í∑∏Î¶º):** ÏúÑÏ™ΩÏóê ÏûàÎäî Í∞ÄÏßÄ Í∑∏Î¶ºÏûÖÎãàÎã§. Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥Ïù¥ ÎπÑÏä∑Ìïú ÌôòÏûêÎÅºÎ¶¨ Î¨∂Ïñ¥Ï§çÎãàÎã§(Clustering).
> > * **Í≤∞Í≥º:** ÌôòÏûêÎì§Ïù¥ **A, B, C, D** ÎÑ§ Í∞ÄÏßÄ Í∑∏Î£π(Tumor classes)ÏúºÎ°ú ÍπîÎÅîÌïòÍ≤å ÎÇòÎâòÎäî Í±∞ Î≥¥Ïù¥Ï£†? Ïù¥Í≤å Î∞îÎ°ú Ï†ïÎ∞ÄÏùòÌïôÏùò ÏãúÏûëÏûÖÎãàÎã§.

> [!NOTE] Pages 81-89: ÎÑ§Ìä∏ÏõåÌÅ¨ ÎèôÏó≠Ìïô (Network Dynamics)
> Ïûê, ÏßÄÍ∏àÍπåÏßÄ Î∞∞Ïö¥ Ïú†Ï†ÑÏûê, Îã®Î∞±Ïßà, ÎåÄÏÇ¨Ï≤¥Îì§ÏùÑ Îã§ Ïó∞Í≤∞ÌïòÎ©¥ Ïñ¥ÎñªÍ≤å Îê†ÍπåÏöî? Îã®ÏàúÌïú ÏÑ†(Line)Ïù¥ ÏïÑÎãàÎùº Î≥µÏû°Ìïú **ÎÑ§Ìä∏ÏõåÌÅ¨(Network)**Í∞Ä Îê©ÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ ÎÑ§Ìä∏ÏõåÌÅ¨Ïùò ÏõÄÏßÅÏûÑÏùÑ ÏàòÌïôÏ†ÅÏúºÎ°ú ÌëúÌòÑÌïú Í≤ÉÏù¥ Î∞îÎ°ú **State Space(ÏÉÅÌÉú Í≥µÍ∞Ñ)**ÏûÖÎãàÎã§. Ïù¥ Í∞úÎÖêÏùÑ Ïù¥Ìï¥Ìï¥Ïïº "ÏÑ∏Ìè¨Í∞Ä Î∂ÑÌôîÌïúÎã§"Îäî ÎßêÏùò ÏßÑÏßú ÏùòÎØ∏Î•º ÏïåÍ≤å Îê©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 81: Ï¢ÖÏñëÏùò Ïù¥ÏßàÏÑ± (Tumor Heterogeneity)
> > 81ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. Ïïî Îç©Ïñ¥Î¶¨Í∞Ä Îã§ ÎòëÍ∞ôÏùÄ ÏÑ∏Ìè¨Í∞Ä ÏïÑÎãàÎùºÎäî Ï¶ùÍ±∞ÏûÖÎãàÎã§. 
> > * **Clonal Evolution:**
> >     * **Monoclonal:** ÌïòÎÇòÏùò Ï°∞ÏÉÅÏóêÏÑú ÏãúÏûëÌï¥ ÎπÑÏä∑ÌïòÍ≤å ÏûêÎûå.
> >     * **Polyclonal:** Ïó¨Îü¨ Ï°∞ÏÉÅÏù¥ ÏÑûÏó¨ÏÑú ÏïÑÏ£º Îã§ÏñëÌïú(Polygenomic) Ïïî Ï°∞ÏßÅÏùÑ ÌòïÏÑ±. ÏπòÎ£åÍ∞Ä Ïñ¥Î†µÍ≤†Ï£†?
> > * **Cancer Stem Cells (Ïïî Ï§ÑÍ∏∞ÏÑ∏Ìè¨):**
> >     * **Single vs Multiple progenitors:** Ï§ÑÍ∏∞ÏÑ∏Ìè¨ ÌïòÎÇòÏóêÏÑú ÏôîÎÉê, Ïó¨Îü¨ Í∞úÏóêÏÑú ÏôîÎÉêÏóê Îî∞Îùº ÏïîÏùò Î≥µÏû°ÎèÑÍ∞Ä Îã¨ÎùºÏßëÎãàÎã§.
> > * **Í≤∞Î°†:** ÏïîÏùÄ **Polygenomic Tumor**Ïù∏ Í≤ΩÏö∞Í∞Ä ÎßéÏïÑÏÑú, ÏïΩ ÌïòÎÇòÎ°ú(One target) ÏôÑÏπòÍ∞Ä ÌûòÎì† Í≤ÅÎãàÎã§.
>
> > [!INFO] PAGE 82-84: Pathway vs Network View
> > 84ÌéòÏù¥ÏßÄ Í∑∏Î¶ºÏù¥ ÌïµÏã¨ÏûÖÎãàÎã§. Í¥ÄÏ†êÏùÑ Î∞îÍæ∏ÏÑ∏Ïöî. 
> > * **Pathway View (A):** $X1 \rightarrow X2$. ÏÑ†ÌòïÏ†ÅÏù¥Í≥† Îã®ÏàúÌï©ÎãàÎã§. "AÏù¥Î©¥ BÎã§"ÎùºÎäî ÏãùÏù¥Ï£†.
> > * **Network View (B):** $X1$Í≥º $X2$Í∞Ä Í±∞ÎåÄÌïú Í±∞ÎØ∏Ï§ÑÏùò ÏùºÎ∂ÄÏùº ÎøêÏûÖÎãàÎã§. $X1$ÏùÑ Í±¥ÎìúÎ¶¨Î©¥ $X2$Îßå Î≥ÄÌïòÎäî Í≤å ÏïÑÎãàÎùº ÎÑ§Ìä∏ÏõåÌÅ¨ Ï†ÑÏ≤¥Í∞Ä Ï∂úÎ†ÅÍ±∞Î¶ΩÎãàÎã§. Ïù¥Í≤å ÏãúÏä§ÌÖú ÏÉùÎ¨ºÌïôÏùò Í¥ÄÏ†êÏûÖÎãàÎã§.
> > * 83ÌéòÏù¥ÏßÄÏùò Î≥µÏû°Ìïú ÌôîÏÇ¥Ìëú(Activation/Inhibition)Îì§Ïù¥ Î™®Ïó¨ÏÑú Ïù¥ ÎÑ§Ìä∏ÏõåÌÅ¨Î•º ÎßåÎì≠ÎãàÎã§. 
>
> > [!IMPORTANT] PAGE 85: 3Í≥ÑÏ∏µ ÌÜµÌï© Í≥µÍ∞Ñ (Space Integration)
> > 85ÌéòÏù¥ÏßÄ, 3Í∞úÏùò Ìåê(Layer)Ïù¥ Í≤πÏ≥êÏ†∏ ÏûàÏ£†? 
> > 1.  **Gene Space (Ïú†Ï†ÑÏûê Í≥µÍ∞Ñ):** Gene 1, 2, 3...
> > 2.  **Protein Space (Îã®Î∞±Ïßà Í≥µÍ∞Ñ):** Protein 1, 2, 3...
> > 3.  **Metabolic Space (ÎåÄÏÇ¨ Í≥µÍ∞Ñ):** Metabolite 1, 2...
> > * **Feedback:** Îß® Ïò§Î•∏Ï™Ω ÌôîÏÇ¥ÌëúÎ•º Î≥¥ÏÑ∏Ïöî. **Metabolite 2**Í∞Ä Îã§Ïãú **Gene 4**Ïùò Ï†ÑÏÇ¨Î•º Ï°∞Ï†àÌïòÎü¨ ÎÇ¥Î†§Í∞ëÎãàÎã§. Ïù¥Î†áÍ≤å Ï∏µÍ∞Ñ ÏÜåÌÜµÏù¥ ÌôúÎ∞úÌï©ÎãàÎã§.
>
> > [!IMPORTANT] PAGE 86-87: ÏÉÅÌÉú Î≤°ÌÑ∞ÏôÄ ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space) - ‚òÖÍ∞úÎÖê ÌïÑÏäπ
> > Ïûê, Ïó¨Í∏∞ ÏßëÏ§ëÌïòÏÑ∏Ïöî. ÏÑ∏Ìè¨Ïùò ÏÉÅÌÉúÎ•º ÏàòÌïôÏúºÎ°ú Ï†ïÏùòÌï©ÎãàÎã§.
> >
> > **1. ÏÉÅÌÉú Î≤°ÌÑ∞ (State Vector, 86p):**
> > * Ïú†Ï†ÑÏûê $N$Í∞úÏùò Î∞úÌòÑÎüâÏùÑ Ïà´ÏûêÎ°ú Ï≠â ÎÇòÏó¥Ìïú Í≤ÅÎãàÎã§. 
> > * Ïãù: $$S = [x_1, x_2, ..., x_N]$$ (Ïòà: $x_1$ÏùÄ Ïú†Ï†ÑÏûê 1Ïùò Î∞úÌòÑÎüâ)
> >
> > **2. ÏÉÅÌÉú Í≥µÍ∞Ñ (State Space, 87p):**
> > * 87ÌéòÏù¥ÏßÄÏùò ÌÅêÎ∏å(Cube) Í∑∏Î¶ºÏùÑ Î≥¥ÏÑ∏Ïöî. 
> > * **Ï∂ï (Axis):** Í∞Å Ïú†Ï†ÑÏûê($X_1, X_2, X_3$)Í∞Ä $x, y, z$ Ï∂ïÏù¥ Îê©ÎãàÎã§.
> > * **Ï†ê (Point):** ÌäπÏ†ï ÏãúÏ†ê($t_1$)Ïùò ÏÑ∏Ìè¨ ÏÉÅÌÉú($S_1$)Îäî Ïù¥ Í≥µÍ∞Ñ ÏïàÏùò **'Ï†ê ÌïòÎÇò'**Î°ú Ï∞çÌûôÎãàÎã§. (Ïòà: $[3.0, 3.0, 3.0]$)
> > * **Í∂§Ï†Å (Trajectory):** ÏãúÍ∞ÑÏù¥ ÏßÄÎÇ®Ïóê Îî∞Îùº ÏÑ∏Ìè¨Ïùò Ïú†Ï†ÑÏûê Î∞úÌòÑÏù¥ Î≥ÄÌïòÏ£†? Ï†êÏù¥ Ïù¥ÎèôÌïòÎ©¥ÏÑú Í∑∏Î¶¨Îäî ÏÑ†ÏûÖÎãàÎã§.
> > * **Attractor (ÎÅåÍ∞ú):** Îπ®Í∞Ñ Ï†ê($S^*$)ÏùÑ Î≥¥ÏÑ∏Ïöî. Ï†êÎì§Ïù¥ Í≤∞Íµ≠ Ïñ¥ÎîîÎ°ú Î™®Ïù¥ÎÇòÏöî? ÏïàÏ†ïÏ†ÅÏù∏ ÏÉÅÌÉúÎ°ú ÏàòÎ†¥ÌïòÏ£†? Ïù¥ ÎèÑÏ∞©Ï†êÏù¥ Î∞îÎ°ú **"ÏÑ∏Ìè¨ ÌÉÄÏûÖ(Cell Type)"**ÏûÖÎãàÎã§.
> >     * "Ï§ÑÍ∏∞ÏÑ∏Ìè¨Í∞Ä Î∂ÑÌôîÌï¥ÏÑú ÌîºÎ∂ÄÏÑ∏Ìè¨Í∞Ä ÎêêÎã§" = "ÏÉÅÌÉú Í≥µÍ∞ÑÏóêÏÑú Ï†êÏù¥ Ïù¥ÎèôÌï¥ ÌîºÎ∂ÄÏÑ∏Ìè¨ÎùºÎäî AttractorÏóê Îπ†Ï°åÎã§."
>
> > [!INFO] PAGE 88-89: WaddingtonÏùò ÌíçÍ≤Ω (Epigenetic Landscape) ÏàòÌïôÏ†Å Ìï¥ÏÑù
> > 89ÌéòÏù¥ÏßÄ, ÏïÑÍπå Î≥∏ Í≥µ Íµ¥Îü¨Í∞ÄÎäî Í∑∏Î¶ºÏùÑ Îã§Ïãú ÏàòÌïôÏ†ÅÏúºÎ°ú Î¥ÖÎãàÎã§. 
> > * **Basin of attraction (ÎÅåÍ∞ú Ïú†Ïó≠):** Í≥µÏù¥ Íµ¥Îü¨ Îñ®Ïñ¥ÏßÄÎäî Í≥®ÏßúÍ∏∞ÏûÖÎãàÎã§.
> > * **Quasi-potential U:** ÏóêÎÑàÏßÄ Ï§ÄÏúÑ Í∞ôÏùÄ Í≤ÅÎãàÎã§. ÎÇÆÏùÑÏàòÎ°ù ÏïàÏ†ïÏ†ÅÏù¥Ï£†.
> > * **Attractors:** Í≥®ÏßúÍ∏∞ Î∞îÎã•. Ïó¨Í∏∞Ïóê ÏïàÏ∞©ÌïòÎ©¥ **Mature cell types (ÏÑ±Ïàô ÏÑ∏Ìè¨)**Í∞Ä ÎêòÎäî Í≤ÅÎãàÎã§.
> > * **Unused attractors:** ÏßÑÌôîÏ†ÅÏúºÎ°ú ÏµúÏ†ÅÌôîÎêòÏßÄ ÏïäÏùÄ, Î≤ÑÎ†§ÏßÑ ÏõÖÎç©Ïù¥Îì§ÎèÑ Ï°¥Ïû¨Ìï† Ïàò ÏûàÏäµÎãàÎã§. (ÏïîÏÑ∏Ìè¨Í∞Ä Ïó¨Í∏∞Î°ú Í∞à ÏàòÎèÑ ÏûàÏ£†)

> [!NOTE] Pages 90-97: ÎÑ§Ìä∏ÏõåÌÅ¨ ÏùòÌïôÍ≥º Ïã†ÏïΩ Í∞úÎ∞ú (Network Medicine)
> Ïûê, Ïù¥Ï†ú Î≥µÏû°Ìïú ÎÑ§Ìä∏ÏõåÌÅ¨ Ïù¥Î°†Ïù¥ Ïã§Ï†ú ÌôòÏûêÎ•º ÏÇ¥Î¶¨Îäî Í∏∞Ïà†Î°ú Î∞îÎÄùÎãàÎã§. ÌôòÏûêÏùò Ïú†Ï†ÑÏûê Î∞úÌòÑ Ìå®ÌÑ¥(Signature)Îßå Î≥¥Í≥†ÎèÑ "Ïù¥ ÌôòÏûêÎäî 5ÎÖÑ Îí§Ïóê ÏÉùÏ°¥Ìï† ÌôïÎ•†Ïù¥ ÎÜíÎã§/ÎÇÆÎã§"Î•º ÎßûÏ∂îÍ≥†, ÎÑ§Ìä∏ÏõåÌÅ¨Ïùò ÌäπÏ†ï Î∂ÄÏúÑÎßå Í≥µÍ≤©ÌïòÎäî Ï†ïÎ∞Ä ÌÉÄÍ≤© ÏïΩÎ¨ºÏùÑ Í∞úÎ∞úÌïòÎäî Í≥ºÏ†ïÏûÖÎãàÎã§.
>
> > [!IMPORTANT] PAGE 90: ÏòàÌõÑ ÏòàÏ∏° Î™®Îç∏ (Survival Prediction) - ‚òÖÏûÑÏÉÅ ÌïÑÏàò
> > 90ÌéòÏù¥ÏßÄ Í∑∏Î¶º, Î≥ëÏõêÏóêÏÑú Îß§Ïùº Î≥¥Îäî Îç∞Ïù¥ÌÑ∞ÏûÖÎãàÎã§. Ìï¥ÏÑùÌï† Ï§Ñ ÏïåÏïÑÏïº Ìï©ÎãàÎã§. 
> > 1.  **Heatmap (Ï¢åÏ∏°):** 70Í∞úÏùò **Reporter genes** Î∞úÌòÑ Ìå®ÌÑ¥ÏùÑ Î∂ÑÏÑùÌñàÎçîÎãà, ÌôòÏûêÎì§Ïù¥ Îëê Í∑∏Î£πÏúºÎ°ú ÎÇòÎâ©ÎãàÎã§.
> >     * **Good signature:** ÏòàÌõÑÍ∞Ä Ï¢ãÏùÄ Ìå®ÌÑ¥.
> >     * **Poor signature:** ÏòàÌõÑÍ∞Ä ÎÇòÏÅú Ìå®ÌÑ¥.
> > 2.  **Survival Curve (Ïö∞Ï∏° Í∑∏ÎûòÌîÑ):** Ïù¥Í≤å Í∑∏ Ïú†Î™ÖÌïú **Ïπ¥ÌîåÎûÄ-ÎßàÏù¥Ïñ¥(Kaplan-Meier) ÏÉùÏ°¥ Í≥°ÏÑ†**ÏûÖÎãàÎã§.
> >     * **XÏ∂ï:** ÏãúÍ∞Ñ(Years).
> >     * **YÏ∂ï:** Ï†ÑÏ≤¥ ÏÉùÏ°¥Ïú®(Overall survival, 1.0 = 100%).
> >     * **Ìï¥ÏÑù:** **Poor signature(Îπ®Í∞Ñ ÏÑ†)** ÌôòÏûêÎì§ÏùÄ 2~4ÎÖÑ ÏÇ¨Ïù¥Ïóê Í∏âÍ≤©Ìûà ÏÇ¨ÎßùÌïòÏó¨ ÏÉùÏ°¥Ïú®Ïù¥ 0.2(20%) Î∞ëÏúºÎ°ú Îñ®Ïñ¥ÏßëÎãàÎã§. Î∞òÎ©¥ **Good signature(ÌååÎûÄ ÏÑ†)**Îäî 10ÎÖÑÏù¥ ÏßÄÎÇòÎèÑ ÏÉùÏ°¥Ïú®Ïù¥ ÎÜíÏäµÎãàÎã§.
> >     * **ÏùòÏùò:** "ÎãπÏã†ÏùÄ Poor signatureÎãà Îçî Í≥µÍ≤©Ï†ÅÏù∏ Ìï≠ÏïîÏ†úÎ•º ÏîÅÏãúÎã§"ÎùºÎäî **Clinically useful prediction(ÏûÑÏÉÅÏ†Å ÌåêÎã®)**Ïù¥ Í∞ÄÎä•Ìï¥ÏßëÎãàÎã§.
>
> > [!INFO] PAGE 92-93: ÎÑ§Ìä∏ÏõåÌÅ¨ ÏùòÌïôÏùò Ï†ïÏùò
> > 92ÌéòÏù¥ÏßÄ, **Network Medicine**Ïù¥ÎûÄ? 
> > * Ïù∏Íµ¨ ÏßëÎã®(Population)Ïùò ÍπäÏùÄ ÌëúÌòÑÌòï(Deep phenotyping) Îç∞Ïù¥ÌÑ∞Î•º Î™®ÏïÑÏÑú, Í∞úÏù∏Îì§ÏùÑ **ÎÑ§Ìä∏ÏõåÌÅ¨ ÏßÄÌëú(Network metrics)**Ïóê Îî∞Îùº ÌÅ¥Îü¨Ïä§ÌÑ∞ÎßÅ(Cluster)ÌïòÎäî Í≤ÅÎãàÎã§.
> > * **Ìå®Îü¨Îã§ÏûÑ Î≥ÄÌôî (93p):** 
> >     * Í≥ºÍ±∞: **Average patient (ÌèâÍ∑† ÌôòÏûê)**Î•º ÏúÑÌïú ÏïΩ. (Ïûò Ïïà Îì£Í±∞ÎÇò Î∂ÄÏûëÏö©)
> >     * ÌòÑÏû¨: ÌôòÏûêÏùò **Genetics, Microbes, Chemical composition**Ïóê Îî± ÎßûÏ∂ò(Tailored) ÏïΩ.
>
> > [!IMPORTANT] PAGE 94-97: ÎÑ§Ìä∏ÏõåÌÅ¨ Í∏∞Î∞ò Ïã†ÏïΩ Í∞úÎ∞ú (Network-based Drug Discovery)
> > 94ÌéòÏù¥ÏßÄÎ∂ÄÌÑ∞Îäî Ïã†ÏïΩ Í∞úÎ∞ú ÌîÑÎ°úÏÑ∏Ïä§ÏûÖÎãàÎã§.
> > * **Îç∞Ïù¥ÌÑ∞ ÌÜµÌï© (94p):** DNA/RNA Î≥ÄÏù¥, Îã®Î∞±Ïßà(Proteomics), ÎåÄÏÇ¨Ï≤¥(Metabolite), ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞(Clinical data), Î¨∏Ìóå(Literature)ÏùÑ Îã§ ÏÑûÏñ¥ÏÑú Í±∞ÎåÄÌïú ÌîåÎû´ÌèºÏùÑ ÎßåÎì≠ÎãàÎã§. 
> >
> > * **ÎÑ§Ìä∏ÏõåÌÅ¨ ÌÉÄÍ≤üÌåÖ (95-97p):** Ïù¥ Í∑∏Î¶ºÏùÑ Ïûò Î≥¥ÏÑ∏Ïöî. 
> >     * Ï†ÑÏ≤¥ ÎÑ§Ìä∏ÏõåÌÅ¨ ÏïàÏóê **Disease subtype 1** (ÌååÎûÄÏÉâ ÏòÅÏó≠)Í≥º **Disease subtype 2** (Ï¥àÎ°ùÏÉâ ÏòÅÏó≠)Í∞Ä ÏÑúÎ°ú Îã§Î•∏ ÏúÑÏπòÏóê Ï°¥Ïû¨Ìï©ÎãàÎã§. Ï¶â, Í∞ôÏùÄ Î≥ëÏù¥ÎùºÎèÑ Î∞úÎ≥ë Í∏∞Ï†Ñ(ÎÑ§Ìä∏ÏõåÌÅ¨ Î™®Îìà)Ïù¥ Îã§Î¶ÖÎãàÎã§.
> >     * **Toxicity (ÎèÖÏÑ±):** Îπ®Í∞ÑÏÉâ ÏòÅÏó≠ÏùÄ Í±¥ÎìúÎ¶¨Î©¥ Ïïà ÎêòÎäî Ï§ëÏöîÌïú ÏÉùÎ™Ö Ïú†ÏßÄ Í∏∞Îä•(Ïòà: Ïã¨Ïû• Î∞ïÎèô)Ïùº Ïàò ÏûàÏäµÎãàÎã§.
> >     * **Screening:** **High-throughput screening**ÏùÑ ÌÜµÌï¥ ÏàòÎßå Í∞ÄÏßÄ ÌôîÌï©Î¨ºÏùÑ ÎøåÎ†§Î¥ÖÎãàÎã§.
> >     * **Î™©Ìëú:** Îπ®Í∞ÑÏÉâ(ÎèÖÏÑ±)ÏùÄ ÌîºÌïòÍ≥†, ÎÇ¥ ÌôòÏûêÏùò ÌÉÄÏûÖ(Ïòà: Subtype 2)Ïóê Ìï¥ÎãπÌïòÎäî ÎÑ§Ìä∏ÏõåÌÅ¨Îßå Ï†ïÌôïÌûà ÌÉÄÍ≤©ÌïòÎäî ÏïΩÎ¨ºÏùÑ Ï∞æÎäî Í≤ÉÏûÖÎãàÎã§.

> [!NOTE] Pages 98-113: ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨ÏôÄ ÎîîÏßÄÌÑ∏ Ìó¨Ïä§Ïùò ÎØ∏Îûò
> Ïûê, Ïù¥Ï†ú ÎßàÏßÄÎßâ ÌçºÏ¶êÏùÑ ÎßûÏ∂•ÏãúÎã§. Íµ¨Í∏Ä ÎßµÏù¥ Ïó¨Îü¨ Î†àÏù¥Ïñ¥(ÍµêÌÜµ, ÏúÑÏÑ±, ÏßÄÎèÑ)Î•º Í≤πÏ≥êÏÑú Í∏∏ÏùÑ Î≥¥Ïó¨Ï£ºÎìØ, Ïö∞Î¶¨ Î™∏Ïùò Îç∞Ïù¥ÌÑ∞ÎèÑ Í≤πÏ≥êÏïº Î≥¥ÏûÖÎãàÎã§. Í∑∏Î¶¨Í≥† Ïù¥ Î™®Îì† Í≤ÉÏù¥ IT Í∏∞Ïà†(IoMT)Í≥º Í≤∞Ìï©ÌïòÏó¨ ÏßÑÏ†ïÌïú **'ÌôòÏûê Ï§ëÏã¨ ÏùòÎ£å'**Í∞Ä ÏôÑÏÑ±ÎêòÎäî Í≤ÉÏûÖÎãàÎã§.
>
> > [!INFO] PAGE 98-99: Íµ¨Í∏Ä ÎßµÍ≥º ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨ (Analogy)
> > 98ÌéòÏù¥ÏßÄ, ÏïÑÏ£º ÌõåÎ•≠Ìïú ÎπÑÏú†Í∞Ä ÎÇòÏòµÎãàÎã§. 
> > * **Google Maps:** ÏßÄÎ¶¨Ï†Å ÏúÑÏπò(Geographical Positioning)Î•º Ï§ëÏã¨ÏúºÎ°ú ÍµêÌÜµ, Í±¥Î¨º, ÏúÑÏÑ± ÏÇ¨ÏßÑ Îì± Ïó¨Îü¨ Ï∏µ(Layers)Ïùò Ï†ïÎ≥¥Î•º Í≤πÏ≥êÏÑú Î≥¥Ïó¨Ï§çÎãàÎã§.
> > * **Information Commons (ÏùòÎ£å Ï†ïÎ≥¥ Í≥µÏú†ÏßÄ):** ÎßàÏ∞¨Í∞ÄÏßÄÏûÖÎãàÎã§. **"Í∞úÎ≥Ñ ÌôòÏûê(Individual Patients)"**Î•º Ï§ëÏã¨ÏúºÎ°ú Îã§Ïùå Ï†ïÎ≥¥Îì§ÏùÑ Í≤πÏ≥êÏïº Ìï©ÎãàÎã§.
> >     * **Signs and Symptoms (Ï¶ùÏÉÅ)**
> >     * **Exposome (ÌôòÍ≤Ω ÎÖ∏Ï∂ú)**
> >     * **Genome (Ïú†Ï†ÑÏûê)**
> >     * **Epigenome & Microbiome**
> > * **Í≤∞Î°†:** ÌôòÏûê Ìïú Î™Ö Ìïú Î™ÖÏù¥ ÎßàÏπò Íµ¨Í∏Ä ÎßµÏùò Ï¢åÌëúÏ≤òÎüº, Î™®Îì† Ï†ïÎ≥¥Í∞Ä ÌÜµÌï©Îêú **ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨**Ïùò Ï§ëÏã¨Ïù¥ Îê©ÎãàÎã§.
> 
>
> > [!IMPORTANT] PAGE 100: ÏóëÏä§Ìè¨Ï¢Ä (Exposome) - ÌôòÍ≤ΩÏùò Ï†ïÎüâÌôî (‚òÖ)
> > 100ÌéòÏù¥ÏßÄ, ÌôòÍ≤Ω(Environment)ÏùÑ Îú¨Íµ¨Î¶Ñ Ïû°Îäî ÏñòÍ∏∞Í∞Ä ÏïÑÎãàÎùº Í≥ºÌïôÏ†ÅÏúºÎ°ú Ï†ïÏùòÌï©ÎãàÎã§. Ïù¥Í≤å **Exposome**ÏûÖÎãàÎã§. 
> > * **Ï†ïÏùò:** ÎÇ¥Î∂Ä ÌôîÌïô ÌôòÍ≤Ω(Internal chemical environment)Ïóê ÎèÑÎã¨ÌïòÎäî **Î™®Îì† ÎÖ∏Ï∂úÏùò Ï¥ùÌï©**ÏûÖÎãàÎã§.
> > * **Íµ¨ÏÑ± ÏöîÏÜå:**
> >     * **External (Ïô∏Î∂Ä):** Stress, Lifestyle, Drugs, Diet, Pollution Îì±.
> >     * **Internal (ÎÇ¥Î∂Ä):** Xenobiotics(Ïù¥Î¨ºÏßà), Inflammation(ÏóºÏ¶ù), Oxidative stress(ÏÇ∞Ìôî Ïä§Ìä∏Î†àÏä§), **Gut flora(Ïû•ÎÇ¥ ÎØ∏ÏÉùÎ¨º)**.
> > * **Í≤ÄÏ∂ú:** Ïù¥Îü∞ ÏöîÏù∏Îì§ÏùÄ ÌòàÏï°Ïù¥ÎÇò ÌòàÏ≤≠(Blood or serum)ÏóêÏÑú **Biomarkers(ÏÉùÏ≤¥ÌëúÏßÄÏûê)**Î°ú Í≤ÄÏ∂ú Í∞ÄÎä•Ìï©ÎãàÎã§. Ï¶â, "Ïä§Ìä∏Î†àÏä§ Î∞õÏïòÎã§"Í∞Ä ÏïÑÎãàÎùº "Ïä§Ìä∏Î†àÏä§ ÎßàÏª§ ÏàòÏπòÍ∞Ä XÎã§"ÎùºÍ≥† ÎßêÌï† Ïàò ÏûàÍ≤å Îêú Í±∞Ï£†.
>
> > [!INFO] PAGE 101-104: ÏÉàÎ°úÏö¥ Î∂ÑÎ•ò Ï≤¥Í≥Ñ (Taxonomy)
> > Ïù¥ Ïä¨ÎùºÏù¥ÎìúÎì§ÏùÄ ÌùêÎ¶ÑÎßå Î≥¥Î©¥ Îê©ÎãàÎã§. 
> > * **Information Commons:** ÌôòÏûêÎì§Ïùò Îç∞Ïù¥ÌÑ∞Í∞Ä Î™®Ïó¨ Í≥µÏú†ÏßÄÎ•º ÌòïÏÑ±ÌïòÍ≥†,
> > * **Taxonomic classification:** Í≥ºÍ±∞Ïùò 'Ï¶ùÏÉÅ' Í∏∞Î∞ò Î∂ÑÎ•òÍ∞Ä ÏïÑÎãàÎùº, Î∂ÑÏûêÏ†Å ÏõêÏù∏Ïóê Í∏∞Î∞òÌïú **'ÏßàÎ≥ë Î∂ÑÎ•ò(Taxonomy)'**Í∞Ä ÏÉàÎ°ú Ïì∞Ïù¥Í≤å Îê©ÎãàÎã§. (Ïòà: ÌèêÏïî 1Í∏∞Í∞Ä ÏïÑÎãàÎùº, EGFR Î≥ÄÏù¥ ÏñëÏÑ± ÌèêÏïî)
> > * **Knowledge network-based medicine:** Í≤∞Íµ≠ Î™®Îì† ÏπòÎ£åÎäî Ïù¥ ÏßÄÏãù ÎÑ§Ìä∏ÏõåÌÅ¨Ïóê Í∏∞Î∞òÌïòÍ≤å Îê©ÎãàÎã§.
>
> > [!INFO] PAGE 105-113: ÎîîÏßÄÌÑ∏ Ìó¨Ïä§ ÌòÅÎ™Ö (Tech Revolution)
> > ÎßàÏßÄÎßâ ÏÑπÏÖòÏûÖÎãàÎã§. Ï†ïÎ∞ÄÏùòÌïôÏùÑ Í∞ÄÎä•ÌïòÍ≤å ÌïòÎäî Í∏∞Ïà†Ï†Å Î∞∞Í≤ΩÏûÖÎãàÎã§. 
> > * **IoMT (Internet of Medical Things):** ÏùòÎ£å ÏÇ¨Î¨º Ïù∏ÌÑ∞ÎÑ∑. Ïõ®Ïñ¥Îü¨Î∏î Í∏∞Í∏∞ Îì±Ïù¥ Ïã§ÏãúÍ∞ÑÏúºÎ°ú ÌôòÏûê Îç∞Ïù¥ÌÑ∞Î•º ÏèüÏïÑÎÉÖÎãàÎã§.
> > * **Big Data & AI:** ÏèüÏïÑÏßÄÎäî Îç∞Ïù¥ÌÑ∞Î•º Î∂ÑÏÑùÌï©ÎãàÎã§.
> > * **Rising of Precision Medicine:** Ïù¥ Î™®Îì† Í≤ÉÏù¥ Ìï©Ï≥êÏ†∏ Ï†ïÎ∞ÄÏùòÌïôÏù¥ Î∂ÄÏÉÅÌïòÍ≥† ÏûàÏäµÎãàÎã§.
> > * **Q & A (113p):** ÏßàÎ¨∏ ÏûàÎÇòÏöî?

